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Abstract 
  
 
Membrane proteins perform in many critical physiological processes, 
constituting 25 – 30% of prokaryotic and eukaryotic genomes, and represent up to 70% 
of current drug targets.  However, the number of three dimensional structures of 
membrane proteins elucidated has been modest in comparison with those of soluble 
proteins, and this is attributable to three major bottlenecks: expression, purification and 
structure determination of these hydrophobic proteins. 
A genomic approach was conducted to overcome these bottlenecks for two 
families of membrane proteins: (1) the NCS1 family of transporters and; (2) the 
histidine kinases of two-component signal transduction systems of E. faecalis.  The 
genes encoding these membrane proteins were cloned separately into plasmid pTTQ18-
His6 and subjected to expression trials in Escherichia coli.  Purification of the 
recombinant intact proteins from E. coli membranes was undertaken using Ni-NTA 
chromatography, and for proteins that were produced in sufficient quantities 
crystallisation trials and investigations of structural characteristics were performed.  The 
activities of membrane-bound and/or purified proteins were also tested, and in the case 
of the histidine kinases, these activity assays were expanded to successfully identify 
modulating signals.  This is the first time that direct in vitro activity assays using intact 
proteins have proven successful for identification of environmental ‗signals‘ in 
enterococci. 
In this study, thirteen NCS1 transporters were cloned.  Twelve of the thirteen 
cloned proteins were expressed in E. coli membranes, seven were successfully purified, 
and substrates transported by five of these were confirmed.  Three of these transporters, 
were further characterised, including; (1) a cytosine transporter – CodB, (2) an allantoin 
transporter – PucI, and (3) a uracil transporter – PA0443, and their substrate 
specificities and kinetics were also determined.   
All sixteen membrane histidine kinases of E. faecalis were successfully cloned 
(six were assigned to me in a joint project with Dr Hayley Yuille).  Fifteen of the 
sixteen histidine kinases were successfully expressed in E. coli, and thirteen were 
purified.  Eleven of the fifteen membrane-bound histidine kinases and twelve of the 
thirteen purified proteins were active in autophosphorylation activity assays.  Three 
histidine kinases were studied further, including; (1) EF3197, which responded to 
 v 
increasing concentrations of a reducing agent, suggesting a possible role in redox-
sensing, (2) EF1051, which was further purified by size exclusion chromatography and 
showed promising results in crystallisation trials for future structural determination, and 
(3) EF1820 (FsrC), which was activated in in vitro assays by its pheromone signal, 
gelatinase biosynthesis-activating pheromone (GBAP).  This study showed GBAP-
induced activity of FsrC was inhibited by the anti-HIV inhibitor, siamycin I, identifying 
unequivocally and for the first time, the target protein for siamycin I inhibition in the 
Fsr pathway. 
This study presents a successful genomic approach for the production of 
milligram quantities of membrane proteins leading to characterisation and 
crystallisation studies.  The methods can now be applied to further membrane proteins. 
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Chapter 1 – Introduction  
  
The first bacteria were observed by Anton van Leeuwenhoek in 1674 using a 
single-lens microscope that he designed (Porter, 1976).  Bacteria are single cell 
organisms classified as prokaryotes and are the most abundant organism on Earth.  
There are approximately five nonillion (5 × 10
30
) bacteria on Earth, forming much of 
the world‘s biomass (Whitman et al., 1998).  In the human body, there are 
approximately ten times as many bacteria cells than there are human cells, with the 
majority residing on the skin and in the gut (Sears, 2005).  Most of the human 
microflora resides harmlessly in the body, some are beneficial, and a few species are 
pathogenic and could cause infectious diseases.  The bacteria being able to live in a 
wide variety of conditions, consequently must have evolved mechanisms for their 
survival.  One form of protection for the bacteria is their cell membrane, which forms a 
barrier against the harmful external environment.  But due to impermeability of the 
cytoplasmic membrane to hydrophilic molecules, transport of nutrients into the cell or 
the extrusion of toxins and waste products wholly rely upon integral membrane proteins.  
In addition, bacteria also have two-component signal transduction systems, a 
mechanism that enables the bacteria to sense and respond to their environment (Stock et 
al., 2000).  This thesis focuses on two different families of membrane proteins: 1) 
nucleobase-cation-symporter-1 (NCS1) family of transporters; and 2) the sensor 
histidine kinase family that forms part of the two-component signal transduction system. 
 
1.1. The bacterial cell membranes 
 
Microorganisms are grouped into either prokaryotes or eukaryotes according to 
their cellular structure.  Prokaryotic cells do not have subcellular organelles separated 
from the cytoplasm by phospholipid membranes like eukaryotes do; thus they do not 
have a nucleus, mitochondria or endoplasmic reticulum.  Most bacteria are classified 
into Gram-positive or Gram-negative based on their reaction with an iodine-based stain 
discovered by Hans Christian Gram that allows visualisation of bacteria in tissues under 
ordinary bright-field microscope (Gram, 1884). 
The Gram-positive cell wall is characterised by the presence of a thick layer of 
peptidoglycan that comprises as much as 90% of the compact cell wall (Figure 1.1).  
Embedded in the Gram-positive cell wall are polyalcohols called teichoic acids, some of 
which are attached to lipid to form lipoteichoic acids (LTA), which anchors the 
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peptidoglycan layer to the cytoplasmic membrane (Figure 1.1).  The peptidoglycan is 
comprised of alternating N-acetylglucosamine (NAG) and N-acetylmuramate (NAM) 
saccharides (Meroueh et al., 2006).  The main difference between the two classes of 
bacteria is that the Gram-positive lacks an outer membrane, and therefore is more 
sensitive to hydrophobic antibiotics, ionophores, lysozyme, and hydrolytic enzymes.  
This also has less constraint on the diffusion of solutes to the cytoplasmic membrane. 
  
Figure 1.1 General cell wall structures of bacteria.  (A) Gram-positive bacteria.  
Lipoteichoic acids (LTA) are present only in Gram-positive bacteria, and these 
polysaccharides extend through the entire peptidoglycan layer and emerge on the cell 
surface.  (B) Gram-negative bacteria.  The outer membrane is comprised of a layer of 
lipopolysaccharide (LPS), found only in Gram-negative bacteria, which is hydrophilic 
in nature and provides a barrier against hydrophobic compounds; and a layer of 
lipoprotein (LP) that stabilises the cell wall structure.  The lipid part of LP is embedded 
in the outer membrane, and the sugar part is covalently bound to murein. 
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In contrast to the Gram-positive cell wall, the Gram-negative cell wall has a thin 
layer of peptidoglycan, comprising only 5 – 20% of the cell wall thickness, and this is 
responsible for its inability to retain the crystal violet stain upon decolourisation with 
ethanol during Gram-staining.  In addition, the Gram-negative cell wall has an outer 
membrane consisting of a layer of phospholipids and a layer of lipopolysaccharide 
(LPS), with high levels of porins, which function as a molecular sieve through which 
molecules with a molecular mass ≥ 600-1000 Da cannot penetrate (Figure 1.1) (Nikaido 
& Vaara, 1985; Nikaido, 2003).  Porins allow for passive transport of many ions, sugars 
and amino acids across the outer membrane.  These molecules enter into the periplasm 
then undergo binding with substrate binding proteins, hydrolysis by periplasmic 
enzymes and/or translocation across the cytoplasmic membrane by specific carriers that 
are integral proteins.  Both types of bacteria have an overall negative charge derived 
from the phosphodiester bonds between teichoic acid monomers in Gram-positive, and 
the LPS in Gram-negative organisms. 
 
1.2. The cytoplasmic membrane of bacteria 
 
1.2.1. Functions and properties of the cytoplasmic membrane 
 
 The cytoplasmic membrane is made of approximately 35 – 50% phospholipid 
and 50 – 65% protein, forming a ‗sea‘ of phospholipids with ‗islands‘ of proteins, 
named the fluid mosaic model (Figure 1.2) (Singer & Nicolson, 1972).  The 
phospholipid bilayer acts as the selective permeability barrier for most molecules.  It 
isolates the cell contents (cytoplasm) from the external environment, but at the same 
time nutrients and wastes are transported into and out of the cell (Section 1.3).  Other 
important physiological processes associated with the cytoplasmic membrane include 
solute transport, maintenance of electrochemical gradients and ATP synthesis, signal 
transduction (Section 1.4) (Facey & Kuhn, 2010), and synthesis of cell surface 
structures and excretion of proteins. 
Phospholipids are amphipathic molecules consisting of hydrophobic 
hydrocarbon tails and a hydrophilic head group (Kim & Gadd, 2008).  In water, the 
hydrophilic head interacts with water and meanwhile the hydrophobic tail hides away, 
forming micelles or liposomes.  Due to this property, broken membranes can 
spontaneously restore their structure to form vesicles.  Membrane vesicles are often 
prepared in laboratories for study.  This includes using French press (Vanderheiden et 
al., 1970) or sonication for inside-out vesicles, or osmotic lysis of protoplast by 
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enzymes for right-side-out vesicles (Altendorf & Staehelin, 1974).  The phospholipid 
bilayer is permeable to hydrophobic solutes and water but not to charged solutes.  Water 
can diffuse slowly across the phospholipid bilayer but rapid flux is mediated by a 
protein called aquaporin. 
 
Figure 1.2 Diagram of the cytoplasmic membrane.  The proteins float around in the 
phospholipid bilayer forming a structure called the fluid mosaic model. 
 
1.2.2. Proteins in the cytoplasmic membrane 
 
 Proteins in the cytoplasmic membrane have many biological functions and they 
are either peripheral or integral according to their location in the membrane (Figure 1.2).  
Integral proteins are hydrophobic and are therefore embedded in the membrane via 
hydrophobic interaction with the hydrophobic tails of the phospholipids, and they could 
be removed by use of detergents.  However, the peripheral proteins could be removed 
by washing with salt solutions as they are attached to the membrane by ionic 
interactions.  There are various important functions carried out by the proteins in the 
cytoplasmic membrane and examples include: the water channels called aquaporin that 
are involved in osmoregulation of the cell (Tanghe et al., 2006); enzymes such as 
phospholipase, protease, and peptidase for the renewal and synthesis of the cell wall 
(Scheffers & Pinho, 2005); enzymes involved in DNA replication since the bacterial 
DNA is attached to the cytoplasmic membrane (Ganesan & Lederberg, 1965; Smith & 
Hanawait, 1967); proteins that maintain the energy status of the cell (Hellingwerf et al., 
1985; Konings et al., 1994), i.e. proteins of the electron transport system, and ATPase 
enzyme complex involved in creating the proton motive force.  Many of the membrane 
proteins have a role in protein secretion or solute transport (Section 1.2.3), and there are 
membrane-bound sensor histidine kinases of the two-component signal transduction 
system (Section 1.2.4) involved in sensing and responding to environmental stimuli. 
Integral protein 
Phospholipid 
Peripheral 
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1.2.3. Membrane transport 
 
 Genes encoding membrane proteins constitute 25 – 35% of prokaryotic and 
eukaryotic genomes and have critical physiological roles in the cells.  The importance 
of transport systems in bacteria was recognised more than half a century ago (Gale & 
Taylor, 1947).  As mentioned earlier in the chapter, the cytoplasmic membrane forms a 
permeability barrier to hydrophilic solutes.  Therefore membrane transport processes are 
mediated by integral membrane proteins, and often they function in conjunction with 
extracytoplasmic receptors or receptor domains together with cytoplasmic energy-
coupling and regulatory proteins or protein domains (Saier, 2000).  Membrane transport 
processes were best understood in Gram-negative bacteria Salmonella typhimurium and 
Escherichia coli because of the ease of their genetic manipulation.  Nevertheless, many 
of the transport processes first identified in these organisms are also found in higher 
organisms, including man (Henderson, 1998).   
 The data generated by whole-genome sequencing projects show that 
approximately 5 – 12% of the complete bacterial genome codes for proteins involved in 
membrane transport (Paulsen et al, 1998; Saier, 1999; Paulsen et al, 2000; Ren et al., 
2004; Saier et al., 2006; Ren & Paulsen, 2007).  In order to survive and function, cells 
must exchange substances such as nutrients, ions and metabolites with their 
environment.  Transport processes involved with nutrient uptake are associated with the 
processes of oxidative and photosynthetic ATP synthesis (Figure 1.3) (Mitchell, 1961; 
Mitchell, 1966) and are conventionally classified as: passive diffusion, facilitated 
diffusion, primary active transport, secondary active transport, and group translocation 
(Figure 1.3), and these are defined below. 
 
1.2.3.1. Passive diffusion is the translocation of solute across a membrane down its 
electrochemical gradient without the need of a transport protein, following Fick‘s law (v 
= Pac, where P is the permeability coefficient for a particular solute, a is the area, and c 
is the difference in solute concentration across the membrane) and where velocity has a 
linear relationship to the concentration of the solute. 
 
1.2.3.2. Facilitated diffusion involves the translocation of a solute across a membrane 
down its electrochemical gradient catalysed by a transport protein, and follows 
Michaelis-Menten relationship that relates the initial rate of transport (v) to initial 
substrate concentration ([S] = c at zero time).  Where Vmax is the maximum velocity and 
Km is the concentration of substrate when v = (Vmax / 2). 
 7 
 
Figure 1.3 Membrane transport across the bacterial cytoplasmic membrane. 
(diagram modified from one of Peter J.F. Henderson).  The large oval represents the 
cytoplasmic membrane of the microorganism.  ATP hydrolysis or respiration of the cell 
generates a transmembrane electrochemical gradient of protons (top left).  This can be 
utilised by the proton-nutrient symport or proton-substrate antiport system (along the 
top).  An ATP-dependent primary transport system for uptake of K
+
 or efflux or toxin is 
shown (bottom).  A phosphotransferase mechanism involving phosphoenolpyruvate 
(PEP) for accumulation of sugars is shown (upper right), and uniport system for 
transport of glycerol (lower right). 
 
1.2.3.3. Active transport involves the net transport of a solute across a biological 
membrane from a low to a high electrochemical potential.  Energy expenditure is 
coupled to transmembrane substrate translocation without chemical modification, where 
the energy may be derived from light, ATP hydrolysis, or pre-existing solute gradients.  
There are two type of active transport, namely primary and secondary.  Primary active 
transport involves the direct conversion of energy into an electrochemical potential of 
solute across the cell membrane.  Consequently, the transport involves hydrolysis of 
ATP, light, or redox energy (Figure 1.3), with the translocation of protons or sodium 
ions driven by oxidation of respiratory substrates.   Many nutrient uptake systems in 
bacteria involve direct utilisation of ATP and binding proteins.  Secondary active 
transport entails the conversion of a pre-existing electrochemical gradient (Na
+
 or H
+
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ion), into a new electrochemical gradient of the transported species.  The source of this 
energy is the ion gradient set up by primary chemical or photochemical conversion.  In 
E. coli, H
+
 gradients are found to energise many transport reactions, and Na
+
 gradients 
are relatively few, though Na
+
 gradients are found predominantly in organisms living in 
salt environments. 
 
1.2.3.4. Group translocation is another form of active transport and involves chemical 
modification of the solute during its transport across the cell membrane so that once the 
solute is inside, it becomes impermeable and it remains within the cell.  One example 
includes the phosphotransferase system; a high-energy phosphate group from 
phosphoenolpyruvate (PEP) is transferred by a series of enzymes to glucose. 
 
1.2.4. Responses to environmental stress 
 
Bacteria are able to live and survive in unique and/or fluctuating environments, 
in which nutrient and toxin levels, acidity, osmolarity, temperature, and many other 
conditions can change unexpectedly and rapidly.  To survive, cells must constantly 
sense and respond to changes in their environment.  To achieve this, cells sense 
environmental change and transmit the information from the cell surface to the 
cytoplasm, a process that requires signal transduction across biological membranes.  
The two most common transmembrane signal-transducing mechanisms in bacteria are 
two-component systems (TCS) and extracytoplasmic function (ECF) σ factors, where 
both systems consist of two proteins. 
 
1.2.4.1. Two-component signal transduction systems (TCS). TCS are widely 
distributed amongst bacteria and constitute the major mechanism of signal transduction.  
Signal transduction involves phosphorylation as a mean of information transfer and 
requires a sensor kinase, often located in the cytoplasmic membrane, that monitors 
changes in the environment, and a cytoplasmic response regulator that mediates an 
adaptive response, often causing a change in gene transcription (Hoch & Silhavy, 1995; 
Stock et al., 2000).  The mechanisms of stimulus perception by sensor kinase include: 
extracellular or periplasmic-sensing, transmembrane region-sensing and cytoplasmic 
sensing; and will be described in more detail in Section 1.4.5. 
 
1.2.4.2. Extracytoplasmic function σ factors.  Extracytoplasmic function σ factors 
(ECF) signal transduction involves a transmembrane sensory protein (anti-σ factor) that 
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detects a specific stimulus, and a cognate cytoplasmic effector protein (σ factor) that 
mediates the cellular response (Brooks & Buchanan, 2008).  This system differs from 
the TCS in the way the two proteins communicate and their output.  TCS entails a 
phosphorylation and dephosphorylation event of both histidine kinase and response 
regulator.  In contrast, ECF signal transduction occurs via protein-protein interaction.  
For example, in the absence of a signal the anti-σ factor binds tightly to the σ factor and 
holds it in an inactive state.  When a specific stimulus is present, the σ factor is released 
and binds to promoter sequences upstream of its target genes.  The ECF σ factor can 
only function as an activator of expression, whereas the TCS is able to inhibit as well as 
induce gene expression.  After the one- and two-component systems (Stock et al., 2000; 
Ulrich et al., 2005), ECF represents the third fundamental mechanism of bacterial signal 
transduction, with an average of six such regulators per bacterial genome (Staroń et al., 
2009).   
 
1.3. Membrane transport proteins 
 
1.3.1. The classification of membrane transport proteins 
 
 The transporter classification database (TCDB) is a comprehensive classification 
system for membrane transport proteins and is freely accessible from the web (Saier et 
al., 2006).  Approximately 3000 distinct proteins from all varieties of known organisms 
are classified into over 550 transporter families based on the transport classification 
system.  The transport systems are classified based on five components and these are V, 
W, X, Y and Z.  Firstly, each category of transporter is assigned a number in relation to 
its molecular mode of transport (V), and energy coupling mechanism (W).  Next, the 
protein is further classified on the basis of its amino acid sequence and phylogenic 
family and subfamily (X and Y), and its substrate specificity (Z).   
 
1.3.2. Transporter families for nucleobases and nucleosides 
 
 Nucleobase and nucleoside transporters are classified into five distinct families 
(de Koning, 2000).  These include nucleobase-ascorbate transporter (NAT), microbial 
purine-related transporter (PRT), plant family of purine-related permeases (PUP), 
equilibrative nucleoside transporter (ENT) and concentrative nucleoside transporter 
(CNT), all of which are electrochemical potential-driven transporters (secondary active 
transporters). 
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1.3.2.1. The NCS2/NAT family.  This family is classified as 2.A.40 according to the 
TCDB system (Saier et al., 2006) and is the largest and most conserved family for 
nucleobases.  It includes members from eubacteria, archea, fungi, plants, insects, 
nematodes and mammals, including human.  Some of the described transporters of the 
NAT family include: purine transporter of Bacillus, PbuX (Christiansen et al., 1997); 
purine transporter of Aspergillus, UapA and UapC (Gorfinkiel et al., 1993; Diallinas et 
al., 1995); uracil transporter of Escherichia coli (E. coli) and Bacillus, UraA (Andersen, 
1995) and PyrP (Ghim & Neuhard, 1994; Turner et al., 1994) respectively; and the 
mammalian (human and rat) ascorbate transporters, SVCT1 and SVCT2 (Faaland et al., 
1998; Daruwala et al., 1999; Rajan et al., 1999; Tsukaguchi et al., 1999).  An 
alternative designation for the NAT family is the nucleobase-cation-symporter-2 (NCS2) 
family. 
 
1.3.2.2. The NCS1/PRT family.  This family is not as broadly distributed compared to 
the NAT family, and is described in further detail in Section 1.3.4. 
 
1.3.2.3. The PUP family consists of members found only in plants.  The members 
studied so far, includes the 21 Arabidopsis PUPs, several of which are known to 
transport adenine, cytosine or secondary compounds such as cytokinins and caffeine 
(Gillissen et al., 2000; Bürkle et al., 2003).  This family does not share any similarity of 
amino acid sequence with the NAT or PRT proteins. 
 
1.3.2.4. The ENT and CNT families.  These families are nucleoside transporters 
mainly described in mammals, and are classified as belonging to 2.A.57 and 2.A.41, 
respectively (Saier et al., 2006).  Homologues of the ENT family have also been 
sequenced from yeast, protozoa and nematodes.  Several members of the ENT have 
been functionally characterised, including: monoamine transporter, PMAT (Engel et al., 
2004); nitrobenzylthioinosine-insensitive ENT transporter, eiENT (Griffiths et al., 
1997); nucleoside transporter of Tyrpanosoma brucei, TbAT1 (Mäser et al., 1999); 
hENT1 and rENT1 (Sundaram et al., 1998); and nucleoside transporter of Leishmania, 
LdNT1 (Vasudevan et al., 1998).  Members of the CNT family include proteins derived 
from Gram-negative and Gram-positive bacteria as well as yeast and animals.  In 
bacteria and yeast, members of the CNT family are energised by H
+
 symport, whereas 
in mammals they are energised by Na
+
 symport.  These transporters also exhibited 
different specificities for nucleosides.  Some members of the CNT family include: 
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NupC and NupG of E. coli (Craig et al., 1994; Westh Hansen et al., 1987); NupG of B. 
subtilis (Johansen et al., 2003); CaCNT of Candida albicans (Loewen et al., 2003); 
hCNT1 of human (Ritzel et al., 1997); and hCNT3 of human (Smith et al., 2005). 
 
1.3.3. Role of nucleobases in organisms 
 
 Nucleobases are essential components of the genetic material in all living 
organisms and play a crucial role in cell metabolism, contributing to base pairings in 
DNA and RNA.  They form part of nucleotides, which are the building blocks for RNA 
and DNA, and precursors for essential coenzymes (NAD
+
, FAD and CoA) as well as 
ATP and GTP that are the main forms of chemical energy of the cell.  In addition, they 
serve as nitrogen sources in plants and many microorganisms. 
 
1.3.3.1. Nomenclature of nucleobases, nucleosides and nucleotides.   Nucleobases 
are nitrogen heterocycles (N-heterocycles) and are either purine (adenine and guanine) 
or pyrimidine (cytosine, thymine and uracil), abbreviated as A, G, C, T and U, 
respectively (Figure 1.4).  Their structures are also shown in Figure 3.7.  Nucleosides 
are glycosylamines comprised of a nucleobase bound to a pentose sugar moiety, either 
ribose or deoxyribose via a beta-glycosidic linkage.  This includes for example 
adenosine, guanosine, cytidine, thymidine, uridine and inosine.  Nucleotides are 
phosphate esters of nucleosides and contain one to three phosphate groups (Figure 1.5). 
 
 
Figure 1.4 Structure of purine and pyrimidine.  Purine and pyrimidine are 
nucleobases and are nitrogen heterocycles. 
 
N 
N 
N 
N 
N 
N 
purine pyrimidine 
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Figure 1.5 Structural elements of nucleotide.  A nucleobase (blue) together with a 
pentose sugar (orange) forms a nucleoside.  A nucleotide is composed of a nucleoside 
and one to three phosphate groups. 
 
1.3.3.2. Role of transport in salvaging 
 
 Degradation of nucleotides rarely occurs inside the cells at site of high demand, 
for example replication of DNA for growth of cells.  Therefore, the acquisition of 
nucleobases or nucleosides from adjacent cells or extracellular sources relies on 
nucleobase transport proteins (Section 1.3.2).  In microorganisms, the uptake of purines 
and pyrimidines fulfils two main functions.  The first is to scavenge exogenous bases 
for nucleotide biosynthesis and the second for catabolism as many purines can serve as 
nitrogen sources (de Koning & Diallinas, 2000). 
 
1.3.4. The NCS1 family of transporters 
 
 The NCS1 family, also named the PRT family (Section 1.3.2), is classified as 
2.A.39 according to the TCDB classification (Saier et al., 2006).  This family of 
transporters consists of more than 1000 currently sequenced proteins derived from 
Gram-negative and Gram-positive bacteria, archaea, yeast, fungi and plants.  
Transporters of this family in yeast and bacteria are widely divergent and do not cluster 
closely on the NCS1 family phylogenetic tree (Figure 3.2).  There are currently eight 
proteins that have been studied from yeast, three of which (Dal4, Fur4 and Fui1) cluster 
tightly together, another two (Thi10 and Ntr1) also cluster closely together, and there 
are the three other yeast proteins (Fcy2, Fcy21 and Tpn1) which cluster quite closely 
together with a fungal protein (FcyB).  Proteins of this family from bacteria were also 
P O P O P O O 
O O O 
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studied (Table 1.1), including E. coli (CodB), Pseudomonas putida (CytX), Bacillus 
subtilis (PucI), Arthrobacter aurescens (HyuP), and Microbacterium liquefaciens 
(Mhp1).  These NCS1 proteins are classified according to the TCDB (Saier et al, 2006) 
(Table 1.1). 
 
TC 
number 
 
Name 
Accession no. 
Organism 
Type 
Example Reference 
2.A.39.1.1 Cytosine permease 
P0AA82 
Bacterium CodB of 
Escherichia coli 
Danielsen et al. (1992) 
2.A.39.1.2 The putative 
hydroxyl-
methylpyrimidine 
transporter 
B1JAG2 
Bacterium CytX of 
Pseudomonas 
putida 
Rodionov et al. (2002) 
2.A.39.2.1 Cytosine-purine 
permease 
P17064 
Yeast Fcy2 of 
Saccharomyces 
cerevisiae 
Pinson et al. (1997) 
Rodriguez et al. (1995) 
2.A.39.2.2 The vitamine B6:H
+
 
symporter 
P53099 
Yeast Tpn1 of  
Saccharomyces 
cerevisiase 
Stolz & Vielreich 
(2003) 
2.A.39.2.3 The hypoxanthine/ 
adenine/ guanine 
(purine) transporter 
Q708J7 
Yeast Fcy21 of 
Candida 
albicans 
Goudela et al. (2006) 
2.A.39.2.4 The cytosine-purine-
scavenging protein 
B1PXD0 
Fungus FcyB of 
Asperillus 
nidulans 
Vlanti & Diallinas 
(2008) 
2.A.39.3.1 Allantoin permease 
Q04895 
Yeast Dal4 of 
Saccharomyces 
cerevisiae 
Yoo et al. (1992) 
2.A.39.3.2 Uracil/uridine 
permase 
P05316 
Yeast Fur4 of 
Saccharomyces 
cerevisiae 
Smits et al. (1994) 
2.A.39.3.3 Urindine:H
+
 
symporter 
YBL042 
Yeast Fui1 of 
Saccharomyces 
cerevisiae 
Wagner et al. (1998) 
Zhang et al. (2006) 
2.A.39.3.4 Allantoin permease 
P94575 
Bacterium PucI of Bacillus 
subtilis 
Schultz et al. (2001) 
2.A.39.3.5 The probable 
hydantoin permease 
Q9F467 
Bacterium HyuP of 
Arthrobacter 
aurescens 
Wiese et al. (2000) 
2.A.39.3.6 Hydantoin permease 
2JLN_A 
Bacterium Mhp1 of 
Microbacterium 
liquefaciens 
Suzuki & Henderson 
(2006) 
Weyand et al. (2008) 
Shimamura et al. (2010) 
2.A.39.4.1 Thiamine permease 
Q05998 
Yeast Thi10 of 
Saccharomyces 
cerevisiae 
Enjo et al. (1997) 
2.A.39.4.2 The nicotinamide 
riboside transporter 
Q08485 
Yeast Nrt1 of 
Saccharomyces 
cerevisiae 
Belenky et al. (2008) 
 
Table 1.1 The nucleobase-cation-symporter-1 (NCS1) family.  This table shows 
some current members of the NCS1 family in the TCDB.  Table adapted from the 
TCDB website (Saier et al, 2006). 
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To date, there is only one structure of a NCS1 family transporter elucidated and 
that is the hydantoin permease of Microbacterium liquefaciens (Mhp1) (Weyand et al., 
2008; Shimamura et al., 2010).  This transporter is described in further detail (Section 
1.3.5).  The NCS1 transporters are essential components of the salvage pathways for 
nucleobases and related metabolites and catalyse the generalised transport reaction: 
 
Nucleobase /Vitamin/Hydantoin (out) + H
+
 or Na
+
 (out) →   
Nucleobase/Vitamin/Hydantoin (in) + H
+
 or Na
+
 (in) 
 
Transporters of the NCS1 family are 419 – 635 amino acid residues long and are 
predicted to possess twelve putative transmembrane helices.  Some of the members of 
this family were shown to function in substrate-proton symport, but one example, Mhp1, 
was shown to be sodium-dependent (Weyand et al., 2008).  Symporters are membrane 
proteins that couple energy stored in electrochemical potential gradients to mediate the 
cotransport of ions and molecules into the cell (Poolman & Konings, 1993).  In sodium-
coupled symporters, sodium is the driving force that causes the conformation change.  
In humans, the malfunctioning of sodium-coupled transporters has been implicated in 
diseases such as glucose-galactose malabsorption, familial renal glucosuria (Wright et 
al., 2007).  Others, such as the sodium-iodide transporter, involved in active iodide 
transport into the thyroid follicular cell have medical significance (Dohan et al., 2003). 
 
1.3.5. The Microbacterium liquefaciens hydantoin permease (Mhp1) 
 
Mhp1 was first discovered by Suzuki et al. (2005b) in a study of proteins of the 
hyu operon of M. liquefaciens.  His study of the soluble protein, hydantoin racemase 
(Suzuki et al., 2005a; Suzuki et al., 2005b) led to the identification of Mhp1, which was 
characterised and shown to transport 5-substituted hydantoins (Suzuki & Henderson, 
2006).  The stereoselective hydrolyses of DL-5-monosubstituted hydantoin compounds 
have been widely studied for the production of optically pure D- or L-amino acids 
(Owaga et al., 1997; Altenbuchner et al., 2001), which have long been of interest in 
industry for production of various drugs and pharmaceuticals (Syldatk et al., 1990; 
Syldatk et al., 1992; Bommarius et al., 1998; Syldatk et al., 1999). 
 
1.3.5.1. Structure of Mhp1.  The first structures of a NCS1 protein, a secondary active 
transporter, Mhp1 was solved to 2.85 Å  and 4.0 Å  of resolution (Weyand et al., 2008), 
providing an insight into the alternating access mechanism.  Mhp1 mediates the uptake 
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of indolylmethyl- and benzyl-hydantoins into M. liquefaciens (Section 1.3.5) (Suzuki & 
Henderson, 2006).  The structures of the outward-facing open and substrate-bound 
occluded conformations of Mhp1 were solved, revealing twelve transmembrane helices, 
ten of which are arranged in two inverted repeats of five helices (Figure 1.6), 
highlighting how the outward-facing cavity closes upon binding of substrate (Figure 1.7 
and 1.8).  This structure was compared to the leucine transporter of Aquifex aeolicus 
(LeuT) (Yamashita et al., 2005; Singh et al., 2007; Zhou et al., 2007) and the galactose 
transporter of Vibrio parahaemolyticus (vSGLT) (Faham et al., 2008), revealing that the 
outward- and inward-facing cavities are symmetrically arranged on opposite sides of the 
membrane.  The reciprocal opening and closing of these cavities is synchronised by the 
inverted repeat helices 3 and 8, providing the structural basis of the alternating access 
model for membrane transporter (Weyand et al., 2008; Shimamura et al., 2010). 
Mhp1 has between 17 – 31% identity and 52 – 65% similarity to the NCS1 
proteins studied in this work (Table 3.1).  Meanwhile, it shares 16% identity and 50% 
similarity to vSGLT, and 15% identity and 48% similarity to LeuT, falling just below 
the range with NCS1 proteins.  Despite the low similarity of the amino acid sequence of 
Mhp1 to the solute-sodium-symporter (SSS) and neurotransmitter-sodium-symporter 
(NSS) families of transporters, the X-ray structure of Mhp1 (Weyand et al., 2008) 
revealed similarities between them, suggesting that the NCS1 proteins are closely 
related to the SSS and NSS family proteins. 
 
 
Figure 1.6 Topology of Mhp1.  The positions of the substrate- and cation-binding sites 
are indicated as brown ellipsoid and a blue circle, respectively.  The phospholipid 
bilayer is shown in grey, and the outward-facing cavity of the structure is highlighted in 
light blue rhombus.  In the three dimensional structure, helices 3 and 8 lie very closely 
onto each other.  Diagram taken from Weyand et al. (2008). 
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Figure 1.7 Structure of Mhp1.  The Mhp1 structure viewed: (A) in the plane of the 
membrane and (B) from outside of the membrane.  These images are based on the high-
resolution structure of Mhp1 with benzylhydantoin.  The position of the 
benzylhydantoin in the structure is shown as reference.  A sodium ion is also shown and 
labelled.  Diagram taken from Weyand et al. (2008). 
 
 
 
Figure 1.8 Outward- and inward- facing cavities in Mhp1.  A slice through the 
Mhp1 structures, viewed parallel to the membrane is shown.  (A) Mhp1 outward-facing 
structure (substrate-free).  (B) Mhp1 substrate-occluded with benzylhydantoin bound.  
(C) Mhp1 substrate-occluded with the inward-facing cavity shown.  The 
benzylhydantoin is shown in cyan.  Diagram taken from Shimamura et al. (2010). 
 
 
A B C 
A B 
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The SSS family proteins catalyse the solute-Na
+ 
symport.  The solutes 
transported could be sugars, amino acids, choline, nucleosides, inositols, vitamins or 
urea (Saier et al., 2006).  Meanwhile the NSS family proteins catalyse uptake of a 
variety of neurotransmitters, amino acids, osmolytes and related nitrogeneous 
substances by a Na
+
 symport mechanism; and sometimes Cl
-
 or K
+ 
is cotransported 
(Saier et al., 2006). 
The inverted repeat units intertwine and forms a central four-helix bundle 
consisting of two broken helices (1 and 6) associated with helices 2 and 7 (Figure 1.6).  
This four-helix bundle comprises the central block between the V-shaped structures 
formed by helices 4 and 5 and helices 9 and 10, and the core for substrate and cation 
binding (Figure 1.6 and 1.7)  Helices 11 and 12 are poorly conserved and their role 
remains unclear. 
 
1.3.5.2. Substrate and cation binding sites.  Benzylhydantoin interacts with amino 
acids W117 (helix 3) and W220 (helix 6) of Mhp1; the hydantoin moiety of 
benzylhydantoin forms a π-stacking with the indole ring of W117 and hydrogen bonds 
to the N318 and Q121, while the side chain of W220 forms π-stacking with the benzyl 
moiety (Figure 1.9A), forming a L-shaped density in the electron density map (Figure 
1.9B) (Weyand et al., 2008).  Residues W117 and N318 are conserved in the NCS1 
family (Appendix 2).  N314 is also conserved, which could hold the N318 side chain in 
position to interact with the substrate (Weyand et al., 2008). 
 A mutant of Fcy2, a member of the NCS1 family that transports cytosine into S. 
cerevisae, with substitutions in the segment (residues 371 – 377 IANNIPN) of Fcy2 
showed altered kinetics of substrate uptake (Chevallier et al., 1975; Bloch et al., 1992; 
Brèthes et al., 1992).  These residues correspond to 311 – 318 in Mhp1.  Site-directed 
mutagenesis on these hydrophilic residues in Fcy2 further suggested their role in 
substrate binding, and are equivalent to N314 and N318 in Mhp1 (Ferreira et al., 1997).  
When benzylhydantoin is bound to Mhp1, helix 10 moves into the outward-facing 
cavity (Figure 1.9, C and D), a position which occludes the substrate-binding site from 
the outside space of the membrane (Figure 1.8B and 1.9C), possible triggered by the re-
positioning of W220 (helix 6) (Weyand et al., 2008).  This outward-facing substrate-
occluded conformation prevents leakage of molecules across the membrane.   
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Figure 1.9 Substrate and cation binding sites of Mhp1.  This Figure is taken from 
Weyand et al. (2008).  (A) Benzylhydantoin and the key residues in the binding site are 
shown.  The benzylhydantoin and sodium are shown in magenta and blue respectively.  
(B) Electron density associated with benzylhydantoin.  (C) Conformational change 
upon substrate binding.  A shift in helix 10 is shown, which occludes the bound 
benzylhydantoin from the outside of the membrane.  Helix 10 with no benzylhydantoin 
(dark blue) and with benzylhydantoin bound (grey).  (D) Electron density and model for 
helix 10.  The benzylhydantoin free structure is shown in magenta and benzylhydantoin 
bound structure in green.  The vSGLT structure (PDB accession code 3DH4) is 
superimposed onto Mhp1 (grey trace).  (E) Helices and key residues in the cation and 
substrate binding sites.  (F) Tryptophan fluorescence quenching of Mhp1 by 
benzylhydantoin (This graph forms part of the work in Chapter 4).  Mhp1 was titrated 
with benzylhydantoin and the decrease in tryptophan fluorescence at 348 nm was 
monitored.  The titration was performed with and without sodium.  Error bars represent 
the mean of triplicates. 
B A 
C D 
E F 
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There is one sodium binding site in Mhp1.  At this site, the carbonyl-oxygen-
atoms of A38 and I41 of helix 1 and the carbonyl-oxygen-atom of A309, and the 
hydroxyl-oxygen-atoms of the side chains of S312 and T313, together form the cation-
binding pocket (Figure 1.9E) (Weyand et al., 2008).  The dipole moment at the C-
terminus of helix 1a possibly contributes to the binding, as seen in other transporters 
(Dutzler et al., 2002; Yernool et al., 2004; Hunte et al., 2005; Yamashita et al., 2005; 
Faham et al., 2008; Ressl et al., 2009).  Mhp1 was confirmed to be sodium-dependent 
by a tryptophan fluorescence quenching study (Figure 1.9F – forms part of the work in 
Chapter 4).  An increase in affinity of Mhp1 for benzylhydantoin was shown in the 
presence of sodium.   
 
1.3.6. Mechanism of alternating access transport 
 
1.3.6.1. Secondary active transporters.  Secondary active transporters are present in 
all species throughout the kingdoms of life (Sobczak & Lolkema, 2005).  They 
participate in many physiological processes in the human, including the uptake of 
nutrients in the intestines (Wright & Turk, 2004), transport of Na
+
 and Cl
-
 in the kidney 
(Hebert et al., 2004), and the reuptake of neurotransmitters from the synaptic cleft 
(Sonders et al., 2005).  They also form the fundamental translocation unit for solutes 
and ions in bacteria (Nikaido & Saier Jr, 1992).  Secondary active transporters are 
biochemically well characterised, including the lactose permease, LacY (Abramson et 
al., 2003; Mirza et al., 2006; Guan et al., 2007; Smirnova et al., 2008; Zhou et al., 
2008), the best-studied representative of the Major Facilitator Super family (MFS). 
Other members of the MFS, such as multidrug transporter (EmrD) and glycerol-3-
phosphate transport (GlpT) (Huang et al., 2003; Yin et al., 2006) are also biochemically 
and structurally characterised, though the mechanism of secondary transport has not yet 
been fully established.   
 
1.3.6.2. Previous models of alternating access transport.  The mechanism of 
alternating access, a central concept for membrane transport could be explained by 
models.  Peter Mitchell proposed an early theory for the mechanism of secondary 
transporters, suggesting two alternating structural states are involved.  One in which the 
substrate binding site is accessible to the extracellular solution (open-to-out), and 
another wherein the binding site is accessible to the cytoplasm (Mitchell, 1957).  In 
1960, Crane discovered sodium-glucose cotransport in intestinal glucose absorption, the 
first proposal of flux coupling in biology (Crane et al., 1960).  Later, Jardezky (1966), 
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proposed a substrate binds to one face of the membrane protein and an energy input 
causes a conformational change to expose the substrate to the opposite face of the 
membrane, followed by release.  Tanford (1983) proposed a similar mechanism, 
suggesting there are at least two states and binding of substrate could cause a change in 
conformation. 
 
1.3.6.3. Emergence of structures of other secondary active transport proteins.  
Models for transport mechanisms were previously based only on biochemical data, but 
with the emergence of membrane protein structures, models based on atomic structure 
are now available.  The first crystal structure of a secondary transporter was reported in 
2002, the proton-multidrug efflux pump AcrB of E. coli, of the resistant nodulation cell 
division (RND) family (Murakami et al., 2002).  In 2003, two further MFS structures 
were solved, GlpT (Huang et al., 2003) and LacY (Abramson et al., 2003).  Their 
structures are shown in Figure 1.10. 
 
 
Figure 1.10 Structures of AcrB, GlpT and LacY.  AcrB at 3.5 Å  (PDB code 1IWG), 
GlpT at 3.3 Å  (PDB code 1PW4), and LacY at 3.5 Å  (PDB code 1PV6). 
 
1.3.6.4. Structures of sodium-coupled transporters.  In 2004, the first atomic 
structures of a sodium-coupled secondary transporter, GltPh, of the 
dicarboxylate/amino-acid:cation symporter (DAACS) family, that transported glutamate 
were reported (Yernool et al., 2004); followed by two other structures in 2005, the 
Na
+
/H
+
 antiporter NhaA of E. coli (Hunte et al., 2005) and the Na
+
-leucine transporter 
LeuT (Yamashita et al., 2005).  These structures of sodium-coupled transporters 
belonging to different membrane protein families revealed unique folds in their 
structure (Figure 1.11), though they all shared an internal two-fold structural pseudo-
symmetry and discontinuous transmembrane helices (Screpanti & Hunte, 2006).  The 
AcrB GlpT LacY 
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recent structures of three more sodium-coupled secondary transporters belonging to 
different families; vSGLT, Mhp1 and BetP surprisingly showed the same protein fold 
seen in LeuT (Figure 1.11 and 1.12). 
Membrane protein classification has been based on sequence homology and 
functional properties, but the crystal structures of four sodium-symporter proteins of 
unrelated sequences revealed a common architecture of inverted repeats of five 
transmembrane helices (Figure 1.12) (Yamashita et al., 2005; Faham et al., 2008; 
Weyand et al., 2008; Ressl et al., 2009).  LeuT was the first high-resolution crystal 
structure of a sodium symporter with two inverted repeats of five helices (Yamashita et 
al., 2005), having two sodium binding sites and solved in the outward-facing substrate 
occluded conformation.  The second structure with the inverted five helices motif is the 
sodium-galactose transporter vSGLT (Faham et al., 2008); the protein was in an inward 
facing conformation with a hydrophobic gate blocking the sugar exit into the 
hydrophilic channel leading to the cytoplasm.  The structures of the outward facing 
LeuT and inward facing vSGLT hinted at a structural basis for the alternating access 
mechanism of these sodium-symporters.  Mhp1 was the third reported transporter with 
inverted repeats of five helices (Weyand et al., 2008).  Two structures of Mhp1 were 
solved, as mention earlier (Section 1.3.5), one in the outward-facing conformation 
without substrate and the other in the outward-facing occluded conformation with 
substrate.  A third structure of Mhp1 in the inward-facing state was recently solved 
(Shimamura et al., 2010) and provides a unique conformation.  Another quite recent 
structure of a sodium symporter with the same structural motif, the sodium-betaine 
transporter BetP of the betaine/carnitine/choline transporter (BCCT) family, in an 
intermediate between the outward and inward facing occluded conformations showed a 
unique conformation in the sodium-coupled transport mechanism (Ressl et al., 2009).   
These four sodium-symporters with inverted repeats belong to different gene 
families, but they have the same structural core.  They have an inverted topology where 
helices 1 – 5 are related to helices 6 – 10 by a two-fold symmetry and the central helices 
(helices 1, 2, 3, 6, 7, 8 and 10) are intertwined to make the substrate and ion binding 
sites, forming the structural hallmark for these sodium-symporters.  This could be an 
alternative for classification of transporters, rather than classification by primary 
sequence alone.  Though the relative substrate-binding sites in these sodium-symporters 
are similar (Figure 1.13), the specific interactions vary consequently to accommodate 
the different substrates (Abramson & Wright, 2009).  For vSGLT, all OH-moieties of 
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galactose are coordinated by hydrogen bonds from polar side chains in the central 
helices (helices 1, 6, 7 and 10).  Meanwhile for BetP, betaine interacts with three 
tryptophan and one tyrosine residues in helices 2 and 6.  For Mhp1, benzylhydantoin 
sits between two tryptophan residues in helices 3 and 6, and is coordinated by conserved 
glutamine and asparagine residues in helices 1 and 8.  Lastly, LeuT coordinates leucine 
through the main chain in the unwould segments of helices 1 and 6.  These transporters 
are highly conserved in terms of their 3D structure, especially in helices 1, 6 and 8, 
which are involved in their substrate and cation binding. 
Other structures with inverted repeat of five helices include: the Na
+
 
independent amino acid transporter ApcT (Shaffer et al., 2009) of the Amino acid, 
Polyamine and organo-Cation (APC) family; the arginine-agamatine antiporter AdiC 
(Fang et al., 2009) of the APC family; the L-carnitine/γ-butyrobetaine exchanger CaiT 
of BCCT family (Tang et al., 2010). 
 
Figure 1.11 Structures of sodium-coupled transporters.  GltPh at 3.5 Å  (PDB code 
1XFH) (Yernool et al., 2004), NhaA at 3.45 Å  (PDB code 1ZCD), LeuT complex with 
L-leucine, sodium and desipramine at 1.9 Å  (PDB code 2QB4), vSGLT with bound 
galactose at 2.7 Å  (PDB code 3DH4), Mhp1 with bound benzylhydantoin at 4 Å  (PDB 
code 2JLO), BetP with bound glycine betaine at 3.35 Å  (PDB code 2WIT). 
GltPh NhaA LeuT 
vSGLT BetP Mhp1 
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Figure 1.12 Topology of sodium-coupled transporters with inverted repeats of five 
helices.  The positions of the substrate- and sodium-binding sites are indicated by light 
and dark blue circles, respectively.  The phospholipid bilayer is shown in grey.  The 
helices are coloured according to LeuT for comparison. 
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A distinctive feature of the two inverted repeats of five helices is that two of the 
helices, 1 and 6, are discontinuous.  Discontinuous helices have been known to correlate 
with ion translocation function (Screpanti & Hunte, 2007), they create a local polar 
environment for the binding of ions and substrates, as in NhaA and GltPh (Yernool et 
al., 2004; Hunte et al., 2005).  Interestingly, a recent structure of an amino acid 
transporter (ApcT) also revealed an inverted structural repeats of five helices (Shaffer et 
al., 2009), but is not sodium-dependent, demonstrating common principles in proton- 
and sodium- coupled transporters. 
 
Figure 1.13 Common substrate and sodium binding sites of sodium-coupled 
transporters.  (A) Structural alignment of helices 1 and 6, and substrate binding site for 
vSGLT (red), BetP (blue), LeuT (green), and Mhp1 (cyan).  (B) Structural alignment of 
helices 1 and 8, and the conserved sodium-binding site.  Coloured as for (A).  Diagram 
taken from Abramson & Wright (2009).  TM = transmembrane/helix. 
 
1.3.6.5. Six-state model for sodium-coupled transporters with inverted repeats.   
 
Structures of sodium-coupled symporters in their different conformations 
provide insights into the mechanism of transport.  Based on these structures a six-state 
model could be explained (Figure 1.14) (Abramson & Wright, 2009).  Firstly, sodium 
ion(s) binding causes opening of the gate allowing substrate to bind (outward-facing 
open conformation of Mhp1) (state 2).  In Mhp1 and human SGLT (Weyand et al., 
2008; Hirayama et al., 2007), the extracellular part of helix 10 bends towards the 
extracellular facing cavity forming the outward facing occluded conformation (state 3) 
upon substrate binding.  For LeuT, this is achieved by stacking of the bulky residues 
F253 and Y108 on the substrate-binding site at the extracellular face (Yamashita et al., 
2005).    State 4 represents the intermediate state for the conversion from the outward 
(B) (A) 
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facing to inward facing conformation.  In this state, there is no extracellular or 
intracellular cavity, as shown by the structure of the BetP complex with both substrate 
and sodium bound (Ressl et al., 2009).   
 
Figure 1.14 A six-state model for sodium-symporters.  Diagram modified from 
Abramson & Wright (2009). (1) No ligand is bound.  (2) One or two sodium ions bind 
to the external surface and external gate opens.  (3) Substrate is then able to bind to its 
binding site and closing the external gate.  (4) The external vestibule closes.  (5) 
Opening of the internal vestibule.  (6) The internal gate opens and substrate and sodium 
ion(s) dissociate and enter the internal face of the membrane.  The internal vestibule 
closes to complete the cycle and returns to state (1).  The crystal structures of Mhp1 
correspond to state 2 and 3 (PDB code 2JLN and 2JLO), LeuT to state 3 (PDB code 
2A65 and 3F3A), BetP to state 4 (PDB code 2W8A), vSGLT to state 5 (PDB code 
3DH4), and Mhp1 to state 6 (PDB code 2X79). 
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Next, the transporter forms the inward-occluded conformation as indicated by 
the structure of vSGLT.  In vsGLT, galactose is packed in between hydrophobic 
residues (Y263 on the inside; M73, Y87 and F424 on the outside), which makes the 
substrate inaccessible to both faces of the membrane.  The intracellular exit pathways of 
these transporters consist of a large hydrophilic cavity formed from portions of helices 1, 
2, 3, 6, 8 and 10.  Very recently, the structure of an inward facing conformation of 
Mhp1 was revealed showing a dramatic change in the structure from its outward-
occluded state to the inward structure (Shimamura et al., 2010).  In order to release the 
sodium and the substrate, Mhp1 achieves this by opening the intracellular thick gate 
with a rigid body rotation of helices 3, 4, 8 and 9 relative to helices 1, 2, 6 and 7 (the 
bundle) (Shimamura et al., 2010).  It is presumed the intracellular thin gate (helix 5) 
also opens to allow the substrates to exit toward the cytoplasm (Shimamura et al., 2010). 
The aims and objective of this work are detailed in Section 1.5.1.  
 
1.4. Two-component signal transduction systems of Enterococcus 
faecalis 
 
1.4.1. Enterococci and Enterococcus faecalis 
 
 Enterococci are natural inhabitants of the oral cavity, normal intestinal 
microflora, and female genital tract of both human and animals (Murray, 1990; Jett et 
al., 1994), and are recognised as opportunistic pathogens.  They are now acknowledged 
to be the second most important cause of hospital-acquired infections in the US and 
fourth in the UK (Schaberg et al., 1991; National Nosocomial Infections Surveillance, 
2004; Oncu et al., 2004).  The two most commonly isolated species of enterococci 
associated with nosocomial infections are Enterococcus faecalis (E. faecalis) and 
Enterococcus faecium (E. faecium), both of which are capable of producing biofilms 
(Mohamed & Huang, 2007).  E. faecalis is responsible for approximately 80 – 90% of 
human enterococcal infections (Jett et al., 1994; Jones et al., 2004), whilst E. faecium 
accounts for the remainder of enterococcal infections (Jett et al., 1994). 
 The genome of a vancomycin-resistant clinical strain of E. faecalis (strain V583) 
was sequenced (Paulson et al., 2003), revealing a total of 3182 open reading frames 
(ORFs) with 1760 of these showing similarity to known proteins and 221 of unknown 
functions.  Approximately 25% of the genome is made up of mobile and exogenously 
acquired DNA, a unique feature of this genome, which includes a number of 
conjugative and composite transposons, a pathogenic island of integrated plasmid genes 
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and phages (Giridhara Upadhyaya et al., 2009).  E. faecalis, like other enterococci, 
exhibits some unusual but characteristic features.  It is able to grow in 6.5% NaCl and 
survive temperatures ranging from 10
o
C to 45
o
C, and it is tolerant to acidic and alkaline 
conditions, commensurate with its intestinal environment.  These observations led to the 
question of how enterococci have evolved to permit such hardy survival.  It is possible 
that sensing of environmental signals plays a very important role in this bacterium, and 
therefore that the two-component signal transduction systems confer important selective 
advantages for the survival of enterococci. 
 
1.4.2. Two-component signal transduction systems 
 
 Signal transduction in bacteria and plants is often mediated by His-Asp 
phosphorelay systems.  Two-component signal transduction systems (TCS) (Figure 1.15) 
enable bacteria to sense, respond, and adapt to the changes in their environment (Hoch 
& Silhavy, 1995; Stock et al., 2000). 
Bacteria possess many distinct TCS pairs, as many as 150 in some species 
depending on genome size (Barakat et al., 2009).  Each TCS consists of a sensor 
histidine kinase (HK) and a response regulator (RR) (Figure 1.15).  Upon detection of a 
specific signal(s), the sensor kinase autophosphorylates on a conserved histidine residue, 
and subsequently transfers the phosphoryl group to a conserved aspartate residue on a 
cognate response regulator (Stock et al., 2000).  The activated response regulator can 
then effect changes in response to the environment stimulus, often by regulating gene 
expression.  There are currently ~50,000 TCS proteins identified from the sequenced 
genomes (Barakat et al., 2009) and over 200 structures of two-component proteins have 
been determined.  TCSs regulate a wide range of cell activities, including fundamental 
processes such as motility and metabolism as well as virulence and development.  TCSs 
are the most abundant signal transduction mechanism utilised by bacteria and they have 
been extensively studied since their discovery more than 35 years ago.  It was hoped 
that the understanding these systems might be useful for development of antibiotics or 
the beneficial use of bacteria to improve agriculture or environment remediation.  
Indeed, it has been suggested that TCSs are excellent new targets for novel antibacterial 
drugs, as these systems are present in bacteria (and lower eukaryotes such as yeasts, and 
in higher plants) but are absent in mammals. 
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Figure 1.15 Two-component signal transduction system.  The system is comprised of 
two proteins, a membrane-bound sensor histidine kinase and a cytoplasmic response 
regulator.  The histidine kinase detects a specific environment stimulus ( ) and 
undergoes a conformational change ( ) resulting in the phosphorylation/activation of 
the kinase domain (transmitter) ( ).  The phosphate of the activated kinase domain is 
transferred to the receiver domain of its cognate response regulator, resulting in 
response regulator phosphorylation and activation ( ).  The activated response 
regulator mediates an appropriate cellular response (output) ( ).  Usually, the response 
regulator has a DNA-binding motif, and binding to its target promoter DNA sites leads 
to differential gene expression ( ).  The response regulator returns to a pre-stimulus 
state by dephosphorylation ( ), either by the intrinsic phosphatase activity exhibited by 
the transmitter domain or by additional phosphatases. 
 
1.4.3. Sensor histidine kinase 
 
1.4.3.1. Protein phosphorylation in bacteria. The discovery of protein 
phosphorylation dates back to the middle of the 19
th
 century when milk and egg proteins 
were found to covalently attached to inorganic phosphate.  Lipmann and Levene (1932) 
detected phosphoserine in egg yolk, and over two decades later, phosphothreonine was 
discovered in casein, meanwhile phosphotyrosine as a mode of protein modification 
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was unknown until 1979 (Eckhart et al., 1979).  Phosphorylation of histidine was first 
reported by Boyer et al. (1962) who identified this type of phosphorylation in 
mitochondrial succinly-CoA synthase.  Phosphorylation was first recognised as 
important in the regulation of enzymatic activities by Krebs & Fischer (1956).  
Subsequently, numerous examples of regulation through phosphorylation were 
identified in eukaryotes, but lack of protein phosphorylation in prokaryotes led to the 
view that this type of modification was exclusive to eukaryotes.  However, this view 
was changed upon publication in 1969 of a paper describing the isolation of a cyclic 
AMP-dependent kinase from E. coli which transferred phosphate from ATP to histones 
of calf thymus (Kuo & Greengard, 1969).   A few other serine- and threonine-
phosphoryl groups from an acidic hydrolysate of bacterial proteins were also identified 
(Wang & Koshland, 1978).  During studies at that time, acidic conditions were 
frequently employed for purification procedures, for example in acidic media or TCA 
precipitation.  Whilst, serine-, threonine-, and tyrosine phosphates are generally tolerant 
of acidic conditions, the phosphoramidate bond of phosphohistidines is prone to acid 
hydrolysis, and therefore the presence of histidine phosphates was often missed.  
Phosphohistidines also have a higher free energy than ATP and tend to function 
substoichiometrically as phosphotransfer intermediates rather than as regulatory 
modifications per se.  Therefore these factors delayed the discovery of histidine protein 
kinases in bacteria, the first being purified and studied by Hess et al. (1988) and Ninfa 
et al. (1988). 
 
1.4.3.2. Histidine kinase.  There are currently ~22000 histidine kinases identified in the 
P2CS database (Barakat et al., 2009).  P2CS is a database for prokaryotic TCSs, which 
contains compilations of TCS genes from 755 completely sequenced genomes and 39 
metagenomes.  The first histidine kinases to be sequenced included EnvZ (Mizuno et al., 
1982), PhoR (Tommassen et al., 1982), CpxA (Albin et al., 1986), NtrB (Nixon et al., 
1986), DctB (Ronson et al., 1987), VirA (Leroux et al., 1987), and CheA (Stock et al., 
1988).  The first model for two-component signal transduction was proposed by Ninfa 
et al. (1988) where NtrB functions as a kinase/phosphatase to control the cellular level 
of NtrC-phosphate in response to nitrogen availability, and NtrC acts to regulate 
transcription at nitrogen-regulated promoters.  Sensor histidine kinases exhibit 
concentrated regions of homology and conservation termed homology boxes and these 
are described in Section 1.4.3.3.  The most conserved region is the kinase core (Figure 
1.16). 
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Figure 1.16 The kinase cores of histidine kinases PhoQ and HK853.  (A) Structure 
of C-terminal catalytic and ATP binding (CA) domain of E. coli PhoQ (PDB: 1ID0) 
(Cheung et al., 2008).  Homology boxes important for ATP binding are shown in blue.  
(B) Structure of the entire kinase core of Thermotoga maritimae HK853 (PDB: 2C2A) 
(Marina et al., 2005).  Dimeric HK853 is shown with one monomer in orange and pink, 
and the other in grey.  An ATP analogue is bound to the CA domain which is covered 
by the ATP lid (orange).  Diagram taken from Gao & Stock (2009). 
 
1.4.3.3. Histidine kinase domains and conserved regions (homology boxes).  
Membrane-bound histidine kinases possesses several identifiable domains and 
conserved regions that are involved in signal perception (the sensory domain), signal 
transduction across the membrane (the transmembrane domain), phosphorylation and 
dimerisation domain for ATP binding and catalysis.  Homology boxes have been 
identified in several of these domains, including the H, N, G1, F, and G2 boxes 
(Parkinson & Kofoid, 1992; Stock et al., 1995; Grebe & Stock, 1999).  The conserved 
H-box, which is located in the histidine kinase and dimerisation domains contains the 
site of histidine phosphorylation, whereas the N, G1, F, and G2 boxes define the 
nucleotide binding cleft (Figure 1.16). 
 
1.4.4. Histidine kinases of E. faecalis 
 
1.4.4.1. Membrane-bound sensor histidine kinases of E. faecalis.  There are 
seventeen TCS pairs along with one orphan response regulator identified in the E. 
faecalis strain V583 (Hancock & Perego, 2002).  The seventeen sensor histidine kinases 
of E. faecalis (Figure 1.17) are subgrouped according to the conservation of amino acids 
surrounding the phosphorylatable histidine residue in the H-box, a scheme proposed by 
Fabret et al. (1999). 
 
A B 
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Figure 1.17 Schematic diagram of the sensor histidine kinases of E. faecalis.  
Diagram taken from Hancock & Perego (2002).  Sensor histidine kinases of E. faecalis 
are grouped according to the scheme of Fabret et al. (1999).  Transmembrane domain 
(green rectangles), histidine phosphorylatable domain (square), PAS or GAF domain 
(orange rectangle). 
 
All the sensor histidine kinases of E. faecalis V583, apart from one (HK17), are 
predicted to be membrane-bound (Figure 1.17) (Hancock & Perego, 2002), consistent 
with the observation that localisation of the kinase in the membrane of the bacterial cell 
is a general feature of most TCSs (Kim & Forst, 2001).  Two of the kinases belong to 
group I and one to group II.  Ten kinases were assigned to group IIIA, which is the most 
abundant class of kinases in Gram-positive bacteria (Ferretti et al., 2001; Kuroda et al., 
2001; Tettelin et al., 2001).  One kinase was classified into group IV.  The remaining 
kinases were not classified as they do not appear to fit into the current classification 
scheme of Fabret et al. (1999); these include FsrC the quorum sensing kinase, and 
HK16 and HK17 of unknown function (Table 1.2). 
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Group
1 
 
Kinase 
Accession 
no.
 
Phosphorylatable 
histidine region
2
 
 
Similarity
3
 
(possible functions or systems it 
control) 
 
I 
EF2219 
(HK01) 
Q832K7 
LQSQINPHFLYNTLEYIR YesM of B. subtilis 
(sugar utilisation and cell wall 
sensitivity to bacitracin) 
EF3197 
(HK02) 
Q82Z75 
LQAQVNPHFFFNAINTIS LytS of S aureus 
(cell wall metabolism and murein 
hydrolase activity) 
 
II 
EF2912 
(HK03) 
Q82ZY5 
HRLAREIHDSVSQQLFAAM YvqE of B. subtilis; VraS of S. aureus 
(increase antibiotic resistance such as 
vancomycin and bacitracin) 
 
 
IIIA 
EF1704 
(HK04 
Q834F1 
DFVSNVSHELKTPVTSLLG PhoR of B. subtilis 
(growth of cell, heat sensitivity and 
virulence) 
EF3290 
(HK05) 
Q82YZ0 
ELITNVSHDIRTPLTSIIG CroS 
(growth, cell morphology and 
virulence) 
EF1261 
(HK06) 
Q835W1 
QFMADASHERMTPLTTING YclK of B. subtilis 
(growth, oxidative stress, virulence, 
membrane function and structure) 
EF1194 
(HK07) 
Q836C1 
EFVSNVSHELRTPLTSMRS YycG of B. subtilis 
(cell wall biosynthesis and division, 
membrane composition, genetic 
competence and virulence) 
EF1863 
(HK08) 
Q833S3 
DFFKGASHELKTPLASLKI VncS of S. pneumonia 
(vancomycin resistant, heat sensitvity, 
and genetic mobile elements) 
EF0927 
(HK09) 
Q837B6 
DYIDSWVHEIKVPLAAITL Similar to lactobacilli protein kinases of 
unknown function 
EF1051 
(HK10) 
Q836Q7 
QFVEDVSHELKTPIAAVSV LisK of L. monocytogenes;  
CsrS of S. pyrogenes 
(virulence, acid and heat sensitivity) 
EF2298 
(HK11) 
Q47745 
YFFAAASHELKTPAAVSV VanSB of E. faecalis 
(vancomycin resistant) 
EF0570 
(HK12) 
Q838F4 
NLLRAVSHDLRTPLTVISG KdpD of Clostridium actobutylicum 
(potassium concentrations, osmotic 
shock, and turgor pressor)  
EF0373 
(HK13) 
Q838R2 
ELIANISHDLKTPITSIIG WalK (yycG or VicK) of S aureus 
(autolysis, cell wall metabolism and 
biofilm formation) 
 
IV 
EF1209 
(HK14) 
Q836A8 
SALQSQSHEFMNKMHVIYG CitA of E. coli; YufL of B. subtilis 
(Citrate and C4 carboxylate 
metabolism, malate utilisation) 
 
Not 
grouped 
EF1820 
(HK15) 
Q833V6 
EELAMFRHDYKNLLYSLYS FsrC of E. faecalis 
(quorum sensing, biofilm, gelatinase 
and serine protease production) 
EF1335 
(HK16) 
Q835P1 
TNVLKLKHDLKNQYLTILG VirS of C. perfringes 
(toxin production, regulation of 
antibiotic uptake) 
EF1632 
(HK17) 
Q834L6 
VAIREIHHRVKNNLQSVVS Unknown function 
 
Table 1.2 Histidine kinases of Enterococcus faecalis V583.  Table after Hancock & 
Perego (2002).  
1
Grouped based on the homology of the phosphorylatable histidine 
region (Fabret et al., 1999).  
2
Amino acid sequence of the phosphorylatable histidine 
region.  
3
Similarity search by FASTA3. 
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1.4.4.2. Predicted biological functions.  Information concerning three-dimensional 
structures and molecular mechanisms and functions of intact membrane TCSs, 
including those of E. faecalis, is generally lacking.  Concerning the E. faecalis V583 
systems, only three systems, FsrCA and VanSR and VicKR have been functionally 
characterised (Evers & Courvalin, 1996; Nakayama et al., 2001; Ma et al., 2008).  
Similarity searches, comparisons with other known bacterial TCSs (Hancock & Perego, 
2002), systematic inactivation of the response regulator components (Teng et al., 2002; 
Le Brenton et al., 2003; Hancock & Perego, 2004; Muller et al., 2008), experiments 
using mouse peritonitis and peritonitis macrophage models (Teng et al., 2002; Muller et 
al., 2008) have all provided valuable insights into the potential roles of each TCS of E. 
faecalis.  Some were shown to be associated with virulence or responses to 
antimicrobial agents and others in stress responses, but their precise molecular 
environmental signals have not been identified, even in the case of the functionally-
characterised VanSR.  Below is a summary of what is currently known about each 
system. 
 The TCS EF2219-EF2218 (HK01-RR01) function is unknown, but it is 
homologous to YesM of B. subtilis that is located next to pectin/rhamnogalacturonan 
utilisation genes (Poncet et al., 2009).  Inactivation of the response regulator RR01 
resulted in increased sensitivity to cell wall active agent bacitracin (Hancock & Perego, 
2004b). 
EF3197-EF3196 (HK02-RR02) is highly homologous to LytSR of S. aureus.  
The sensor histidine kinase EF3197 possesses 55% identity with LytS (Brunskill & 
Bayles, 1996; Hancock & Perego, 2002), suggesting a possible role for this system in 
cell wall metabolism and lysis through intrinsic murein hydrolase activity (Rice & 
Bayle, 2008).  However, no changes in rate of autolysis were observed in an RR02 
mutant, only an altered uptake of antibiotics such as erythromycin was observed in this 
mutant, and possibly the system was involved in cell wall permeability functions 
(Hancock & Perego, 2004b).  The EF3197 kinase was investigated in this study and is 
more fully described in Section 5.2. 
EF2912-EF2911 (HK03-RR03) is homologous to YvqE of B. subtilis that is 
involved in resistances to bacitracin and nisin (Mascher et al., 2003; Hansen et al., 
2009), and is also homologous to VraS of S. aureus that contributes to methicillin-
resistance (Kuroda et al., 2003; Boyle-Vavra et al., 2006; Yin et al., 2006); 
overexpression of response regulator VraR leads to an increased resistance to 
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vancomycin (Kuroda et al., 2000).  Interestingly, the system is highly conserved in 
Gram-positive bacteria including S. aureus, S. pyogenes, and S. pneumonia (identity of 
60 – 70%).  Mutations in RR03 resemble that of RR01, exhibiting increased sensitivity 
to bacitracin (Hancock & Perego, 2004b). 
EF1704-EF1703 (HK04-RR04) is similar to the PhoPR system of B. subtilis 
(Hancock & Perego, 2002; Teng et al., 2002; Howell et al., 2003).  HK04 is 30% 
identical to PhoR and RR04 is 54% identical to PhoP (Hulett, 1996).  Disruption of the 
response regulator gene RR04 resulted in sensitivity towards heat in strain JH2-2 (Le 
Breton et al., 2003) and in a growth defect in strain V583 (Hancock & Perego, 2004b).  
The system was shown to be induced under phosphate deprivation conditions, and 
required for full survival in macrophages, confirming its role in virulence (Muller et al., 
2008).    
EF3290-EF3289 (HK05-RR05) is named the CroSR system and is required for 
intrinsic β-lactam resistance (Hancock & Perego, 2004b; Comenge et al., 2003).  A 
RR05 mutant caused growth defects and alteration in cell morphology in strain JH2-2 
(Le Breton et al., 2003).  The system is also involved in virulence since the mutation 
also impaired survival in macrophages (Muller et al., 2008). 
EF1261-EF1260 (HK06-RR06) is also associated with virulence and is most 
similar to YclK of B. subtilis (Kobayashi et al., 2001).  A RR06 mutant was shown to 
exhibit impaired survival and susceptibility to oxidative stress (Muller et al., 2008).  
RR06 mutant was found to be more susceptible than wild type to heat and SDS, 
suggesting the system could be linked with membrane functions and structure (Hancock 
& Perego, 2004b).   
EF1194-EF1193 (HK07-RR07), also named VicKR is reported an essential 
system for E. faecalis.  The system is highly similar to essential YycFG of B. subtilis, 
which is also found highly conserved in Gram-positive bacteria (Bolotin et al., 2000; 
Ferretti et al., 2001; Glaser et al., 2001; Kunst et al., 1997; Kuroda et al., 2001; Nolling 
et al., 2001; Tettlelin et al., 2001).  The EF1194 kinase is 70% similar and 45% 
identical to the YycG kinase (Yamamoto et al., 2001).  Studies have shown that the 
system is involved in regulation of genes involved in cell wall biosynthesis or cell 
membrane composition (Howell et al., 2003; Ng et al., 2003; Ng et al., 2004; Dubrac & 
Msadek, 2004; Mohedano et al., 2005; Ng et al., 2005), cell division (ftsAZ operon) 
(Fukuchi et al. 2000), virulence and genetic competence (Ng et al., 2005; Wagner et al., 
2002; Senadheera et al., 2005) and biofilm formation (Senadheera et al., 2005).  
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Hancock & Perego (2004) provided suggestive evidence for the essential nature of this 
system, since knockouts in the response regulator gene vicR appeared to result in a 
lethal phenotype. 
EF1863-EF1864 (HK08-RR08) is most similar (56% similarity and 35% identity) 
to the VncSR system of S. pneumoniae implicated in vancomycin tolerance (Novak et 
al., 1999), and linked to mobile genetic elements (Hancock & Perego, 2004b).  In 
common with the EF1704-EF1703 and EF3329 mutations, disruption of RR08 led to 
heat sensitivity (Le Breton et al., 2003). 
Little is known about the EF0927-EF0926 (HK09-RR09) system.  Similarity 
searches showed that the HK09 is most similar to some lactobacilli proteins, but of 
unknown function. 
EF1051-EF1050 (HK10-RR10) is also named EtaSR, and has been shown to 
contribute to virulence in a mouse peritonitis model and peritoneal macrophages (Teng 
et al., 2002; Muller et al., 2008).  Mutants show increased acid sensitivity (Teng et al., 
2002) and heat resistance correlated with DnaK and GroEL levels (Le Breton et al., 
2003).  This system is most similar to the LisKR and CsrSR systems of other Gram-
positive bacteria.  The EF1051 kinase was investigated in this study and is described in 
Section 5.3. 
EF2298-EF2299 (HK11-RR11) also called VanSBRB regulates VanB-type 
vancomycin resistance.  Inactivation of the genes leads to significantly more sensitivity 
towards vancomycin (Evers & Courvalin, 1996; Hancock & Perego, 2004b). 
EF0570-EF0571 (HK12-RR12) shares similarity with KdpDE from several 
Gram-positive and Gram-negative organisms (Treuner-Lange et al., 1997).  The genes 
are often located on a pathogenicity island, though not always present in all E. faecalis 
strains and therefore suggesting that it may not be essential for a commensal life style 
(Teng et al., 2002; Hancock & Perego, 2004b; Shankar et al., 2002). 
EF0373-EF0372 (HK13-RR13) is homologous to WalK (synonums: VicK, 
yycG) of S. aureus, having 34.2% identity and 73.8% similarity.  WalK is shown to 
regulate genes involved in autolysis, biofilm formation and cell wall metabolism 
(Wagner et al., 2002; Clausen et al., 2003; Jansen et al., 2007).  Expression of EF0373-
EF0372 was only detectable at high temperature (55
o
C), suggesting a possible role in 
stress response (Le Breton et al., 2003). 
EF1209-EF1210 (HK14-RR14) is most similar to CitBA and DcuSR that are 
involved in regulation of citrate and/or C4 dicarboxylate transport (Scheu et al., 2008; 
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Yamamoto et al., 2009).  EF1209 is 30% identical and 65% similar to DcuS of E. coli.  
Mutant RR14 lacks the response regulator component which resulted in a growth defect 
(Hancock & Perego, 2004b) and increased sensitivity at high temperature (50
o
C), 
suggesting that the system is involved in stress responses (Le Breton et al., 2003).  The 
system is also similar to YufLM of B. subtilis (the kinase being 34% identical and 65% 
similar to YufL) that is involved in regulation of malate utilisation (Tanaka et al., 2003; 
Doan et al., 2003). 
EF1820-EF1821 (HK15-RR15) is the Fsr quorum sensing system of E. faecalis 
(Qin et al., 2000; Nakayma et al., 2001; Qin et al., 2001; Nakayama et al., 2006).  In a 
systemic inactivation of all two-component systems present in E. faecalis, it was 
demonstrated that the fsr system is the only system affected in biofilm formation 
(Hancock & Perego, 2004b).  The fsr regulatory locus is comprised of four genes; 
designated fsrA, fsrB, fsrC and fsrD, and its genes organisation are highly similar to the 
agr system in Staphylococcus and other Gram-positive bacteria (Autret et al., 2003; 
Nakayama et al., 2006).  The Fsr kinase (EF1820) was investigated in this study and is 
described in Section 5.4. 
EF1335-EF1336 (HK16-RR16) is homologous to the VirRS system of 
Clostridium perfringens (28% identity and 61% similarity) that is involved in toxin 
production (Cheung et al., 2009).  A knockout of RR16 in E. faecalis V583 displayed 
faster doubling times during growth in the presence of subinhibitory concentrations of 
erythromycin, suggesting that the system could affect upake of this class of drug 
(Hancock & Perego, 2004b). 
EF1632-EF1633 (HK17-RR17) is the only system in E. faecalis with a 
cytoplasmic sensor histidine kinase (Hancock & Perego, 2002).  The system showed no 
similarity to known TCSs and the function is unknown.   
 
1.4.5. Mechanism of stimulus perception 
  
 Sensor histidine kinases of the TCSs play important roles in bacterial signal 
transduction by sensing external signals and directly affecting the phosphorylation state 
of the cytoplasmic kinase domain through stimulating its kinase or phosphatase activity.  
A classic sensor histidine kinase is homodimeric and typically has two transmembrane 
segments with an extracellular loop though which signal is sensed.  With the increasing 
number of kinase domain structures it was shown that depending on the subcellular 
localisation of the specific system and properties of the detected signal, input domains 
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could be extracellular, membrane-embedded, or intracellular (Figure 1.18) (Cheung & 
Hendrickson, 2010).  Current structures of some portions of the histidine kinases 
provide insights into the architecture relating to the overall mechanisms of the kinases 
(Figure 1.19).  The precise mechanisms by which signals are perceived by the kinase 
and transduced across the membrane remains elusive, particularly in the absence of 
intact proteins possessing their transmembrane and sensory domains. 
 
 
Figure 1.18 Mechanisms of stimulus perception by sensor kinases.   (A) 
Periplasmic-sensing kinase.  (B) Transmembrane region-sensing kinases.  Stimulus 
perception either occurs with the membrane-spanning helices alone or with combination 
of the transmembrane regions and short cytoplasmic loops.  (C) Cytoplasmic-sensing 
kinase (could be soluble or membrane bound).  The stimulus is represented by a yellow 
arrow. 
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Figure 1.19 Structures of histidine kinase domains.  Diagram after Szurmant et al. 
(2007).  Sensor histidine kinase is a large modular protein comprised of the conserved 
C-terminal catalytic core and several optional N-terminal elements involved in signal 
sensing or propagation of signal to the catalytic core.  Example structures for 
periplasmic domains include: CitA of Klebsiella pneumoniae (PDB: 1P0Z) (Reinelt et 
al., 2003), DcuS of E. coli (PDB: 3BY8) (Cheung & Hendrickson, 2008), PhoQ of E. 
coli (PDB: 3BQA) (Cheung et al., 2008), LuxQ of Vibrio harveyi (PDB: 2HJE) 
(Neiditch et al., 2006).  An example of HAMP (Histidine kinases, adenylyl cyclises, 
methyl-accepting chemotaxis proteins, and phosphatases) domain: Af1503 of 
Archaeoglobus fulgidus (PDB: 2ASX) (Hulko et al., 2006).  Example structures of 
cytoplasmic sensing domain: FixL of Bradyrhizobium japonicum (PDB: 1DRM) (Gong 
et al., 1998), PYP of Rhodospirillum centenum (PDB: 1MZU) (Rajagopal & Moffat, 
2003), BphP of Deinococcus radiodurans (PDB: 1ZTU) (Wagner et al., 2005).  
Example structures of catalytic domain: HK0853 of Thermotoga maritime (PDB: 2C2A) 
(Marina et al., 2005). 
 
1.4.5.1. Periplasmic-sensing.  The three classes of periplasmic sensor domain include: 
mixed alpha-beta folds, all-alpha folds, and periplasmic binding protein-like folds.  
Recent sequence analysis revealed a putative additional class of all-beta sensor domains, 
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though currently there is no structural evidence for this.  The first three periplasmic 
sensing domain structures solved include PhoQ (Cheung et al., 2008; Cho et al., 2006), 
DcuS (Cheung & Hendrickson, 2008; Pappalardo et al., 2003) and CitA (Reinelt et al., 
2003; Sevvana et al., 2008) (Figure 1.19), all with alpha-beta folds, and were termed 
PDC (PhoQ-DcuS-CitA) domains.  These periplasmic domains sense divalent ions, C4-
dicarboxylates and citrate respectively.  PDC sensors are the most prevalent, 
distinguishable by a long N-terminal helix and often a short C-terminal helix, and a 
central five-stranded anti-parallel β-sheet scaffold.  The central β-sheet scaffold has the 
same topology as Per-Arnt-Sim (PAS) domains (Moglich et al., 2009), but also contains 
other distinctive structural features (Cheung et al., 2008).  The most recent structures of 
PDC sensor domain include the oligosaccharide sensor AbfS (Emami et al., 2009) and 
the PhoR periplasmic domain (PDB code: 3cwf).  Often observed in extracellular sensor 
domains are domain insertions in which a second membrane-distal PDC domain is 
inserted between the first and second helices of the membrane-proximal PDC domain, 
forming a double-PDC domain (Cheung & Hendrickson, 2010).  Double-PDC domains 
were first reported in quorum sensor LuxQ (Neiditch et al., 2005; Neiditch et al., 2006) 
that forms a complex with the periplasmic binding protein LuxP in order to sense its 
autoinducer.  Comparable structures were also found in a C4-dicarboxylate sensor (DctB) 
(Cheung & Hendrickson, 2008; Zhou et al., 2008b) that has a ligand binding pocket in 
the membrane-distal domain (Figure 1.20), as well as recent structures including: 
sensors HK1s-Z2 (PDB code: 3LI9), HK1s-Z3 (PDB code: 3LIB), HK1s-Z6 (PDB code: 
3LIC), HK1s-Z8 (PDB code: 3LID), and HK1s-Z16 (PDB code: 3LIF (Zhang and 
Hendrickson, to be published). 
 All-alpha folds periplasmic sensor domains are represented by NarX (Cheung & 
Hendrickson, 2009), TorS (Moore & Hendrickson, 2009) (Figure 1.20), and a structure 
in PDB (3KKB) (Tan et al., to be published).  A membrane-distal left-handed four-helix 
bundle is stacked against a membrane-proximal right-handed four-helix bundle (Figure 
1.20).  NarX senses nitrite and nitrate through direct binding, whereas TorS froms a 
complex with the accessory periplasmic binding protein TorT to bind trimethylamine-
N-oxide (Baraquet et al., 2006). 
 The third class of periplasmic sensor domain has a similar fold to periplasmic 
binding proteins, and is represented by HK29s (Cheung et al., 2009b) where the signal 
for this protein is not yet determined.   
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Figure 1.20 Periplasmic sensing domains.  Structures are shown for: (A) PDC sensors 
DcuS and DctB; (B) all-alpha periplasmic sensor NarX and TorS; and (C) sensor with 
similar fold to periplasmic binding proteins HK29s (PDB code: 3H7M).  Diagram 
modified from Cheung & Hendrickson (2010).   
 
1.4.5.2. Transmembrane-sensing.  Sensor histidine kinases that possess many 
transmembrane helices often lack periplasmic sensing domains.  In these cases the 
sensing domain usually lies within the transmembrane region.  There are currently no 
structures of transmembrane-sensing domains of sensor histidine kinase, but 
biochemical studies have shown that the membrane regions for some histidine kinases 
are important for stimulus sensing.  Examples of transmembrane sensing kinases 
include the DesK kinase that responds to temperature changes (Albanesi et al., 2009; 
Martin et al., 2009), SenS redox sensing which requires binding of secreted octameric 
haem-binding protein HbpS to its N-terminal transmembrane region (Bogel et al., 2009), 
Etr1, a plant histidine kinase that detects ethylene within the hydrophobic N-terminal 
transmembrane region (Voet-van Vormizeele & Groth, 2008), RegB and ArcB that 
sense redox potential through the redox state of membrane-located quinines (Geogellis 
et al., 2001; Swem et al., 2003; Mapica et al., 2004; Bekker et al., 2010), PrrB that 
senses redox potential through interactions with the cbb3-type cytochrome c oxidase 
complex of the respiratory electron transport chain (Oh & Kaplan, 2000), and AgrC 
quorum sensor that detects its autoinducing peptide through two short extracellular 
loops in proximity to the transmembrane region (Geisinger et al., 2008; Jensen et al., 
2008).  As there are currently no structures of transmembrane sensing domains of 
histidine kinases, the structure of a phototaxis sensory rhodopsin II-transducer complex 
(HtrII-SrII) (Gordeiliy et al., 2002), which forms a four-helix bundle in the membrane, 
provides some insights into the helical arrangement of histidine kinases in the 
membrane. 
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DcuS            DctB                   NarX              TorS                             HK29s  
 41 
1.4.5.3. HAMP domains.  Many sensory proteins, including some histidine kinases, 
have a domain consisted of ~50 residues located just inside the membrane and within 
the cytoplasm, called the HAMP (Histidine kinases, adenylyl cyclises, methyl-accepting 
chemotaxis proteins, and phosphatases) domain.  Hence, these are found in histidine 
kinases, adenylyl cyclases, methyl-accepting chemotaxis proteins, and phosphatases 
(Aravind & Ponting, 1999).  HAMP domains are thought to link the transmembrane 
domain of the kinase to its catalytic domain, important for transducing signals from the 
membrane to the kinase core (Hulko et al., 2006).  An example structure of HAMP 
domain is shown by Af1503 in Figure 1.19. 
 
1.4.5.4. Cytoplasmic-sensing. Current data indicate that many cytoplasmic sensing 
domains of sensor kinases have a PAS-fold, distinctive from that of PDC-fold in 
extracellular sensing domains.  A putative PAS domain has been identified in EF1194 
VicK sensor of E. faecalis (Hancock & Perego, 2002; Ma et al., 2008).  PAS domains 
have a five-stranded anti-parallel β-sheet core flanked by α-helices, and it may bind 
with a cofactor and involve in protein-protein interaction.  The first two structures of 
histidine kinase cytoplasmic sensing domain include FixL of Bradyrhizobium 
japonicum (Figure 1.19) and Rhizobium meliloti (Figure 1.21) (Gong et al., 1998; Gong 
et al., 2000; Miyatake et al., 2000; Hao et al., 2002; Dunham et al., 2003; Key & 
Moffat, 2005; Gilles-Gonzalez et al., 2006; Key et al., 2007; Moore & Hendrickson, 
2009), which sense oxygen through haem.  Other examples of cytoplasmic sensing in 
histidine kinases include NreB that detects oxygen through an iron-sulfur ([4Fe-4S]
2+
) 
group (Mullner et al., 2008), the LovK photosensor which forms a flavin adduct upon 
absorption of blue light (Purcell et al., 2007), the MmoS redox-sensor (Figure 1.21) that 
contains two tandem PAS domains (PAS-A and PAS-B) with a FAD cofactor bound to 
an N-terminal PAS domain (Ukaegbu & Rosenzweig, 2009). 
 
 
Figure 1.21 Cytoplasmic sensing domains.  Structures from left to right are: PAS 
domain of FixL (PDB code: 1D06); PAS domains of MmoS (PDB code: 3EWK); GAF 
domain of DosS (PDB code: 2W3D); GAF domain of DevS (PDB code: 2VKS). 
FixL         
  
 
MmoS         
  
DosS         
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 Some cytoplasmic sensor domains have a GAF fold (Ho et al., 2000), which 
consists of a six-stranded anti-parallel β-sheet core related to the PAS domain.  The first 
reported structures of GAF domains were those of histidine kinases DosS (Cho et al., 
2009) and DosT (Podust et al., 2008) of Mycobacterium tuberculosis.  Both of these 
sensors are haem-containing redox sensors that detect changes in the redox state of 
bound iron, or in binding of oxygen, respectively.  Another example of haem-bound 
redox sensor include the DevS (Lee et al., 2008) of Mycobacterium smegmatis, which 
also has a GAF domain (GAF-A) that is controlled through binding of oxygen.  
Additionally, two other structures of GAF domains from sensor histidine kinases were 
deposited in the PDB (PDB codes: 3HCY and 3CIT) but of unknown function. 
 Apart from PAS and GAF domains, there is a third family of cytoplasmic sensor 
domains found in phytochromes, soluble histidine kinase photoreceptors of bacteria, 
fungi, and plants.  One example is the Pseudomonas aeruginosa bacteriophytochrome 
photosensory core domain (PaBphP-PCD) (Figure 1.21); which has a tripartite PCD 
with a PAS, GAF, and phytochrome (PHY) domain arranged along an extended α-helix 
(Yang et al., 2008; Yang et al., 2009).  The PHY domain is very similar to the PAS and 
GAF domains, having a five-stranded anti-parallel β-sheet scaffold, and the PAS and 
GAF domain together forms the chromophore binding domain (CBD). 
 The aims and objectives of this work is detailed in Section 1.5.2. 
 
1.5. Aims and objectives of this work 
 
The determination of membrane protein structures using crystallographic 
methods has been hampered by several major bottlenecks including protein production, 
purification and crystallisation.  The ultimate aim is to facilitate determination of the 
structures of membrane proteins, not just of isolated domains, but of the full-length 
protein, which will allow a complete understanding of structure relating to function. 
 
1.5.1. The NCS1 family of transporters 
 
1.5.1.1. Importance of the NCS1 proteins.  Obtaining crystals of membrane transport 
proteins has been difficult due to their low expression level, hydrophobicity and them 
being dynamic, which makes them hard to extract from the membrane and to crystallise. 
Three structures of Mhp1, each in a different state were elucidated providing 
insights into the mechanism of alternating access (Weyand et al., 2008; Shimamura et 
al., 2010).  NCS1 transporters are particularly interesting to study as they are 
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homologous to Mhp1, the structures which are reminiscent of LeuT and vSGLT, the 
bacterial homologues of the human neurotransmitter and sugar transporters respectively 
(Yamashita et al., 2005; Faham et al., 2008; Weyand et al., 2008), and hence these 
proteins are structurally-related.  Elucidating the mechanism of substrate transport by 
these proteins will therefore be of wide significance. 
  NCS1 transporters also play important roles in the salvage pathways of bacteria, 
fungi and plants; in the capture of nutrients such as nucleobases, hydantoins, 
nucleosides and other related compounds from the environment.  In many organisms, 
the transport of nucleobases into the cell serves as nitrogen sources.  At least one 
protein, Mhp1, has commercial significance; others could putatively have commercial 
significance too. 
 
1.5.1.2. Aims and research objectives.  At the beginning of this research, Mhp1 was 
undergoing crystallisation in a collaborative project between two principlal investigators 
Henderson and Iwata, and no structures of the NCS1 proteins, including Mhp1, were 
solved.  The aim of my work was to clone and overexpress many NCS1 proteins for 
characterisation and crystallisation studies in order to elucidate their structure-function 
relationships.  However, during the course of this research three structures of Mhp1 
were elucidated and this further highlights the importance of the NCS1 transporters. 
The ultimate aim of this research was to define the structure-activity 
relationships and establish the molecular mechanism of the NCS1 family of bacterial 
membrane transporters. 
 
Research objectives 
1) Selecting protein targets – this will involve a search for Mhp1 homologues (the 
targets), followed by in silico analysis of the targets including identifying the 
conserved residues and topology predictions. 
2) Cloning and heterologous expression of bacterial NCS1 transporters (Mhp1 
homologues) – the genes encoding NCS1 transporters will be amplified from the 
organism of interest by PCR, followed by insertion into plasmid pTTQ18-His6 
which showed successful amplification of many membrane proteins (Ward et al., 
2000) as well as introducing a hexahistidine tag.  The resultant recombinant 
construct will be transformed into an E. coli host for expression trials. 
 44 
3) Investigation of substrates transported by the NCS1 transporters – intact cells 
expressing the NCS1 transporter will be screened for the transported substrate.  
The substrate will be in the radiolabelled form for transport assays. 
4) Investigation of transport specificity and kinetics – once substrate(s) for the 
target protein are identified, intact cells expressing the NCS1 transporter will be 
tested for transport kinetics and substrate specificity. 
5) Purification of the NCS1 transporters and testing their integrity – solubilisation 
will be performed to extract the target protein from membranes expressing it, 
followed by purification using Ni-NTA chromatography.  The purified protein 
will be subjected to circular dichroism to test its secondary structure integrity. 
 
1.5.2. The sensor histidine kinases of Enterococcus faecalis 
 
1.5.2.1. Importance of sensor histidine kinases of E. faecalis.  Currently, one of the 
most serious concerns encountered in the clinic is the increasing proportion of 
enterococci that are resistant to the last-line antibiotic vancomycin.  E. faecalis V583 is 
of course is one of those strains.  Evidence has shown that bacterial resistance to 
antibiotics can be regulated by two-component systems (Evers & Courvalin, 1996; 
Matsushia & Janda, 2002).  Since E. faecalis is an important pathogenic organism that 
causes up to 20% of hospital-acquired infections and since it exhibits survival under 
harsh environmental conditions and exhibits increasing resistance to current therapies 
including vancomycin, this study included studies of the membrane histidine kinases of 
the bacterium.  The study was timely, given the recent advances in methods for 
expression and purifying intact sensory kinases that possess their sensory domains 
(Potter et al., 2002; Potter et al., 2006).  The aims included production of intact sensor 
kinases for signal identification, and initiation of structural studies for intact kinases 
using crystallisation and other methods. 
 
1.5.2.2. Aims and research objectives.  The TCSs work is a collaborative project 
between two principal investigators Henderson and Phillips-Jones.  The ultimate aim is 
to define the structure-activity relationships and establish the molecular mechanism of 
the sensor histidine kinases of E. faecalis. 
 
Research objectives 
1) In silico analysis of the membrane-bound sensor histidine kinases of E. faecalis 
– to identify conserved residues and to undertake topology predictions. 
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2) Cloning and heterologous expression of the genes encoding the sensor histidine 
kinases of E. faecalis – The sensor histidine kinase genes will be amplified from 
E. faecalis by PCR, followed by cloning into plasmid pTTQ18-His6.  The 
resultant plasmids will be transformed into expression host for expression trials. 
3) Purification of sensor histidine kinases and confirmation of their intact state – 
the sensor kinases will undergo solubilisation trials followed by purification 
using Ni-NTA chromatography.  The purified proteins will be confirmed as 
intact by Western blotting together with N-terminal sequencing and/or mass 
spectrometry. 
4) Comparison of activities of sensor histidine kinases when in the membrane-
bound and purified forms – the sensor histidine kinases will be subjected to 
autophosphorylation assays using radiolabelled ATP. 
5) Identification of ‗signalling‘ ligands and/or inhibitors that modulate the activities 
of the histidine kinases of E. faecalis. 
6) To initiate structural studies in order to increase understanding of how signals 
are transduced across the membrane by intact membrane histidine kinases.  This 
will include crystallisation trials that may ultimately lead to the elucidation of a 
three-dimensional structure at atomic resolution, and the use of fluorescence and 
circular dichroism experiments in the presence and absence of signalling ligands. 
 
1.6. Outline of research 
 
Chapter 1: Introduction – This chapter highlights the importance of bacterial cell 
membrane and provides a literature review on two families of membrane proteins: the 
NCS1 transporters; and the sensor histidine kinases of E. faecalis.  The aims and 
objectives of the research are specified at the end of the chapter. 
 
Chapter 2: Methods – All methods used to carry out the research are detailed in this 
chapter; including recombinant DNA technologies, protein preparation and 
manipulation, and biochemical and biophysical techniques. 
 
Chapter 3: Overexpression, purification and characterisation of the NCS1 family 
of transport proteins – This chapter describes the investigation of NCS1 transporters, 
outlines how the genes of interest are isolated from the bacterium and expressed in E. 
coli cells allowing their extraction from the membrane (Section 3.1).  The substrates for 
some transporters were also explored and identified (Section 3.1).  Three NCS1 
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transporters for which the substrates were identified were further investigated and are 
described in Section 3.2 to 3.4. 
 
Chapter 4: Purification and substrate binding studies of Microbacterium 
liquefaciens hydantoin permease (Mhp1) – Binding of substrate and ligand to Mhp1 
were investigated and described in this chapter. 
 
Chapter 5: Overexpression and purification of the intact membrane histidine 
kinases of Enterococcus faecalis V583 for activity, structural and ligand binding 
studies – This chapter outlines the expression, purification and activities of sensor 
histidine kinases of E. faecalis (Section 5.1).  Further sections investigate the sensor 
kinases EF3197, EF1051 and FsrC in detail (Sction 5.2 to 5.4). 
 
Chapter 6: Conclusions and future perspectives – A detailed conclusion for the 
research are discussed in this chapter, highlighting the impact of the research, followed 
by concluding remarks. 
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2.1. Sources of materials 
 
2.1.1. Antibiotics 
Carbenicillin (Melford laboratories, U.K.); siamycin I (synthesised by Kenzo 
Nishiguchi, Kyushu University, Japan); tetracycline (Sigma-Aldrich, U.K.).  
 
2.1.2. Bacterial growth media 
CaCl2, glycerol, KH2PO4, MES, MgSO4, NaCl, Na2HPO4, NH4Cl, (Sigma-Aldrich, 
U.K.); casamino acids (Q.BIOgene, U.K.); isopropyl β-D-1-thiogalactopyranoside 
(IPTG) (Melford laboratories, U.K.); microagar, tryptone and yeast extract (Oxoid Ltd., 
U.K.). 
 
2.1.3. Filters, membranes and chromatography paper 
0.45 μm cellulose nitrate/acetate membrane filter, type HA (Millipore Ltd., U.K.); 0.22 
μm nitrocellulose membrane filters, type GTSF (Millipore Ltd., U.K.); 0.1, 0.2 and 0.4 
μm Nucleopore®  polycarbonate (Whatman International Ltd. U.K.). 
 
2.1.4. Protein assay, membrane preparation, purification, phosphorylation assay 
and fluorimetry 
Acetic acid, bovine serum albumin (BSA), chicken lysozyme, choline Cl, dimethyl 
sulfoxide (DMSO), dithiothreitol (DTT), ethylenediaminetetraacetate (EDTA), HgCl2, 
imidazole, KCl, mercaptoethanol, MgCl2, MgSO4, NaCl, NaOH, naphthol blue black, 
sodium dodecyl sulphate (SDS), sucrose, trichloroacetate (TCA), tris base ultrapure 
(TRIS) (Sigma Chemicals Co., U.K.); detergents list – see Section 2.5.2 (Melford 
laboratories, U.K. and Sigma-Aldrich); ethanol, methanol, Na2HPO4, NaH2PO4 (Fisher 
Scientific UK Ltd., U.K.); nickel-nitriloacetic acid (Ni-NTA) resin (QIAGEN Ltd., 
U.K.); gelatinase biosynthesis-activating pheromone (GBAP). 
 
2.1.5. Protein standards 
High-range rainbow coloured protein molecular weight marker (GE Healthcare Ltd., 
U.K.); precision plus protein
TM 
standards (BioRad laboratories, U.K.); Sigma7 protein 
molecular weight markers (Sigma-Aldrich, U.K.). 
 
2.1.6. Radiolabelled compounds 
Radiolabeled 
32
P or 
33
P-ATP (GE Healthcare Ltd., U.K.); radiolabeled nucleobases 
(Perkin Elmer., UK; Sigma-Aldrich Co., U.K.); 
14
C-allantoin was synthesised by Dr 
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Simon Patching; 
3
H-L-5-benzylhydantoin and 
3
H-indolymethylhydantoin were 
synthesised by Dr Simon Patching and Dr Shun‘ichi Suzuki. 
 
2.1.7. Recombinant DNA technology 
1 kb Plus DNA ladder and 1 kb DNA ladder (Invitrogen Ltd, U.K.); E. coli BL21(DE3) 
cells (EMD Biosciences, Inc. Novagen Brand, U.S.A.); dNTPs, Pfu Turbo
®
 DNA 
polymerase, Taq thermal polymerase and thermal polymerase buffer, XL10-Gold 
ultracompetent cells (Stratagene, U.S.A); EcoRI, HindIII, NdeI, PstI, restriction enzyme 
buffers, T4 DNA ligase and T4 DNA ligase buffer (New England Biolabs
®
 Inc., U.K.); 
Lambda DNA EcoRI and HindIII markers (Promega Ltd., U.K.); oligonucleotide 
primers (MWG-Biotech Ltd., U.K.); QIAquick gel extraction kit & QIAprep spin 
miniprep kit using a microcentrifuge (QIAGEN Ltd., U.K.); SYBR Safe
TM
 DNA gel 
stain (Invitrogen, U.S.A.). 
 
2.1.8. Scintillation fluid and vials 
Scintillation fluid (Perkin Elmer, U.K.); scintillation vials (Sarstedt Ltd., U.K.). 
 
2.1.9. Substrates 
Hydantoin (Fluka chemika); L-5-benzylhydantoin and L-5-indolylmethylhydantoin 
were synthesised by Dr Simon Patching and Dr Shun‘ichi Suzuki; nucleobases, 
nucleosides, allantoin, allantoic acid and uric acid (Sigma-Aldrich, U.K.). 
 
2.1.10. SDS-PAGE and Western blotting 
2 % bis-acrylamide, 40 % acrylamide (BioRad laboratories, U.K.); acetic acid, 
ammonium persulphate, BSA standards, brilliant blue R, bromophenol blue, glycine, 
KCl, mercaptoethanol, methanol, TEMED, TRIS, Triton X-100, Tween 20 (Sigma-
Aldrich, U.K.); Fluorotrans
TM
 membrane (Pall BioSupport, U.K.); supersignal®  west 
pico chemiluminescent substrate, HisProbe
TM
 HRP (Pierce Science UK Ltd., U.K.). 
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2.2. General microbiology 
 
2.2.1. Bacterial strains used in this study 
 
The Escherichia coli strains used throughout this study are detailed in Table 2.1.   
 
Strain Genotype Source 
XL10-Gold Tet
rΔ(mcrA)183Δ(mcrCB-hsdSMR-mrr)173 
endA1 supE44 thi-1 recA1gyrA96 relA1 lac 
Hte [F
‘
 proAB lacl
q
ZΔM15Tn10(Tetr)Amy 
Cam
r
] 
Stratagene
TM 
BL21(DE3) (F
-
 ompT hsdSB (r
-
B m
-
B) gal dcm (DE3)) Novagen
TM 
 
Table 2.1 E. coli strains used for cloning and expression.  Genotypes after the 
nomenclature taken from (Sambrook et al., 1989). 
 
2.2.2. Growth and storage media 
 
All media used for growth and storage of bacterial cultures are detailed in Table 2.2. 
 
Medium 
 
Ingredients 
Luria Bertani (LB) 10 g/L tryptone; 10 g/L NaCl; 5 g/L yeast 
extract; pH to 7.5 
Minimal  0.2% (w/v) casamino acids; 20mM glycerol; 
2mM MgSO4; 0.2mM CaCl2; 1x M9 salts 
(stock of 5x M9 salts was made: 64 g/L 
Na2HPO4; 15 g/L KH2PO4; 2.5 g/L NaCl; 5 g/L 
NH4Cl) 
2x Tryptone / Yeast extract (2TY) 10 g/L tryptone, 10 g/L yeast extract, 5 g/L 
NaCl; pH to 7.5 
Freezing mixture 12.6 g/L K2HPO4; 0.9 g/L Na3C6H5O7.2H2O; 
0.18 g/L MgSO4; 1.8 g/L (NH4)2SO4; 3.6 g/L 
KH2PO4; 96.0 g/L glycerol  
TSS LB-medium containing 10% (w/v) PEG 8000; 
5% (w/v) DMSO; 25mM MgCl2; pH6.5 
SOB 20 g/L Tryptone; 5 g/L yeast extract; 0.5 g/L 
NaCl; 20mM MgSO4 
 
Table 2.2 Growth media for bacterial cultures.   
 
Solutions were prepared using deionised or MilliQ
TM
 water, and sterilised by 
autoclaving at 15 psi for 20 min at 121
o
C.  Heat-labile solutions were filter-sterilised 
using 0.2 µM cellulose acetate filters.  Carbenicillin (100 mg/ml) and tetracycline stocks 
(15 mg/ml) were prepared in water and ethanol respectively, filter sterilised and stored 
at -20
o
C. 
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A frozen stock of each clone was made by inoculating a single colony of 
BL21(DE3) cells harbouring the clone into 5 ml LB medium with 100 μg/ml 
carbenicillin and growing for approximately 4 hours.  The culture, 0.5 ml was taken and 
added to an equal volume of freezing mix, quick frozen in liquid nitrogen and stored at -
70
o
C. 
 
2.2.3. Plasmid pTTQ18 
 
Plasmid pTTQ18 (Stark, 1987) is based on the pUC high expression series of 
plasmids and contains a polylinker/lacZ alpha flanked by the strong hybrid trp-lac (tac) 
promoter (de Boer et al., 1983) and the rrnB transcription terminator.  A hexa-histidine 
site was engineered into plasmid pTTQ18 by Liang (2005) that introduces hexa-
histidine tag (His-tag) into the C-terminal end of the protein for purification purposes, 
yielding pTTQ18-His6 (Figure 2.1).  This plasmid subsequently showed successful 
overexpression of many prokaryotic membrane proteins (Ward et al., 2000; Saidijam et 
al., 2003; Liang et al., 2005; Potter et al., 2002; Saidijam et al., 2005; Surade et al., 
2006; Suzuki & Henderson, 2006; Betanney, 2008) and was used in this project. 
 
 
Figure 2.1 The plasmid pTTQ18.  The multiple cloning site consists of several 
restriction enzymes sites illustrated by EcoRI, BamHI, PstI and HindIII.  The actual 
multiple cloning site consists of (in the 5‘-3‘ order) EcoRI, EclI36, SacI, Asp718, KpnI, 
AvaI, SmaI, XmaI, BamHI, XbaI, AccI, SalI, Sse8387, PstI, SphI, and HindIII.  The 
plasmid comprises the synthetic tac promoter (ptac), over-expressed LacI repressor 
gene (lacI
q), and regions encoding β-lactamase (bla), and β-galactosidase alpha 
fragment gene (lacZα), and E. coli rrnB operon transcriptional terminator (rnnBtlt2) and 
pUC18 origin of replication (not shown).  Diagram adapted from Ward et al. (2000). 
ptac 
lacZ 
rrnBt1t2 
lacI
q 
bla 
pTTQ18 
4.56 Kb 
EcoRI 0.00 
BamHI 0.02 
PstI 0.03 
HindIII 0.05 
BstEII 1.61 
EcoRV 1.88 
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2.3. DNA preparation and manipulation 
 
Standard methods such as polymerase chain reaction (PCR) amplification, gel 
electrophoretic DNA separation, DNA extraction from agarose gel, plasmid preparation 
and restriction digestion were performed as described in Sambrook et al. (1989). 
 
2.3.1. Cloning strategy – overview 
 
Each target gene was inserted into the multiple cloning site (MCS) downstream 
of the tac promoter in the plasmid pTTQ18-His6 in order to amplify protein expression 
(Figure 2.2).  Two different restriction enzymes, EcoRI and PstI were used to ensure 
correct orientation of the gene on ligation into plasmid pTTQ18-His6, as well as 
preventing re-ligation of the plasmid.  Firstly the membrane protein gene was amplified 
by PCR using bacterial genomic DNA as template, followed by digestion with EcoRI 
and PstI and ligation with EcoRI-PstI digested pTTQ18-His6.  The plasmid construct 
with the gene inserted was then transformed into E. coli XL10-Gold cells, followed by 
colony PCR to identify positive clones. 
 
 
 
Figure 2.2 Cloning strategy for membrane proteins using plasmid pTTQ18-His6.  
This cloning strategy was previously used by Peter J.F. Henderson lab members, 
successfully overexpressing membrane proteins (Ward et al., 2000; Saidijam, 2004; 
Saidijam et al., 2005; Bettaney, 2008). 
 
 Ligation 
 Digestion 
by EcoRI 
and PstI 
PCR gene sequence 
 out of organism 
EcoRI PstI 
pTTQ18-His6 
BstEII 1.66 
EcoRI 0.00 
BamHI 0.02 
ptac 
lacZ 
lacI
q
 bla 
PstI 
0.04 HindIII 0.05 
EcoRV 1.93 
rrnBt1t2 
PstI 0.04 
 4.56 Kb 
pTTQ18(gene)-His6 
HindIII 
His6-tag 
ptac 
lacI
q
 
bla 
PstI 
EcoRI 
rrnBt1t2 
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2.3.2. Primer design and amplification of membrane protein genes 
 
The DNA sequence of the gene of interest was obtained from TransportDB 
(Paulsen et al., 1998; Ren et al., 2007) or UniProt (The UniProt Consortium, 2008).  
Webcutter 2.0 (Heiman, 2000) was used to map the restriction sites in the gene to 
ensure absence of EcoR1 and PstI sites, as these will be the restriction enzymes used for 
cloning.  If an EcoRI or PstI site was found in the gene, NdeI or HindIII were used 
instead respectively.  Since the HindIII site is located downstream of the hexahistidine 
site in the plasmid, the primer introducing the HindIII site must therefore additionally 
contain the His6-tag sequence.  The primers are designed to introduce an EcoRI site 
(GAATTC) or NdeI site (CATATG) in the 5‘ end, and a PstI site (CTGCAG) or HindIII 
(AAGCTT) in the 3‘ end of the gene to promote subsequent ligation with plasmid 
pTTQ18-His6.  The gene sequence was also submitted for topology prediction using 
TMHMM (Krogh et al., 2001) to test that the C-terminal end of the protein is in the 
cytoplasm for incorporation of His6-tag.   
Some considerations for designing primers include: primers should be between 
25 and 45 bases in length; melting temperature ≥70oC; a minimum GC content of 40% 
and usually terminating in G or C bases; should not form primer dimers or other 
secondary structures; primability > 90%; stability 60-70%. 
AmplifX 1.5.4 software was used to design and predict the quality of primers.  
Each primer pair was used in a PCR reaction to isolate a specific membrane protein 
gene from the bacterium of interest.  Primers were prepared in sterilised water (15 
pmol/μl) and stored at -20oC.  The primer pairs used in this project for the amplification 
of NCS1 genes are listed in Table 2.3, and for histidine kinase genes in Table 2.4. 
For a 50 μl PCR mix, 2.5U PFU Turbo, 50 ng bacterium genomic DNA, 0.2 mM 
dNTPs, 0.3 pmole forward and reverse primers, 1x PFU Turbo buffer, 1 mM MgCl2  
were used.  The reaction was carried out as follows: 
 
Steps 
 
Time 
1) Warm-up at 94
o
C 3 min 
2) Denaturation at 94
o
C 1 min 
3) Annealing at 56
o
C 1 min 
4) Extension at 72
o
C 4 min 
5) Final extension at 68
o
C 15 min 
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NCS1 
proteins 
Primer sequence 5’ 3’ 
Forward primer (top) 
Reverse primer (bottom) 
b0336 GCAGAATTCGCATATGTCGCAAGATAACAACTTTAGCC 
  CCCAAGCTTTTAATGATGATGATGATGATGTTCGACACTGTTAGCCTCCACA 
b0511 CCGGAATTCGCATATGGAACATCAGAGAAAACTATTCCAG 
 AAAACTGCAGCACCTATGGTTTTTTGCTCTCCTGTTTTTTC 
Bsu36470 CCGGAATTCGCATATGAAATTAAAAGAGAGTCAGCAGCAATCCA 
 AAAACTGCAGCTTCAGCCTGGCGGACCTGCGCATGTT 
lp_3374 CCGGAATTCGCATATGCAGCAAGAGTCAAAGTATCAAATAGAA 
 AAAACTGCAGCGACACGTTTGGCAGGTAACGGGTAGAAAATTCG 
PA0438 GCAGAATTCGCATATGTCCGCAGACAGCAACTACAG 
 CCCAAGCTTTTAATGATGATGATGATGATGATCAGCATGGAGGACCTCTTC 
PA0443 CCGGAATTCGCATATGCAACAGAGCAGATCGGAAGTGACCGAGCGCGA 
 AAAACTGCAGCGGGCAGCGGTTTGGCCAATGCCGCCGGGCTCCG 
PA0476 CCGGAATTCGCATATGTCCAGCACCCCGAAGCCGCCCGCCTCG 
 AAAACTGCAGCGTGCTGCACGCTGTCCACCGCGATCGCTTCG 
PA2073 CCGGAATTCGCATATGAGCAATAACAACGAGGCGTCACGCCCG 
 AAAACTGCAGCGGCGCCCCCCTCTTCCAGCAGGCGCTCGC 
PPA0619 CCGGAATTCGCATATGACGCAGACCGCCACCAAAACG 
 AAAACTGCAGCTCGTGACTCCTGACGACGCACGGT 
PPA2211 CCGGAATTCGCATATGGTGTCCGCGCCAAATAGTGCTC 
 AAAACTGCAGCCCGAGAAACAATGCTTGGATCCAGC 
SCO0572 GCAGAATTCGCATATGGCCATGCACAAGAACCCCGCCG 
 CCCAAGCTTTTAATGATGATGATGATGATGCGGTGCTCCTACGGTGGCCGTG 
SCO5579 CCGGAATTCGCATATGAGCAAGACCGCCGAGAACGAAGGC 
 AAAACTGCAGCGACGGTCACGGTCTCGGCCTCGGGCTGCT 
SCO6417 CCGGAATTCGCATATGATTGGCCTGCCCATGACCGACACCGCGCC 
 AAAACTGCAGCGGCGGAACGGTTGCGGCTTCCGGCCGCGTCGGT 
SCO7500 CCGGAATTCGCATATGACTGCCCTGGAAGACCGCCGCTCGTC 
 AAAACTGCAGCTTCCGCGGCGACGGCGATGGACTCGCCGTCCAC 
 
Table 2.3 Primer sequences for PCR amplification of NCS1 family genes.  The 
EcoRI, PstI and HindIII sites are in blue, red and green respectively.  The hexahistidine 
tag is coloured purple for the primers containing HindIII restriction site. 
 
For the amplification of genes from a bacterium with high GC content, such as 
for Streptomyces coelicolor and Pseudomonas aeruginosa, the annealing temperature 
was lowered to 40
o
C with addition of 5-10% DMSO in the PCR mix as detailed below. 
 
Steps 
 
Time 
1) Warm-up at 94
o
C 3 min 
2) Denaturation at 94
o
C 1 min 30 secs 
3) Annealing at 40
o
C 1 min 
4) Extension at 72
o
C 4 min 
5) Cycle to step 2 for 2 more times  
6) Denaturation at 94
o
C 30 secs 
7) Annealing at 40
o
C 1 min 
8) Extension at 72
o
C 4 min 
9) Cycle to step 6 for 25 more times  
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HK 
no. 
Histidine 
kinases 
Primer sequence 5’ 3’ 
Forward primer (top) 
Reverse primer (bottom) 
01 EF2219 CCGGAATTCGCATATGAAGCGAATCTTCAAAAAACTGT 
  AAAACTGCAGCTGCTACAAACGAAAGACGAATTG 
02 EF3197 CCGGAATTCGCATATGGTCGAATTATTTATTTTAATGATGGAA 
  AAAACTGCAGCACGATTAATACGTGCATCTAATTCCTCCTGT 
03 EF2912 CCGGAATTCGCATATGACCGATCGGATTTCAAGACGCAT 
  AAAACTGCAGCTCCACTAACATTACTTTGATCACTTGC 
04 EF1704 CCGGAATTCGCATATGAAAAAGAGACTGCGGATTGAATATTT 
  AAAACTGCAGCGGCTTCTTTTTTTGTTAAAAGCAAAGTG 
05 EF3290 CCGGAATTCGCATATAGCTCGTTAAACCTAAAAAGATTGAAAA 
  AAAACTGCAGCACTCTCTGAATTTCTTGTTGGTACGC 
06 EF1261 CCGGAATTCGCATATGAAGTATTTGTATCAACAATTA 
  AAAACTGCAGCGTTTTCAGTAATTTCAACATCAGGAAAT 
07 EF1194 CGATCATGAATTCCAAGAAAAAAGTTCACTTT 
  CGATCCTGCAGCTTCCCACCAATCCTCTTCATA 
08 EF1863 CGATCATGAATTCCAAAAAATTAAAGATATTT 
  CATCCTGCAGCAGAAAATATTTTTATTTTAAAGAT 
09 EF0927 CCGGAATTCGCATATGACCATTCTAAAGTATTTAAAAGAT 
  AAAACTGCAGCTTTCACTTCATTATAATAACTGAGGGA 
10 EF1051 CCGGAATTCGCATATGAAAAGAACGATTAAAAAAGAACTG 
  AAAACTGCAGCTTGTACGTTGCTCTCTTCTTTTATTCCAGCGA 
11 EF2298 CCGGAATTCGCATATGGAAAGAAAAGGGATTTTCATTAAG 
  AAAACTGCAGCTAGTGTTGATGTGGGCGGTAAATC 
12 EF0570 CCGGAATTCGCATATGCAATCTGGCGATGGACGCC 
  AAAACTGCAGCCTTCAAATAAATTCGAACCAATGTTT 
13 EF0373 CCGGAATTCGCATATGACCATTAAACGCCGCTTTTTTA 
  AAAACTGCAGCTTTTTCATCCTCCAACAACGGCAGC 
14 EF1209 CCGGAATTCGCATATGAAGCGTGGCGGGAAATTATGGTGTT 
  AAAACTGCAGCATAATCAATAGGTTCATTTTCCTCTGCTC 
15 EF1820 CCGGAATTCGCATATGATTTTGTCGTTATTAGCTACTAACGTTT 
  AAAACTGCAGCTTCGTTAACAACTTTTTTACTGTTATGATT 
16 EF1335 CCGGAATTCGCATGCTTGATATAACATTACGAAGCCGAAGCC 
  AAAACTGCAGCGTTATCACCGCATTTGTTTCCTTTGTA 
  
Table 2.4 Primer sequences for PCR amplification of E. faecalis sensor kinase 
genes.  The EcoRI, PstI and NdeI sites are in blue, red and brown respectively.  Primers 
for EF3197, EF2912, EF1051, EF0373, EF1209 and EF1820 were designed by myself.  
Primers for EF1194 were designed by Dr Victor Blessie, and the remaining primers 
were designed by Dr Hayley M. Yuille. 
 
2.3.3. Preparation of plasmid pTTQ18-His6 
 
To clone each membrane protein gene into pTTQ18-His6, the plasmid pNorAH6 
(pTTQ18-His6 containing the norA gene) (Hoyle, 2000) was isolated from E. coli strain 
BLR and digested with restriction endonucleases EcoRI or NdeI and PstI or HindIII.  
This yields two fragments, a small fragment of ~1200 bp which is the norA gene and a 
larger fragment of pTTQ18-His6 which was isolated from the agarose gel for cloning. 
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2.3.4. Agarose gel electrophoresis and restriction digestion of PCR product 
 
The PCR products were separated and analysed on 1% (w/v) agarose gel 
electrophoresis.  The 1kb DNA ladder was used for size determination of the PCR 
product (Table 2.5), the key product confirmed was excised and extracted from the 
agarose gel using QIAquick gel extraction kit (QIAquick Spin Handbook 07/2002) and 
subjected to digestion with EcoRI / NdeI and PstI / HindIII or for 3 hours or overnight 
at 37
o
C, this yields the gene with the overhangs for ligation into pTTQ18-His6. 
 
Fragments 1 kb DNA extension ladder 
(Invitrogen
TM) (1 μl = 50 ng) 
Lambda DNA/EcoRI + 
HindIII marker  (Promega
TM
) 
(5 μl = 25 ng) 
Base pairs Amount (ng) Base pairs Amount (ng) 
1 12,216 10 21,226 109.0 
2 11,198 7 5,148 26.5 
3 10,180 7 4,973 25.4 
4 9,162 7 4,268 21.9 
5 8,144 7 3,530 19.0 
6 7,126 7 2,027 10.4 
7 6,108 6 1,904 9.8 
8 5,090 6 1,584 8.15 
9 4,072 6 1,375 7.0 
10 3,054 6 947 5.0 
11 2,036 6 831 4.2 
12 1,636 10 564 2.9 
13 1,018 5 125 0.6 
14 506 3 - - 
 
Table 2.5 DNA molecular weight markers used for determination of DNA 
concentration and size.  Table modified from Saidijam (2004). 
 
Restriction digestion of the PCR products is as follows: 30 μl PCR product; 29 
μl sterile MQTM water; 40 Units EcoRI / NdeI restriction enzyme; 40 Units PstI / 
HindIII restriction enzyme; 7 μl 10x restriction buffer.   
The following buffers or stocks were for agarose gel electrophoresis: 50x TAE 
buffer (2 M Tris, 1 M Acetate, 50 mM EDTA); 1% (w/v) agarose gel (70 ml 1x TAE, 
0.7 g agarose, 1 μl 10 mg/ml SYBR SafeTM DNA gel stain); 10x DNA loading buffer 
(0.005% bromophenol blue, 50% glycerol). 
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2.3.5. Quantification of DNA 
 
2.3.5.1. The Lambda DNA marker method.  To determine the concentration of a 
DNA sample, 1 μl of the DNA was run on a 1% agarose gel electrophoresis alongside 
the Lambda DNA EcoRI+HindIII Markers of known DNA concentrations.  The 
intensity of the DNA band was compared to the markers to determine the concentration.  
This is an approximate estimation of the DNA concentration. 
 
2.3.5.2. The absorbance method.  A dilution of 1:100 of pTTQ18-His6 in MQ
TM
 water 
was made and absorbance at 260 nm and 280 nm measured using the WPA Biowave 
S2100 Diode Array Spectrometer.  The measured absorbance at 260 nm was used to 
calculate the DNA concentration using the standard rule where 1 mg/ml of DNA has an 
A260nm of 20.   A ratio of A260nm / A280nm gives the purity of the DNA sample.  For a pure 
DNA sample, A260nm / A280nm = 1.8.  Above 1.8 is RNA contamination, and below 1.8 is 
protein contamination. 
 
2.3.6. Ligation of gene into plasmid pTTQ18-His6 
 
Ligation reactions were performed using 1:1, 1:3 and 1:5 plasmid to gene molar 
ratios (Table 2.6).  Ligation mixture 4 and 5 are controls with no ligase or no gene. 
 
 Ligation mixture 
1 2 3 4   5 
pTTQ18-His6 5 ng/μl 5 ng/μl 5 ng/μl 5 ng/μl 5 ng/μl 
gene 5 ng/μl 15 ng/μl 25 ng/μl 15 ng/μl No gene 
DNA T4 ligase 1 μl 1 μl 1 μl No ligase 1 μl 
10x T4 ligase 
buffer 
1.5 μl 1.5 μl 1.5 μl 1.5 μl 1.5 μl 
sterile H2O 10.5 μl 8.5 μl 6.5 μl 9.5 μl 11.5 μl 
Total volume  15 μl 15 μl 15 μl 15 μl 15 μl 
 
Table 2.6 Ligation reactions using various plasmid:insert ratios.   
 
Firstly, water, plasmid and gene were added into a 1.5 ml eppendorf tube and 
were mixed by gentle pipetting.  The sample was centrifuged at 1400 g for 2 secs and 
placed in a water bath at 45
o
C for 5 min, then it was placed on ice for 2 min and the T4 
ligase buffer and T4 ligase added.  The ligation mix was centrifuged at 1400 g for 2 secs 
and left at room temperature for 10 min before incubation for 1 hour at 37
o
C.  Prior to 
transformation into E. coli XL10-Gold cells (Section 2.3.8), the ligation mix was cooled 
on ice for 5 min. 
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2.3.7. Preparation of E. coli competent cells and transformation 
 
2.3.7.1. Chung et al. (1989) method.  E. coli Competent cells were prepared by 
inoculating a single colony into 5 ml of LB medium and incubation overnight at 37
o
C 
and 220 rpm.  This stationary-phase overnight culture (0.5 ml) was transferred to 50ml 
LB medium and incubated at 37
o
C and 220 rpm until the Absorbance at 600 nm (A600nm) 
reached 0.3 – 0.4 (after approximately 2 hours).  The cells were chilled on ice for 10 
min, followed by centrifugation at 2500 g for 10 min at 4
o
C and resuspended in 1/10 the 
original volume of ice-cold TSS (Table 2.2) solution (5 ml ice-cold TSS); then it was 
ready to be transformed.  Cells prepared by this method were stored at 4
o
C for a 
maximum of 6 hours without significant loss of competency, as well quick frozen in 
liquid nitrogen for long-term storage at -70
o
C. 
For transformation, 1 μl of DNA (1-200 ng) was added to 100 μl ice cold 
competent cells and incubated on ice for 30-60 min, followed by addition of 900 μl of 
TSS or LB medium plus 20 mM glucose and the cells were incubated at 37
o
C for 60 
min.  The cells were then centrifuged at 2500 g for 2 min, plated on 1.5 % agar-LB, and 
incubated at 37
oC overnight.  For transformation of the ligation mix, 15 μl of ligation 
mix was added to 85 μl competent cells and the method followed as above. 
 
2.3.7.2. Inoue et al. (1990) method.  Approximately 10-12 large colonies were 
inoculated into 250 ml SOB medium in a 2 litre flask, incubated at 18
o
C with 220 rpm 
until cell density reached A600nm of 0.6 (approximately 36-40 hours).  Subsequently, the 
cells were placed on ice for 10 min prior to centrifugation at 2500 g for 10 min at 4
o
C.  
The cell pellet was gently resuspended in 80 ml ice-cold transformation buffer (10 mM 
PIPES, 55 mM MnCl2, 15 mM CaCl2.2H2O, 250 mM KCl) with 7% DMSO and were 
left on ice for a further 10 min prior to aliquoting into 500 μl volumes.  The cells were 
frozen in aliquots in liquid nitrogen and stored at -70
o
C. 
For transformation, a frozen stock of competent cells was thawed on ice for 
approximately 20 min, 85 μl was added per ligation reaction and mixed gently (for 
plasmid transformation, 3 μl plasmid in 50 μl competent cells).  The ligation was placed 
on ice for 30 min, followed by heat shock at 42
o
C for 1 min and on ice again for 2 min.  
The reaction was made up to 1 ml with LB medium, incubated in an orbital incubator at 
37
o
C for 1 hour, then pelleted at 2500 g.  Some supernatant was removed (800 μl) and 
the cells were resuspended in the remaining 200 μl and plated out onto 1.5% agar-LB 
containing 100 μg/ml carbenicillin and grown overnight at 37oC. 
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2.3.8. Transformation of XL-10 Gold cells 
 
The methods of Chung et al. (1989) or Inoue et al. (1990) were used, described 
in Section 2.3.7. 
 
2.3.9. PCR screening for the presence of the correct gene in a recombinant clone 
 
As the efficiency of restriction digestion may not be 100%, it is possible the 
prepared pTTQ18-His6 used for ligation may contain undigested plasmids, resulting in 
carbenicillin-resistant colonies of the original parent plasmid with the norA gene 
(Section 2.3.3.).  The colonies grown are therefore subjected to PCR screening to 
confirm the presence of the correct gene.  To PCR screen, a colony of XL-10 Gold cells 
was suspended in 20 μl sterile MQTM water, and 10 μl taken and added to an equal 
volume of 2x PCR mix (0.2U Taq DNA polymerase, 1x Taq buffer, 0.4 mM dNTPs and 
1pmol forward and reverse primers of the relevant gene), using the following conditions. 
 
Steps Time 
1) Warm-up at 95
o
C 5 min 
2) Denaturation at 95
o
C 1 min 
3) Annealing at 40, 56 or 62
o
C 30 secs 
4) Extension at 72
o
C 
5) Cycle to step 2 for 25 more times 
1 min 
6) Final extension at 72
o
C 10 min 
 
The PCR product (3 μl PCR product, 6 μl MQTM water, and 1 μl 10x DNA 
loading buffer) was subjected to 1% agarose gel electrophoresis to identify the 
amplified positive clones.  The remaining 10 μl of the positive colony was grown in 5ml 
LB medium containing 100 μg/ml carbenicillin at 37oC and 220 rpm overnight, 
followed by plasmid extraction (Section 2.3.10.) 
 
2.3.10. Extraction of plasmid 
 
Plasmids were extracted using the ‗QIAprep Spin Miniprep Kit Using a 
Microcentrifuge‘ method (QIAprep Miniprep Handbook 05/2004). 
 
2.3.11. Restriction digestion analysis 
 
The extracted plasmids were subjected to restriction digestion analysis with 
EcoRI / NdeI and PstI / HindIII (Table 2.7) to confirm the correct size of the gene in 
plasmid pTTQ18-His6. 
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  Double digest Single digest Control 
Plasmid 2 μl 2 μl 2 μl 
EcoRI or NdeI (20,000 U/ml) 1 μl 1 μl - 
PstI or HindIIII(20,000 U/ml) 1 μl - - 
10x EcoRI buffer 1 μl 1 μl 1 μl 
MQ
TM
 water 5 μl 6 μl 7 μl 
 
Table 2.7 Restriction digestion reactions to verify the present of target gene.  
Plasmids were single and double digested.  Control is undigested. 
 
2.3.12. Automated DNA sequencing  
 
The plasmid constructs were submitted for automated DNA sequencing.  This 
was performed using equipment and protocols by Amersham Biosciences DYEnamic 
ET
TM
 Terminator Cycle Sequencing Protocol in conjunction with the ABI 373A 
automated DNA sequencer in the sequencing facility at the University of Leeds 
(performed by Denise Ashworth).  The following thermal cycling conditions were used: 
 
Steps Time 
1) Rapid thermal ramp to 95
o
C 20 secs 
2) Rapid thermal ramp down to 50
o
C 15 secs 
3) Rapid thermal ramp up to 60
o
C 
4) Cycle to step 1 for 25 more times 
60 secs 
 
 
To sequence the plasmid constructs 10 μl 50 ng/μl plasmid and 4 μl 1.6 pmol/μl 
primers were prepared and submitted for sequencing.  Table 2.8 shows the primers used 
for DNA sequencing.  These are forward and reverse pTTQ18-His6 primers that bind 
upstream and downstream of the inserted gene. 
 
 Primer sequence 5’3’ 
pTTQ18-His6 forward primer ATGAATTCGCAT 
pTTQ18-His6 reverse primer GCTGCAGGCGGTCGTGGCAGCCACCATCACC
ATCACCATTAATAG 
 
Table 2.8 Primers used for sequencing of plasmid constructs. 
 
2.3.13. Transformation of plasmid into E. coli BL21(DE3) cells 
 
The plasmid constructs were transformed into E. coli BL21(DE3), for 
expression trials, using the methods of Chung et al. (1989) or Inoue et al. (1990) 
(Section 2.3.7). 
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2.4. Protein preparation and manipulation 
 
Methods for protein preparation and manipulation are found in Ward et al. (2000). 
 
2.4.1. Testing for the expression of cloned protein 
 
Cultures for expression tests were prepared by inoculating 5 ml of LB media 
with 100 μg/ml carbenicillin with a single colony of BL21(DE3) cells harbouring 
pTTQ18(gene)-His6 and incubating overnight at 30
o
C or 37
o
C and 220 rpm.  1.5 ml of 
the overnight culture was transferred to 50 ml LB medium with 100 μg/ml carbenicillin 
and 20 mM glycerol in a conical flask and grown at 37
o
C and 220 rpm.  The cells were 
induced with 0.5 mM IPTG when A680nm reached 0.4-0.6 and were harvested 3 hours 
post-induction by centrifugation at 2500 g for 10 min.  Cells were stored at -20
o
C if a 
membrane preparation was not immediately carried out. 
 
2.4.2. Preparation of total E. coli membranes 
 
The total membrane fraction was prepared by the water lysis procedure (Ward et 
al., 2000).   
 
2.4.3. Determination of protein concentration 
 
The Schaffner and Weissman (1973) protein assay was used to determine the 
concentration of proteins in the membrane preparations.  A calibration curve was 
constructed from a range of standards of 0.1 mg/ml Bovine Serum Albumin (BSA) 
between 0-20 μg (Figure 2.3).  All procedures were performed at room temperature.  
Each sample was made up to 270 μl with deionised water.  30 μl 1M TRIS pH7.5, 10% 
w/v SDS, and 60 μl 60% w/v TCA were added, the mixture vortexed and left for 20 min.  
The precipitated proteins were transferred drop wise onto a pre-soaked 0.45 μm HAWP 
Millipore membrane filter under a vacuum manifold.  Remnant proteins in the tube 
were washed with 0.3 ml of 6 % TCA and transferred to the filter.  The filter was 
washed two times with 2 ml 6 % TCA and transferred to a Petri dish containing 30 ml 
naphthalene black stain (0.1 % naphthalene black in methanol, acetic acid and water 
45:10:45 v/v) for 3 min, followed by washing in deionised water for 30 secs and 
subsequent washing two times in destain (methanol, acetic acid, water 90:2:8 v/v) for 1 
min.  The filters were then washed once in deionised water and blotted onto paper towel 
and the stained spots cut out. 
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Each spot was transferred to a 1.5 ml eppendorf tube and the stained protein 
eluted by addition of 1 ml 25 mM NaOH, 0.05 mM EDTA, 50% aqueous ethanol and 
left for 1 hour, vortexing at intervals.  Absorbance at 630 nm for the protein samples 
was recorded and the linear relationship between absorbance and BSA concentration 
(Figure 2.3) was used to determine unknown concentration.  The standard curve was 
drawn using the GraphPad Prism computer software. 
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Figure 2.3 A typical calibration curve using BSA standards (Section 2.4.3.). 
 
2.4.4. Analysis of proteins by SDS-PAGE 
 
The prepared membranes were analysed by SDS-PAGE composed of a 15% (v/v) 
resolving gel and a 4 % (v/v) stacking gel (Table 2.9).  Proteins (1-30 μg) were 
solubilised in 1x sample loading buffer and incubated at 37 
o
C for 20 min.  The 
molecular weight standards used are detailed in Tables 2.10 and 2.11.  The samples 
were loaded onto the gel and electrophoresis performed for approximately 2 hours at 30 
mA in running buffer.  The gel was stained overnight in Coomassie brilliant blue and 
destained in SDS gel destain solution.  
The following stock solutions were made: 4x sample loading buffer (60 mM 
TrisHCL pH 7.2; 10% v/v glycerol; 2% w/v SDS; 0.005% bromophenol blue; 3% β-
mercaptoethanol); 5x SDS running buffer (6 g/L Tris; 28.8 g/L glycine; 1 g/L SDS); 
Coomassie brilliant blue (90 ml/L glacial acetic acid; 450 ml/L methanol; 1 g/L 
Coomassie brilliant); SDS gel destain (50 ml/L methanol; 70 ml/L glacial acetic acid). 
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Stock solutions Resolving gel (15%) Stacking gel (4%) 
40% acrylamide 4.22 ml 0.77 ml 
2% bis-acrylamide 0.49 ml 0.39 ml 
1.5 M TrisHCl (pH 8.7) 2.81 ml - 
1.5 M TrisHCl (pH 6.8) - 0.75 ml 
10% SDS 0.10 ml 0.05 ml 
deionised H2O 3.48 ml 3.20 ml 
10% ammonium persulphate (APS) 37 μl 30 μl 
TEMED 12 μl 9 μl 
 
Table 2.9 Composition of SDS-PAGE gel with 15% resolving and 4% stacking gels. 
 
 
Protein Mwt (kDa) 
Bovine serum albumin 66.0 
Ovalbumin 45.0 
G-3-P dehydrogenase 36.0 
Carbonic anhydrase 29.0 
Trypsinogen 24.0 
Trypsin inhibitor 20.1 
Alpha-Lactalbumin 14.2 
 
Table 2.10 SDS-PAGE molecular weight markers (Sigma).  This marker was used 
for protein molecular weight (MWt) determination in SDS-PAGE. 
 
 
Protein Mwt (kDa) 
Myosin (blue) 220.0 
Phosphorylase b (brown) 97.0 
Bovine serum albumin (red) 66.0 
Ovalbumin (yellow) 45.0 
Carbonic anhydrase (orange) 30.0 
Trypsin inhibitor (blue) 20.1 
Lysozyme (magenta) 14.3 
 
Table 2.11 High-range rainbow molecular weight markers (Amersham Biosciences) 
used for protein molecular weight determination in Western blots and chemiluminescent 
detection. 
 
A linear relationship between log molecular weight (Mwt) of standard protein 
markers and its distance migrated on the SDS-PAGE gel was generated to determine the 
size of a particular protein on the SDS-PAGE gel (Figure 2.4). The standard curve was 
drawn using the GraphPad Prism computer program. 
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Figure 2.4 A typical log Mwt-distance curve to determine size of protein on a SDS-
PAGE. 
 
2.4.5. Drying of SDS-PAGE gels onto cellophane 
 
SDS-PAGE gels were photographed using FluoroS MultiImager (Biorad
TM
) and 
gels were dried onto cellophane.  Prior to drying the gel, the destained gel and the 
cellophane were pre-soaked in deionised H2O for 5 min.  The gels were enclosed 
between two layers of cellophane and held firmly using a gel frame.  All air bubbles 
were removed and the gel was left to dry at room temperature overnight. 
 
2.4.6. Detection of His6-tagged proteins by immunoblotting & chemiluminescent 
 
The proteins separated by SDS-PAGE gel were transferred to Fluorotrans
TM
 
membrane by construction of a blot sandwich between two layers of filter papers 
(Towbin et al., 1979).  The filter papers were pre-soaked in 1x SDS running buffer and 
the membranes soaked in methanol.  The transfer of proteins was achieved by 
application of 50 mA for 2 hours to the blot sandwich in a TE77 semi-dry transfer unit.  
After the proteins were transferred, the membrane was washed in 1x Tris buffer saline 
containing Tween 20 and Triton X100 (TBSTT) (20 mM TRIS pH 7.5, 500 mM NaCl, 
0.05% v/v Tween 20,  0.2% Triton X100) for 10 min and blocked overnight in 3 % 
BSA TBSTT at 4
o
C.  The membrane was then washed twice for 10 min in 1x TBSTT, 
then incubated in 10 ml HisProbe
TM
-HRP (1 in 5000 dilution) for 1 hour at room 
temperature.  A further four washes in 1x TBSTT were carried out, followed by 
incubation for 5 min in 10 ml SupersignalWest Pico Chemiluminescent (5 ml West Pico 
stable peroxide solution and 5 ml West Pico luminol/enhancer solution)(Supersignal® ).  
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The membrane was wrapped in cling film and exposed for 1 min to X-ray film in X-
ograph 20.  Rainbow markers were used for subsequent identification of the position of 
the signal produced by superimposition onto the PVDF membrane. 
 
2.4.7. Optimisation of protein expression 
 
The effects of growth medium (LB / 2TY / Minimal) and IPTG concentration on 
protein expression levels were investigated.  Previous expression tests involved 0.5 mM 
IPTG; therefore a range of 0.1 mM, 0.25 mM, 0.5 mM, 0.75 mM and 1 mM IPTG was 
investigated using the same method described in Section 2.4.1 to 2.4.4.  Also the time of 
harvesting after IPTG induction was investigated.  The levels of overexpressed protein 
were analysed using scanning densitometry. 
2.5. Biochemical techniques  
 
2.5.1. Preparation of inner membranes using sucrose gradients 
 
A total of 4-6 L culture of E. coli BL21(DE3) expressing his-tagged proteins 
were grown aerobically in 500-750 ml batches in 2 L flasks and induced with IPTG as 
described in Section 2.4.1. and harvested by centrifugation at 5000 g for 15 minutes.  
Pelleted cells were resuspended in 20 mM Tris, 0.5 mM EDTA and 10 % glycerol, and 
lysed by explosive decompression using a cell disruptor to produce predominantly 
inside-out membrane vesicles that were purified by separation on sucrose density 
gradients (Ward et al., 2000). 
 
2.5.2. Solubilisation trials of membrane proteins using detergents 
 
This method is described previously (Gutmann et al., 2007).  Inner membranes 
(100 µg) were incubated with 100 µl solubilisation buffer containing 20 mM Tris pH 
8.0, 20 mM imidazole pH 8.0, 300 mM NaCl, 20% v/v glycerol and 1% w/v detergents  
at 4
o
C for 1 hour prior to centrifugation at 100,000 g for 30 min to pellet any insoluble 
proteins.  The detergents trialed included: n-hexyl-β-D-maltoside; n-octyl-β-D-
maltoside; n-nonyl-β-D-maltoside; n-decyl-β-D-maltoside; n-undecyl-β-D-maltoside; n-
dodecyl-β-D-maltoside; n-hexyl-β-D-glucopyranoside; n-heptyl-β-D-glucopyranoside; 
n-octyl-β-D-glucopyranoside; n-nonyl-β-D-glucopyranoside; n-decyl-β-D-
glucopyranoside; cyclohexyl-n-hexyl-β-D-maltoside; Triton X-100; ethyleneglycol 
monooctylether (C8E1); octaethyleneglycol monododecylether (C12E8); 
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nonaethyleneglycol monodocecylether (C12E9); N,N-dimethyl dodecylamine oxide 
(LDAO); N,N-dimethyl decylamine oxide (DDAO);  N,N-dimethyl octylamine oxide 
(ODAO); N-octyltetraoxyethylene; N-octylpentaoxyethylene; methyl-6-O-(N-
heptylcarbamoyl)-α-D-glucopyranoside (HECAMEG); n-octyl-β-D-glucoside (βOG); 
and n-octyl-β-D-maltopyranoside. The total inner membrane and solubilised membrane 
fractions were analysed using SDS-PAGE and compared, to determine the location of 
each protein and therefore its solubilisation in detergent (Figure 2.5). 
 
Figure 2.5 Procedures for solubilisation trial of membrane proteins.  Membranes 
were solubilised in 1% w/v detergent, and one half of the sample was subjected to 
centrifugation to remove insoluble proteins.  Soluble protein fraction obtained post-
centrifugation was analysed together with the total membrane fraction by SDS-PAGE. 
 
2.5.3. Purification of hexahistidine-tagged proteins 
 
2.5.3.1. Purification of NCS1 family proteins.  2-4 mg/ml of inner membranes were 
incubated in solubilisation buffer (20 mM Tris pH8.0, 20 mM imidazole pH 8.0, 300 
mM NaCl, 20% glycerol v/v and 1% w/v DDM) for 1 hour at 4
o
C (Mhp1 of M. 
liquefaeciens and PucI of B. subtilis were solubilised for 2 hours or overnight).  The 
insoluble fractions were removed by centrifugation at 100,000 g for 30 min and the 
solubilised fractions incubated with Ni-NTA for 30 min at 4 
o
C (Mhp1 membranes were 
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bound to Ni-NTA overnight), followed by transfer to a Bio-rad Inc. column to remove 
any unbound proteins.  The resins were washed with 20 mM Tris pH 8.0, 10 or 20 mM 
imidazole pH 8.0, 1M NaCl (no NaCl for Mhp1), 5% glycerol and 0.05% DDM.  The 
bound (hexahistidine-tagged) proteins were then eluted with 10 mM Tris HCl pH 8.0, 
300 mM imidazole pH 8.0, 2.5% glycerol and 0.05% DDM (No NaCl was used in the 
elution for Mhp1).  The protein was concentrated using a Centricon
TM
 30 kDa MWCO 
at 3000 g. 
 
2.5.3.2. Purification of sensor kinases.  Inner membranes (2.5-5 mg/ml) were 
incubated for 1-2 hours at 4
o
C in solubilisation buffer (20 mM Tris HCl pH 7.9, 20 mM 
imidazole pH 7.9, 2 mM β-mercaptoethanol, 20% glycerol, 250-300 mM NaCl and 1 % 
w/v detergent).  Insolubilised proteins were removed by centrifugation at 100,000 g for 
30 min, and the soluble proteins incubated between 0.5-15 hours with Ni-NTA at 4
o
C 
with gentle rotation, followed by transfer to a Bio-rad Inc. column to remove the 
unbound proteins.  The bound proteins in the resin were washed with 20 mM Tris HCl 
pH 7.9, 20 mM imidazole pH 7.9, 2 mM β-mercaptoethanol, 10-20% v/v glycerol and 
0-0.05% DDM, and in most cases 250 mM NaCl.  The His6-tagged protein was trialed 
with increasing concentrations of imidazole, 0.1 M, 0.2 M, 0.3 M and 0.5 M in wash 
buffer to elute the protein, and samples were analysed by SDS-PAGE.  The eluted 
fractions containing the His6-tagged protein were concentrated using Centricon
TM
 30 
kDa MWCO at 3000 g, and exchanged into the required buffers for further analysis. 
 
2.5.3.3. Size exclusion chromatography.  Purified proteins were buffer exchanged into 
25 mM Tris-HCl pH 8.0, 100 mM NaCl, 5% glycerol and 0.05% DDM (FPLC buffer) 
using BioRad Econo-Pac
®
 10DG column and concentrated using Centricon
TM
 50 kDa 
MWCO at 3000 g, followed by centrifugation at 13,000 rpm, 4
o
C, for 5 minutes on a 
bench-top centrifuge to remove particulate material.  The concentrated protein sample 
(<1ml) at 10 – 15 mg/ml was loaded onto a S-200 column equilibrated with FPLC 
buffer and eluted at a flow rate of 1 ml/min.  All buffers used were degassed and a 
constant temperature (4
o
C) was maintained throughout the size exclusion 
chromatography.  Proteins were eluted in 10 ml fractions (first 40 ml) then in 1ml 
fractions, detected by UV absorbance at 280 nm, and subsequently analysed by 
chromatograph and SDS-PAGE to determine the monodispersity and purity.  A sample 
(15 µl) was taken from each 1 ml fraction and 5 µl 4x SDS loading buffer was added 
prior to loading onto SDS-PAGE for analysis. 
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2.5.4. Uptake of radiolabeled substrates by the NCS1 family of transporters 
 
Transport assays using intact bacteria were carried out as described Henderson 
& Macpherson (1986).  A single colony was inoculated into 5 ml LB medium 
containing 100 μg/ml carbenicillin and was cultured aerobically overnight at 30oC and 
220 rpm.  For uptake assays, 1.5 ml of overnight culture was inoculated into 50 ml 
minimal medium (Section 2.2.2.) and induced with 0.5 mM IPTG when cell density at 
A680nm reached 0.4-0.6 and harvested 1 hour post-induction by centrifugation at 2800 g 
for 10 min.  Subsequently, the cells were washed three times with 30ml KCl.MES 
buffer (150 mM KCl, 5 mM MES pH6 .6) and resuspended in the same buffer to a cell 
density of 2 at A680nm.  For each uptake, 482.5 μl of cell suspension was energised with 
20 mM glycerol in a bijou bottle at 25
oC and aerated for 3 min.  At time = 0, 12.5 μl of 
radiolabelled substrate was added to the cells and vortexed; at time = 15 secs and time = 
2 min, 200 μl of the sample was transferred onto pre-soaked 0.45 μm Whatman 
cellulose nitrate membrane filters under vacuum, followed by immediate washing with 
4 ml ice-cold KCl.MES.  The filter was transferred to a 20 ml scintillation vial.  
Standards were prepared by adding 4 μl of radiolabelled substrate to a pre-wetted filter.  
Background was a pre-wetted filter on the manifold washed with KCl.MES buffer.  All 
filters were then submerged in 10ml scintillation fluid (Emulsifier-Safe
TM
) and counted 
using a TRI-CARB PACKARD liquid scintillation analyzer 1500.  The number of 
milligrams of cells and the rate of radiolabelled substrate uptake were determined using 
the following equations:  
 
A680nm of 1 = 0.68 mg of dry cell mass 
 
mg of cells = total sample volume × A680nm x 0.68 
 
Uptake (nmol/mg) = (dpm-background) ×   total volume     ×      1       ×   nmol standard 
             sample volume      mg cells       dpm standard 
 
 
2.5.5. Autophosphorylation assays for sensor kinases and signal testing 
 
2.5.5.1. Assays using inner membranes.  These assays were performed as described 
previously (Potter et al., 2002; Potter et al., 2006; Ma et al., 2008).  Briefly, inner 
membrane proteins (200 μg) were incubated at 24oC in assay buffer containing 50 mM 
Tris-HCl pH 7.6, 10 mM MgCl2, 50 mM KCl, 0.005% DDM and 1 mM DTT.  Total 
reaction volumes were 200 μl and reactions were initiated by the addition of 50 μM 
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ATP containing 50 μCi [γ – 32P] or [γ – 33P].  Samples (20 μl) were removed at time 
intervals between 0 and 60 min, and reactions stopped by the addition of 6 μl 4x SDS-
PAGE sample loading buffer.  Samples were incubated at 37
o
C for 30 min prior to 
SDS-PAGE analysis containing 4% and 12% stacking and resolving gels respectively 
(Table 2.12).  The gels were washed briefly in deionised water and dried under vacuum 
at 70
o
C.  Labelled protein bands were visualized by autoradiography using BioMax film 
(Kodak) exposed for 1-7 days, and quantified using a Fuji BAS 1000 phospho-imaging 
analyzer system (Fujifilm Co., Japan) and AIDA 2D analytical software (Raytest). 
 
2.5.5.2. Assays using purified sensor kinases.  Purified histidine kinases were buffer-
exchanged in storage buffer containing 10 mM Tris-HCl pH 8.0, 25% glycerol and 2 
mM β-mercaptoethanol.  This protein (800 pmoles) was incubated in reaction buffer 
containing 50 mM Tris-HCl pH 7.6, 10 mM MgCl2 and 50 mM KCl.  Total reaction 
volumes of 150 μl were prepared and the reaction initiated by addition of 50 μM ATP 
containing 37.5 μCi  [γ – 32P] or [γ – 33P].  Samples (15 μl) were removed at time 
intervals between 0 and 60 min and reactions stopped by the addition of 5 μl 4x SDS-
PAGE sample loading buffer.  All samples were analysed as described in Section 
2.5.5.1.  (Note: HEPES-Na was used instead of Tris-HCl for sensor kinase EF1051). 
 
2.5.5.3. Signal testing.  For signal screening, 80 pmoles of proteins were tested in the 
presence of individual candidate signal molecules per 15 μl reaction buffer as described 
(Section 2.5.5.2.).  Protein and signal were incubated at 24 
o
C for 20 minutes prior to 
the addition of radiolabelled ATP to initiate the autophosphorylation reactions which 
proceeded for 40 or 60 minutes.  Stock solutions of synthetic GBAP, which is identical 
in structure to natural GBAP, were prepared in 20% (w/v) acetonitrile, stored at -20
o
C 
as described previously (Nakayama et al., 2001). 
 
Stock solutions Resolving gel (12%) Stacking gel (4%) 
30% acrylamide 3 ml 0.66 ml 
1.5 M TrisHCl (pH 8.8) 1.9 ml - 
1.5 M TrisHCl (pH 6.8) - 0.36 ml 
10 % SDS 0.075 ml 0.05 ml 
deionised H2O 2.5 ml 3.61 ml 
10% ammonium persulphate (APS) 0.05 ml 0.05 ml 
TEMED 0.003 ml 0.005 ml 
 
Table 2.12 Composition of mini-gels (12% resolving and 4% stacking gels). 
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2.6 Biophysical techniques 
 
2.6.1. Circular dichroism studies of secondary structure of purified membrane 
proteins 
 
Purified proteins were buffer exchanged into 20 mM sodium or potassium 
phosphate buffer pH 7.6 with 0.05% DDM prior to analysis of secondary structure using 
Jasco J-715 spectropolarimeter.  Purified protein (30-40 µg) or 0.05 mg/ml suspended in 
300 μl Na / K phosphate buffer was placed into a Far UV cuvette.  CD spectral analysis 
was performed at 18
o
C with the following parameters: 1nm step resolution; scan rate at 
10 nm/min; response time at 1 sec; sensitivity at 50 mdeg; bandwidth at 1.0 nm; and 
accumulation of ten scans.  A sample containing the buffer was measured and 
subtracted from the protein sample.  An alternative parameter was also used for some 
proteins and indicated otherwise. 
 
2.6.2. Electrospray ionisation mass spectrometry 
 
Purified membrane proteins (50 μl at ~5mg/ml) were prepared for electrospray 
ionisation (ESI) mass spectrometry by mixing with 150 μl of analytical grade methanol, 
followed by addition of 50 μl of chloroform and mixed to form a single phase, then 150 
μl of water was added and mixed vigorously to initiate phase separation.  After 
centrifugation at 10,000 g for 2 min to precipitate the protein, the bulk of the aqueous 
methanol phase was removed and 100 μl methanol was added.  Following a second 
identical centrifugation step and removal of the solution the pellet of precipitated 
protein was dried under a flow of nitrogen.  The protein was dissolved in 50 µl 100% 
formic acid and immediately subjected to size-exclusion chromatography using 
Sephadex
TM
 LH-20 to complete the preparation of membrane proteins, as described 
previously (Venter et al., 2002).  Ionisation of the sample was by nano-ESI using a 
nanomate (Advion Bioscience Inc., Ithaca, N.Y.), and mass spectrometry by LCT 
Premier (Waters, U.K. Ltd., Manchester, U.K.) with a single time-of-flight analyser. 
 
2.6.3. Fluorimetry studies of purified proteins 
 
 Steady-state fluorescence measurements were performed by Photon Technology 
International QM-1 spectrophotometer (PTI, U.K.) with LPS 200B lamp.  Reaction was 
placed in Hellma
®
 precision cells made of Quartz Suprasil
®
 with 10 mm path-length for 
measurements.  Acquisition parameters prior to scan: excitation at 285 nm; emission at 
300-400 nm; length at 100 nm; step size at 1 nm; integration at 1 sec; and average at 1.   
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2.6.3.1. Titration by substrate.  Purified proteins were buffer-exchanged into 10 mM 
Tris-HCl pH 7.6 and 0.05% DDM.  A stock of 100 mM substrate was made in 100% 
DMSO for titration.  Benzylhydantoin (0-20 μl) was titrated into a reaction volume of 
980 μl containing 140 μg protein, 10 mM Tris-HCl pH 7.6, 135 mM choline Cl, 0.05% 
DDM and plus / minus 15 mM NaCl, shown in Table 2.13.  Note: potassium phosphate 
buffer was sometimes used instead of Tris-HCl and is indicated otherwise. 
 
Volume additions of 
100 mM substrate (µl) 
Final [substrate] 
(mM) 
Final 
DMSO (%) 
0.0 0.00 0.00 
1.0 0.10 0.10 
1.0 0.20 0.20 
3.0 0.50 0.50 
2.5 0.75 0.75 
2.5 1.00 1.00 
5.0 1.50 1.50 
5.0 2.00 2.00 
 
Table 2.13 Titration by substrate.  Proteins were incubated at 18
o
C throughout the 
experiment, and were left stirring for 4 minutes prior to each volume addition.  The final 
substrate and DMSO concentrations, with each volume of substrate added, are indicated 
in the table. 
 
2.6.3.2. Titration by salt.  Purified proteins were buffer-exchanged into 10 mM 
potassium phosphate pH 7.6 and 0.05% DDM.  Stocks of 100 mM salt was made in 
deionised water.  Salt (0-50 μl) was titrated into a reaction volume of 950 μl containing 
140 μg protein, 10 mM potassium phosphate pH 7.6 and 0.05% DDM.  The final 
concentration of salt for each volume addition is shown in Table 2.14. 
 
Volume additions (μl) Final [Salt] (mM) 
0.0 0.00 
0.25 0.025 
0.25 0.05 
0.5 0.10 
1.5 0.25 
2.5 0.50 
5.0 1.00 
15.0 2.50 
25.0 5.00 
 
Table 2.14 Titration by salts.  Proteins were incubated at 18
o
C throughout the 
experiment, and were left stirring for 4 minutes prior to each volume addition.  The final 
salt concentrations, with each volume of salt added, are indicated in the table. 
 
 72 
2.6.3.3. Titration by HgCl2.  Purified proteins were buffer-exchanged into 10 mM Tris-
HCl pH 7.6 and 0.05% DDM.  Stocks of 10 mM and 100 mM HgCl2 were made in 
deionised water.  HgCl2 (0-19 μl) was titrated into a reaction volume of 980 μl 
containing 140 μg protein, 10 mM Tris-HCl pH 7.6, 140 mM choline Cl (or 125 mM 
choline Cl with 15 mM NaCl and 2mM substrate) and 0.05% DDM.  The volume 
additions of HgCl2 are shown in Table 2.15. 
 
Volume additions (μl) Final [HgCl2] (mM) 
1.0 μl of 10 mM 0.01 
2.0 μl of 10 mM 0.03 
2.0 μl of 10 mM 0.05 
5.0 μl of 10 mM 0.10 
1.5 μl of 100 mM 0.25 
2.5 μl of 100 mM 0.50 
5.0 μl of 100 mM 1.00 
 
Table 2.15 Titration by HgCl2.  Proteins were incubated at 18
o
C throughout the 
experiment, and were left stirring for 4 minutes prior to each volume addition.  The final 
HgCl2 concentrations, with each volume added, are indicated in the table. 
 
2.6.3.4. Titration by ATP.  Purified proteins were buffer-exchanged into 10 mM Tris-
HCl pH 7.6.  A stock of 2 mM ATP was made in deionised water.  ATP (0-15 μl) was 
titrated into a reaction volume of 975 μl containing 140 μg protein and 10 mM Tris-HCl 
pH 7.6.  The volume additions of ATP are shown in Table 2.16. 
 
Volume additions of 
2 mM ATP (μl) 
Final [ATP] (mM) 
0.0 μl  0.0 
0.5 μl  1.0 
0.5 μl  2.0 
1.5 μl 5.0 
2.5 μl 10.0 
5.0 μl  20.0 
15.0 μl  50.0 
 
Table 2.16 Titration by ATP.  Proteins were incubated at 18
o
C throughout the 
experiment, and were left stirring for 4 minutes prior to each volume addition.  The final 
ATP concentrations, with each volume added, are indicated in the table. 
 
2.6.3.5 Titration by GBAP.  Purified proteins were buffer-exchanged into 10 mM Tris-
HCl pH 7.6.  A stock of 1 mM GBAP was made in 3.4% acetonitrile.  GBAP (0-5.4 μl) 
was titrated into a reaction volume of 989.3 μl containing 140 μg protein and 10 mM 
Tris-HCl pH 7.6.  The volume additions of GBAP are shown in Table 2.17. 
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Volume additions of 
1 mM GBAP (μl) 
Final [GBAP] (mM) 
0.0 μl  0.0 
0.7 μl  0.7 
0.6 μl  1.3 
1.4 μl 2.7 
2.6 μl 5.3 
5.4 μl  10.7 
 
Table 2.17 Titration by GBAP.  Proteins were incubated at 18
o
C throughout the 
experiment, and were left stirring for 4 minutes prior to each volume addition.  The final 
GBAP concentrations, with each volume added, are indicated in the table. 
 
2.6.4. N-terminal sequencing 
 
Proteins were separated by SDS-PAGE (Section 2.4.4) and the gel was rinsed 
briefly in blotting buffer (10 mM CAPS pH 11, 10% v/v methanol HPLC grade, in 
Milli-Q water) to remove excess Tris/glycine/SDS which may interfere with sequencing.  
A stock 100 mM CAPS buffer (pH using NaOH) was made and stored at 4
o
C, and 
methanol and water was added shortly before use.  Fluorotrans
TM
 PVDF-membrane was 
soaked in methanol and equilibrated in the blotting buffer for several minutes.  The 
proteins were transferred from the gel to the membrane by electroblotting at 50 mA for 
2 hours in a TE77 semi-dry transfer unit.  The membrane was then stained in Coomassie 
Blue for 10 minutes and destained overnight in 50% (v/v) methanol in H2O.  The 
stained protein band was excised from the membrane and N-terminal sequencing by 
Edman degradation (Edman, 1950) was performed by Dr Jeff Keen (University of Leeds). 
 
2.6.5. Removal of N-terminal formyl group by acid-methanol treatment 
 
 The N-terminal formyl group of the membrane protein was removed by 
incubating the protein (0.1 mg) in at least ten volumes of 2M HCl in anhydrous 
methanol for 48 hours at room temperature with occasional vortexing (Venter, 2001).  
 
2.6.6. Crystallisation trials 
 
Proteins (10 – 15 mg) were purified by Ni-NTA and subjected to size-exclusion 
chromatography as described in Section 2.5.3.3 to produce homogenous proteins.  The 
pure homogeneous protein fraction was concentrated using Vivaspin 50,000 MWCO to 
~15 mg/ml for crystallization trials using the Hampton screening kits (Crystal Screen I 
and II, MemFrac
TM
 and MemStart
TM
).  The vapour diffusion drops were set up in a 
Corning®  Plate 3552 (96 wells) by Douglas Instruments Oryx6 crystallisation robot. 
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Chapter 3 – Introduction  
 
This chapter is divided into four sections: 
Section 3.1 – Cloning, expression and activities of the NCS1 family proteins 
Section 3.2 – Characterisation of an Escherichia coli cytosine transporter (b0336) 
Section 3.3 – Characterisation of a Bacillus subtilis allantoin transporter (Bsu36470) 
Section 3.4 – Characterisation of a Pseudomonas aeruginosa uracil transporter (PA0443) 
 
Section 3.1 describes the pipeline for the study of the NCS1 family of transporters; it 
includes an in silico analysis of the target proteins, followed by cloning, expression and 
substrate identification.  Subsequent sections, 3.2 to 3.4, describe the characterisation in 
more detail of three NCS1 proteins; these are the cytosine transporter of E. coli (b0336), 
the allantoin transporter of B. subtilis (Bsu36470), and the uracil transporter of P. 
aeruginosa (PA0443). 
3.1. Cloning, expression and activities of the NCS1 family proteins 
 
3.1.1. Introduction – A genomic approach 
 
Recently genomics approaches have been developed to overcome the lack of 
knowledge of membrane protein structural biology (Dobrovetsky et al., 2005; Surade et 
al., 2006; Carpenter et al., 2008).  The idea is to study a number of targets that are 
homologues of the targeted protein, in the hope that at least a few will produce 
diffracting crystals, knowing that some will fall out during the following stages.   
In this project a pipeline involving some innovative methods developed in 
Professor Henderson‘s laboratory was exploited to investigate the NCS1 family of 
proteins (Figure 3.1).  Firstly, a pre-cloning stage involved a search for Mhp1 
homologues that belong to the NCS1 family and an in silico analysis of the selected 
homologues.  Secondly, the homologues were cloned into an expression vector and their 
expression in E. coli was examined.  Successfully overexpressed candidates were then 
progressed to purification, characterisation and crystallisation trials. 
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Figure 3.1 Pipeline of genomic approach for the study of NCS1 family proteins.  
Key: Start/end ( ), process ( ) and decision ( ). 
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3.1.2. An homology search and in silico analysis of of Mhp1 homologues  
 
A search for Mhp1 homologues belonging to the NCS1 family using FASTA3 
(Pearson, 2000) was performed, and twenty proteins from various bacteria were chosen 
as targets based on the availability of the genomic DNA in the laboratory and their 
similarity to the Mhp1 protein.  The selected Mhp1 homologues (Table 3.1) have 17-31% 
identity and 52-65% similarity to Mhp1 (Table 3.1). 
An affinity tag, for identification and purification purposes, was introduced at 
the C-terminal end of the protein since alteration of the N-terminus may be inimical to 
expression.  Depending on the position of the C-terminus of the protein, cytoplasmic or 
perisplamic, a His6-tag or Strep-tag was used, respectively. 
The topology of a membrane protein follows the ‗positive inside‘ rule (von 
Heijne, 1986) and predictions using TMHMM (Krogh et al., 2001) showed the selected 
proteins generally have a putative cytoplasmic C-terminus, apart from the PA0438 and 
Pden0678 proteins, which were predicted to be outside and have eleven transmembrane 
regions (Appendix 1).  The TMHMM diagram clearly suggests there could be a twelfth 
transmembrane region in PA0438 and this will then make the C-terminus cytoplasmic 
(Appendix 1) and therefore a His6-tag was introduced.  The Pden0678 having a C-
terminus that is periplasmic suggests a strep-tag should be used.  The topology 
predictions by TMHMM are summarised in Table 3.2.  The majority of the selected 
proteins have twelve putative transmembrane helices and their N-terminus and C-
terminus are predicted to be located on the cytoplasmic side of the membrane (Table 
3.2), which is a typical feature of the NCS1 as well as the MFS family transporters. 
Comparisons of the selected NCS1 proteins against Mhp1 showed some 
conserved sequences in the family (Appendix 2).  The phylogenetic tree of these 
selected proteins with the previously studied NCS1 proteins (Table 1.1) are shown in 
Figure 3.2, and showed HyuP of Arthrobacter aurescens clustered most closely to 
Mhp1.  The S. cerevisiae Dal4, Fur4 and Fui1 proteins clustered closely together 
(Figure 3.2); they transport allantoin, uracil and uridine, respectively.  The S. cerevisiae 
Thi10 and Nrt1 are on the same sub-branch and also clustered closely together, 
transporting thiamine and nicotinamide riboside, respectively (Figure 3.2).  Other 
previously studied NCS1 proteins that clustered closely together include the S. 
cerevisiae Fcy2, S. cerivisiae Tpn1, C. albicans Fcy21 and A. nidulans FcyB proteins; 
which transport cytosine, vitamin B6, purine and cytosine-purine respectively (Figure 
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3.2).  Here, the P. putida CytX and L. plantarum lp3374 proteins do not cluster close to 
any of the NCS1 proteins in the phylogenetic tree (Figure 3.2). 
 
 
 Protein name 
(bacteria) 
Size of protein 
(amino acids) 
Accession no. 
Putative/known 
substrate(s) 
Identity to 
Mhp1 (%) 
Similarity to 
Mhp1 (%) 
0 Mhp1 
(M. liquefaeciens) 
489 hydantoins 100.0 100.0 
1 b0336 
(E. coli) 
419 
P0AA82 
cytosine 22.8 58.1 
2 b0511 
(E. coli) 
484 
P75712 
allantoin, uracil 26.1 58.7 
3 Bsu36470 
(B. subtilis) 
490 
P94575 
allantoin, uracil 27.3 63.3 
4 Bsu3867 
(B. subtilis) 
457 
P94369 
cytosine/purine 16.6 52.4 
5 EF3000 
(E. faecalis) 
498 
Q82ZQ0 
allantoin 
nucleobase 
25.8 62.2 
6 lp3374 
(L. plantarum) 
457 
Q88SN4 
cytosine/purines, uracil, 
thiamine, allantoin 
19.3 57.9 
7 PA0438 
(P. aeruginosa) 
416 
Q9I679 
cytosine 24.1 57.5 
8 PA0443 
(P. aeruginosa) 
496 
Q9I674 
cytosine/purines, uracil, 
thiamine, allantoin 
29.3 59.8 
9 PA0476 
(P. aeruginosa) 
575 
Q9I642 
cytosine/purines, uracil, 
thiamine, allantoin 
26.4 61.8 
10 PA2073 
(P. aeruginosa) 
476 
Q9I242 
cytosine/purines, uracil, 
thiamine, allantoin 
23.1 54.4 
11 PA5099 
(P. aeruginosa) 
480 
Q9HU84 
cytosine/purines, uracil, 
thiamine, allantoin 
22.2 52.2 
12 Pden0678 
(P. denitrificans) 
450 
Q9I5P7 
cytosine/purines, uracil, 
thiamine, allantoin 
25.3 65.0 
13 Pden4351 
(P. denitrificans) 
490 
A1BA71 
cytosine/purines, uracil, 
thiamine, allantoin 
30.9 65.3 
14 Pden1111 
P. denitrificans 
494 
A1B125 
nucleobase 28.6 60.6 
15 PPA0619 
(P. acnes) 
487 
A1AZN7 
cytosine/purine 22.2 54.2 
16 PPA2211 
(P. acnes) 
495 
Q6A5P8 
cytosine/purine 18.6 53.0 
17 SCO0572 
(S. coelicolor) 
466 
Q93RZ8 
cytosine 23.3 57.1 
18 SCO5579 
(S. coelicolor) 
485 
Q9ZBQ0 
cytosine/purine 24.6 57.6 
19 SCO6417 
(S. coelicolor) 
522 
O69811 
allantoin 31.0 62.3 
20 SCO7500 
(S. coelicolor) 
495 
Q93J97 
allantoin 27.9 61.6 
 
Table 3.1 Proteins of the NCS1 family studied in this project.  The size, 
putative/known substrates, identity and similarity to Mhp1, of the target proteins are 
shown.  Similarity and identity values were calculated by FASTA3 (Pearson, 2000). 
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Protein name 
Predicted position of: No. of predicted 
transmembrane regions 
N-terminus C-terminus 
0 Mhp1 inside inside 12 
1 b0336 (CodB) inside inside 12 
2 b0511 inside inside 12 
3 Bsu36470 (PucI) inside inside 12 
4 Bsu3867 inside inside 12 
5 EF3000 inside inside 12 
6 lp3374 inside inside 12 
7 PA0438 inside outside/inside 11/12 
8 PA0443 inside inside 12 
9 PA0476 outside inside 11 
10 PA2073 inside inside 12 
11 PA5099 outside inside 13 
12 Pden0678 inside outside 11 
13 Pden4351 inside inside 12 
14 Pden1111 inside inside 12 
15 PPA0619 inside inside 12 
16 PPA2211 inside inside 12 
17 SCO0572 inside inside 12 
18 SCO5579 inside inside 12 
19 SCO6417 inside inside 12 
20 SCO7500 inside inside 12 
 
Table 3.2 Summary of the topology predictions determined by TMHMM (Krogh et 
al., 2001) for the selected NCS1 proteins. 
 
Figure 3.2 Phylogenetic tree of Mhp1, its homologues and previously studied NCS1 
proteins.  The phylogenetic tree was created by Geneious Pro 4.6.5 software using 
amino acid sequences of the NCS1 proteins. 
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3.1.3. Cloning of genes encoding NCS1 proteins 
 
The genes of interest were amplified by PCR (Figure 3.3).  The amplified 
products after restriction digestion were ligated into plasmid pTTQ18-His6 (Section 
2.3.3. to 2.3.6.) using the strategy described in Section 2.3.1. 
 b0336  b0511  Bsu36470 lp3374 
     
 
 PA0438  PA0443  PA0476  PA2073 
     
 
 PPA0619  PPA2211  SCO0572  SCO5579  
     
 
 SCO7500 
   
Figure 3.3 NCS1 family genes amplified by PCR.  Samples after PCR were analysed 
on a 1% agarose gel.  Lane: 1kb DNA ladder (left) and PCR products (right).  Note: 
results for EF3000, Pden1111 and Pden4351 are not shown. 
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Out of the twenty NCS1 targets, sixteen are currently amplified by PCR (Figure 
3.3).  The EF3000 construct was made by Dr Kim Bettaney (Bettaney, 2008), and the 
Pden1111 and Pden4351 constructs were made by Dong Leng (unpublished).  The 
cloning results for them are therefore not shown in this thesis.  Genes from organisms 
with high GC content such as the Pseudomonas and Streptomyces were more difficult to 
amplify and addition of DMSO with lowered annealing temperatures were required to 
overcome this problem (Section 2.3.2). 
 
 b0336  b0511  Bsu36470 lp3374 
     
 
 PA0438  PA0443  PA2073  PPA0619 
     
 
 PPA2211  SCO5579   
    
Figure 3.4 PCR screening for positive colonies.  Colonies obtained from ligation and 
transformation were subjected to PCR screening to identify colonies containing the 
correct plasmids (Section 2.3.9).  Samples after PCR were analysed on a 1% agarose gel.  
Lane: 1kb DNA ladder (left) and colony PCR products (middle and right) – only two 
out of six screened colonies are shown.  Note: results for EF3000, Pden1111 and 
Pden4351 are not shown. 
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Out of the sixteen amplified genes, thirteen were successfully cloned into 
plasmid pTTQ18-His6, and confirmed by PCR screening (Figure 3.4), restriction 
digestion analysis (Figure 3.5) and DNA sequencing (Appendix 3) as described in 
Sections 2.3.9 to 2.3.12.  The recombinant clones were each transformed into E. coli 
BL21(DE3) cells (Section 2.3.13) for expression trials (Section 2.4.1). 
 b0336     b0511        Bsu36470           lp3374 
   1   2   3   4   5       1   2    3   4  5         1   2   3  4   5           1   2   3   4   5 
                   
 
 PA0438     PA0443        PA2073         PPA0619 
   1   2    3   4   5       1    2    3    4           1   2   3   4   5            1    2    3    4 
               
 
 PPA2211     SCO5579  
    1    2     3    4        1    2    3    4          
      
Figure 3.5 Restriction digestion analysis to confirm the correct size gene in plasmid 
pTTQ18-His6.  XL-10 Gold cells harbouring the putative clone were grown overnight 
as described in Section 2.3.9.  The plasmids from the overnight culture were extracted 
and subjected to restriction digestion for 3 hours.  Samples after digestion were 
analysed on a 1% agarose gel.  Lane (1) 1kb DNA ladder.  Plasmids harbouring the 
putative gene were digested as follows: Lane (2) EcoRI and PstI; (3) EcoRI; (4) 
undigested.  Lane (5) EcoRI and PstI digested PCR product.  Note: results for EF3000, 
Pden1111 and Pden4351 are not shown. 
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The genes for PA0476, SCO0572 and SCO7500 were successfully amplified by 
PCR (Figure 3.3), but their cloning into plasmid pTTQ18-His6 is not yet completed.  
Therefore seven genes are still at the cloning stage, and thirteen of the twenty selected 
NCS1 proteins are currently successfully cloned. 
 
3.1.4. Expression of the NCS1 proteins 
 
The native expression level of any particular membrane protein is typically less 
than 0.1% of total cell protein and consequently amplified expression is required for 
production of milligram quantities of proteins.  The selected NCS1 genes from various 
bacteria were therefore cloned into plasmid pTTQ18-His6 (Section 2.2.3), under control 
of the tac promoter, which allows successful overexpression of many membrane 
proteins (Ward et al., 2000; Ward et al., 2001; Potter et al., 2002; Saidijam et al., 2003; 
Liang et al., 2005; Saidijam et al., 2005; Saidijam et al., 2006; Suzuki & Henderson, 
2006; Surade et al., 2006).  E. coli was chosen as the expression host since it is 
inexpensive, easy to handle and has proven successful for producing prokaryotic 
membrane proteins (Hockney, 1994; Grisshammer & Tate, 1995; Ward et al., 2000; 
Wang et al., 2003).  Also, most of the structures of bacterial membrane proteins that are 
present in the Protein Data Bank (Berman et al., 2000) were successfully expressed in E. 
coli. 
Of the target list, the EF3000, Pden1111 and Pden4351 genes were previously 
shown to express in E. coli host cells (Bettaney, 2008; Leng, unpublished).  Their 
expression in E. coli membranes is repeated in this project for comparison with the 
other NCS1 proteins (Figure 3.6).  All the NCS1 proteins currently cloned in this 
project contained a His6-tag, because their C-termini were predicted to be inside the 
inner membrane (Table 3.2 & Appendix 1).  The amino acid sequences of the resulting 
expressed recombinant proteins are shown in Appendix 4. 
Twelve out of thirteen cloned NCS1 proteins were successfully expressed in the 
E. coli membrane (Figure 3.6).  Only PPA0619 was not detectable in the Western 
blotting using India-HisProbe
TM
 (Figure 3.6).  The selected NCS1 proteins were 
expressed at 3-24% of the total membrane, determined by scanning densitometry (Table 
3.3).  The Western blot to the His6-tag (Figure 3.6) confirmed the insertion of the genes 
into plasmid pTTQ18-His6, and that the C-termini of the cloned proteins were intact.  
No protein degradation was generally detected on the Western blot, though possibly a 
small amount of degraded or truncated SCO5579 protein was observed (Figure 3.6).  
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Proteins that were intensely overexpressed, such as the PA0443, PA2073 and SCO5579, 
tended to have an upper band on the Western blot which could indicate more than one 
form of the protein in the gel (Figure 3.6), perhaps because of the incomplete unfolding 
of the protein in SDS.  The theoretical mass of each His6-tagged protein was calculated 
using the Compute pI/Mw tool (Gasteiger et al., 2005) and compared with the size of 
the protein on the SDS-PAGE gel determined from a log Mr-distance curve (Section 
2.4.4).  The NCS1 family proteins migrate at approximately 62-74% of their predicted 
sizes on SDS-PAGE (Table 3.5).  It is typical for membrane proteins to migrate 
anomalously on a SDS-PAGE due to their hydrophobic nature, high binding of SDS or 
the retention of their secondary structure facilitating the migration through the gel 
(Ward et al., 2000).   
Figure 3.6 Expression of thirteen NCS1 genes in E. coli.  The NCS1 genes from 
various bacteria were cloned into plasmid pTTQ18-His6 and expressed in E. coli 
BL21(DE3) cells under the control of tac promoter.  The cells were cultured in LB 
medium as described in Section 2.4.1. Cells were induced with 0.5 mM IPTG and 
harvested 3 hours post-induction.  Total membranes were prepared by water lysis and 
samples (15 µg) were analysed by SDS-PAGE (top) and Western blotting (bottom). 
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Protein 
name 
Predicted size 
(kDa)
1 
Size on SDS-
PAGE (kDa)
2 
Difference in 
size (%) 
Expression in 
total E.coli 
membrane (%)
3
 
b0336 44.9 33 73 9 
b0511 54.3 35 64 7 
Bsu36470 55.8 37 66 5 
EF3000 56.0 39 70 16 
lp3374 51.6 34 66 6 
PA0438 44.3 31 70 3 
PA0443 55.5 41 74 24 
PA2073 53.2 35 66 17 
Pden4351 54.9 34 62 7 
Pden1111 55.0 40 73 20 
PPA0619 53.7 - - - 
PPA2211 54.7 40 73 8 
SCO5579 52.6 39 74 23 
 
Table 3.3 Expression level, predicted and observed size of the NCS1 transporters.  
1
Predicted using Compute pI/MW tool (Gasteiger et al., 2005); 
2
calculated using a log 
Mr-distance curve; 
3
determined by scanning densitometry of a Coomassie Blue stained 
SDS-PAGE in Figure 3.6. 
 
3.1.5. Analysis of the codon usage in the NCS1 proteins 
 
The fraction of usage of each codon in the protein was computed and plotted 
against the fraction of usage of the codon in the E. coli expression host (relative 
adaptiveness), and a mean difference value (an average of the relative adaptiveness) of 
codon usage calculated (Appendix 5).  The analyses were computed and plotted by 
‗Graphical codon usage analyser‘ (Fuhrmann et al., 2004). 
A comparison of the codon usage of the NCS1 family proteins with the E. coli 
expression host showed a mean difference of 20.38 to 43.88% (Appendix 5).  The 
codon in PA0438 has the highest mean difference to the E. coli expression host, and 
b0511 has the lowest mean difference (Appendix 5).  These proteins were expressed at 
3 and 7 %, respectively (Figure 3.6 and Table 3.3), which were low compared to the 
other NCS1 proteins (Table 3.3).  The PPA0619 protein that did not express (Figure 
3.6), has a calculated mean difference of 29.70% which was in the middle of the range 
for the NCS1 proteins (Appendix 5).  These results suggest that differences in the codon 
usages of the NCS1 proteins from the E.coli expression host do not necessarily affect its 
expression level (Appendix 5). 
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An analysis of the number of E. coli rare codons in each of the NCS1 proteins 
showed they have between 11-56 rare codons (Appendix 6).  PPA0619 has the highest 
number of rare codons, and the second-highest consecutive rare codons (Appendix 6).  
There are also three consecutive rare codons of the same bases (ACG,ACG,ACG) in 
PPA0619, which was not found in the other NCS1 proteins (Appendix 6), that could 
contribute to this protein not being expressed in the E. coli cells (Figure 3.6).  The 
PA0443 protein has 28 rare codons (one of the least) and no consecutive rare codons, 
and was expressed at 24% in the E. coli membrane, which was the highest amongst all 
the NCS1 proteins tested (Appendix 6).  The results indicate the number of rare codons 
and consecutive rare codons could affect the expression level of the NCS1 proteins. 
 
3.1.6. Identification of substrates for the NCS1 proteins 
 
The substrates transported by most of the selected NCS1 proteins are unknown 
but they are predicted to transport nucleobases, thiamine and allantoin (Saier et al., 
2006) (Figure 3.7).  In order to identify the substrates for the selected transporters 
(Table 3.1), transport assays were performed using radiolabelled substrates and intact E. 
coli cells overexpressing each target protein (Section 2.5.6).  Both uninduced and 
induced cells were tested and the uptake of a particular substrate was identified by 
higher uptake in the induced cells than in the uninduced; hence the uninduced cells 
served as a control. 
Ten different substrates were chosen in an attempt to identify the substrates for 
nine of the selected NCS1 proteins (Table 3.4) that had moderate or high 
overexpression levels.  It was previously reported that the CodB and PucI proteins are 
cytosine and allantoin transporters, respectively (Danielsen et al., 1992; Schultz et al., 
2001).  These proteins were tested and their transported substrates further confirmed 
(Table 3.4); allantoin was not the only substrate for the PucI protein, but uracil was also 
(Table 3.4).  Further characterisation of these two proteins is described in Section 3.2 
and 3.3. 
Sequence alignment by ClustalW (Thompson et al., 2002; Larkin et al., 2007) 
(Appendix 2) showed that the b0511 and EF3000 proteins were highly similar to the 
PucI protein, 75.1 and 73.1 %  respectively, but surprisingly, allantoin or uracil were not 
taken up by these proteins (Table 3.4). 
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      Allantoin    Hydantoin       L-5-Benzylhydantoin        5-Hydroxyhydantoin 
                                 
 
    Allantoic acid               Indolylmethylhydantoin     Thiamine 
              
 
      Guanine  Adenine       Cytosine            Thymine            Uracil 
 
H2N
                  
 
        Guanosine          Adenosine              Cytidine                       Thymidine 
                     
 
         Uridine               Inosine                 Xanthine          Hypoxanthine 
                             
 
        Urea      Uric acid 
C
  
 
Figure 3.7 Chemical structures of possible substrates for the NCS1 family of 
transporters.  The structures were drawn using Symyx Draw 3.2. 
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b0336 
(CodB) 
U  
 
N/T 
 
 
N/T 
0.130 
0.138 
0.144 
 
 
N/T 
 
 
N/T 
 
 
N/T 
 
 
N/T 
 
 
N/T 
 
 
N/T 
 
 
N/T 
 I 0.800 
0.859 
0.930 
 
b0511 
U 0.626 
0.671 
0.698 
 
 
N/T 
0.086 
0.091 
0.113 
0.335 
0.324 
- 
 
 
N/T 
 
 
N/T 
2.882 
3.886 
4.369 
0.107
0.213 
- 
 
 
N/T 
3.349 
3.622 
3.641 
 I 0.869 
0.872 
0.900 
0.090 
0.097 
0.108 
0.367 
0.410 
- 
2.966 
3.139 
3.146 
0.064 
0.147 
- 
3.826 
4.031 
4.628 
 
Bsu36470
(PucI) 
U 1.124 
1.281 
1.339 
 
 
N/T 
0.081 
0.089 
0.122 
0.335 
0.421 
- 
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2.107 
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9.924 
9.736 
- 
 
 
N/T 
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3.256 
- 
 I 0.890 
0.968 
1.056 
0.097 
0.103 
0.104 
0.608
0.720 
- 
1.571 
1.807 
1.841 
43.91 
44.16 
- 
2.632 
2.684 
- 
 
EF3000 
U 1.052 
1.096 
 
N/T 
 
N/T 
0.335 
0.311 
 
N/T 
 
N/T 
 
N/T 
0.067 
0.050 
0.485 
0.543 
3.636 
3.645 
 I 1.312 
1.394 
0.286
0.306 
0.063
0.066 
0.279 
0.493 
3.817 
4.035 
 
PA0443 
U 1.229 
1.231 
1.239 
 
 
N/T 
0.273 
0.274 
0.292 
0.253 
0.264 
- 
1.565 
1.599 
1.679 
0.312 
0.322 
0.339 
2.328 
2.882 
2.959 
0.062
0.094 
- 
 
 
N/T 
2.777 
3.269 
3.339 
 I 1.064 
1.126 
1.157 
0.170 
0.236 
0.236 
0.841 
0.886 
- 
1.638 
1.706 
1.718 
0.318 
0.357 
0.358 
1.967 
2.114 
2.903 
0.041 
0.072 
- 
3.191 
3.227 
3.285 
 
PA2073 
U 1.237 
1.239 
1.248 
0.270 
0.277 
0.420 
0.241 
0.268 
0.269 
0.098 
0.121 
0.131 
 
 
N/T 
 
 
N/T 
 
 
N/T 
0.095 
0.097 
- 
0.144 
0.145 
0.359 
2.730 
2.808 
3.141 
 I 0.807 
0.820 
0.835 
0.198 
0.198 
0.204 
0.136 
0.140 
0.143 
0.900 
0.104 
0.114 
0.098 
0.103 
- 
0.259 
0.271 
0.362 
2.788 
3.204 
3.206 
 
Pden1111 
U 0.762 
0.908 
 
N/T 
0.110 
0.116 
0.304 
0.309 
1.372 
1.382 
0.264 
0.272 
1.067 
1.150 
0.026 
0.039 
0.394 
0.414 
2.462 
2.606 
 I 1.512 
1.715 
0.099 
0.104 
0.648 
0.736 
1.684 
1.892 
0.428 
0.477 
1.794 
1.791 
0.032 
0.063 
0.379 
0.382 
2.652 
2.656 
 
Pden4351 
U  
N/A 
 
N/T 
0.137 
0.139 
0.271 
0.297 
 
N/T 
 
N/T 
 
N/T 
0.049 
0.089 
 
N/T 
2.784 
3.027 
 I 0.201 
0.212 
0.741 
0.764 
0.070 
0.110 
3.037 
3.449 
 
SCO5579 
U 1.114 
1.289 
1.340 
 
 
N/T 
0.141 
0.162 
0.177 
0.285
0.321 
- 
 
 
N/T 
0.262 
0.268 
0.269 
1.757 
1.902 
2.290 
0.055 
0.076 
- 
 
 
N/T 
2.320 
2.330 
3.063 
 I 0.858 
0.880 
0.920 
0.090 
0.100 
0.100 
0.329 
0.357 
- 
0.212 
0.213 
0.223 
1.764 
1.779 
1.780 
0.057
0.063 
- 
1.645 
2.022 
2.596 
 
Table 3.4 Substrate screening of the NCS1 family transporters.  Transport assays 
were performed as described in Section 2.5.6.  Cells were cultured in minimal media 
supplemented with 100 µg/ml carbenicillin and 20 mM glycerol, and induced with 0.5 
mM IPTG when A680nm reached 0.4 – 0.6.  Cells were harvested 1 hour post-induction. 
Uninduced (U) and induced (I) cells harbouring the target clone were tested.  The 
uptake (nmol/mg of cells) two minutes after addition of radiolabelled substrate was 
examined.   Uptake (in green), potential uptake (in amber) and no uptake (in red) by the 
proteins are indicated in the table.  N/T, not yet tested.  Criteria for green = ≥100% 
increase I/U.  Each value in the table represents a single transport experiment. 
 89 
The P. denitrificans proteins, Pden1111 and Pden4351, took up uracil in the 
induced cells at 2.3 and 2.7 times higher than in the uninduced cells (Table 3.4).  The 
Pden1111 protein also mediated uptake of adenosine and thymidine, though the extent 
is not as great when compared to uracil, but it suggested the ability to transport a range 
of substrates (Table 3.4).  The PA0443 protein from P. aeruginosa transported uracil at 
3.3 times higher in the induced cell and therefore is an uracil transporter (Table 3.4).  
This protein is further discussed in Section 3.4. 
 
3.1.7. Discussion: cloning, expression and activities of NCS1 proteins 
 
To date, the structures of one NCS1 family protein, Mhp1, has been solved 
(Weyand et al., 2008; Shimamura et al., 2010).  In this genomic approach for studying 
the NCS1 family transporters, twenty proteins that were homologues of Mhp1 were 
selected (Table 3.1).  In silico analysis of these proteins suggested that most of them 
have twelve transmembrane domains and possess a cytoplasmic N- and C- terminus 
(Table 3.2 and Appendix 1). 
Thirteen of the selected proteins were cloned and a His6-tag introduced at the C-
termini, and another seven are undergoing cloning (Table 3.5).  Of the thirteen cloned 
proteins, twelve were successfully expressed in E. coli and their presence was 
confirmed by Western blotting (Figure 3.6).  The NCS1 proteins were expressed at 3-24% 
of the E. coli total membrane, and like other membrane proteins, they migrated 
anomalously on SDS-PAGE, at 62-74% of their actual mass (Table 3.3). 
All but two of the NCS1 proteins are heterologously expressed in E. coli.  There 
are many factors that could contribute to the low level of expression of some of the 
NCS1 proteins.  For example, codon usage is important for genes to be expressed 
efficiently (Grosjean & Fier, 1982), and could be a problem in recombinant expression 
systems.  Analysis of the NCS1 family proteins have shown that their differences in 
codon usage from that in the expression host does not affect their expression level 
(Appendix 5), but the number and consecutiveness of rare codons in the protein will 
affect their expression (Appendix 6). 
To overcome this, host strains such as the Rosetta
TM
 (Novagen) and CodonPlus-
RIL
TM
 (Strategen), which are BL21 derivatives, could be used to provide the rare tRNA 
species to match the codon usage of the heterologous gene.  The modest expression 
levels of two E. coli genes (b0336 and b0511) were 9 and 7 % respectively, lower than 
some of the heterologously expressed genes (Figure 3.6 and Table 3.3).  There are 22 
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and 24 rare codons in these proteins, respectively; fewer in number than the other NCS1 
proteins (Appendix 6).  This could suggest that not only codon usage is an important 
factor for protein expression, but the overexpression of the gene itself might cause 
toxicity and limit the level of protein being expressed. 
 
 Protein 
name 
Cloned Expression Purified 
(Ni-NTA) 
Substrate(s) 
transported 
N-terminal 
sequence 
Circular 
Dichroism 
1 b0336 yes moderate yes cytosine not tried yes 
2 b0511 yes moderate not tried not identified not tried not tried 
3 Bsu36470 yes moderate yes allantoin 
uracil 
MNSHMKLKES Yes 
4 Bsu3867 UC N/A N/A N/A N/A N/A 
5 EF3000
 yes high yes not identified not tried not tried 
6 lp3374 yes low not tried not tried not tried not tried 
7 PA0438 yes low not tried not tried not tried not tried 
8 PA0443 yes high yes uracil MNSHMQQSRS yes 
9 PA0476 UC N/A N/A N/A N/A N/A 
10 PA2073 yes high yes not identified MNSQMSNNNE not tried 
11 PA5099 UC N/A N/A N/A N/A N/A 
12 Pden0678 UC N/A N/A N/A N/A N/A 
13 Pden4351 yes moderate not tried uracil not tried not tried 
14 Pden1111 yes high yes uracil not tried yes 
15 PPA0619 yes ND N/A N/A N/A N/A 
16 PPA2211 yes low not tried not tried not tried not tried 
17 SCO0572 UC N/A N/A N/A N/A N/A 
18 SCO5579 yes high yes not identified MNSHMSKTAE not tried 
19 SCO6417 UC N/A N/A N/A N/A N/A 
20 SCO7500 UC N/A N/A N/A N/A N/A 
 
Table 3.5 Current status of the selected NCS1 family proteins.  UC, under cloning; 
N/A, not available to test; ND, not detected in Western blotting.  The EF3000 protein 
was cloned and purified by Dr Kim Bettaney.  The Pden4351 and Pden1111 proteins 
were cloned by Mr Dong Leng, and Pden1111 was purified by Mr Shen Wei Lim. 
 
Here, CodB (b0336) and PucI (Bsu36470) proteins were tested for the uptake of 
their reported substrates (Danielsen et al., 1992; Schultz et al., 2001) and the assays 
further confirmed that their substrates were cytosine and allantoin, respectively (Table 
3.4). 
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Three uracil transporters were identified; Pden4351, Pden1111 and PA0443 
(Table 3.4).  PucI also transported uracil (Table 3.4).  The substrates transported by 
some of the NCS1 proteins were not yet identified (Table 3.4).  A wider range of 
substrates should now be tested and possibly the buffer components of the transport 
assay modified, e.g. by addition of NaCl.  Since structure of Mhp1 revealed a sodium 
binding site (Weyand et al., 2008), the selected NCS1 transporter may potentially rely 
on the presence of sodium for transport. 
Currently, seven of the selected NCS1 proteins are purified from the inner 
membrane and this allows us to proceed to characterisation studies and crystallisation 
trials (Table 3.5).  Some targets are still at the cloning stage (Table 3.5), and once 
cloned they will proceed to expression trials and onwards. 
3.2. Characterisation of an Escherichia coli cytosine transporter – 
CodB (b0336) 
 
3.2.1. Introduction – the codBA operon of E. coli 
 
The E. coli codBA operon encodes two pyrimidine salvage proteins, the cytosine 
permease (codB) and the cytosine deaminase (codA), whose genes overlap, and are 
located in a cytosine-inducible operon (Danielsen et al., 1992; Qi & Turnbough, 1995) 
(Figure 3.8).  E. coli can utilise cytosine as its sole source of nitrogen by using CodB to 
mediate the uptake of exogenous cytosine, and CodA to catalyse the hydrolytic 
deamination of cytosine to uracil (a source of pyrimidines) and ammonia (a source of 
nitrogen) (Danielsen et al., 1992). 
 
  
 
Figure 3.8 Map of the E. coli codBA region.  The bent arrow denotes the codB 
promoter site.  Diagram modified from the codBA operon in regulonDB (Gama-Castro 
et al., 2008). 
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Transcription of the codBA operon of E. coli is regulated by nitrogen and purine, 
with approximately three times more codBA expression  in cells grown in nitrogen-
limiting medium (Muse et al., 2003) and reduced codBA expression in cells grown on 
medium containing hypoxanthine (Danielsen et al., 1992).   
Expression of codBA is induced under nitrogen-limited growth conditions and 
repressed by purines or pyrimidines.  Induction and repression are mediated by the 
nitrogen assimilation control (Nac) (Anderson et al., 1989; Muse et al., 1998; Muse et 
al., 2003) and PurR proteins respectively (Anderson et al., 1989; Kilstrup et al., 1989), 
and their binding sites are located upstream of the codBp promoter (Figure 3.8). 
Nitrogen-limited growth leads to a starvation for glutamine, causing a cascade of 
events, including activation of a transcription regulator, NtrC, a protein kinase that 
activates RNA polymerase carrying ơ54 to transcribe a number of genes, one of which is 
nac, which codes for the Nac protein.  Nac activates RNA polymerase carrying ơ70, 
which leads to transcription of several operons whose products can supply the cell with 
ammonia or glutamate from alternative organic sources (Bender, 1991; Muse & Bender, 
1998), i.e. codBA, nac, glutamate dehydrogenase (gdhA) (McPherson & Wootton, 1983), 
glutamate synthase operon (gltBDF) (Castaño et al., 1988; Castaño et al., 1992), and 
nupC (Craig et al., 1994). 
PurR is a repressor that controls the synthesis of the enzymes of purine 
biosynthesis (Rolfes & Zalkin, 1988).  This regulator binds two products of purine 
metabolism, hypoxanthine and guanine, to induce the conformational change that 
allows binding to DNA at the PurR box (Figure 3.8). 
Section 3.2 describes the characterisation of the CodB protein.  Firstly, the 
topology and the conserved residues in the protein are examined, followed by the 
kinetics and substrate specificity studies, and finally purification and circular dichroism. 
 
3.2.2. The E. coli cytosine transporter (CodB): topology analysis and conserved 
residues 
 
In a whole cell transport assay, the cloned codB gene was able to complement 
mutants with cytosine transport defects (Danielsen et al., 1992) suggesting CodB is a 
cytosine permease.  Previous topology analysis using alkaline phosphatase and β-
galactosidase fusions suggested CodB has twelve transmembrane segments (Danielsen 
et al., 1995).  Here, a topology model of CodB in the cytoplasmic membrane, predicted 
using TMHMM (Krogh et al., 2001), also showed twelve transmembrane helices 
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(Figure 3.9).  The N- and C- termini of CodB comprise approximately twenty amino 
acids, and the lengths of the periplasmic and cytoplasmic loops between the helices is 
variable (Figure 3.9). 
 
 
 
 
Figure 3.9 Topology model of E. coli cytosine permease (CodB).  Topology 
prediction by TMHMM (Krogh et al., 2001).  The predicted helices are numbered from 
the N- to C-terminus and are shown in roman numerals.  Conserved residues of the 
NCS1 family proteins are highlighted in grey and black according to the alignment in 
Appendix 2. 
 
The conserved residues of CodB are highlighted in the topology model (Figure 
3.9).  Most of these are identical or highly similar within the NCS1 family proteins 
(Appendix 2).  How some of these residues may contribute to its substrate recognition 
and binding are discussed in Section 3.2.9. 
A search through the databases using FASTA3 showed the amino acid sequence 
of CodB is highly conserved throughout the E. coli strains, 99.3-100% identity; the 
Salmonella species, 79.9-93.2% identity (95.7-96.2% similarity); and the Vibrio species, 
73.7-78.0% identical (93.0-94.8% similar).  CodB is 76.5 % identical (92.6% similar) to 
PA0438, and 27.4% identical (65.5% similar) to SCO0572, and clustered very closely 
with these proteins, shown by the phylogenetic tree (Figure 3.2).  This could suggest 
that these selected proteins are cytosine transporters. 
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3.2.3. Cloning and expression of CodB 
 
To characterise the E. coli cytosine permease, the codB gene (b0336) was 
amplified from the genomic DNA of E. coli K-12 strain by PCR (Figure 3.3), and 
cloned into plasmid pTTQ18-His6 with a His6-tag added to the C-terminus of the protein.  
The clone was subjected to analysis by PCR screening and restriction digestion, which 
confirmed the correct sized gene in the plasmid construct (Figure 3.4 and 3.5).  DNA 
sequencing also confirmed a single silent mutation in the cloned codB gene but 
confirmed the correct encoded amino acid sequence (Appendix 3 and 4).  This was 
followed by transformation of the construct into E. coli BL21(DE3) cells for expression 
test, as described in Section 2.3 and 2.4.  The CodB protein was overexpressed to 9% in 
the E. coli total membrane (Figure 3.6 and Table 3.3) and the growth curves of the 
uninduced and induced cells harbouring the pTTQ18(codB)-His6 are shown in Figure 
3.10.  The induced culture continued to grow after addition of IPTG but was slower than 
the uninduced cells (Figure 3.10).  The SDS-PAGE gel and Western blot confirmed the 
presence of the CodB protein in the induced cell, and not in the uninduced cell (Figure 
3.10). 
 
Figure 3.10 Growth and expression of E. coli BL21(DE3) cells transformed with 
pTTQ18(codB)-His6.  (A) E. coli BL21(DE3) cells transformed with pTTQ18(codB)-
His6 were grown in LB medium supplemented with 20 mM glycerol.  Cells were 
induced with 0.5 mM IPTG when A680nm reached 0.4 – 0.6 and harvested 3 hours post-
induction.  Total E. coli membranes were prepared and analysed by (B) SDS-PAGE and 
(C) Western blotting.  U (uninduced) and I (induced).  Arrow indicates position of the 
CodB protein. 
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3.2.4. Uptake of radiolabelled cytosine by CodB 
 
A time course of cytosine transport by CodB showed an increase in uptake of 
cytosine in the induced cells expressing CodB, up to a maximum of 1.8 nmol mg
-1
 cells 
(Figure 3.11).  The level of radioactivity decreased after the peak, which could indicate 
metabolism of cytosine inside the cells, to radiolabelled product(s) that leave the cell.  
In bacteria, cytosine taken up into the cell is either incorporated into DNA and RNA or 
hydrolytically deaminated to uracil and ammonia.  The ammonia is excreted from the 
cell and the uracil is converted to barbituric acid, which is then degraded to urea and 
malonic acid (Figure 3.12).  Oxidation of malonic acid then produces carbon dioxide 
and 
3
H-water (Figure 3.12). 
The radiolabelled cytosine used in this project is 
3
H-5-cytosine.  The decreased 
radioactivity in the induced cells could be caused by the excretion of radiolabelled water 
from the cell (Figure 3.12).  Here, the proportion of uptake or excretion of these 
compounds could not be defined.  The induced cells expressing CodB showed an 
increase in uptake of radiolabelled compound after 5 minutes of the time course, this 
could suggest the cells recommence taking up cytosine when levels get low (Figure 
3.12).   
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Figure 3.11 Time course of cytosine uptake by CodB.  Uptake of 
3
H-cytosine in E. 
coli BL21(DE3) cells transformed with pTTQ18(codB)-His6.  Cells were cultured in 
minimal medium in the presence of 100 μg/ml carbenicillin and 20 mM glycerol.  When 
cells reached an A680nm of 0.4-0.6, 0.5 mM of IPTG was added the induced sample and 
cells were harvested 1 hour post-induction, followed by washing of cells.  Cells were 
energised with 20 mM glycerol, and incubated in 50 µM 
3
H-cytosine in 5 mM MES pH 
6.6 and 150 mM KCl for uptake studies.  Results represent means of triplicates (±SEM). 
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The rapid decrease in radioactivity might indicate a high level of cytosine is 
toxic to the E. coli cells, and so the cell tries to metabolise and excrete the toxic 
compound.  At present there are no known cytosine exporters in bacteria, so it is most 
likely that the decrease in radioactivity is due to excretion of water as a waste product of 
cytosine metabolism. 
In the uninduced cells, a gradual increase in radioactivity suggested cytosine is 
taken up into the cells (Figure 3.11).  No expression of CodB is observed in the 
uninduced cells, shown by the SDS-PAGE and Western blot of total membrane of 
CodB expression (Figure 3.10); therefore the uptake observed could be endogenous 
cytosine transport system in the host cell. 
 
 
 
Figure 3.12 Pyrimidine catabolic pathways in bacteria.  Bacterial reductive and 
oxidative pathways for catabolism of pyrimidine rings.  Enzymes in the pathways are as 
follows: (1) cytosine deaminase; (2) dihydropyrimidine dehydrogenase; (3) 
dihydropyrimidinase; (4) ureidopropionase; (5) uracil dehyrogenase; (6) barbiturase; (7) 
ureidomalonase.  The radiolabelled hydrogen in 
3
H-5-cytosine is highlighted in green, 
showing its catabolism through the two pathways.  Diagram modified from Loh et al. 
(2006) and Hayaishi & Kornberg (1952). 
 
3.2.5. Substrate specificity of CodB 
 
To study the substrate specificity of CodB, 
3
H-cytosine uptake in E. coli cells 
expressing CodB was determined in the presence of ten-fold molar excess of potential 
substrates (Figure 3.7 and 3.12).  This competition assay of CodB showed 
benzylhydantoin and uracil are able to inhibit transport of cytosine into the cells (Figure 
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3.13).  Benzylhydantoin was able to inhibit uptake of cytosine at 15 seconds and 2 
minutes post-addition of cytosine, whereas uracil only had an effect at 15 seconds 
(Figure 3.13).  Possible competition of cytosine uptake in presence of ten-fold molar 
excess of potential competitors showed relative uptake of 80-120% (Figure 3.13).  
These results indicated CodB has a narrow substrate specificity, being specific for 
cytosine transport and no other nucleobases that were tested here apart from the effect 
of uracil at 15 seconds. 
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Figure 3.13 Substrate specificity of CodB.  Competition of 
3
H-cytosine (50 µM) 
uptake into E. coli BL21(DE3) cells expressing CodB in the presence of a ten-fold 
molar excess of potential competitors.  The noncompeted uptake rate was taken as 100% 
corresponding to 1.88 and 1.93 nmol cytosine per mg of cells for 15 seconds and 2 
minutes post-addition of 
3
H-cytosine, respectively.  Buffers contain 2% DMSO.  
Results represent means of duplicated experiments.  None = no competitors or DMSO 
(control). 
 
Competition with an excess of unlabelled cytosine caused a reduction of the 
uptake at 15 seconds and 2 minutes, to 13 and 18% respectively (Figure 3.13), 
confirming that CodB mediates the transport of cytosine.  L-Benzylhydantoin was also 
found to be effective at inhibiting 
3
H-cytosine uptake when applied in excess, 
suggesting that CodB also binds benzylhydantoin (Figure 3.13). 
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The common features of cytosine, benzylhydantoin, uracil and hydantoin are 
highlighted in Figure 3.14.  Hydantoin is a poor substrate for CodB, indicated by the 
small reduction in 
3
H-cytosine uptake in presence of ten-fold molar excess of hydantoin 
(Figure 3.13).  This suggested the six-membered ring, rather than the hydantoin group, 
of the benzylhydantoin might play a crucial role in binding to CodB (Figure 3.13). 
 
      Cytosine      L-Benzylhydantoin Uracil  Hydantoin 
 
 
 
 
 
Figure 3.14 Common structural features of CodB substrates.  The unique NH2 
group in cytosine (yellow); common structural groups in CodB substrates (pink and 
blue). 
 
The structure of uracil is highly similar to cytosine.  Uracil also has a six-
membered ring, but the results suggested that the NH2 group in cytosine is important for 
CodB to select cytosine over uracil (Figure 3.13 and 3.14).  However, the highlighted 
pink and blue part of the selected substrates (Figure 3.14) may be important for initial 
recognition by CodB. 
 
3.2.6. Kinetic analysis of cytosine transport by CodB 
 
Transport studies in E. coli BL21(DE3) cells expressing CodB with 
3
H-cytosine 
confirmed cytosine uptake is concentration dependent and showed a Michaelis-Menten 
constant (Km) for cytosine of 30.96 ± 11.06 µM, and displayed saturation kinetics with a 
Vmax of 1.495 ± 0.1016 nmol mg
-1
 cells (Figure 3.15).  Uninduced cells demonstrated a 
continuous uptake of cytosine and no saturation was observed with the concentrations 
tested (Figure 3.15).  Since the SDS-PAGE and Western blot showed no expression of 
His6-tagged CodB in the total E. coli membrane (Figure 3.10), the effect in the 
uninduced cells must be the host cells constitutively expressing proteins that transport 
cytosine, thus this could be the host cell‘s CodB.  Therefore the kinetics of the 
uninduced cells was subtracted from the induced cells (Induced minus uninduced), 
giving rise to kinetics for the His6-tagged CodB (Figure 3.10), which showed a Km and 
Vmax for cytosine of 7.748 ± 4.894 µM and 1.006 ± 0.0591 nmol mg
-1
, respectively. 
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Figure 3.15 Michaelis-Menten kinetics of 
3
H-cytosine uptake by CodB.  E. coli 
BL21(DE3) cells transformed with pTTQ18(codB)-His6 were cultured in minimal 
medium in presence of 100 μg/ml carbenicillin and 20 mM glycerol.  When cells 
reached an A680nm of 0.4-0.6, 0.5 mM IPTG was added to the induced sample and cells 
were 20 mM glycerol harvested 1 hour post-induction, followed by washing of cells.  
Cells were energised with 20 mM glycerol, and incubated in various concentrations of 
3
H-cytosine (40 – 1600 µM) in 5 mM MES pH 6.6 and 150 mM KCl for uptake studies.  
Samples were taken 15 seconds post-addition of 
3
H-cytosine.  Results represent means 
of triplicates (±SEM). 
 
3.2.7. Purification of CodB from the inner membrane 
 
A six litre culture of E. coli BL21(DE3) expressing the His6-tagged CodB was 
grown aerobically as described in Section 2.4.1.  The harvested cells were lysed by 
explosive decompression using a cell disruptor and the inner membrane was prepared 
by separation of the outer from the inner membrane on a sucrose gradient (Ward et al., 
2000) (Section 2.5.1).  The membrane fractions obtained from the sucrose gradients 
were analysed by SDS-PAGE (Figure 3.16).  The gel showed the presence of CodB in 
the prepared inner and outer membranes, suggesting poor separation by the sucrose 
gradients for this protein.  CodB was present at 13% in the prepared inner membrane, 
and 9% and 8% in the mixed and outer membrane respectively (Figure 3.16), as 
determined by scanning densitometry.  The sucrose gradients step appears to be an 
important step for making CodB more abundant, as indicated by densitometry, the 
protein was increased from 9% in the mixed membrane (Figure 3.6 and Figure 3.16) to 
13% in the inner membrane after the sucrose gradients (Figure 3.16).  The red arrow 
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shows the position of a abundant protein migrating at ~31 kDa in the mixed and outer 
membranes, that is not CodB (Figure 3.16).  The abundance of this protein (red arrow) 
in the outer membrane and its absence or low abundance in the inner membrane after 
sucrose gradients, could suggest this protein is porin, which is found abundantly in the 
outer membranes of E. coli. 
 
    Marker     Inner       Mixed     Outer  
 
 
Figure 3.16 SDS-PAGE of membrane fractions of E. coli BL21(DE3) expressing 
CodB.  Total E. coli membranes were prepared from E. coli BL21(DE) pTTQ18(codB)-
His6 grown on LB medium containing 20 mM glycerol and 100 µg/ml carbenicillin in 
the presence of 0.5 mM IPTG and harvested 3 hours post-induction.  Total membranes 
were separated on 25-55% sucrose gradients and membrane fractions extracted from the 
gradients were analysed by SDS-PAGE.  The black arrow indicates the position of the 
CodB protein, and the red arrow shows the position of the protein removed from the 
inner membrane. 
 
The inner membranes were subjected to solubilisation and purification as 
described in Section 2.5.2 and Section 2.5.3.  Fractions from the purification of CodB 
were analysed by SDS-PAGE and Western blotting (Figure 3.17).  The majority of the 
CodB protein was solubilised in the 1% DDM buffer, indicated by very small amount of 
CodB in the insoluble fraction, shown by the SDS-PAGE and Western blot (Figure 
3.17).  Some CodB proteins that were not bound to the Ni-NTA resin was lost in the 
flow-through, unbound fraction (Figure 3.17), and indicates a longer binding time or 
increased amount of resin could reduce the loss. 
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Some contaminants were co-eluted with the CodB protein, migrating at ~45 kDa 
and >66 kDa on the SDS-PAGE, which were not detected by the Western blotting 
(Figure 3.17).  The upper contaminant on the SDS-PAGE is often found in E. coli 
overexpression systems; this is the multidrug efflux protein (AcrB) of E. coli, which 
was previously confirmed by Mass spectrometry (Bettaney, 2008).  A further 
purification step, such as size-exclusion chromatography, could be used to remove the 
contaminating proteins.  The arrows in Figure 3.17 indicate the position of the CodB 
protein, migrating at 33 kDa and 55 kDa.  The CodB protein was purified to 
approximately 70% as estimated by scanning densitometry. 
 
Figure 3.17 SDS-PAGE and Western blot of purification of E. coli CodB.  CodB 
was purified from the inner membrane of E. coli BL21(DE3) pTTQ18(codB)-His6 cells.  
The inner membranes were solubilised in 1% DDM.  Samples (15 µg), and the final 
eluted fraction (10 µg) were analysed by SDS-PAGE (top) and Western blotting 
(bottom).  The arrow indicates the position of the CodB protein. 
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3.2.8. Testing the integrity of CodB by circular dichroism 
 
The secondary structure of the part-purified CodB was examined by circular 
dichroism (Section 2.6.1).  The negative indentations at 208 and 222 nm, and a positive 
signal at 190 nm, are indicative of a predominantly α-helical content, agreeing with the 
previous topology analysis (Danielsen et al., 1995) and prediction by TMHMM (Figure 
3.9), confirming the retention of the secondary structure of CodB during the purification 
process (Figure 3.18). 
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Figure 3.18 Circular dichroism spectrum of purified CodB of E. coli.  Purified 
CodB (0.05 mg/ml) was buffer-exchanged into 10 mM potassium phosphate buffer pH 
7.6 and 0.05% DDM.  CD spectral analysis of CodB was performed using Jasco J-715 
spectropolarimeter at 18
o
C with constant nitrogen flushing.  The sample was analysed in 
Hellma quartz-glass cell of 1mm path length.  Spectrum was recorded with 1 nm step 
resolution at a scan rate of 10 nm/min.  Response time was set at 1 second with a 
sensitivity of 20 mdeg and bandwidth of 1.0 nm.  The spectrum represents an 
accumulation of ten scans, from which the buffer contribution was subtracted. 
 
3.2.9. Discussion: characterisation of CodB 
 
 Currently, only one cytosine transporter, CodB (Danielsen et al., 1992) has been 
identified in E. coli.  Analysis using FASTA3 showed that the E. coli CodB is highly 
conserved throughout the E. coli strains, Salmonella and Vibrio species (Section 3.2.2.).  
In the phylogentic tree analysis of the selected NCS1 proteins, CodB clustered very 
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closely with the P. aeruginosa PA0438 protein, suggesting this protein could be a 
cytosine transporter too (Figure 3.2).  The S. coelicolor SCO0572 protein also clustered 
quite closely, indicating this may also be a cytosine transporter (Figure 3.2). 
The conserved residues of the NCS1 proteins are highlighted in the topology 
model of CodB (Figure 3.9); most of these are identical or highly similar within the 
family (Appendix 2).  In CodB, the conserved residues are found in: the N-terminus 
(R17 and K18); helix I (V26, M27, L28 and G29); the cytoplasmic loop between helices 
I and II (G46 and L47); the cytoplasmic loop between helices II and III (G74, K76, G78, 
L79, R86, F89, G90, G93 and S94); helix III (L96, P97, W108 – where a F, G and V 
residue often follow after it); helix IV (G146 and L150); helix VI and the cytoplasmic 
loop after it (F204, D213, F214, V215, R216 and F217); and in helix X and the 
cytoplasmic loop after it (W324, L325, G337, V338, I340, D342,Y343, R347, R348 and 
Y350) (Figure 3.9 and Appendix 2). 
Based on the structures of Mhp1 (Weyand et al., 2008) and the alignment in 
Appendix 2, the potential residues in CodB that could be involved in substrate 
recognition and binding were identified.  As mentioned earlier in Chapter 1, residue 
W117 in helix III of Mhp1 forms π-stacking with the hydantoin moiety of its substrate 
(Figure 1.9).  Here, if the alignment in Appendix 2 is correct, residue W108 in helix III 
of CodB may potentially form π-stacking with the hydantoin moiety of L-
benzylhydantoin, a compound which inhibited uptake of cytosine by CodB (Figure 
3.13).  Residue W220 in helix VI of Mhp1 is predicted to form π-stacking with the 
benzyl moiety of its substrate (Figure 1.9).  Alignment in Appendix 2 suggests residue 
F204 in helix VI of CodB could potentially form π-stacking with the aromatic moiety of 
cytosine or benzylhydantoin.  Residues S312 and T313 are involved in cation binding in 
Mhp1; these align with T278 and T279 in CodB, suggesting these two threonine 
residues have the potential to play a role in cation binding (Appendix 2). 
Here, the CodB protein is cloned into plasmid pTTQ18-His6 (Figure 3.3 – 3.5) 
and expressed at 9% in the E. coli total membrane, migrating at ~33 kDa on the SDS-
PAGE (Figure 3.6 and Table 3.3), which is similar to the migration (32 kDa) previously 
reported by Danielsen et al. (1992).  The higher migration of CodB in this project could 
be as a result of the incorporated MNSH and His6-tag at the N- and C- terminus of the 
protein, respectively.  A slightly slower growth rate was observed in E. coli BL21(DE3) 
pTTQ18(CodB)-His6 induced with IPTG (Figure 3.10), possibly as a consequence of 
the cells‘ expression of CodB and reduced growth rate to compensate.  No expression of 
 104 
CodB was observed in the uninduced cells, indicated by the negative Western blot of 
the uninduced cells (Figure 3.10), suggesting tight repression of the tac promoter. 
Transport assays showed cytosine is transported into the cell by CodB (Figure 
3.11), and CodB has a narrow substrate specificity, for cytosine, and only 
benzylhydantoin inhibited the uptake of cytosine by CodB (Figure 3.12).  Uptake of 
cytosine by CodB is concentration dependent, having a Km and Vmax of 7.748 ± 4.894 
µM and 1.006 ± 0.0591 nmol mg
-1
, respectively, in cells expressing CodB (Figure 3.15).  
Two previously studied transporters, cytosine-purine permease of S. cerevisiae (Fcy2) 
and cytosine-purine scavenger of A. nidulans (FcyB), of the NCS1 family have a Km of 
13 µM and 20 µM respectively (Benoît et al., 1997; Vlanti & Diallinas, 2008), which is 
higher than that of the E. coli CodB.  Since the uninduced cells of BL21(DE3) 
pTTQ18(CodB)-His6 are shown to take up cytosine (Figure 3.11 and 3.15), the transport 
experiment should be repeated with an E. coli codB-negative strain to confirm the 
transport activity is carried by the host cell. 
The percentage of α-helical or β-sheet contents of CodB was not determined, 
since it was conventional CD being performed and does not give accurate data at 
wavelength below 190 nm, due to the limitation of the xenon lamp in the J-715 
spectropolarimeter, but it was a quick in-house tool that successfully checked the 
integrity of CodB (Figure 3.18).  HT voltage is roughly proportional to absorbance.  If 
the protein sample is too concentrated, not enough light reaches the detector, which 
causes saturation and an accurate spectrum will not be recorded.  Synchrotron radiation 
CD (SRCD) could be used, giving reliable spectra measured down to 160 nm, where the 
complete spectra of α-helical, β-sheet or random coil element could be achieved (Lees 
& Wallace, 2002).   
 In this study, CodB was successfully cloned into pTTQ18-His6 and expressed in 
E. coli BL21(DE3) host to allow purification and production of the protein in 
milligrams, and activity studies have shown the expressed CodB is functional.  This 
allows the protein to proceed to further studies, which may include mutagenesis to 
identify residues in CodB that could be important for its substrate binding and 
recognition, and crystallisation trials for structural studies. 
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3.3. Characterisation of a Bacillus subtilis allantoin transporter – PucI 
(Bsu36470) 
 
3.3.1. Introduction – nitrogen metabolism & the puc genes of B. subtilis 
 
 Bacillus subtilis is a gram-positive, sporulating soil bacterium that is able to 
utilise a diverse range of low-molecular-weight compounds as a nitrogen source when 
the preferred nitrogen sources, glutamate, ammonium, or glutamine, are depleted 
(Fisher, 1999).  Nitrogen metabolism in B. subtilis is controlled by the availability of 
rapidly metabolisable nitrogen sources, rather than by the two-component Ntr 
regulatory system found in most enteric bacteria (Fisher, 1999).  At least three 
regulatory proteins independently control the expression of genes involved in nitrogen 
metabolism in response to nutrient availability (Fisher, 1999).  Genes expressed at high 
levels during nitrogen-limited growth are controlled by two related proteins, GlnR and 
TnrA (Schreier et al., 1993; Wray et al., 1996; Wray et al., 2000) (Table 3.6).  CodY, a 
third regulatory protein, controls expression of several genes involved in nitrogen 
metabolism and acetate metabolism in response to growth rate (Fisher et al., 1996; 
Wray et al., 1997) (Table 3.6). 
Under the preferred nitrogen source conditions, B. subtilis assimilates all of its 
nitrogen by the glutamine synthetase (GlnA)-catalysed reaction (NH3 + glutamate + 
ATP → glutamine + ADP + Pi).  When B. subtilis is grown with a less preferred 
nitrogen source, a number of other enzymes and permeases involved in the 
assimililation of nitrogen are induced (Fisher, 1999) (Table 3.6).  This includes 
asparaginase (Atkinson & Fisher, 1999), γ-aminobutyric acid permease (gabP) (Ferson 
et al., 1996), urease (ureABC), a putative ammonium permease (nrgA) (Wray et al., 
1994), and the nitrate assimilatory enzymes (nasABCDEF) (Nakano et al., 1995; 
Nakano et al., 1998) (Table 3.6).  The transcription of these genes is controlled by TnrA 
(Wray et al., 1996; Nakano et al., 1998).  In addition, TnrA positively regulates its own 
transcription, and also functions as a negative regulatory protein under nitrogen limited 
growth, repressing the expression of the ammonium assimilatory enzymes, GlnA, as 
well as the glutamate synthase operon (gltAB) (Wray et al., 1996; Fisher, 1999; 
Doroshchuk et al., 2006) (Table 3.6). 
TnrA and GlnR are homologous, belonging to the MerR family of regulatory 
proteins, and bind to the same DNA sequence known as the GlnR/TnrA box (5‘-
TGTNAN7TNACA-3‘); they are negative regulatory proteins for the glutamine synthase 
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operon (glnRA)  (Wray et al., 1996).  During growth with excessive nitrogen (glutamine 
or ammonia plus glutamate), GlnR functions as a repressor and inhibits the expression 
of the glnRA operon encoding GlnR and GlnA (Wray et al., 1996; Fisher, 1999).  
Whereas, TnrA binds to GlnA, forming an inactive complex (TnrA-GlnA), and 
consequently, TnrA cannot interact with its specific operator, leading to inhibition of 
the expression of alternative nitrogen-assimilatory pathways (Wray et al., 1996; Wray et 
al., 2000; Wray et al., 2001).  Under nitrogen-limited conditions, TnrA is release from 
the TnrA-GlnA complex and GlnR binding activity is inhibited, allowing TnrA to bind 
to its specific operator, and hence activation of the alternative nitrogen-assimilatory 
pathways (Fisher, 1999; Wray et al., 2000; Doroshchuk et al., 2006). 
CodY is activated under nitrogen-limited conditions where rapid growth occurs 
on amino acids (Wray et al., 1997).  It is a negative regulator of the histidine 
degradative operon (hut) (Fisher et al., 1996), the dipetide transporter operon (dpp) 
(Slack et al., 1995), the isoleucine and valine degradative operon (dkd), ureABC and 
gabP (Ferson et al., 1996) (Table 3.6).  A summary of the regulatory proteins involved 
in nitrogen metabolism in B. subtilis is listed in Table 3.6. 
 
Regulatory 
protein 
Growth conditions 
under which 
regulation occurs
 
Regulation
 
Regulated 
gene/promoter/ 
enzymes 
References 
 
 
 
TnrA 
 
 
 
Nitrogen limitation 
 
 
 
Positive 
 
 
nrgAB, gabP 
P2, ureABC P3, 
nasDEF, tnrA, 
asparaginase, 
puc genes 
Wray et al. (1994) 
Ferson et al. (1996) 
Wray et al. (1996) 
Cruz-Ramos et al. 
(1997) 
Nakano et al. (1998) 
Schultz et al. (2001) 
Yoshida et al. (2003) 
Doroshchuk et al. 
(2006) 
Nitrogen limitation Negative glnRA, gltAB Yoshida et al. (2003) 
 
GlnR 
 
Excess nitrogen 
 
Negative 
 
glnRA, tnrA, 
ureABC P3 
Fisher et al. (1984) 
Strauch et al. (1988) 
Cruz-Ramos et al. 
(1997) 
Yoshida et al. (2003) 
 
 
CodY 
 
Rapid growth with 
amino acids 
 
Negative 
 
Hut, gabP P1, 
ureABC P3, 
ureABC P2,  
dpp 
Yoshida et al. (1995) 
Ferson et al. (1996) 
Cruz-Ramos et al. 
(1997) 
Mathiopoulos et al. 
(1991) 
Yoshida et al. (2003) 
 
Table 3.6 The regulatory proteins involved in nitrogen metabolism in B. subtilis.  
Table modified from Fisher, S. (1999). 
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B. subtilis is capable of taking up purine bases and using them for nucleotide 
synthesis and as a source of nitrogen.  In B. subtilis, the natural purine bases all serve as 
nitrogen sources when the preferred nitrogen source are exhausted, and the puc genes 
(Figure 3.19 and 3.20) are required for the catabolism of purines (Schultz et al., 2001).  
The puc region contains two binding sites for TnrA, and expression of pucR is activated 
by TnrA (Beier et al., 2002).  The PurR transcription factor is a pathway-specific 
regulator of the purine catabolic genes of the puc regulon (Schultz et al., 2001; Beier et 
al., 2002), enabling the cell to utilise purines as an alternative nitrogen source 
(Doroshchuk et al., 2006).  Surprisingly, separate genes of the puc regulon were found 
in B. lichieniformis, but they are not regulated by TnrA; also the other bacilli are known 
to lack purine catabolism genes (Doroshchuk et al., 2006), making B. subtilis unique in 
terms of utilisation of purine as an alternative nitrogen source. 
 
 
 
Figure 3.19 Map of the B. subtilis puc genes region.  The bent arrow denotes the 
promoter site ( ).  The lollipop indicates the position of transcription termination ( ).  
The pink box represents a puc gene ( ), and the number below corresponds to the 
genome position of the gene.  The diagram is drawn based on the information in the 
DBTBS website (Ishii et al., 2001) and Schultz et al. (2001). 
 
The PucR protein of B. subtilis regulates expression of fifteen genes involved in 
purine catabolism (Beier et al., 2002).  PucR functions as both a transcriptional 
activator and repressor.  The expression of genes regulated by PucR is enhanced by 
growth in medium containing intermediates in purine catabolism, for example, uric acid, 
allantoin or allantoic acid (Schultz et al., 2001; Beier et al., 2002).  Analysis using pucR 
deletion mutants, comfirmed that PucR induces the expression of pucFG (allantoate 
amidohydrolase and unknown, respectively), pucH (allantoinase), pucI (allantoin 
permease), pucJKLM, and (uric acid transporter and uricase), gde (guanine deaminase), 
whereas it represses the expression of pucR (purine catabolism regulator) and 
pucABCDE (xanthine dehydrogenase) (Beier et al., 2002). 
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Figure 3.20 Pathway of nitrogen metabolism in Bacillus subtilis.  Purine degradative 
genes (puc) of B. subtilis are shown in the top half of the diagram.  The nas, gln, glt and 
gab genes are involved in nitrite oxide, glutamine, glutamate and γ-aminobutyrate 
metabolism, and are shown in the bottom part, respectively.  Diagram taken and redraw 
from Doroshchuk et al. (2006). 
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Potential PucR boxes were identified in the promoters of the the five induced 
operons, consisting of the conserved sequence 5‘-WWWCNTTGGTTAA-3‘, and a 
possible PucR box was also found in the pucABCDE promoter region and downstream 
of the pucR transcription start site (Beier et al., 2002).  These genes are required for the 
complete degradation of purine bases to ammonia, as well as for the transport of uric 
acid and allantoin (Schultz et al., 2001; Beier et al., 2002).  All puc genes except pucI 
are located in a gene cluster at 284 to 285
o
 on the chromosome.  The genome position of 
pucI is much further downstream of all the puc genes (Figure 3.19).  Intracellular 
purines, such as guanine, adenine, and hypoxanthine are first converted to xanthine 
before entering the catbolic pathway (Figure 3.20).  These puc genes form part of the 
important components in the pathways of nitrogen metabolism in B. subtilis (Figure 
3.20).  Section 3.3 describes the characterisation of the allantoin permease, PucI 
(Bsu36470).  Firstly, the topology and the conserved sequence in PucI are analysed.  
The cloning, expression, purification and the transport activity of PucI are also studied. 
 
3.3.2. The B. subtilis allantoin transporter (PucI): topology analysis and conserved 
residues 
 
 Topology prediction using TMHMM (Krogh et al., 2001) showed PucI is highly 
hydrophobic, composed of twelve transmembrane helices (Figure 3.21).  Conserved 
residues in PucI are highlighted in the model and are positioned mainly in helices I, II 
and X, as well as in the cytoplasmic loops between helices II and III, helices IV and V, 
and helices X and XI (Figure 3.21). 
Studies reported that B. subtilis is able to utilise uric acid, allantoin, allantoic 
acid, adenine, hypoxanthine, xanthine, guanine and urea as sole nitrogen source (Rouf 
& Lomprey, 1986; Nygaard et al., 1996; Cruz-Ramos et al., 1997; Nygaard et al., 2000).  
Mutants in the pucI gene were demonstrated not to grow on allantoin, suggesting the 
gene encodes an allantoin transporter (Schultz et al., 2001).  PucI is 28.8% identical 
(61.1% similar) to the allantoin permease of S. cereviase (DAL4).  It is also related to 
the NCS1 proteins studied in this project; 43.3% identical to SCO6417 (74.4% similar), 
38.8% identical to b0511 (75.1% similar) and 37.9% identical to EF3000 (73.9%) 
(Table 3.1).  The phylogenetic tree showed PucI clustered most closely with the putative 
allantoin permeases, b0511 and EF3000 of the NCS1 family (Figure 3.2).  Here, 
successful cloning, expression and activity studies of PucI revealed the pucI gene surely 
encodes for an allantoin transporter (Section 3.3.3 to 3.3.10).  This work also 
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investigates the kinetics and substrate specificity of allantoin transport by PucI (Section 
3.3.3 to 3.3.10). 
 
 
 
 
 
Figure 3.21 Topology model of B. subtilis allantoin permease (PucI).  Topology 
prediction by TMHMM (Krogh et al., 2001).  The predicted helices are numbered from 
the N- to C-terminus and are shown in roman numerals.  Conserved residues of the 
NCS1 family proteins are highlighted in grey and black according to the alignment in 
Appendix 2. 
 
3.3.3. Cloning and expression of the B. subtilis PucI 
 
 Here, the pucI gene (Bsu36470) was amplified from the genomic DNA of B. 
subtilis 168 strain by PCR (Figure 3.3), and cloned into plasmid pTTQ18-His6 with a 
His6-tag added to the C-terminus of the protein.  The clone was analysed by PCR 
screening and restriction digestion, confirming the correct sized gene in the plasmid 
construct (Figure 3.4 and 3.5).  DNA sequencing confirmed no mutations in the cloned 
pucI gene, encoding for the correct amino acid sequence (Appendix 3 and 4).  
Subsequently, the clone was transformed into E. coli BL21(DE3) cells for expression 
trials, as described in Sections 2.3 and 2.4.  The expression of PucI was optimised by 
testing in LB, 2TY and minimal media.  Growth of the cells transformed with 
pTTQ18(pucI)-His6 showed a detrimental effect when induced with IPTG (Figure 3.22).  
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Figure 3.22 Growth of E. coli BL21(DE3) cells transformed with pTTQ18(pucI)-
His6 in LB, 2TY and minimal media.  E. coli BL21(DE3) cells transformed with 
pTTQ18(pucI)-His6 were grown in LB, 2TY and minimal media supplemented with 20 
mM glycerol.  Cells were induced with 0.5 mM IPTG when A680nm reached 0.4 – 0.6 
and harvested 3 hours post-induction. 
 
 
Figure 3.23 Expression of E. coli BL21(DE3) cells transformed with 
pTTQ18(pucI)-His6.  BL21(DE3) cells transformed with pTTQ18(pucI)-His6 were 
grown in LB, 2TY and minimal media supplemented with 20 mM glycerol.  Cells were 
induced with 0.5 mM IPTG when A680nm reached 0.4 – 0.6 and harvested 3 hours post-
induction, followed by preparation of total E. coli membranes and analysis by SDS-
PAGE.  M (marker), U (uninduced) and I (induced).  Arrow indicates position of the 
PucI protein. 
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Similar growth rates were observed when cells were grown in either LB or 2TY 
medium (Figure 3.22).  The absorbance of the uninduced cultures at time of harvesting 
was 2.880, 2.950 and 1.862 for cells grown in LB, 2TY and minimal media, 
respectively, and the rate of growth in minimal medium is approximately half that of 
cells grown on the other media (Figure 3.22).  The absorbance of the induced cultures at 
time of harvesting were 0.806, 0.702 and 0.488 for LB, 2TY and minimal media, 
respectively (Figure 3.22), and densitometry suggests PucI is expressed at 
approximately 6% in the total prepared membrane for cells grown in LB, 2TY or 
minimal medium (Figure 3.23).  The optimisation test suggests that LB is the choice of 
medium for expressing PucI, given that the cell density is highest in LB at time of 
harvesting, and since all media produce PucI at approximately the same percentage in 
the total E. coli membrane (Figure 3.22 and 3.23). 
 
3.3.4. Time course of uptake of radiolabelled allantoin by PucI 
 
 A time course of allantoin transport by PucI showed increasing uptake of 
allantoin in the uninduced and induced cells expressing PucI, up to a maximum of 18.3 
and 35.8 nmol mg
-1
 cells, respectively (Figure 3.24).   
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Figure 3.24 Time course of allantoin uptake by PucI.  Uptake of 
14
C-allantoin in E. 
coli BL21(DE3) cells transformed with pTTQ18(pucI)-His6 or pTTQ18 – no genes.  
Cells were cultured in minimal medium in the presence of 100 μg/ml carbenicillin and 
20 mM glycerol.  When cells reached an A680nm of 0.4-0.6, 0.5 mM IPTG was added 
and cells were harvested 1 hour post-induction, followed by washing.  Cells were 
energised with 20 mM glycerol, and incubated in 50 µM 
14
C-allantoin, 5 mM MES pH 
6.6 and 150 mM KCl for uptake studies.  Results represent means of triplicates (±SEM). 
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The uninduced and induced cells transformed with pTTQ18(pucI)-His6 expressed the 
His6-tagged PucI, no matter how long the cells were induced with IPTG, shown by the 
SDS-PAGE and Western blot in Figure 3.26, indicating leaky expression of PucI in the 
uninduced cells.  As a control, uninduced and induced cells with plasmid containing no 
pucI gene (pTTQ18) were examined for the ability to transport allantoin (Figure 3.24).  
The results demonstrated relatively little uptake (< 0.13 nmol mg
-1
 cells) in these cells, 
further confirming leaky expression from uninduced cells with pTTQ18(pucI)-His6 
(Figure 3.24).  In induced cells harbouring pTTQ18(pucI)-His6, the maximum uptake 
was reached at approximately 5 and 10 minutes after addition of the radiolabelled 
substrate, suggesting rapid uptake of allantoin into the cells (Figure 3.24). 
 
3.3.5. Optimisation of uptake of allantoin by PucI 
 
 The transport of allantoin by PucI was optimised by testing a range of IPTG-
induction periods.  BL21(DE3) cells transformed with pTTQ18(pucI)-His6 were 
induced with IPTG for 0.1 to 22 hours when absorbance at 680 nm reached 0.4 – 0.6.  
Cells were harvested and washed three times in 5 mM MES pH 6.6 and 150 mM KCl, 
followed by transport assays.  In the induced cells, an increasing transport of 
radiolabelled allantoin by PucI is observed when induction time was increased from 0.1 
to 2 hours (Figure 3.25).   
0.1 0.5 1.0 1.5 2.0 3.0 4.5 22.0
0
10
20
30
40
uninduced
induced
Induction time (hour)
U
p
ta
k
e
 o
f
1
4
C
-a
ll
a
n
to
in
 (
n
m
o
l 
m
g
-1
 c
e
ll
s
)
 
Figure 3.25 Effect of induction time with IPTG on allantoin uptake by PucI.  
Uptake of 
14
C-allantoin in E. coli BL21(DE3) cells transformed with pTTQ18(pucI)-
His6.  Cells were cultured in minimal medium in presence of 100 μg/ml carbenicillin 
and 20 mM glycerol.  When cells reached an A680nm of 0.4 – 0.6, 0.5 mM IPTG was 
added and cells were induced for 0.1 – 22 hours before harvesting.  Uninduced cells 
were grown according to the induced cells, but no IPTG was added.  Harvested cells 
were energised with 20 mM glycerol, and incubated in 50 µM 
14
C-allantoin with 5 mM 
MES pH 6.6 and 150 mM KCl for uptake studies.  Samples were taken 2 minutes post-
addition of radiolabelled allantoin.  Results represent means of triplicates (±SEM). 
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After that the uptake of allantoin by PucI was reduced (Figure 3.25).  The cells, 
22 hours post-induction, had significantly lost allantoin transport activity (Figure 3.25).  
After the transport assays the cells were subjected to a total membrane preparation, and 
analysis by SDS-PAGE and Western blotting, confirming the expression of His6-tagged 
PucI in the cells that were tested (Figure 3.26).The uninduced cells showed leaky 
expression of PucI, indicated by the Western blotting (Figure 3.26), giving rise to the 
transport activity in the uninduced cells (Figure 3.25).  This optimisation test suggested 
the optimal induction time for transport activity of PucI is approximately between 1 and 
2 hours post-induction (Figure 3.25), and optimal expression of PucI is achieved when 
cells were induced for 1.0 to 4.5 hours with 0.5 mM IPTG (Figure 3.26). 
 
Figure 3.26 SDS-PAGE and Western blot analysis of total membranes of 
BL21(DE3) pTTQ18(pucI)-His6 cells induced for different periods of time.  
BL21(DE3) pTTQ18(pucI)-His6 cells were cultured in minimal medium in presence of 
100 μg/ml carbenicillin and 20 mM glycerol, and 0.5 mM IPTG was added when A680nm 
= 0.4 – 0.6.  Cells were harvested between 0.1 and 22 hours post-induction.  Uninduced 
cells were grown according to the induced cells, but no IPTG was added.  Total 
membranes were prepared and analysis by SDS-PAGE and Western blotting.  Arrow 
indicates position of PucI. 
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3.3.6. Assessing the effect of sodium ions on the uptake of allantoin by PucI 
 
To test whether the transport of allantoin by PucI is sodium-dependent, a range 
of NaCl concentrations in the transport assay buffers was tested.  The salt contents of 
the buffer were adjusted with KCl and kept constant at 150 mM for all experiments.  
The uptake of allantoin in a range of NaCl concentrations, in cell expressing PucI was 
10.87 to 12.8 nmol mg
-1
 cells at 15 seconds and 35.7 to 39.4 nmol mg
-1
 cells at 2 
minutes (Figure 3.27).  Results indicate the transport of allantoin by PucI is not greatly 
affected by presence of sodium (Figure 3.27). 
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Figure 3.27 Effect of sodium ions on allantoin uptake by cells expressing PucI.  E. 
coli BL21(DE3) cells transformed with pTTQ18(pucI)-His6 were cultured in minimal 
medium in presence of 100 μg/ml carbenicillin and 20 mM glycerol.  Cells were 
induced with 0.5 mM IPTG when A680nm =  0.4 – 0.6, and harvested 1 hour post-
induction.  Harvested cells were washed and energised with 20 mM glycerol, and 
incubated in 50 µM 
14
C-allantoin, 5 mM MES pH 6.6 and 0 – 150 mM NaCl for uptake 
studies.  Samples were taken 15 seconds and 2 minutes post-addition of radiolabelled 
allantoin.  Results represent means of duplicates. 
 
3.3.7. Substrate specificity of PucI 
 
 To study the substrate specificity of PucI, 
14
C-allantoin uptake in E. coli 
cells expressing PucI was determined in the presence of a ten-fold molar excess of 
potential substrates.  This competition assay showed a range of substrates was able to 
inhibit the transport of allantoin into the cell (Figure 3.28).  Competition with an excess 
of unlabelled allantoin caused a massive reduction of the uptake at 15 seconds and 2 
minutes, to 3 and 4 % respectively (Figure 3.28), confirming that PucI mediates the 
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transport of allantoin. Hydantoin and other hydantoin derivatives, such as 
benzylhydantoin and hydroxyhydantoin, also reduced allantoin uptake by PucI to 
approximately 8-36% (Figure 3.28), suggesting these are also possible substrates 
transported by PucI.  The hydantoin moiety and the –NH group of these substrates must 
therefore be important for their binding to PucI (Figure 3.29).  The common structural 
features are highlighted in the diagram (Figure 3.29).  To a lesser degree excessive 
thymine, allantoic acid, hypoxanthine and uracil also caused a reduction of allantoin 
uptake (29-57%) (Figure 3.28).  These substrates contain a six-membered ring, but still 
share some common structural features with allantoin and the hydantoin derivatives 
(Figure 3.29), further indicating the importance of the highlighted features of the 
substrates (Figure 3.29). 
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Figure 3.28 Substrate specificity of PucI.  Competition of 
14
C-allantoin (50 µM) 
uptake into E. coli BL21(DE3) cells expressing PucI in the presence of a ten-fold molar 
excess of potential competitors.  The noncompeted uptake rate was taken as 100% 
corresponding to 14.6 and 30.4 nmol allantoin per mg of cells for 15 seconds and 2 
minutes post-addition of 
14
C-allantoin, respectively.  Buffer contains 2% DMSO.  
Results represent means of two experiments.  None = no competitors or DMSO. 
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       Allantoin              Hydantoin           L-benzylhydantoin      Hydroxyhydantoin 
                            
 
 
     Thymine                       Allantoic acid          Hypoxanthine           Uracil 
                       
 
Figure 3.29 Common structural features of PucI substrates.  Arranged in the order 
of effectiveness in inhibiting transport of allantoin by PucI. 
 
The substrate specificity results suggest that besides allantoin, PucI binds 
hydantoin, the hydantoin derivatives tested and allantoic acid, but not the purines 
guanine and adenine, or precursors of allantoin synthesis xanthine and uric acids, except 
for hypoxanthine (Figure 3.20 and 3.28). 
 
3.3.8. Kinetic analysis of allantoin transport by PucI 
 
 A kinetic study of PucI was performed using E. coli BL21(DE3) cells 
transformed with pTTQ18(pucI)-His6. Cells were incubated in various 
concentrations of 
14
C-allantoin (12.5 – 500 µM) in 5 mM MES pH 6.6 and 150 mM 
KCl with 20 mM glycerol for energisation.  Samples were taken 15 seconds post-
addition of 
14
C-allantoin, which is the initial rate of uptake.  Transport of allantoin by E. 
coli BL21(DE3) cell expressing PucI is concentration dependent, showing a Km for 
allantoin of 24.44 ± 3.072 µM in the induced cells (Figure 3.30), and a Vmax of 14.83 ± 
0.4592 nmol mg
-1
 cells (Figure 3.30).  Uninduced cells demonstrated leaky expression 
of PucI (Figure 3.26), which also displayed saturation kinetics (Km of 15.36 ± 2.970 µM 
and Vmax of 3.071 ± 0.1216 nmol mg
-1
 cells (Figure 3.30). 
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Figure 3.30 Michaelis-Menten kinetics of 
14
C-allantoin uptake by PucI.  E. coli 
BL21(DE3) cells transformed with pTTQ18(pucI)-His6 were cultured in minimal 
medium in presence of 100 μg/ml carbenicillin and 20 mM glycerol.  When cells 
reached an A680nm of 0.4 – 0.6, the induced sample received 0.5 mM IPTG and cells 
were harvested 1 hour post-induction, followed by washing.  Cells were energised with 
20 mM glycerol, and incubated in various concentrations of 
14
C-allantoin (12.5 – 500 
µM) in 5 mM MES pH 6.6 and 150 mM KCl for kinetic studies.  Samples were taken 
15 seconds post-addition of 
14
C-allantoin.  Results represent means of triplicates 
(±SEM). 
 
3.3.9. Purification of PucI from the inner membrane 
 
  A six litre culture of E. coli BL21(DE3) cells expressing the His6-tagged PucI 
were grown aerobically, described in Section 2.4.1.  The cells harvested were lysed by 
explosive decompression and the total membrane obtained was separated on sucrose 
density gradients (Section 2.5.1).  The membrane fractions obtained were analysed by 
SDS-PAGE, and showed the presence of PucI in the prepared inner membrane (Figure 
3.31).  Some PucI was also found in the mixed membrane, and a little in the outer 
membrane (Figure 3.31), indicating reasonable separation of the membranes.  In section 
3.1.4, the expression test showed PucI is present at 5% in the total E. coli membrane 
(Figure 3.6 and Table 3.3).  Here, after the sucrose gradient step, PucI is present at 10% 
in the inner membrane, and 5% and 2% in the mixed and outer membrane respectively 
(Figure 3.31), as determined by scanning densitometry.  This indicates the sucrose 
gradients step is important for concentrating PucI in the membrane. 
 
 119 
 
Figure 3.31 SDS-PAGE of membrane fractions of E. coli BL21(DE3) cells 
expressing PucI.  Total E. coli membranes were prepared from E. coli BL21(DE3) 
pTTQ18(pucI)-His6 grown on LB medium containing 20 mM glycerol and 100 µg/ml 
carbenicillin in the presence of 0.5 mM IPTG and harvested 3 hours post-induction.  
Total membranes were separated on 25-55% sucrose gradients and membrane fractions 
extracted from the gradients were analysed by SDS-PAGE.  The black arrow indicates 
the position of the PucI protein. 
 
Figure 3.32 SDS-PAGE of total and solubilised inner membranes of E. coli 
BL21(DE3) cells expressing PucI.  Total E. coli inner membranes transformed with 
pTTQ18(pucI)-His6 were tested for solubilisation in eight detergents.  Membranes were 
solubilised in 1% detergent for 1 hour and subjected to centrifugation to remove the 
insoluble fraction (Section 2.5.2).  Total inner membranes (T) and soluble fractions (S) 
were then analysed by SDS-PAGE.  Arrows indicate position of PucI. 
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The inner membranes were subjected to solubilisation trials, described in 
Section 2.5.2.  NN-dimethyloctylamine N-oxide is a poor detergent for PucI (Figure 
3.32).  N-octyl-βD-maltopyranoside and N-dodecyl-βD-maltopyranoside (DDM) were 
the best for solubilising PucI (Figure 3.32).  Therefore purification was performed using 
DDM (Section 2.5.3).  Fractions from the purification of PucI were analysed by SDS-
PAGE and Western blotting (Figure 3.33); the majority of PucI was solubilised using 1% 
DDM, and only a very small amount of PucI remains in the insoluble fraction (Figure 
3.33).  Almost all the PucI was successfully bound to the Ni-NTA resin, indicated by 
the faint band of PucI in the unbound fraction (Figure 3.33). 
 
 
 
Figure 3.33 SDS-PAGE and Western blot of purification of B. subtilis PucI.  PucI 
was purified from the inner membrane of E. coli BL21(DE3) pTTQ18(pucI)-His6 cells.  
The inner membranes were solubilised in 1% DDM.  Fractions (15 µg), and eluted 
fraction (10 µg) from the purification were analysed by SDS-PAGE (top) and Western 
blotting (bottom).  The arrows indicate the position of the PucI protein. 
 
Size 
(kDa) 
 
66 
 
45 
36 
 
29 
24 
 
20 
 
 
 
 
 
 
97 
66 
 
45 
 
 
30 
 
20 
14 
 
 
 
 
 
 M
ar
k
er
 
 In
n
er
 
m
em
b
ra
n
e 
 In
so
lu
b
le
 
  S
o
lu
b
il
is
ed
 
  U
n
b
o
u
n
d
 
  E
lu
te
d
  
p
ro
te
in
s 
  
 121 
PucI was purified to 77%, determined by scanning densitometry, and migrates at 
37 kDa and 66 kDa on the SDS-PAGE gel (Figure 3.33).  A contaminant was co-eluted 
with PucI, migrating at >66 kDa on the SDS-PAGE.  The >66 kDa protein is commonly 
recognised as an AcrB contaminant in E. coli expression systems, and could possibly be 
removed by size-exclusion chromatography. 
 
3.3.10. Testing the integrity of PucI by circular dichroism 
 
 The secondary structure of PucI was examined by circular dichroism (Section 
2.6.1).  The negative indentation at 208 and 222 nm, and a positive signal at ~ 190 nm, 
are indicative of a predominantly α-helical content (Figure 3.34).  This agrees with the 
topology analysis by TMHMM, which predicts twelve transmembrane helices (Figure 
3.21), and confirms retention of the secondary structure of PucI during the purification 
process.   
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Figure 3.34 Circular dichroism spectrum of purified PucI of B. subtilis.  Purified 
PucI (0.05 mg/ml) was buffer-exchanged into 10 mM potassium phosphate buffer pH 
7.6 and 0.05% DDM.  CD spectral analysis of PucI was performed using Jasco J-715 
spectropolarimeter at 18
o
C with constant nitrogen flushing.  The sample were analysed 
in Hellma quartz-glass cell of 1mm path length.  Spectrum was recorded with 1 nm step 
resolution at a scan rate of 10 nm/min.  Response time was set at 1 second with a 
sensitivity of 20 mdeg and bandwidth of 1.0 nm.  The spectrum represents an 
accumulation of ten scans, from which the buffer contribution was subtracted.  The blue 
line represents the voltage applied to the photomultiplier. 
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3.3.11. Discussion: characterisation of PucI 
 
The pucI gene of B. subtilis encodes an allantoin transporter (Danielsen et al., 
1992), important in providing the bacterium with a nitrogen source when the preferred 
nitrogen sources such as glutamine and ammonium, or glutamate, are depleted (Fisher, 
1999).  pucI is one of the 14 puc genes (Figure 3.19) that constitute the purine 
catabolism pathway in B. subtilis (Schultz et al., 2001), allowing the bacterium to utilise 
a wide range of low molecular weight compounds as nitrogen source (Schultz et al., 
2001) (Figure 3.20). 
In this study, the phylogenetic tree of the selected NCS1 proteins showed the 
PucI protein clustered closely with b0511 and EF3000 (Figure 3.2).  The b0511 and 
EF3000 proteins were tested for allantoin uptake in Section 3.1.6, which revealed that 
these were not transporters for allantoin under the test conditions (Table 3.4).  The 
conserved residues in PucI are highlighted in Figure 3.21.  These are in: the N-terminus 
(K26 and R27); helix I (I36, W37, M38 and G39); the periplasmic loop between helices 
I and II (G57 and L58); the cytoplasmic loop between helices II and III (G85, K87, G89, 
L90, R97, Y100, G101, G104, A105, I107 and P108); helix III (W119, G121 and I122); 
the cytoplasmic loop between helices IV and V (G176 and I180); the cytoplasmic loop 
between helices VI and VII (D249, F250, T251, R252 and F253); helix X (F386, L387, 
G399 and V400); and in the cytoplasmic loop between helices X and XI (M402, D404, 
Y405, I408, R409, K410, V415, L418 and Y419) (Figure 3.21 and Appendix 2). 
Based on the structures of Mhp1 (Weyand et al., 2008) and the alignment in 
Appendix 2, potential residues in PucI that could be involved in substrate recognition 
and binding were identified.  The W117 in Mhp1 aligns with W119 in helix III of PucI 
and therefore this residue could potentially form π-stacking with the hydantoin moiety 
of allantoin, hydantoin, L-benzylhydantoin and hydroxyhydantoin (Figure 3.28).  Also, 
W240 in helix VI of PucI aligns with W220 in Mhp1 and could suggest this residue 
may form π-stacking with the aromatic moiety of L-benzylhydantoin (Appendix 2).  
Residues S323 and V324 in PucI could be involved in cation binding since these align 
with S312 and T313 of Mhp1 which binds sodium (Appendix 2).  Further investigations, 
e.g. by producing PucI mutants, will be needed to completely understand the function of 
these residues. 
Previous studies demonstrated that mutants in the pucI gene were unable to 
grow on allantoin and therefore it could encode for an allantoin transporter (Schultz et 
al., 2001).  Here, cloning of the pucI gene into plasmid pTTQ18-His6 (Figure 3.2 to 3.5) 
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and transformation into E. coli BL21(DE3) cells (Figure 3.6), followed by transport 
assay, demonstrated PucI does transport allantoin (Table 3.4 and Figure 3.24).  The 
induction time test showed the optimal transport activity of PucI is between 1 and 2 
hours after induction with IPTG (Figure 3.25 and 3.26).  The transport characteristic of 
PucI were also investigated, showing Km and Vmax of 24.44 ± 3.072 µM and 14.83 ± 
0.4592 nmol mg
-1
 cells, respectively (Figure 3.30), and indicating that transport activity, 
under the test condition is not sodium-dependent (Figure 3.27).  PucI is able to interact 
with a wide range of substrates, being most specific for allantoin, hydantoin and 
hydantoin derivatives, therefore suggesting the hydantoin moiety is important for 
substrate recognition by PucI (Figure 3.28 and 3.29).  Further tests are required to 
determine if these compounds are transported by, or are inhibitors of, allantoin uptake 
by PucI.  Therefore radiolabelled forms of these compounds are needed.  The transport 
of allantoin by PucI could also be tested for pH-dependence by preincubation of 
vesicles with 2,4-dinitrophenol, a proton ionnophore that can shuttle protons across 
biological membranes, uncoupling oxidative phosphorylation, and hence destroying 
active transport. 
PucI was overexpressed to 5% in the total E. coli membranes, migrating at 37 
kDa on the SDS-PAGE gel (Figure 3.6 and Table 3.3).  Tests for the expression of PucI 
in LB, 2TY and M9 minimal media suggested LB was the best for expressing PucI 
(Figure 3.23).  After the sucrose density gradient step, PucI increased from 5-6% in the 
total membrane to 10% in the inner membrane, successfully concentrating PucI (Figure 
3.31).  The expression of PucI could be further optimised by testing in various IPTG 
concentrations, and different expression hosts and plasmids with different promoter or 
features, and using different affinity tags for purification.  The circular dichroism 
confirmed the integrity of the secondary structure of PucI (Figure 3.34), and the 
transport assay verified the expressed protein is active (Figure 3.24 to 3.29).  PucI was 
purified to 77% using Ni-NTA, and migrates at 37 and 66 kDa on the SDS-PAGE gel 
and Western blotting (Figure 3.33).  Further optimisation of the purification, using gel 
filtration and varying the buffer components, might further increase the purity of PucI.  
The purified protein could be reconstituted into liposomes (Ward et al., 2000), for 
functional tests, as well as to test accurately for cation-dependence.  Crystallisation 
could then be undertaken to elucidate the structure of PucI, which might help to 
understand the structure-activity relationship of the NCS1 family of transporters, and 
the fundamentals of the alternating access model. 
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3.4. Characterisation of a Pseudomonas aeruginosa uracil transporter 
(PA0443) 
 
3.4.1. Introduction – Pseudomonas aeruginosa and PA0443 
 
Pseudomonas aeruginosa is a versatile Gram-negative bacterium that grows in 
soil, costal marine habitats, and on plant and animal tissues.  It is one of the top three 
causes of opportunistic human infections, including bacteraemia in burn victims, 
urinary-tract infections in cathetherised patients and hospital-acquired pneumonia in 
patients on respirators.  The emergence of this bacterium as a major opportunistic 
human pathogen could be a consequence of its resistance to the antibiotics and 
disinfectants that eliminated other environmental bacteria.  The whole genome sequence 
of this bacterium was completed (Stover et al., 2000), showing high proportion of 
regulatory genes and a large number of genes involved in the catabolism, transport and 
efflux of organic compounds, as well as potential chemotaxis systems, which may give 
rise to the environmental adaptability of this bacterium (Stover et al., 2000). 
Here the PA0443 protein of P. aeruginosa is studied, for its high similarity and 
identity to the Mhp1 protein (Table 3.1), although of unknown function.  PA0443 lies 
next to a putative N-carbamoyl-beta-alanine amidohydrolase (hyuC) gene, also referred 
to as beta-ureidopropionase (Figure 3.35).  The transcription start and termination sites 
are not yet annotated in this part of the Pseudomonas genome and are therefore not 
labeled in the diagram (Figure 3.35).   
 
 
 
Figure 3.35 Map of the P. aeruginosa PA0443 gene region.  Each arrow represents a 
gene, and the number below corresponds to the genome position of the gene.  The 
diagram is modified from the Pseudomonas genome database (Stover et al., 2000). 
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As can be seen, the PA0438 (putative cytosine tranporter), which was also 
studied in this NCS1 transporters project (Section 3.1), lies very close to the PA0443 
protein, and both are located near the putative purine catabolism genes of P. aeruginosa 
(Figure 3.35), important in providing an alternative nitrogen source for the bacterium.  
In Pseudomonas, adenine, hypoxanthine, xanthine and guanine are broken down to 
allantoin by the enzymes adenine deaminase, guanine deaminase, xanthine 
dehydrogenase and uricase (Bongaerts et al., 1997), the same as in B. subtilis (Figure 
3.20).  Pyrimidine catabolism in P. aeruginosa is induced by uracil, and this bacterium 
was able to utilise uracil and thymidine as well as their respective reductive catabolic 
products as sole sources of nitrogen, indicating the bacterium contains genes for the 
catabolism and utilisation of these compounds (Kim & West, 1991).  The reductive 
catabolic pathway enzymes (Figure 3.12) dihydropyrimidine dehydrogenase, 
dihydropyrimidinase and ureidopropionase were all detected in minimal medium grown 
Pseudomonas aeruginosa cells (Kim & West, 1999), suggesting P. aeruginosa is able to 
utilise pyrimidine as well as purine, as sole sources of nitrogen.  This section studies the 
PA0443 protein of P. aeruginosa, a NCS1 family protein shown to transport uracil 
(Section 3.1.6).  Firstly, the topology and conserved residue of this transporter are 
analysed, followed by purification of the cloned His6-tagged protein, and kinetic and 
substrate specificity studies. 
 
3.4.2. The P. aeruginosa uracil transporter (PA0443): topology analysis and 
conserved residues 
 
 Topology prediction by TMHMM (Krogh et al., 2001) showed PA0443 is 
highly hydrophobic, consisting of twelve transmembrane α-helices.  A topology model 
of PA0443 is shown in Figure 3.36, with the conserved residues highlighted, which are 
positioned mostly in helices I, II and X, as well as in the cytoplasmic loops between 
helices II and III, helices IV and V, and helices X and XI (Figure 3.36).  PA0443 is 29.3% 
identical and 59.8% similar to Mhp1 (Table 3.1), and clustered most closely with 
Pden1111 and SCO6417 on the phylogenetic tree (Figure 3.2).  Both PA0443 and 
Pden1111 were shown to transport uracil in Section 3.1.6. (Table 3.4), therefore 
suggesting SCO6417 could also be an uracil transporter. 
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Figure 3.36 Topology model of P. aeruginosa uracil permease (PA0443).  Topology 
prediction by TMHMM.  The predicted helices are numbered from the N- to C-terminus 
and are shown in roman numerals.  Conserved residues in the NCS1 family proteins are 
highlighted in black and grey according to the alignment in Appendix 2. 
 
3.4.3. Cloning and expression of PA0443 
 
 In order to study the PA0443 transporter of P. aeruginosa, the PA0433 gene was 
amplified from the genomic DNA of P. aeruginosa PAO1 strain by PCR (Figure 3.2), 
and cloned into plasmid pTTQ18-His6 that introduces a C-terminal His6-tag (Section 
2.3.1).  The clone was analysed by colony PCR and restriction digestion, confirming the 
correct gene in the plasmid construct (Figure 3.3 and 3.4).  DNA sequencing revealed 
no mutations in the cloned PA0443 gene and the correct protein sequence (Appendix 3 
and 4).  Subsequently, the clone was transformed into E. coli BL21(DE3) cells showing 
overexpression of the PA0443 protein in the IPTG-induced E. coli total membranes, 
migrating at 41 kDa on the SDS-PAGE gel (Figure 3.6 and Table 3.3). 
 
3.4.4. Optimisation of expression of PA0443 
 
 Expression tests showed PA0443 of P. aeruginosa was expressed to 24% in the 
total E. coli membrane (Figure 3.6 and Table 3.3).  The expression of PA0443 was 
optimised by testing in 2TY and minimal media, as well as in a range of IPTG 
concentrations.  Growth of the E. coli BL21(DE3) cells transformed with 
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pTTQ18(PA0443)-His6 showed little effect when induced with IPTG (Figure 3.37).  
Cell growth was higher and similar in LB and 2TY, than in M9 minimal medium 
(Figure 3.37).  The absorbance of the induced cultures at time of harvesting was 2.040, 
2.345 and 0.913 for cells grown in LB, 2TY and minimal media, respectively (Figure 
3.37).  Harvested cells were subjected to total membrane preparation and analysis by 
SDS-PAGE and Western blotting, showing the presence of the His6-tag PA0443 in the 
induced cells, and absence in the uninduced cells (Figure 3.38), confirming tight 
regulation of the expression of PA0443.  Scanning densitometry showed PA0443 was 
expressed to 10% and 26% in the total membranes of cells grown in 2TY and minimal 
medium, respectively.  Given the expression of PA0443 is highest in minimal medium, 
a range of IPTG concentrations was tested; all slowed growth (Figure 3.39A), and 
scanning densitometry indicated induction with 0.5 mM IPTG is optimal for the 
expression of PA0443 in minimal medium (Figure 3.39B).  The cells grown in LB 
medium start to reach stationary phase towards the time of harvesting, whereas cells 
grown in minimal medium are still in the exponential phase (Figure 3.37); therefore, 
further tests in minimal medium to test for longer induction times is required to 
determine the optimal expression level of PA0443, i.e. harvesting cells 4, 6, 8 and 10 
hours post-induction should be tested. 
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Figure 3.37 Growth of E. coli BL21(DE3) cells transformed with 
pTTQ18(PA0443)-His6 in LB, 2TY and M9 minimal media.  E. coli BL21(DE3) 
cells transformed with pTTQ18(PA0443)-His6 were grown in LB, 2TY and minimal 
media supplemented with 20 mM glycerol.  Cells were induced with 0.5 mM IPTG 
when A680nm reached 0.4 – 0.6 and harvested 3 hours post-induction. 
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Figure 3.38 Expression of P. aeruginosa uracil permease (PA0443) in cells grown in 
2TY and M9 minimal medium.  BL21(DE3) cells transformed with 
pTTQ18(PA0443)-His6 were grown in 2TY and M9 minimal media supplemented with 
20 mM glycerol.  Cells were induced with 0.5 mM IPTG when A680nm reached 0.4 – 0.6 
and harvested 3 hours post-induction, followed by preparation of total E. coli 
membranes and analysis by SDS-PAGE and Western blotting.  M (marker), U 
(uninduced) and I (induced).  Arrows indicate position of the PA0443 protein. 
 
 
 
 
 
Size 
(kDa) 
66 
 
45 
36 
29 
24 
20 
 
14 
 
 
 
 
 
  M            U          I           U          I 
97 
66 
 
45 
 
30 
 
20 
14 
 
 
 
 
 
2TY                    M9  
 129 
0 100 200 300 400
0.0
0.5
1.0
1.5
2.0
uninduced
0.10 mM
0.25 mM
0.50 mM
0.75 mM
1.00 mM
Time (min)
A
b
s
o
rb
a
n
c
e
 a
t 
6
8
0
n
m
 
 
 
 
Figure 3.39 Growth and expression of P. aeruginosa uracil permease (PA0443) 
using a range of IPTG concentrations in minimal medium.  E. coli BL21(DE3) 
pTTQ18(PA0443)-His6 cells were cultured in minimal medium in presence of 100 
µg/ml carbenicillin and 20 mM glycerol, and samples were induced with a range of 
IPTG concentrations (0 – 1 mM) when A680nm reached 0.4 – 0.6, and harvested 3 hours 
post-induction.  (A) Growth curves.  Total membranes were prepared from the 
harvested cells and analysed by (B) SDS-PAGE (top) and Western blotting (bottom).  
Arrows indicate position of PA0443. 
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3.4.5. Uptake of radiolabelled uracil by PA0443 
 
A time course of uracil transport by PA0443 showed an increase uptake of uracil 
in the induced cells expressing PA0443, up to a maximum of 2.0959 nmol mg
-1
 cells, 
from 0 to 3 minutes (Figure 3.40).  The amount of radioactivity then decreased to 
0.8040 nmol mg
-1
 cells, which could indicate metabolism of uracil inside the cell, 
followed by radiolabelled metabolites leaving the cell.  The radiolabelled uracil used in 
this work is 
3
H-5,6-uracil.  Uptake of uracil into the cell is either incorporated into RNA 
or metabolised in the reductive and oxidative pathways to products shown in Figure 
3.12.  The decrease in radioactivity in the cells could be due to excretion of 
radiolabelled water from the cells.  At 5 to 10 minutes of the time course, an increasing 
amount of uracil is shown inside the cells, which could suggest that, when the cellular 
level of uracil becomes low, the cells start to take up uracil again (Figure 3.40).  A 
similar uracil uptake pattern is shown in the uninduced cells (Figure 3.40), previously 
indicated by the SDS-PAGE gel and Western blotting not to express PA0443 (Figure 
3.38 and 3.39B), therefore the activity observed may be the uracil transporter of E. coli, 
UraA, which was previously characterised and demonstrated to be necessary for uracil 
uptake at low exogenous uracil concentrations (Andersen et al., 1995). 
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Figure 3.40 Time course of uracil uptake by PA0443.  Uptake of 
3
H-uracil in E. coli 
BL21(DE3) cells transformed with pTTQ18(PA0443)-His6.  Cells were cultured in 
minimal medium in presence of 100 μg/ml carbenicillin and 20 mM glycerol.  When 
cells reached an A680nm of 0.4-0.6, 0.5 mM IPTG was added to the induced sample and 
cells were harvested 1 hour post-induction, followed by washing of cells.  Cells were 
energised with 20 mM glycerol, and incubated in 50 µM 
3
H-uracil in 5 mM MES pH 
6.6 and 150 mM KCl for uptake studies.  Results represent means of duplicates. 
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3.4.6. Substrate specificity of PA0443 
 
The substrate specificity of PA0443 was studied using radiolabelled uracil and 
testing uptake in E. coli cells expressing PA0443, in presence of ten-fold molar excess 
of potential substrates (Figure 3.41).  The competition assay showed PA0443 has a 
narrow substrate specificity, being specific for transport of uracil and thymine into the 
cell (Figure 3.41).  Competition with an excess of unlabelled uracil caused a reduction 
of uptake to 20.4 and 50.1 % at 15 seconds and 2 minutes respectively (Figure 3.41), 
confirming that PA0443 mediates the uptake of uracil.  Excessive thymine also caused 
reduction of radiolabelled uracil uptake to 29.9 and 50.3 % at 15 and 2 minutes 
respectively (Figure 3.41), confirming this could also be transported by PA0443. 
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Figure 3.41 Substrate specificity of PA0443.  Competition of 
3
H-uracil (50 µM) 
uptake into E. coli BL21(DE3) cells expressing PA0443 in the presence of a ten-fold 
molar excess of potential competitors.  The non-competed uptake rate was taken as 100% 
corresponding to 0.18 and 0.25 nmol uracil per mg of cells for 15 seconds and 2 
minutes post-addition of 
3
H-uracil, respectively.  Results represent means of two 
experiments. 
 
Both uracil and thymine are six-membered ring compounds, and are very similar 
in structure (Figure 3.42).  Thymine is also known as 5-methyluracil, derived by 
methylation of uracil at the 5
th
 carbon.  The two compounds inhibited uptake of the 
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radiolabelled uracil in the competition assay (Figure 3.41), suggesting the six-
membered ring and the highlighted features in Figure 3.42 are important for transport 
by PA0443. 
 
      Uracil        Thymine    
 
         
 
Figure 3.42 Common structural features of PA0443 substrates. 
   
Hydantoin is structurally similar to uracil, but a five-membered ring, and 
excessive hydantoin in the competition assay caused a relative uptake of 72.9 and 110.1% 
(Figure 3.41), showing this substrate is not favoured for transport by PA0443, and 
indicates the size of substrate is important for transport by PA0443. 
 
3.4.7. Kinetic analysis of uracil transport by PA0443 
 
Kinetic studies of PA0443 were performed using E. coli BL21(DE3) cells 
transformed with pTTQ18(PA0443)-His6.  Cells were incubated in various 
concentrations of 
3
H-uracil (40 – 400 µM) in 5 mM MES pH 6.6 and 150 mM KCl with 
20 mM glyercol for kinetic study.  Samples were taken at 15 seconds post-addition of 
3
H-uracil, which is the initial rate of transport.  Transport of uracil by E. coli BL21(DE3) 
cells expressing PA0443, induced cells, is concentration dependent, showing a Km for 
uracil of 26.72 ± 3.219 µM (Figure 3.43), and displayed saturation kinetics with a Vmax 
of 1.181 ± 0.03442 nmol mg
-1
 cells (Figure 3.43).  Uninduced cells did not express 
PA0443 (Figure 3.38 and 3.39), the kinetics observed in the uninduced cells (Figure 
3.43) are likely to be the uracil transporter of the host cells, possibly activity of UraA of 
E. coli (Andersen et al., 1995).  As a control, uninduced and induced cells with plasmid 
pTTQ18-His6 containing no PA0443 gene could be tested. 
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Figure 3.43 Michaelis-Menten kinetics of 
3
H-uracil uptake by PA0443.  E. coli 
BL21(DE3) cells transformed with pTTQ18(PA0443)-His6 were cultured in minimal 
medium in presence of 100 μg/ml carbenicillin and 20 mM glycerol.  When cells 
reached an A680nm of 0.4-0.6, 0.5 mM IPTG was added to the induced sample and cells 
were harvested 1 hour post-induction, followed by washing.  Cells were energised with 
20 mM glycerol, and incubated in various concentrations of 
3
H-uracil (40 – 400 µM) in 
5 mM MES pH 6.6 and 150 mM KCl for uptake studies.  Samples were taken 15 
seconds post-addition of 
3
H-allantoin.  Results represent means of triplicates (±SEM). 
 
3.4.8. Purification of PA0443 from the inner membrane 
 
A six litre culture of E. coli BL21(DE3) cells expressing the His6-tagged 
PA0443 was grown aerobically (Section 2.4.1).  The cells harvested were lysed by 
explosive decompression and the total membrane obtained was separated on sucrose 
density gradients, described in Section 2.5.1.  From the amino acid sequence and 
analysis by TMHMM, the PA0443 protein is predicted to be an integral membrane 
protein; therefore the membrane fractions obtained were analysed by SDS-PAGE and 
Western blotting, and showed the PA0443 protein enriched in the membrane fractions 
(Figure 3.44). 
Cells lysed by explosive decompression were subjected to centrifugation to 
remove the cell debris from the cytosol + membrane fractions, followed by separation 
of the membrane from the cytosol fraction at high speed centrifugation, described in 
Ward et al. (2000).  Using scanning densitometry, the percentage of expression of 
PA0443 in each cellular fraction was determined.  The PA0443 protein is present at ~15% 
in the cell debris, and 9 % in the cytosol + membrane fraction (Figure 3.44); indicating 
loss of the PA0443 protein in the cell debris.  The percentage of PA0443 in the cell 
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debris is high, but nevertheless, the loss of PA0443 is very little in comparison to the 
volume of cytosol + membrane fraction obtained.  An intense band migrating at ~31 
kDa in the cell debris, which is also present in the outer membrane fraction, suggest this 
protein band could be porin which is abundant in outer membranes of bacteria.  The 
PA0443 protein is present in the outer, mixed and inner membranes at 22, 29 and 30%, 
respectively (Figure 3.44), so the fractionation was probably inefficient. 
 
 
Figure 3.44 SDS-PAGE and Western blotting of fractions obtained from the 
preparation of inner membranes of E. coli expressing PA0443.  E. coli BL21(DE3) 
cells transformed with pTTQ18(PA0443)-His6 were grown on M9 minimal medium 
containing 20 mM glycerol and 100 µg/ml carbenicillin in the presence of 0.5 mM 
IPTG and harvested 3 hours post-induction.  Total membranes prepared were separated 
on 25-55% sucrose density gradients and fractions from the preparation were analysed 
by SDS-PAGE and Western blotting.  The arrows indicate position of PA0443. 
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Inner membranes expressing PA0443 were solubilised in 1% DDM and 
purification was performed using NiNTA, described in Section 2.5.3.  Fractions from 
the purification were analysed by SDS-PAGE, showing poor solubilisation of the 
PA0443 protein (Figure 3.45).  The PA0443 protein was successfully bound to the Ni-
NTA resin, indicated by the absence or small amount of PA0443 in the unbound 
fraction (Figure 3.45).  PA0443 was purified to 89%, determined by scanning 
densitometry, and migrates at 41 kDa on the SDS-PAGE gel (Figure 3.45). 
 
Figure 3.45 SDS-PAGE of purification of P. aeruginosa PA0443.  PA0443 was 
purified from the inner membrane of E. coli BL21(DE3) pTTQ18(PA0443)-His6 cells.  
The inner membranes were solubilised in 1% DDM.  Fractions from the purification 
were analysed by SDS-PAGE.  The arrow indicates the position of the PA0443 protein. 
 
3.4.9. Testing the integrity of PA0443 by circular dichroism 
 
The secondary structure of PA0443 was examined by circular dichroism 
(Section 2.6.1).  The negative indentation at 208 and 222 nm, and a positive signal at 
~190 nm, are indicative of a predominantly α-helical content (Figure 3.45), agreeing 
with the prediction by TMHMM that this protein is highly hydrophobic, confirming the 
retention of the secondary structure of PA0443 during purification. 
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Figure 3.46 Circular dichroism spectrum of purified PA0443 of P. aeruginosa.  
Purified PA0443 (0.05 mg/ml) was buffer-exchanged into 10 mM potassium phosphate 
buffer pH 7.6 and 0.05% DDM.  CD spectral analysis of PA0443 was performed using 
Jasco J-715 spectropolarimeter at 18
o
C with constant nitrogen flushing.  The sample 
were analysed in Hellma quartz-glass cell of 1mm path length.  Spectrum was recorded 
with 1 nm step resolution at a scan rate of 20 nm/min.  Response time was set at 1 
second with a sensitivity of 50 mdeg and bandwidth of 1.0 nm.  The spectrum 
represents an accumulation of thirty scans, from which the buffer contribution was 
subtracted. 
 
3.4.10. Discussion: characterisation of PA0443 
 
Prior to this study, the function of the PA0443 protein of P. aeruginosa was 
unknown, but this protein shows high identity and similarity to the Mhp1 protein (Table 
3.1), potentially transporting nucleobases, nucleosides, allantoin and thiamine.  It was 
therefore chosen as a target of the NCS1 family protein study.  Here, the PA0443 gene 
was cloned into the membrane protein expression vector pTTQ18-His6 and transformed 
into the expression host BL21(DE3) cells, successfully identifying this as an uracil and 
thymine transporter of P. aeruginosa (Section 3.1). 
The PA0443 of P. aeruginosa clustered most closely to the Pden1111 and 
SCO6417 proteins on the phylogenetic tree of the selected NCS1 proteins (Figure 3.2).  
Pden1111 was identified to uptake uracil, adenine and thymidine in the signal screening 
test (Table 3.4).  PA0443 transported uracil, but also thymine (Table 3.4 & Figure 3.41).  
The conserved residues in PA0443 are highlighted in Figure 3.36.  These are in: the N-
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terminus (Q40 and R41); helix I (L51, W52, I53 and G54); the periplasmic loop 
between helices I and II (G73 and L74); helix II and the periplasmic loop after it (G101, 
R103, G105, I106, R113, F116, G117, G120, S121, V123 and P124); helix III (W135, 
F136, G137 and I138); the cytoplasmic loop between helices IV and V (G184 and I188); 
the cytoplasmic loop between helices VI and VII (D256, F257, S258, R259 and Y260); 
and helix X and the cytoplasmic loop after it (W393, L394, G406, I407, V409, D411, 
Y412, F413, V415, R416, R417, L422, L425 and Y426) (Figure 3.36 and Appendix 2). 
Based on the structures of Mhp1 (Weyand et al., 2008) and the alignment in 
Appendix 2, the conserved residues in PA0443 that could potentially be involved in 
substrate recognition and binding were identified.  For example, residues W135 and 
W247 in PA0443 align with residue W117 and W220 in Mhp1, respectively, suggesting 
these residues may potentially be involved in substrate binding, forming π-stacking with 
the six-membered ring substrates of PA0443.  Residues in Mhp1 that were involved in 
cation binding were also found conserved in the PA0443 protein; these are S329, T330 
and N331 in PA0443 (Appendix 2), suggesting PA0443 could potentially be cation 
dependent, and therefore this could be tested by reconstitution of PA0443 into 
liposomes and testing the uptake in presence of cations.  Mutagenesis on these residues 
and testing the substrate specificity of the mutants will be needed to fully understand the 
functions of these residues. 
In the substrate screening test, PA0443 was identified to transport uracil (Table 
3.4).  The transport characteristics of this transporter were therefore investigated, 
showing Km and Vmax of 26.72 ± 3.219 µM and 1.181 ± 0.03442 nmol mg
-1
 cells, 
respectively (Figure 3.43).  PA0443 has a narrow substrate specificity, being specific 
for the transport of uracil and thymine (Figure 3.41), showing the substrates transported 
by PA0443 are relatively small in size compared to CodB and PucI‘s substrate.  It is not 
known whether the transport of uracil and thymine by PA0443 is pH-dependent, 
therefore this could be tested by using 2,4-dinitrophenol on membrane vesicle 
expressing PA0443. 
PA0443 was overexpressed to 24% in the total E. coli membranes, migrating at 
41 kDa on the SDS-PAGE gel (Figure 3.6 and Table 3.3).  Tests for the expression of 
PA0443 in LB, 2TY and minimal medium suggested M9 minimal medium gave the 
highest expression of PA0443 under the test conditions (Figure 3.38), but time of 
harvesting should also be tested.  The IPTG concentration test showed the highest level 
of expression of PA0443 when cells were induced with 0.5 mM IPTG (Figure 3.39).  
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The inner membranes prepared showed a higher level of PA0443 than in the total E. 
coli membrane, 30% compared to 24% (Figure 3.44), indicating this step is important 
for concentrating the protein.  Some PA0443 proteins in the cell debris (Figure 3.44) 
could suggest this protein is forming inclusion bodies.  Inclusion bodies are very dense 
and they tend to sediment readily under the influence of a low centrifugal force, and 
therefore they often cosedimented with cell debris (Walsh, 2001).  Both inner and outer 
membrane fractions showed presence of the PA0443 protein (Figure 3.44).  Some 
studies have shown aggregated proteins, being more dense, tend to cosediment with the 
outer membrane proteins (Laskowska et al., 2004); therefore this could indicate the 
PA0443 protein is forming aggregations. The PA0443 protein was successfully purified 
from the inner membranes (Figure 3.45), and circular dichroism confirmed the integrity 
of the secondary structure of PA0443, showing predominantly α-helical content of the 
protein (Figure 3.46).  Next, size-exclusion chromatography could be used to test the 
monodispersity and the suitability of PA0443 for crystallisation.   
Here, the PA0443 gene, encoding a hydrophobic membrane protein, was 
confirmed to transport uracil and thymine (Figure 3.41).  This is the first uracil/thymine 
transporter in Pseudomonas to be studied and characterised.  Pyrimidine salvage 
enzymes are present in Pseudomonas, which enables the bacterium to utilise these 
compounds as sole source of nitrogen (Kim & West, 1999).  Also, the PA0443 protein 
is important for the transport of pyrimidine into the cell when the preferred nitrogen 
source is depleted.  The PA4647 gene of P. aeruginosa, belonging to the NCS2 family, 
and an orthologue of the UraA of E. coli (Andersen et al., 1992), is also a putative uracil 
transporter but there are no experimental data to prove this at present.   
Prokaryotic cells use RNA-based intracellular signals, cAMP, cGMP and c-
diGMP for diverse biological functions.  For example, c-diGMP regulates virulence 
factors and biofilm formation in P. aeruginosa (Cotter & Stibitz, 2007), and cAMP 
regulates various in vivo bacterial functions by binding to intracellular receptors and 
protein kinases (Baker & Kelly, 2004).  A recent study showed that uracil could 
influence the quorum-sensing pathways of P. aeruginosa (Ueda et al., 2009); biofilms 
of this organism are notoriously difficult to control.  Whole-transcriptome analysis 
showed Pseudomonas with an altered uridine monophosphate (UMP) synthesis pathway 
had hundreds of quorum-sensing genes repressed; the transcription of these genes was 
restored by exogenous uracil, and an anticancer uracil analogue, 5-fluorouracil was able 
to repress biofilm formation (Uede et al., 2009), so identifying UMP as an important 
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signal for biofilm formation in Pseudomonas.  UMP is synthesised by several pathways 
in P. aeruginosa.  One way includes the conversion of L-glutamine to UMP by the 
carbmoylphosphate synthetase (carAB) and pyr genes, or the conversion of uracil to 
UMP by uracil phosphoribosyltransferase (Kanehisa & Goto, 2000).  The extracellular 
uracil transported into Pseudomonas is important for UMP synthesis, and hence biofilm 
formation (Uede et al, 2009); therefore, the PA0443 protein may be a potential target 
for inhibiting biofilm formation in Pseudomonas.  Further studies, including creating 
mutants to understand the residues important for substrate binding, and solving the 
structure of the PA0443 uracil transporter of Pseudomonas will be crucial for 
understanding the fundamentals of uracil transport by this protein. 
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Chapter 4 
 
 
Purification and substrate binding 
studies of Microbacterium liquefaciens 
hydantoin permease-1 (Mhp1) 
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4.1. Introduction – the hydantoin permease of M. liquefaciens 
 
As previously described in the Introduction (Section 1.3.5), Mhp1 is composed 
of twelve transmembrane helices, ten of which are arranged in two inverted repeats of 
five helices (Figure 1.6).  Based on this structure, a topology diagram of Mhp1 is made, 
highlighting the conserved residues amongst the NCS1 family of transporters (Figure 
4.1).  The phylogenetic tree (Figure 3.2) showed Mhp1 clustered most closely to HyuP 
of Arthrobacter aurescens (Table 1.1), a hydantoin transporter, and to Pden4351 and 
Pden0678, which were the NCS1 targets in this project, indicating that these two targets 
could also transport hydantoin. 
 
 
Figure 4.1 Topology diagram of Microbacterium liquefaciens hydantoin permease 
(Mhp1).  Transmembrane segments are coloured and drawn based on the published 
structure of Mhp1 in Weyand et al. (2008).  The helices are numbered from the N- to C-
terminus and are shown in roman numerals.  Conserved residues of the NCS1 family 
proteins are highlighted in grey and black according to the alignment in Appendix 2.  
Residues involved in substrate or cation binding are highlighted in red. 
 
 In the diffracting crystal of Mhp1, the electron density map at 2.85 Å  showed a 
possible cation-binding site between helix I and helix VIII (Weyand et al., 2008).  The 
site is comprised of carbonyl-oxygen-atoms of amino acids A38, I41 and A309, and the 
hydroxyl-oxygen-atoms of the side chains of S312 and T313, which are predicted to 
form a cation-binding pocket.  In other similar structures with also two inverted repeats 
of five helices, LeuT and vSGLT (Yamashita et al., 2005; Faham et al., 2008), an 
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equivalent sodium site was reported.  The cation-binding site in close proximity to the 
substrate binding site presents a basis for the coupling of cation to substrate 
translocation.  The work in this chapter was performed prior to publication of the 
structure of Mhp1 (Weyand et al., 2008), and uses fluorimetry and the radiolabelled 
transport assay, to elucidate the cation that coupled to L-benzylhydantoin uptake. 
 
4.2. Assessing the effect of sodium ions on the uptake of 5-L-
benzylhydantoin by Mhp1 
 
In a previous whole cell uptake experiment of Mhp1 for sodium dependency, a 
single concentration of 10 mM NaCl was tested and showed no evident effect on uptake 
(Suzuki & Henderson, 2006).  Therefore it was repeated in this work using a wider 
range of NaCl concentrations (0 – 150 mM).  The salt contents of the buffer were 
adjusted accordingly with KCl and kept constant at 150 mM for all experiments, and 
performed as described (Section 2.5.4).  The greatest reduction in the uptake of L-
benzylhydantoin (L-BH) was observed in the presence of 10 mM NaCl (Figure 4.2).  
0 10 25 50 75 100 125 150
0.0
0.5
1.0
1.5
2.0
2.5
3.0
120 seconds
15 seconds
NaCl concentration (mM)
U
p
ta
k
e
 o
f 
[3
H
]-
L
-5
-b
e
n
z
y
lh
y
d
a
n
to
in
(n
m
o
l/
m
g
 o
f 
c
e
ll
s
)
 
Figure 4.2 Effect of sodium ions on L-benzylhydantoin uptake by cells expressing 
Mhp1.  E. coli BLR cells transformed with pTTQ18(mhp1)-His6 were cultured in 
minimal medium in the presence of 100 µg/ml carbenicillin and 20 mM glycerol.  When 
cells reached an A680nm of 0.4 – 0.6, 0.5 mM IPTG was added, and cells were harvested 
1 hour post-induction.  Harvested cells were washed and energised with 20 mM 
glycerol, and incubated in 50 µM [
3
H]-L-5-benzylhydantoin, 5 mM MES pH 6.6 and 0 
– 150 mM NaCl for uptake studies.  Samples were taken 15 seconds and 2 minutes post-
addition of radiolabelled L-benzylhydantoin.  Results represent means of triplicates 
±SEM. 
 143 
Further increases in NaCl concentrations showed subtle increase in uptake (Figure 4.2), 
and suggest sodium could exert an effect on Mhp1 substrate uptake.  Therefore this was 
further investigated using fluorimetry (Section 4.4). 
 
4.3. Purification of Mhp1 from the inner membrane 
 
 Firstly for fluorimetry studies, Mhp1 was purified.  The E. coli BLR strain 
transformed with pTTQ18(mhp1)-His6 for this work is taken from Suzuki & Henderson 
(2006).  Cells were cultured by Mr David Sharples, and the inner membranes he 
subsequently prepared were used in this work.  Mhp1 was solubilised in DDM and 
purified from the inner membrane, and migrates at ~37 kDa on the SDS-PAGE (Figure 
4.3), which is the same as previously described (Suzuki & Henderson, 2006).  The 
purified protein at ~98% purity, determined by scanning densitometry, was confirmed 
intact by mass spectrometry showing the correct mass (Figure 4.4).   Samples were also 
prepared for N-terminal sequencing (Section 2.6.4) and analysis by Dr Jeff Keen 
indicated the correct amino acids sequence for Mhp1 (MNSTPIEEAR).  The purified 
protein was subjected to spectrophotofluorimetry experiments (Section 4.4), to assess 
the binding of ligands. 
 
Figure 4.3 SDS-PAGE of purification of Mhp1.  Mhp1 was purified from the inner 
membrane of E. coli BLR pTTQ18(mhp1)-His6 cells (Section 2.5.3.1).  The inner 
membranes were solubilised in 1% DDM.  Fractions (15 µg), and eluted protein (10 µg) 
from the purification were analysed by SDS-PAGE.  The arrow indicates the position of 
Mhp1. 
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Figure 4.4 Electrospray ionisation mass spectrometry of Mhp1.  Purified protein (5 
mg/ml) in 10 mM Tris pH 8.0 and 5% glycerol was prepared (Section 2.6.2).  SEC, 
mass spectrometry and analysis were performed by Miss Lynsey Jones.  There is 
evidence of formylation of the protein during its preparation for mass spectrometry.  
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4.4 Fluorimetry studies of Mhp1 
 
 Mhp1 has fifteen tryptophan residues, two of which are involved in substrate 
binding (W117 and W220) (Weyand et al., 2008).  Spectrophotofluorimetry 
experiments were performed to measure the intrinsic tryptophan fluorescence activity of 
Mhp1 upon titration with benzylhydantoin, NaCl or HgCl2 (Section 2.6.3).  Purified 
Mhp (140µg) protein in 10 mM potassium phosphate or Tris-HCl pH 7.6 buffer 
containing 0.05% DDM at 18
o
C was mixed for 4 minutes and titrated with one of the 
above compounds.  Two minutes after each volume addition, a spectrum was scanned 
through 300 – 400 nm with an excitation wavelength of 285 nm, and the decrease in 
fluorescence at 348 nm was expressed as a percentage of the peak height. 
 Titrations of 5-indolymethylhydantoin and 5-benzylhydatoin, substrates of 
Mhp1, were both initially tested.   5-indolymethylhydantoin was very insoluble and 
precipitated at the tested concentrations, whereas 5-benzylhydantoin remained in 
solution and was therefore used in the following fluorimetry experiments.   
Firstly, the effect of sodium ions on the affinity of benzylhydantoin to the 
protein was investigated using fluorescence quenching (Section 2.6.3.1).  There was an 
over 10-fold increase in affinity in the presence of sodium, with an apparent 
dissociation constant (Kd) 0.054 ± 0.007 mM compared to 0.88 ± 0.27 mM (Figure 4.5). 
 
    
 
 
Figure 4.5 Quenching of tryptophan fluorescence in Mhp1 with benzylhydantoin.  
Purified Mhp1 was buffer-exchanged into 10 mM potassium phosphate pH 7.6 with 
0.05% DDM, and titrated with benzylhydantoin (Section 2.6.3.1).  The decrease in 
tryptophan fluorescence at 348 nm was monitored.  Results represent means of 
triplicates ±SEM.  This work was performed with help from Dr Massoud Saidijam and 
is published in Weyand et al. (2008).   
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Also, an increase in affinity for sodium was observed in the presence of 2 mM 
benzylhydantoin (Figure 4.6); in the absence and presence of benzylhydantoin, the 
apparent Kd for sodium was 1.15 ± 0.28 mM and 0.15 ± 0.04 mM respectively, which is 
an approximately 8-fold increase.  These results indicate that the binding of 
benzylhydantoin and sodium are tightly coupled in Mhp1. 
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Figure 4.6 Quenching of tryptophan fluorescence in Mhp1 with NaCl.  Purified 
Mhp1 was buffer-exchanged into 10 mM potassium phosphate pH 7.6 with 0.05% 
DDM, and titrated with 0 – 5 mM NaCl (Section 2.6.3.2).  The decrease in tryptophan 
fluorescence at 348 nm was monitored.  Results represent singlet data.  This work was 
performed together with Dr Massoud Saidijam. 
 
 To examine at the cation specificity of Mhp1, a range of different cations were 
tested, this including lithium, sodium, potassium, rubidium and caesium (Figure 4.7).  
No indication was found that chloride ions interacted with the protein (Figure 4.7).  
Choline chloride was used to balance the osmolarity, so total salt concentration is 150 
mM in the reaction volume, which is the same as in the transport assay (Section 2.5.4), 
i.e. where 15 mM chloride salt was added, 125 mM choline chloride and 10 mM Tris-
HCl were also included.  Similar to earlier observations, the presence of sodium caused 
an increased affinity of Mhp1 for benzylhydantoin, apparent Kd for benzylhydantoin 
was 0.0825 ± 0.0121 mM (Figure 4.7).  The slight difference in the Kd could be due to 
Tris-HCl buffer used instead of potassium phosphate.  The presence of other cations 
allowed a reduced fluorescence quench, and hence the affinity for benzylhydantoin was 
decreased (Figure 4.7), suggesting these cations are not stimulatory. 
 The effect of anions was also tested (Figure 4.8).  Potassium acetate (CH3COOK) 
caused an increase in fluorescence quench, possibly due to pH of the buffer (apparent 
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Kd of 0.1451 ± 0.01677).  Other anions (CO3
2-
, SO4
2-
 and PO4
2-
) had relatively very little 
effects, as the fluorescence quench is similar to the control. 
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Figure 4.7 Quenching of tryptophan fluorescence in Mhp1 by different cations.  
Purified Mhp1 was buffer-exchanged into 10 mM Tris-HCl pH 7.6 with 125 mM 
choline chloride and 0.05% DDM, and titrated with benzylhydantoin (0 – 2 mM) in 
presence of different metal cations (15 mM) (Section 2.6.3.1).  The decrease in 
tryptophan fluorescence at 348 nm was monitored.  Results represent a single 
experiment.  Control contains an additional 15 mM choline chloride. 
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Figure 4.8 Quenching of tryptophan fluorescence in Mhp1 by different anions.  
Purified Mhp1 was buffer-exchanged into 10 mM Tris-HCl pH 7.6 with 0.05% DDM, 
and titrated with benzylhydantoin (0 – 2 mM) in presence of different anions (130 mM 
CH3COOK; 130 mM KHCO3; 90 mM K2SO4; or 90 mM K2HPO4 KH2PO4) (Section 
2.6.3.1).  The decrease in tryptophan fluorescence at 348 nm was monitored.  Results 
represent a single experiment.  Control = 140 mM choline chloride. 
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Mhp1 crystals were phased by soaking in 2.5 mM methyl mercury acetate, 10 
mM K2Pt(NO2)4 or 0.5 mM ethyl mercury thiosalicylate (supplementary material for 
Weyand et al, 2008).  Mercury (Hg
2+
) has a high affinity for functional groups like –SH, 
–OH and –COOH.  A negative fluorescence quenching is shown in the presence of 2 
mM HgCl2 (Figure 4.9), suggesting mercury could possibly affect substrate binding of 
Mhp1.   
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Figure 4.9 Quenching of tryptophan fluorescence in Mhp1 by benzylhydantoin in 
the presence and absence of HgCl2.  Mhp1 (140 µg) was added to a reaction volume 
(980 µl) containing 10 mM Tris-HCl pH 7.6, 135 mM Choline chloride, 0.05% DDM 
and 5 mM NaCl, and titrated with benzylhydantoin (0 – 2 mM) (Section 2.6.3.1).  The 
decrease in tryptophan fluorescence at 348 nm was monitored.  Results represent 
duplicates. 
 
Further experiments involving titrations with HgCl2 in the presence and absence 
of NaCl and/or benzylhydantoin were performed (Figure 4.10).  Results indicate in the 
presence of these compounds a reduction in the fluorescence quench was observed 
(Figure 4.10).  Sodium caused the most dramatic reduction.  Benzylhydantoin caused a 
smaller reduction than sodium, with the presence of these two compounds showing an 
intermediate effect (Figure 4.10).  When mercury was present prior to titration with 
benzylhydantoin (Figure 4.9), the fluorescence quench became negative and there was 
an increase in fluorescence intensity.  Looking at it the other way, when 
benzylhydantoin was present and the solution was titrated with mercury (Figure 4.10), 
the fluorescence quench stay positive.  This could suggest benzylhydantoin protects the 
protein against HgCl2, as does sodium. 
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Figure 4.10 Quenching of tryptophan fluorescence in Mhp1 by HgCl2.  Purified 
Mhp1 was buffer-exchanged into 10 mM Tris-HCl pH 7.6 with 0.05% DDM, and 
titrated with HgCl2 (0 – 1.0 mM) (Section 2.6.3.3).  The decrease in tryptophan 
fluorescence at 348 nm was monitored.  Results represent duplicates. 
 
4.5 Discussion: the substrate binding studies of Mhp1 
 
 Mhp1, as well as other NCS1 family transporters from yeast, fungi and bacteria, 
were previously thought to be proton-dependent (Suzuki & Henderson, 2006; 
Pantazopoulou & Diallinas, 2007; Ren et al., 2007).  Whole cell transport experiments 
showed an initial decrease in transport of benzylhydantoin in the presence of 0 – 10 mM 
sodium, which was followed by an increase in the presence of 10 – 150 mM sodium 
(Figure 4.2).  Sodium dependence in whole cell transport assays may be obscured by the 
presence of other sodium transport systems in the membrane.  Purified Mhp1 (Figure 
4.3), which was confirmed to be intact (Figure 4.4), was subjected to reconstitution into 
liposomes, followed by transport assay, but attempts to measure transport were 
unsuccessful (data not shown) due to the low solubility and the lipophilic nature of the 
substrate.   
 This work showed that binding of benzylhydantoin to Mhp1 is sodium-
dependent, with an increased affinity shown for benzylhydantoin when 15 mM NaCl 
was present (Figure 4.5), and the same was shown for the binding of NaCl in the 
presence of benzylhydantoin (Figure 4.6).  Other cations that were tested showed little 
stimulatory effect, demonstrated by the modest reduction in fluorescence quench 
(Figure 4.7).  Mhp1 is shown to have a high affinity for sodium over the other cations.  
The anions tested showed that potassium acetate gave the highest fluorescence quench 
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(Figure 4.8).  The solutions were of variable pHs, and therefore it was difficult to tell if 
these anions had an effect on Mhp1.  The highest fluorescence quench was observed at 
pH 6.5 (Figure 4.8).  Mhp1 was previously thought to be proton dependent; the optimal 
transport observed at pH 6.6 (Suzuki & Henderson, 2006) - the observed pH in this 
work is similar.  It appears Mhp1, like the MelB sugar-cation symporter (Wilson & 
Ding, 2001), could have a flexible cation selectivity, being proton- as well as sodium-
dependent. 
 Mercury was used in phasing and therefore its ability to quench fluorescence 
was tested.  A substantial quench by mercury occurred with possible protection of 
Mhp1 by sodium and benzylhydantoin from mercury (Figure 4.9 and 4.10).  It is likely 
that Hg
2+
 targets the cysteine at position 69, therefore further experiments such as 
mutation of this residue and repeating the fluorimetry are needed.   
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Chapter 5 – Introduction  
 
This chapter is divided into four sections: 
Section 5.1 – Evaluation of the expression, purification and activities of all membrane-
bound histidine kinases from Enterococcus faecalis V583  
Section 5.2 – Trials to identify the signalling ligands for histidine kinase EF3197 
Section 5.3 – Structural studies: crystallisation trials of histidine kinase EF1051 
Section 5.4 – Characterisation of signal interactions by the quorum sensor EF1820 (FsrC) 
 
This chapter investigates the 16 membrane histidine kinases of the two-component 
systems of E. faecalis, which is a collaborative project between two Principal 
Investigators, Professor Peter Henderson and Dr Mary Phillips-Jones.  Section 5.1 
describes the expression, purification and activities of these membrane proteins; the 
contributions by members of the research team are indicated in Section 5.1.1 (work 
published in Ma et al., 2008).  Sections 5.2 to 5.4 are solely my own work.  Section 5.2 
describes the signal screening of one of the proteins, a homologue of LytS, EF3197.  
The work involved testing putative compounds for their possible effects on the 
autophosphorylation activity of EF3197.  Section 5.3 describes the optimisation of 
expression and crystallisation trials of EF1051.  Section 5.4 investigates in detail the 
quorum sensing kinase EF1820 (FsrC), to characterise the effects of ligand binding and 
an inhibitor on kinase activities. 
 
5.1. Evaluation of the expression, purification and activities of all 
membrane-bound histidine kinases from Enterococcus faecalis V583 
 
5.1.1. Introduction –the histidine kinases of Enterococcus faecalis 
 
The completed genome sequencing of the E. faecalis strain V583 led to the 
identification of 17 two-component systems (TCS) pairs and one orphan response 
regulator (Hancock & Perego, 2002).  All but one histidine kinase (HK) of E. faecalis 
was predicted to be membrane-bound.  This study investigates the entire family of intact 
membrane-bound HKs of E. faecalis, evaluating the systematic cloning, expression, 
purification and activity assays of each of the 16 membrane-bound HKs of E. faecalis.  
In this project, the work for six HKs (EF3197, EF2912, EF1051, EF0373, EF1209 and 
EF1820) were carried out by myself, nine HKs (EF2219, EF1704, EF3290, EF1261, 
EF1863, EF0927, EF2298, EF0570 and EF1335) were studied by Dr Hayley Yuille, and 
work with EF1194 was carried out by Dr Victor Blessie, Miss Nadine Göhring and Miss 
Zsófia Iglói. 
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5.1.2. Cloning and expression of histidine kinases of E. faecalis 
 
Each membrane-bound HK gene was amplified by PCR (Section 2.3.2) using 
the specific primer pairs shown in Table 2.4 with E. faecalis V583 chromosomal DNA 
as template.  The amplified products were digested with the relevant restriction enzymes 
and cloned into plasmid pTTQ18-His6 (Section 2.3.1).  The resulting plasmids of the 
recombinant clones were transformed into E. coli BL21(DE3) for expression, 
purification and activity trials.  The clones were confirmed by DNA sequencing 
(Appendix 7), and the resulting amino acid sequences are shown in Appendix 8. 
Since the expression of membrane proteins is significantly lower than that of 
soluble proteins, amplified expression is therefore required for the production of 
milligram quantities of proteins.  Conditions previously reported for successful 
production of other bacterial membrane proteins (Ward et al., 2000; Potter et al., 2002; 
Saidijam et al., 2003; Suzuki & Henderson, 2006) were therefore tested initially.  
Typically use of LB medium, induction of expression using 0.5 – 1 mM IPTG, and a 
post-induction temperature of 30
o
C have proved successful for the overexpression of 
most of the HKs.  For proteins exhibiting low expression, optimisation of culture and 
expression conditions were subsequently performed, such as testing growth in different 
media (LB, 2TY and M9 minimal medium), different IPTG concentrations for induction, 
and different temperature and time of harvesting post-induction with IPTG.  The 
expression of each HK was assessed by analysis of the total E. coli membranes by SDS-
PAGE and Western blotting to detect each His6-tagged protein.  The results are 
summarised in Table 5.1. 
Most HKs were optimally expressed in LB medium, with only one protein 
(HK06) expressed at higher levels in 2TY medium and none of the low-expressing 
proteins exhibited better expression in minimal medium compared with the other media 
(Table 5.1).  The optimisation tests suggested that the most suitable conditions for post-
induction temperature varied between 15, 30 and 37
o
C; suitable IPTG concentrations 
ranged from 0.2 to 1 mM; and the time of harvesting post-induction was adequate at 3 
hours, with only HK08 and HK16 benefitting from overnight incubation at a lower 
temperature, 15
o
C (Table 5.1).   
The observed molecular masses of all recombinant proteins in the SDS-PAGE 
and Western blot analysis of the total membranes appeared less than the predicted mass 
(Table 5.1 and Figure 5.1), which is typical for the migration of membrane proteins on 
SDS-PAGE due to their hydrophobicity (Ward et al., 2000). 
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Table 5.1 Expression conditions and solubilisation of the 16 intact histidine kinases of E. faecalis.  
1
Predicted using TMHMM (Krogh et al., 
2001) and/or TopPred (Claros & von Heijne, 1994); 
2
mass of the His6-tagged protein predicted using the ExPASy proteomic server (Gasteiger et al., 
2003; Gasteiger et al., 2005); 
3
Western blotting analysis with INDIA
TM
 His probe; 
4
determined by scanning densitometry of SDS-PAGE gel shown 
in Figure 5.1.  DDM, n-dodecyl-β-D-maltoside; UDM, n-undecyl-β-D-maltoside; LDAO, N,N-dimethyl dodecylamide oxide; ND, included in the 
trials but not detected or identifiable; NP, not possible to undertake.  HY, Dr Hayley Yuille; PM, Pikyee Ma; VB, Dr Victor Blessie; NG, Miss 
Nadine Göhring; ZI, Miss Zsófia Iglói.  These results have been published in Ma et al., (2008). 
Kinase 
name 
 
Work 
carried 
out by 
 
Predicted 
number 
TMs
1 
Expression 
medium 
Post-
induction 
temperature 
(
o
C) 
[IPTG] 
(mM) 
Harvest time 
post-induction 
(hours) 
Predicted 
mass with 
His6-tag 
(kDa)
2
 
Observed 
mass (kDa) in 
mixed 
membranes
3
  
Proportion of 
mixed 
membrane 
proteins (%)
4
 
Solubilisation 
detergent 
Observed mass 
(kDa) of intact 
purified proteins
3
 
EF2219 
(HK01) 
HY 
2 ND ND ND ND 67.9 ND ND NP NP 
EF3197 
(HK02) 
PM 
6 LB 37 0.5 3 66.8 53 12 DDM 55 
EF2912 
(HK03) 
PM 
2 LB 37 0.5 3 44.0 38 15 DDM 38 
EF1704 
(HK04) 
HY 
2 LB 30 1.0 3 69.3 52 11 DDM 54 
EF3290 
(HK05) 
HY 
2 LB 30 1.0 3 46.4 37 14 DDM 38 
EF1261 
(HK06) 
HY 
2 2TY 30 0.2 3 57.8 52 8 DDM 54 
EF1194 
(HK07) 
VB, NG 
and ZI 
2 LB 30 0.4 3 71.2 60 11 DDM 60 
EF1863 
(HK08) 
HY 
2 LB 15 1.0 16 52.6 42 12 LDAO 45 
EF0927 
(HK09) 
HY 
2 LB 30 1.0 3 41.7 31 6.5 DDM 32 
EF1051 
(HK10) 
PM 
2 LB 37 0.5 3 60.2 50 16 DDM 50 
EF2298 
(HK11) 
HY 
2 LB, 2TY 30 0.5, 1.0 3 52.0 42 10 DDM / UDM 48 
EF0570 
(HK12) 
HY 
4 LB, 2TY 30 1.0 3 98.7 38 10 ND NP 
EF0373 
(HK13) 
PM 
2 LB 30 0.5 3 58.1 46 4.5 DDM 44 
EF1209 
(HK14) 
PM 
2/3 LB 30 0.5 3 61.1 48 16.5 DDM 48 
EF1820 
(HK15) 
PM 
7 LB 37 0.5 3 53.4 35 3.5 DDM 34 
EF1335 
(HK16) 
HY 
7 LB 15 1.0 16 52.2 32 ND DDM NP 
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In general, it appears that proteins possessing higher numbers of predicted 
transmembrane regions generally exhibited greater mass differences.  For example, 
EF1820 (HK15) and EF1335 (HK16) (Table 5.1), both possess seven putative 
transmembrane regions, respectively, and their apparent masses on SDS-PAGE were 35 
and 32 kDa, whilst their predicted masses are 53 and 52 kDa, respectively (Table 5.1 
and Figure 5.1). 
 
Figure 5.1 Expression of the 16 intact membrane-bound histidine kinases of E. 
faecalis in E. coli BL21(DE3).  Cells transformed with pTTQ18 harbouring the 
recombinant gene for each of the intact histidine kinases were cultured as described in 
Section 2.4.1, and total membrane proteins prepared by water lysis.  Samples (15 µg) 
were separated and analysed by: (A) SDS-PAGE and visualized using Coomassie blue 
staining; and (B) and (C), Western blotting to detect the His6-tagged proteins.  Panel C 
shows a longer exposure required for detection of the successful expression of EF2298 
(HK11).  M, molecular mass standards; U, total membranes of an uninduced culture of 
E. coli BL21(DE3) pTTQ18(EF2219)-His6.  Total membranes prepared by: myself 
(blue); Dr Hayley Yuille (black); Miss Zsófia Iglói (red).  SDS-PAGE and Western 
blotting performed by myself and Dr Hayley Yuille, respectively.  These results have 
been published in Ma et al. (2008). 
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Fifteen of the sixteen intact membrane HKs of E. faecalis were successfully 
overexpressed in E. coli membranes, with only EF2219 (HK01) not detectable by 
Western blotting under the test conditions (Figure 5.1).  Some degradation was 
observed for EF1209 (HK14), and use of protease inhibitors in the water lysis 
membrane preparations of this protein did not prevent such degradation.  A large 
proportion of the EF3197 protein migrated at 53 kDa and some at ~120 kDa on the 
SDS-PAGE; the higher mass observed for this protein was not seen for the other HKs 
(Figure 5.1). 
 
5.1.3. Autophosphorylation activities of E. faecalis histidine kinases within E. coli 
inner membranes 
 
 To test the activities of the cloned histidine kinases, inner membrane vesicles 
expressing each histidine kinase were prepared as described in Section 2.5.1.  Each 
assay employed 200 µg of inner membrane proteins; the reactions were initiated by 
addition of radiolabelled ATP, and 20 µg samples were taken at time intervals.  The 
levels of phosphorylated proteins were analysed as described in Section 2.5.5.1.  Eleven 
histidine kinases showed detectable activity in inner membranes (Figure 5.2).  No 
detectable activity was shown in at least three attempts for EF0927 (HK09), EF2298 
(HK11), EF0570 (HK12) and EF1335 (HK16), suggesting that these proteins are either 
inactive or that there is an absence of an activating signal (Figure 5.2).  The membrane-
localised histidine kinases displayed a range of different kinetics (Figure 5.2).  Nine of 
the kinases (EF3197, EF1740, EF1261, EF1194, EF1863, EF1051, EF0373, EF1209 
and EF1820) reached maximum autophosphorylation within the initial 20 minutes, and 
for EF3197, EF1704, EF1194, EF1863, EF1051, EF0373 and EF1209, this was 
followed by rapid dephosphorylation (Figure 5.2).  The phosphorylation of EF2912 
increased steadily throughout the assay time, and did not reach a maximum in the 60 
minutes time course (Figure 5.2).  EF3290 was atypical, reaching maximum 
phosphorylation after approximately 30 minutes, followed by slow dephosphorylation, 
maintaining approximately 60% of its maximum activity by the end of the time period 
(Figure 5.2). 
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Figure 5.2 Autophosphorylation activities of intact histidine kinases in inner 
membrane vesicles.  Inner membrane proteins (200 µg) were incubated at 24
o
C and 
reactions initiated by the addition of radiolabelled ATP in a total reaction volume of 200 
µl, as described in Section 2.5.5.1.  Samples (20 µl) were removed at the time points 
indicated.  (A) Image and (B) quantitative representation of the data for each 
radiolabelled phosphorylated protein during phosphorylation.  The arrows indicate 
position of the phosphorylating proteins.  Graphs show the pixel counts relative to the 
maximum value attained during the assays.  Assays performed by: myself – EF3197, 
EF2912, EF1051, EF0373, EF1209 and EF1820; Dr Victor Blessie – EF1194; Dr 
Hayley Yuille – EF1704, EF3290, EF1261 and EF1863). 
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5.1.4. Solubilisation and purification of E. faecalis histidine kinases 
 
Solubilisation trials were performed as described in Section 2.5.2.  Fourteen out 
of the fifteen histidine kinases were successfully solubilised from the E. coli membranes.  
Most of the histidine kinases were successfully solubilised by DDM (Table 5.1), a 
widely used detergent for solubilising bacterial membrane proteins (Ward et al., 2000; 
Saidijam et al., 2003), except for EF1863 (HK08) and EF0570 (HK12).  LDAO was 
used for successful solubilisation of EF1863 (HK08), whilst none of the detergents 
tested was able to solubilise EF0570 (HK12) from the E. coli membranes (Table 5.1). 
 
Figure 5.3 One-step purification of the expressed intact membrane histidine 
kinases of E. faecalis.  Proteins were solubilised using detergent and purified from the 
inner membranes by Ni-NTA affinity chromatography, as described in Section 2.5.3.2.  
Eluted fractions from the purification (10 µg) were analysed by: (A) separation on SDS-
PAGE and staining with Coomassie Blue, and % purity determined by densitometry; 
and (B) Western blotting analysis using an INDIA
TM
 HisProbe (performed by myself).  
M, molecular mass marker.  HKs purified by: myself (blue); Dr Victor Blessie (red); 
and Dr Hayley Yuille (black). 
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Following histidine kinase solubilisation from E. coli inner membranes, 
purification of the His6-tagged proteins was performed by Ni-NTA purification, 
(Section 2.5.3.2).  Thirteen of the fifteen expressed histidine kinases were successfully 
purified from the E. coli inner membranes.  Only EF1335 (HK16) could not be eluted 
from the Ni-NTA column under the test conditions.  The one-step purifications of the 
histidine kinases are shown in Figure 5.3.  The purity of the eluted proteins ranged from 
19-90 % (Figure 5.3).  The purities of EF1704 (HK04), EF1261 (HK06) and EF1051 
(HK10) were ranked highest, attaining 87, 78 and 90%, respectively, as determined by 
scanning densitometry.  The lowest purity obtained was 19% for EF0373 (HK13) 
(Figure 5.3), which could be due to the low level of expression of this protein (Table 
5.1).  The positions of the purified His6-tagged proteins on the SDS-PAGE was 
confirmed by Western blotting using the INDIA
TM
 HisProbe-HRP, and their observed 
masses agreed with their obtained masses in mixed membranes (Table 5.1, Figures 5.1 
and 5.3).   
Western blotting of the purified histidine kinases suggested possible degradation 
of some of the proteins, as proteins of lower masses were observed in gels for the eluted 
samples of EF3197 (HK02), EF2912 (HK03), EF3290 (HK05), EF1863 (HK08), 
EF1209 (HK14) and EF1820 (HK15), in addition to the undegraded intact form. 
 
5.1.5. Integrity of purified histidine kinases determined by Western blotting, N-
terminal sequencing and/or mass spectrometry 
 
The 13 purified proteins were verified to be intact and undegraded by N-
terminal sequencing and/or electrospray ionisation mass spectrometry (ESI-MS), 
together with Western blotting that shows the His6-tagged C-terminus is retained.  N-
terminal sequence and/or MS data were obtained for all but three proteins: EF3197 
(HK02) for which no N-terminal or MS data could be obtained; EF0570 (HK12), which 
was not solubilised from the membranes; and EF1335 (HK16), which was not 
successfully eluted from the Ni-NTA columns (Table 5.2).  Both EF3197 (HK02) and 
EF1820 (HK15) appear to be N-terminally blocked by possibly a formyl group, and 
initial N-terminal sequencing gave very high backgrounds, suggesting random 
degradation of protein.  These proteins were therefore treated with acid-methanol 
(Section 2.6.5), prior to N-terminal sequencing.  The EF1820 protein was chemically 
unblocked and N-terminal sequence successfully obtained, whereas the treatment failed 
for the EF3197 protein. 
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Kinases 
name 
N-terminal sequence of purified 
protein 
Electrospray ionisation mass 
spectrometry of purified protein 
EF2219 
(HK01) 
No expression No expression 
EF3197 
(HK02) 
Possible formylation of protein 
preventing Edman-degradation of 
protein 
N/T 
EF2912 
(HK03) 
MNSHMTDRIS N/T 
EF1704 
(HK04) 
MNSHMKKRL N/T 
EF3290 
(HK05) 
MNSHMLVKP N/T 
EF1261 
(HK06) 
MNSHMK N/T 
EF1194 
(HK07) 
MNSKKV 71235 Da 
EF1863 
(HK08) 
MNSKKLKIFP N/T 
EF0927 
(HK09) 
MNSHMTILKY N/T 
EF1051 
(HK10) 
MNSHMKRT 60189 Da 
EF2298 
(HK11) 
MNSHME N/T 
EF0570 
(HK12) 
Not solubilised from membrane Not solubilised from membrane 
EF0373 
(HK13) 
MNSHMTIKR N/T 
EF1209 
(HK14) 
MNSHMKRGGK N/T 
EF1820 
(HK15) 
MNSHMILSLL N/T 
EF1335 
(HK16) 
Not purifiable Not purifiable 
 
Table 5.2 N-terminal sequencing and ESI-MS of histidine kinases of E. faecalis.  
Purified proteins separated by SDS-PAGE were electroblotted onto PVDF-membrane 
and stained with Coomassie Blue.  The stained protein was subjected to N-terminal 
sequence (Section 2.6.4) by Edman degradation (Edman, 1950), performed by Dr Jeff 
Keen.  ESI-MS was performed as described in Section 2.6.2 and samples analysed by 
Miss Lynsey Jones.  N/T, Not yet tested for ESI-MS.  Samples for N-terminal 
sequencing and ESI-MS were prepared by: myself – EF3197, EF2912, EF1051, EF0373, 
EF1209 and EF1820; Dr Victor Blessie – EF1194; Dr Hayley Yuille –EF1704, EF3290, 
EF1261, EF1863, EF0927 and EF2298. 
 
5.1.6. Autophosphorylation of purified E. faecalis histidine kinases 
 
Twelve out of thirteen histidine kinases retained autophosphorylation activity 
after purification from E. coli inner membrane (Figure 5.4).  Two of these proteins, 
EF2298 (HK11) and EF1209 (HK14) were also active, but the very weak activity 
observed is not shown.  Of the eleven histidine kinases that were active in the E. coli 
inner membranes (Figure 5.2), all but one, EF1863 (HK08), remained active post-
purification.  EF1863 (HK08) was highly aggregated after extraction from the inner 
membranes and 0.1% LDAO was added to the assays to reduce this aggregation, so the 
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loss of detectable activity observed may be attributable to the LDAO.  In this work, 
even low concentration of detergents, such as 0.05% DDM in the autophosphorylation 
assays were observed to be inhibitory for the activities of some purified histidine 
kinases, and therefore detergents were often not added post-solubilisation unless it was 
necessary to prevent the aggregation of proteins. 
It appears that EF0927 (HK09), which previously produced no detectable 
activity in the inner membranes, was active following purification (Figure 5.2).  EF2298 
(HK11) VanSB had a low activity level and showed no detectable increase in 
phosphorylation upon addition of a 10-fold molar excess of vancomycin, a putative 
signal for this kinase.  This suggests that this antibiotic is not an activating signal for 
this kinase under the test conditions, or that the recombinant protein is not able to 
respond to its signal. 
Only two histidine kinases, EF2912 (HK03) and EF1261 (HK06), showed 
similar kinetics in both membranes and in the purified form (Figure 5.2 and 5.4).  The 
kinetics of most of the purified histidine kinases, except for EF1704 (HK04), EF3290 
(HK05) and EF1261 (HK06), exhibited increased autophosphorylation during the sixty 
minutes time-course (Figure 5.4).  For purified EF3197 (HK02), EF1704 (HK04), 
EF3290 (HK05), EF1194 (HK07), EF1051 (HK10), EF0373 (HK13) and EF1820 
(HK15), autophosphorylation activities reached maximum levels later in the time-
course, with little desphosphorylation compared to that observed when membrane-
bound (Figure 5.2 and 5.4).  Although the different protein concentrations present may 
affect kinetics, these data suggest that autophosphorylation rates are faster when the 
kinases are bound to the membrane than when extracted or in their purified form 
(Figure 5.2 and 5.4).  As the kinases are expressed heterologously in E. coli, the inner 
membrane vesicles prepared and used for the assay may contain E. coli phosphatases 
that could also contribute to the decrease in phosphorylation of the kinases in the 
membrane-bound kinases assay; also there could be E. coli components promoting the 
rapid phosphorylation of the membrane-bound histidine kinases (Figure 5.2).   
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Figure 5.4 Autophosphorylation activities of purified intact histidine kinases.  
Purified proteins (600 – 1000 pmoles) were added to reaction buffer, and 
autophosphorylation initiated using radiolabelled ATP in a total reaction volume of 150 
µl (Section 2.5.5.2).  Samples (15 µl) were removed at the time points indicated.  (A) 
Image and (B) quantitative representation of the data for each radiolabelled 
phosphorylated protein during autophosphorylation.  The arrows indicate position of the 
phosphorylating proteins.  Graphs show the pixel counts relative to the maximum value 
attained during the assays.  Assays performed by: myself – EF3197, EF2912, EF1051, 
EF0373 and EF1820; Dr Mary Phillips-Jones – EF1194; Dr Hayley Yuille – EF1704, 
EF3290, EF1261 and EF0927. 
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5.1.7. Discussion: expression, purification and activities of the entire family of 
intact membrane histidine kinases from E. faecalis 
 
Production of membrane proteins has previously been one of the bottlenecks in 
determination of structure and activities, and studies of most of the previously studied 
histidine kinases have been confined to only the soluble domain or truncated forms of 
the kinase, owing to the difficulties of producing proteins that possess their 
transmembrane domains.  The present study evaluated the heterologous expression, 
production and activities of sixteen full-length membrane histidine kinases of E. 
faecalis.  The genes for each histidine kinase were systemically amplified and cloned 
into plasmid pTTQ18-His6, and all but one (EF2219 – HK01) were successfully 
expressed in E. coli membranes (Figure 5.1).  Plasmid pTTQ18 has been shown to be 
successful for production of many membrane proteins (Ward et al., 2000; Saidijam et 
al., 2003; Bettaney, 2008), and in a comparison of expression data for 37 membrane 
proteins, out of eight vectors tested, pTTQ18 showed the greatest number of targets 
expressed (Surade et al., 2006).   
The expression trials for the sixteen histidine kinases showed variable 
expression levels, 3.5 – 16.5% of total membrane proteins (Table 5.1 and Figure 5.1).  
In this study the choice of host strain, expression medium, induction temperature, 
concentration of inducer and post-induction time were based on previous experience in 
the laboratory for expression of transporters and histidine kinases (Ward et al., 2002; 
Potter et al., 2002; Saidijam et al, 2003).  Generally, LB medium at induction 
temperatures of 30 or 37
o
C with 0.5 or 1 mM IPTG and 3 hours post-induction time 
were successful for the overexpression of most of the E. faecalis histidine kinases 
(Table 5.1).  Here, high success rates for the solubilisation and purification of the 
histidine kinases were also achieved.  Fourteen out of fifteen were solubilised 
successfully from E. coli membranes and thirteen were successfully purified.  Most 
were successfully solubilised using DDM and the purity of the purified kinases ranged 
from 19 – 90% in these one-step experiments (Table 5.1 and Figure 5.3). 
There are different mechanisms of stimulus perception by histidine kinases, 
either by periplasmic, transmembrane or cytoplasmic-sensing, as described in the 
Introduction (Figure 1.4.5).  Most previous studies of histidine kinases employed only 
the cytoplasmic domains that constituted soluble forms lacking their sensing domains.  
Once example, includes a genomic study of the two-component systems of E. coli 
(Yamamoto et al., 2005), which consequently was unable to characterise the sensing 
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mechanisms.  But our work here demonstrates successful production of full-length 
histidine kinases that generally retain their autophosphorylation activities, either within 
inner membranes or after purification.  Unlike the truncated soluble versions, the full-
length histidine kinases are suitable for signal identification.  The activity studies 
showed that eleven of the fifteen membrane-bound proteins and twelve of the thirteen 
purified proteins were active in autophosphorylation assays (Figures 5.2 and 5.4), and 
that a remarkable thirteen of the fifteen expressed kinases were active in E. coli 
membranes and/or as purified proteins. 
 
5.2. Trials to identify the signalling ligands for histidine kinase EF3197 
 
5.2.1. Introduction 
 
5.2.1.1. Histidine kinase EF3197: a putative LytS homologue in E. faecalis.  The 
histidine kinase EF3197 of E. faecalis is 55% identical (85% similar) to Staphylococcus 
aureus LytS and is therefore likely to be the orthologue of the functionally characterised 
LytSR two-component regulatory system.  The S. aureus LytSR system was first 
identified in 1996 (Brunskill & Bayles, 1996a), and is involved in controlling the rate of 
autolysis during cell wall biosynthesis by affecting the intrinsic murein hydrolase 
activity of the cell (Brunskill & Bayles, 1996b).  Downstream from the lytSR genes is a 
bicistronic operon, lrgAB, containing genes that modulate murein hydrolase activity and 
penicillin tolerance (Groicher et al., 2000).  Upon signal perception by LytS, the 
histidine kinase presumably interacts with its partner response regulator, LytR, which 
then activates the transcription of genes under its control i.e. lrgAB (Figure 5.5). 
In bacteria, the LytSR system is associated with the molecular control of 
bacterial death and lysis.  The self-destructive end stage of the bacterial life cycle is 
termed ‗autolysis‘ and involves the bacteriolytic enzymes referred to as murein or 
peptidoglycan hydrolases, or autolysins.  Purified autolysins were able to dissolve 
isolated bacterial cell walls, digesting the peptidoglycan layer (Nomura & Hosoda, 
1956).  Murein hydrolases are widely diverse, a unique family of enzymes that 
specifically cleave structural components of peptidoglycan, shown to be important in a 
number of biological processes, such as cell growth and division, daughter cell 
separation and peptidoglycan recycling and turnover (Perkins, 1980; Shockman et al., 
1983; Ward & Williamson, 1985; Holtje et al., 1991; Archilbald et al., 1993; Shockman 
et al., 1994). 
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Figure 5.5 LytSR two-component regulatory system of S. aureus.  The LytSR 
system is hypothesised to sense decrease in membrane potential and respond by 
inducing lrgAB transcription (Patton et al., 2006).  The overlapping lrgA and lrgB 
transcripts are indicated by the black bars. 
 
5.2.1.2. Bacterial cell lysis.  The best-characterised example of regulated bacterial cell 
lysis comes from studies of the control of the lytic cycle during bacteriophage infection, 
in which a ‗holin‘ and an ‗endolysin‘ (a murein hydrolase) are involved (Young, 1992; 
Wang et al., 2000).  There are two proposed mechanisms for holin-controlled murein 
hydrolase activity in cell lysis (Figure 5.6). 
 
 
Figure 5.6 Model of the holin and endolysin function.  (A) Endolysin (murein 
hydrolase), such as that produced by bacteriophage lambda, accumulates in an active 
form in the cytoplasm.  Holin forms rafts by helix-helix packing and is activated by 
localised depolarisation causing changes in holin conformation, leading to asymmetric 
disruption of the helix packing.  The membrane becomes leaky, followed by release of 
endolysin to the peptidoglycan.  (B) SAR-endolysin, such as that produced by 
bacteriophage P1, is attached to the cytoplasmic membrane in an inactive form by the 
SAR-domain (orange bar).  Upon holin activation the membrane becomes de-energised 
and the endolysin is released.  Adapted from Rice & Bayles (2008). 
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The first mechanism, utilised by lambda- and T4-like bacteriophage, involves 
the control of murein hydrolase transport across the membrane. Murein hydrolase 
typically accumulates harmlessly in the cytoplasm, lacking signal peptides, until holin 
allows passage across the membrane and thus access to its substrate, peptidoglycan 
(Figure 5.6).  Although the mechanism by which the holins mediate the passage of 
murein hydrolases is uncertain, it is thought to involve their oligomerisation in the 
membrane causing membrane permeabilisation and allowing passive passage of murein 
hydrolase into the periplasm (Gründling et al., 2000; Young et al., 2000; Wang et al., 
2003).  The second mechanism, utilised by P1 bacteriophage, involves murein 
hydrolases containing signal-arrest-release (SAR) domains (Xu et al., 2004; Xu et al., 
2005).  Similar to signal sequences, the SAR domain targets the murein hydrolase to the 
Sec machinery, but anchors the protein in the outer face of the membrane in an inactive 
form until holin releases it (Figure 5.6). 
 
5.2.1.3. The lrgAB and cidABC genes.  In S. aureus, lrgA and lrgB, putatively 
encoding anti-holin-like protein and murein hydrolase regulatory protein respectively, 
are regulated by the LytSR two-component regulatory system (Brunskill & Bayles, 
1996a).  Deletion of the lrgAB operon caused a decrease in penicillin tolerance for cells 
that were nearing stationary phase, whereas overexpression of this operon caused 
increased penicillin tolerance for cells in the early exponential phase, consistent with the 
observation that lrgAB was only minimally expressed during the early exponential 
phase of growth (Groicher et al., 2000).  Changes in membrane potential affecting 
uptake of antibiotics, such as gentamicin, were observed approximately thirty years ago 
(Mates et al., 1982).  Although the mechanism affecting uptake is unknown, the lrgAB 
genes could putatively be involved by producing holin lesions and thus allowing or 
preventing antibiotic uptake. 
Study of the lrg operon later led to the identification of the cid operon, a 
homologue of lrgAB, designated cidA and cidB (23% and 31% amino acid identity with 
LrgA and LrgB, respectively).  CidAB also regulate cell death and lysis but mutants 
lacking these proteins exhibited phenotypes that were the reverse of those of LrgAB 
knockouts (Rice et al., 2003); mutants of cidA showed decreased murein hyrdolase 
activity and increased tolerance to antibiotics (Rice et al., 2003; Patton et al., 2005; 
Rice et al., 2005).  Expression of the cid and lrg operons is regulated by LytSR 
(Brunskill et al., 1996) and CidR (Yang et al., 2005) proteins, which function in 
response to changes in membrane potential (Patton et al., 2006) and acetic acid 
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produced during glucose metabolism, respectively (Rice et al., 2005).  The 
accumulation of acetate or acetic acid byproducts in culture media could result from the 
expression of the cidC gene, which encodes a pyruvate oxidase (Patton et al., 2005).  
The cidB and lrgB genes encode homologous hydrophobic proteins and the exact 
function is unknown, but hydrophobicity analyses of these proteins reveal that they are 
unlikely to encode murein hydrolases.  The cidA gene encodes a putative holin protein, 
an effector of murein hydrolase activity and cell lysis, and the lrgA gene encodes a 
putative anti-holin that inhibits these processes; both of which are homologous 
hydrophobic proteins and are believed to be analogues to bacteriophage-encoded holins 
and anti-holins respectively (Groicher et al., 2000; Rice et al., 2003). 
Recent studies revealed that cid and lrg operons that regulate death of bacterial 
cells are important for biofilm development (Bayles, 2007; Rice et al., 2007; Rice & 
Bayles, 2008), by providing a source of extracellular genomic DNA (eDNA), which is 
an essential matrix molecule produced by many bacterial species during biofilm 
development (Whitchurch et al., 2002; Allesen-Holm et al., 2006; Spoering & Gilmore, 
2006; Rice et al., 2008).  The cidA gene product was a positive effector of cell lysis and 
DNA release in biofilm (Rice et al., 2007), and the lrg operon was an inhibitor of cell 
lysis and inhibition of DNA release in the biofilm (Mann et al., 2009). 
 
5.2.1.4. The histidine kinase EF3197 of E. faecalis.  Genome sequencing of E. 
faecalis and identification of the seventeen two-component systems led to discovery of 
a putative LytSR system of E. faecalis (EF3197-EF3196), named the LytST two-
component regulatory system (Figure 5.7).  The histidine kinase EF3197 is 55% and   
52% identical to the LytS proteins of S. aureus and B. anthracis, respectively.  EF3196, 
EF3194 and EF3193 are also highly similar to the Bacillus species LytR response 
regulator, murein hydrolase regulator, and anti-holin-like protein, respectively.  A 
recent study of a lytS knockout mutant generated in a clinical S. aureus isolate (UAMS-
1) showed that LytSR is required for lrgAB expression, and that this mutant formed a 
more adherent biofilm compared to wild-type and complemented strains (Sharma-
Kuinkel et al., 2009), suggesting LytS is a negative effector of biofilm formation.  The 
histidine kinase EF3197 was therefore further characterised in this project for its 
possible function in regulating cell lysis and biofilm development. 
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Figure 5.7 Map of the LytST two-component regulatory system in E. faecalis.  The 
bent arrows denote promoter sites ( ).  The blue arrows represent genes ( ), and 
the number below corresponds to the genome position of the gene.  This diagram is 
based on the genome map in the KEGG database (Kanehisa, 2002). 
 
 
 
 
 
 
Figure 5.8 Topology model of E. faecalis histidine kinase EF3197.  Topology 
prediction by TMHMM (Krogh et al., 2001).  The predicted helices are numbered from 
the N- to C-terminus and are shown in roman numerals.  The phosphorylatable histidine 
is highlighted in yellow, and cysteine residues in red.  The residues boxed in blue 
comprise a putative GAF domain.  Conserved residues are highlighted in grey and black 
according to the alignment in Appendix 9. 
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EF3197 of E. faecalis is classified as a Group I kinase, as determined by the 
conservation of amino acids flanking the phosphorylatable histidine residue (Hancock 
& Perego, 2002).  It possesses six putative transmembrane helices, followed by a GAF 
domain presumed to bind cGMP, and a core catalytic domain (Figure 5.8).  Alignment 
of the EF3197 primary sequence with the LytS protein sequences of S. aureus and 
Bacillus strains revealed that these proteins are highly similar with many conserved 
sequence (Appendix 9). 
EF3197 clusters most closely to LytS of S. aureus on the phylogenetic tree, and 
the LytS proteins of Bacillus species also clustered very closely (Figure 5.9).  Included 
in the phylogenetic tree analyses are redox-sensing kinases; EF3197 was shown not to 
be closely related to these proteins (Figure 5.9).  The SMART web-based tool showed 
that EF3197 and LytS of other bacteria have a conserved GAF domain, and that the 
sizes and positions of the conserved domains in these proteins are highly similar (Figure 
5.10).  The redox sensors were also compared because EF3197 was shown to respond to 
redox (Section 5.2.7). 
 
 
 
Figure 5.9 Phylogenetic tree of EF3197, LytS and redox sensors.  Phylogenetic tree 
was created by Geneious Pro 4.6.5 software using amino acid sequences of EF3197 and 
the LytS proteins.  LytS of: Bacillus subtilis (BS_LytS); Bacillus cereus (BC_LytS); 
Bacillus anthracis (BA_LytS); Staphylococcus aureus (SA_LytS).  ArcB of E. coli 
(EC_ArcB).  RegB of Rhodobacter sphaeroides (RS_RegB).  OxyR of E. coli 
(EC_OxyR).  DevS of Mycobacterium tuberculosis (MT_DevS). 
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Figure 5.10 Domain analysis of EF3197 and LytS of S. aureus and Bacillus.  The 
figure is based on the graphical output of the SMART web-based tool (Schultz et al., 
1998; Letunic et al., 2008).  The scale bar is in amino acids.  Blue vertical bars 
represent putative transmembrane segments ( ).  Sizes and positions of conserved 
domains are indicated by the labeled symbols.  EF3197 (putative LytS of E. faecalis), 
SA_LytS (LytS of S. aureus), BS_LytS (LytS of B. subtilis), BC_LytS (LytS of B. 
cereus), BA_LytS (LytS of B. anthracis). 
 
5.2.2. Cloning, expression and purification of EF3197 
 
The EF3197 gene was amplified from the chromosomal DNA of E. faecalis 
V583 strain by PCR and cloned into plasmid pTTQ18-His6, followed by expression 
trials.  The results are shown in Section 5.1.2 of this chapter.  Histidine kinase EF3197 
was heterologously expressed in E. coli membranes (Figure 5.1) to a level of 12% of 
total membrane proteins, migrating at 53 kDa in SDS-PAGE (Table 5.1).  Expression of 
EF3197 in LB, 2TY and M9 minimal media suggests that the protein is present at 12, 9 
and 5% of total  E. coli membranes, respectively (Figure 5.11), as determined by 
scanning densitometry; therefore LB medium was used for subsequent expression of 
EF3197. 
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Figure 5.11 Expression of E. coli BL21(DE3) cells transformed with 
pTTQ18(EF3197)-His6.  BL21(DE3) cells transformed with pTTQ18(EF3197)-His6 
were grown in LB, 2TY or minimal media supplemented with 20 mM glycerol.  Cells 
were induced with 0.5 mM IPTG when A680nm reached 0.4 – 0.6 and harvested 3 hours 
post-induction, followed by total E. coli membranes preparation and analysis by SDS-
PAGE.  M (marker), U (uninduced) and I (induced).  Arrow indicates position of 
EF3197 deduced from previous SDS-PAGE and Western blots (Figure 5.1). 
 
 A six litre culture of E. coli BL21(DE3) cells expressing His6-tagged EF3197 
was grown aerobically at 37
o
C (Section 2.4.1).  The harvested cells were lysed by 
explosive decompression and membranes separated on sucrose density gradients 
(Section 2.5.1).  The membrane fractions obtained were analysed by SDS-PAGE, and 
showed the presence of EF3197 mostly in the inner membrane fraction (Figure 5.12).  
EF3197 was expressed at approximately 14, 4 and <1% in the prepared inner, mixed 
and outer membranes respectively (Figure 5.12).  The inner membrane proteins were 
subjected to solubilisation and purification using 0.05% DDM added to all buffers post-
solubilisation, as described in Section 2.5.3.2.  Fractions from the purifications were 
analysed by SDS-PAGE (Figure 5.13). 
EF3197 was successfully solubilised from inner membranes (Figure 5.13), and 
separated from a protein band migrating at a slightly lower molecular weight in the 
insoluble fractions (Figure 5.13).  Following analysis by scanning densitometry, the 
purity of EF3197 was 85% when 0.05% DDM was included in buffers post-
solubilisation (Figure 5.13), compared to 57% when no DDM was added (Figure 5.3).  
Addition of DDM to post-solubilisation buffers improved the purity of EF3197. 
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Figure 5.12 SDS-PAGE of membrane fractions of E. coli BL21(DE3) cells 
expressing EF3197.  Total E. coli membranes were prepared from E. coli BL21(DE3) 
pTTQ18(EF3197)-His6 grown on LB medium containing 20 mM glycerol and 100 
µg/ml carbenicillin in the presence of 0.5 mM IPTG and harvested 3 hours post-
induction.   Total membranes were separated on 25-55% sucrose gradients and 
membrane fractions extracted from the gradients were analysed by SDS-PAGE.  The 
arrow indicates position of EF3197. 
 
 
 
Figure 5.13 SDS-PAGE of fractions obtained from the purification of E. faecalis 
EF3197.  EF3197 was purified from the inner membranes of E. coli BL21(DE3) 
pTTQ18(EF3197)-His6 cells.  The inner membranes proteins were solubilised in 1% 
DDM.  Fractions (15 µg) and final eluted protein fraction (5 µg) were analysed by SDS-
PAGE.  The arrow indicates the position of EF3197. 
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Although increased purity could be achieved through optimisation trials using 
different detergent levels, the phosphorylation activity of this histidine kinase was 
reduced when detergents were included.  This was first shown to be true for VicK 
(Phillips-Jones, personal communication) and later for other histidine kinases tested.  
One example is shown in Figure 5.31.  This histidine kinase and all other kinases were 
therefore purified according to the procedure in Section 2.5.3.2 in which no detergent 
was included in post-solubilisation buffers, unless stated otherwise.  
 
5.2.3. Circular dichroism of purified EF3197 
 
 The secondary structure of EF3197 was examined by circular dichroism 
(Section 2.6.1).  The negative indentation at 208 and 222 nm, and a positive signal at 
~190 nm, are indicative of a predominantly α-helical content (Figure 5.14), agreeing 
with the prediction by TMHMM that this protein is highly hydrophobic, and confirming 
the retention of the secondary structure of EF3197 after purification. 
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Figure 5.14 Circular dichroism spectrum of purified EF3197.  Purified EF3197 
(0.05mg/ml) was buffer-exchanged into 10 mM potassium phosphate buffer pH 7.6 and 
0.05% DDM.  CD spectral analysis of EF3197 was performed using Jasco J-715 
spectropolarimeter at 18
o
C with constant nitrogen flushing.  The sample were analysed 
in Hellma quartz-glass cell of 1 mm path length.  Spectrum was recorded with 1 nm step 
resolution at a scan rate of 10 nm/min.  Response time was set at 1 second with a 
sensitivity of 20 mdeg and bandwidth of 1.0 nm.  The spectrum represents an 
accumulation of ten scans, from which the buffer contribution was subtracted.  The blue 
line represents the voltage applied to the photomultiplier. 
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5.2.4. Autophosphorylation activities of EF3197 
 
 Different phosphorylation kinetics were observed for EF3197 when bound in E. 
coli inner membranes compared with the purified version (Figure 5.2 and 5.4).  Using 
inner membrane preparations, EF3197 exhibited rapid autophosphorylation up to the 
first minute, followed by a slow desphosphorylation after 10 minutes (Figure 5.2).  In 
the purified form, EF3197 showed continuing phosphorylation and maximum 
phosphorylation was not reached even in sixty minutes (Figure 5.4).  As indicated 
earlier in this chapter, the membrane vesicles containing E. coli phosphatase may give 
rise to desphosphorylation of kinases.  However, as EF3197 is highly identical to the 
histidine kinase LytS of S. aureus that is involved in cell wall metabolism, it is possible 
there are other components in the prepared membrane vesicles that could give rise to the 
dephosphorylation effect, for example cell wall derivatives. 
 
5.2.5. Autophosphorylation of purified EF3197 is not affected by penicillin 
 
Previous studies indicated that a S. aureus lrgAB mutant produced increased 
level of extracellular murein hydrolase activity compared to the wild-type strain, and 
complementation of the lrgAB defect restored the wild-type phenotype, indicating that 
these genes conferred negative control on extracellular murein hydrolase activity 
(Groicher et al., 2000).  Furthermore, expression of the lrgAB operon inhibited 
penicillin-induced killing of S. aureus, independently of cell lysis (Groicher et al., 
2000).  Since the LytSR two-component system of S. aureus regulates the lrgAB operon, 
and EF3197 is highly homologous to LytS of S. aureus, experiments wre therefore 
performed to determine whether penicillin exerted any effect on the 
autophosphorylation activities of EF3197. 
Autophosphorylation assays were performed in the presence of a range of 
penicillin concentrations (0 – 10 mM) (Section 2.5.5.3).  It was found that the presence 
of the antibiotic exerted no detectable effect on the phosphorylation of purified EF3197 
(Figure 5.15).  However, it is possible that penicillin exerts an effect on 
dephosphorylation rate of EF3197, rather than autophosphorylation rate, but this was 
not investigated in this study. 
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Figure 5.15 Autophosphorylation of purified EF3197 in response to the presence 
and absence of penicillin.  Each reaction employed 80 pmoles (5.3 µM) of purified 
EF3197 in a final reaction volume of 15 µl.  Reactions were initiated by the addition of 
50 µM radiolabelled [γ-33P]ATP and were allowed to proceed for 40 minutes in the 
presence of the indicated penicillin concentrations (Section 2.5.5.3).  Autoradiographic 
film (left) and graphical representation (right) of phosphorylated EF3197 are shown. 
 
5.2.6. Signal testing of EF3197 
 
 The molecular signal for EF3197 is unknown and therefore a range of candidate 
signals were screened using purified protein in in vitro autophosphorylation assays.  
This includes testing monovalent cations, temperature and sodium fumarate, which 
were previously shown to affect the rate of cell wall autolysis (Cheung & Freese, 1985; 
Madiraju et al., 1987; Tobin et al., 1994); hence Na
+
, K
+
, Mg
2+
 and Fe
2+
 (NaCl, 
K2HPO4/KH2PO4, MgCl2, Fe2SO4) were tested.  Also, cGMP was tested since EF3197 
was predicted to have a putative GAF domain (Figure 5.8 and 5.10).  Glucose and acetic 
acid were tested as they were shown to affect CidR which stimulated cid and lrg 
transcription (Rice et al., 2003; Patton et al., 2005; Rice et al., 2005). 
In the signal testing assays, 80 pmoles of purified EF3197 (5.3 µM) were added 
per 15 µl reaction in the presence of each candidate signal and assayed as described in 
Section 2.5.5.3.  The proportion of phosphorylated EF3197 was determined by scanning 
densitometry and represented graphically (Figure 5.16).  Results indicated that Fe2SO4, 
acetic acid and temperature at 55
o
C greatly reduced the proportion of phosphorylated 
EF3197 (EF3197-P) to 3, 2 and 7% respectively (Figure 5.16), suggesting that EF3197 
is sensitive to acidic conditions and high temperature stress conditions.  
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Phosphohistidine residues are known to be acid labile (Attwood et al., 2007) and 
therefore this may also be responsible for the loss of activity.  However Fe
2+
 needs to be 
retested at an appropriate pH.  Meanwhile, the inactivity of the kinase at high 
temperature could be caused by denaturation of the protein and therefore a circular 
dichroism spectrum or thermal melt of this kinase could be performed to test if the 
protein is unfolded at the tested temperature.  MgCl2, cGMP and sucrose caused a 
reduction in the proportion of EF3197-P (84, 72 and 80% respectively); whereas DTT, 
NaCl, erythromycin (dissolved in 100% ethanol), K2HPO4/KH2PO4, glucose and 
sodium fumarate caused an increase in proportion of EF3197-P (Figure 5.16).  All 
candidate signals tested showed possible effects on the phosphorylation of EF3197, 
though without further repeat experiments no statistical analyses can be performed and 
therefore no firm conclusions can yet be drawn. 
 
Figure 5.16 In vitro signal screening for EF3197.  Purified EF3197 (80 pmoles or 5.3 
µM) was incubated in the presence of 50 mM Tris-HCl pH 7.6, 10 mM MgCl2 and 50 
mM KCl and in the presence and absence of candidate signals for 20 minutes in a final 
reaction volume of 15 µl.  Reactions waere initiated and were allowed to proceed for 15 
minutes (Section 2.5.5.3).  Autoradiographic film (top) and graphical representation 
(bottom) of phosphorylated EF3197.  Control (no signal added).  
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5.2.7. Changes in redox potential affect EF3197 autophosphorylation 
 
 To determine whether reducing agents exert any effect on the 
autophosphorylation activity of EF3197, assays were prepared using 80 pmoles of 
purified EF3197 (5.3 µM) per 15 µl reaction in the presence of a range of reducing 
agent concentrations (Section 2.5.5.3).  Initiation of reactions was through addition of 
ATP.  The results indicated that the proportion of EF3197-P was increased by 21% in 
the presence of 1 mM DTT; and with further increases in DTT concentrations (5 – 20 
mM), a gradual decline in the proportion of EF3197-P was observed (Figure 5.17).  
When DTT concentration was increased to 50 mM, the proportion of EF3197-P was 
greatly reduced to 12% of the maximum (Figure 5.17).  Further increase in DTT 
concentrations, 75 and 100 mM, showed little further effect on the proportion of 
EF3197-P (Figure 5.17).   
 
Figure 5.17 Effect of reducing agents on autophosphorylation activity of EF3197 in 
vitro.  DTT or sodium dithionite (0 – 100 mM) with 80 pmoles (5.3 µM) purified 
EF3197 were added to a final reaction volume of 15 µl.  Reactions were initiated and 
were allowed to proceed for 40 minutes (Section 2.5.5.3).  Autoradiographic film (top) 
and graphical representation (bottom) of phosphorylated EF3197. 
0     1     5   10   20   50   75  100 
DTT concentrations (mM) 
sodium dithionite 
concentrations (mM) 
Size 
(kDa) 
 
250 
150 
100 
75 
 
50 
 
37 
 
 
25 
 
20 
 
0     1     5   10   20   50   75  100 
Size 
(kDa) 
 
250 
150 
100 
75 
 
50 
 
37 
 
 
25 
 
20 
 
0 1 5 10 20 50 75 100
0
50000
100000
150000
200000
DTT concentrations (mM)
E
F
3
1
9
7
-P
 (
p
ix
e
l 
c
o
u
n
t)
0 1 5 10 20 50 75 100
0
20000
40000
60000
Na dithionite concentration (mM)
E
F
3
1
9
7
-P
 (
p
ix
e
l 
c
o
u
n
t)
 178 
A similar effect was observed using an alternative reducing agent, sodium 
dithionite.  Increasing concentrations of dithionite caused a decrease in levels of 
EF3197-P (Figure 5.17).  The proportion of EF3197-P was maximal in the absence of 
sodium dithionite (0 mM), and the greatest change was observed in the presence of 
between 10 and 20 mM sodium dithionite, which decreased levels from 85% to 40% of 
maximum respectively (Figure 5.17).  Between 50 and 100 mM sodium dithionite, the 
proportion of EF3197-P was lowest, 21 – 34% of the maximum EF3197-P (Figure 5.17). 
 
5.2.8. Discussion: towards identification of a signalling ligand for EF3197 
 
Prior to this study, the function of EF3197 was unknown, and therefore my in 
silico analyses, such as topology prediction and searches for putative domains, found 
that the two-component system EF3197-EF3196 is highly similar to the LytSR of S. 
aureus; the histidine kinase EF3197 possess 55% identity to LytS (Brunskill & Bayles, 
1996a; Hancock & Perego, 2002), suggesting a possible role for the enterococcal 
system in cell wall integrity, mediated through the lrgAB operon that regulates murein 
hydrolase activity of the cells.  However, Hancock and Perego found no change in 
autolysis rates in a mutant of response regulator EF3196, and therefore the role was 
unconfirmed, but alterations in uptake of antibiotics such as erythromycin were 
observed in the mutant, suggesting some involvement in cell wall-related permeability 
function (Hancock & Perego, 2004b). 
Recently, the LytSR system of B. anthracis was identified and it was shown to 
have an important role in the control of cell death and lysis, as for the LytSR system in 
S. aureus, and to positively regulate lrgAB expression.  Transcription of lrgAB was 
induced by dissipation of the proton motive force in a lytSR-dependent manner 
(Chandramohan et al., 2009).  The enterococcal two-component system EF3197-
EF3196 which is highly identical to these systems (Appendix 9) is therefore likely to 
have the same important function. 
Successful production of active EF3197 (Figure 5.2 and 5.4) allowed 
investigation of the signal for this protein.  The candidate signals tested showed effects 
on the phosphorylation of EF3197 (Figure 5.16) and these need to be further 
investigated in future studies; for example, a range of concentrations of the candidate 
signal should be tested to determine the extent of any effect on EF3197 phosphorylation.  
Here, EF3197 was shown not to respond to increasing concentrations of penicillin (0 – 
10 mM) (Figure 5.15).  Perhaps penicillin has an indirect effect.  Penicillin is known to 
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bind to the DD-transpeptidase that links peptidoglycan molecules, thereby weakening 
the cell wall via the peptidoglycan layer (Yocum et al., 1979), which may in turn induce 
phosphorylation of EF3197 that activates the anti-holin like protein and murein 
hydrolase regulator and therefore prevents cell lysis, and leads to penicillin tolerance.  
The penicillin test should therefore be repeated with EF3197 bound in the inner 
membrane. 
A reducing environment generated by DTT or sodium dithionite, in vitro, caused 
a decreased in the proportion of phosphorylated protein (Figure 5.17), suggesting a role 
of EF3197 in redox-sensing. 
A sequence alignment of EF3197 with LytS of S. aureus and Bacillus species 
showed the presence of two conserved cysteine residues in a putative GAF domain 
(Appendix 9).  Cysteine residues play important roles in the biochemistry of many 
proteins because of their redox properties, and ability to coordinate metal ions.  
Cysteine is therefore a common amino acid involved in forming key catalytic 
components of enzymes (Barford, 2004).  In the past decade, cysteines have been 
recognised in reversible thiol modifications in response to reactive oxygen or nitrogen 
oxide species, as well as having important roles in gene transcription, metabolism and 
signal transduction cascades in both prokaryotic and eukaryotic cells (Paget & Buttner, 
2003; Brandes et al., 2009).  Some bacterial histidine kinases, RegB and ArcB, were 
also found to have redox-active cysteine residues involved in regulating the 
environmental redox potential (Swem et al., 2003; Malpica et al., 2004).  It appears that 
redox-active cysteines are widespread in bacteria, for example the electron transporter, 
DsbD (Katzen & Beckwith, 2003), and the thioredoxin-like protein, CcmG (Edeling et 
al., 2004), both possess redox-active cysteine centres that play an important role in their 
function. 
The nature of the signal that modulates activity of EF3197 was not identified 
further due to the time constraints of this study but there are further tests which could be 
performed and are mentioned below.  As EF3197 was shown to respond to reducing 
agents, DTT and sodium dithionite (Figure 3.13), the conserved cysteine residues could 
play a role in regulation of protein activity.  Additionally, to test whether EF3197 is a 
true redox-sensing protein, further tests such as use of hydrogen peroxide to determine 
whether the reaction is reversible in the presence of oxidising agents, and mutation of 
the cysteine residues will be important for determining how these residues contribute to 
its function.  Since DTT, a metal chelating agent, had a greater effect on 
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phosphorylation of EF3197 than sodium dithionite, this might suggest metal is a 
cofactor for redox control in vitro, and therefore should be tested for metal dependence; 
for example, effects of Cu
2+
 and Fe
2+
 on the protein. 
Bacteria are able to employ various mechanisms to sense redox and oxygen 
(Bauer et al., 1999; Green & Paget, 2004).  The conserved cysteine residues of the LytS 
proteins (Appendix 9) could have important roles in redox-sensing or otherwise could 
be involved in oligomerisation of the protein into the active or inactive form, just like 
the global regulator RegB of R. capsulatus, which under oxidising conditions resulted in 
formation of a metal-dependent intermolecular disulphide bond that converted the 
kinase from an active dimer to an inactive tetramer state (Swem et al., 2003).  Most 
histidine kinases have only two transmembrane helices (Stock et al., 1989), but analysis 
of the amino acid sequence of LytS revealed six potential transmembrane domains 
(Figure 5.10).  These multiple domains could be ideally suited for sensing a membrane-
associated signal such as ΔΨ.  Therefore, the effects of ΔΨ-dissipating agents such as 
valinomycin (Ahmed & Booth, 1983; Rose & Jenkins, 2007) on membrane expressed 
EF3197 activity could also be tested, as well as producing truncated forms of EF3197 to 
determine the position of the sensing domain. 
EF3197 might respond to signals of cell energy status.  Another redox sensor, 
RegB of R. capsulatus, was shown to respond to oxidised ubiquinone resulting in 
decreased phosphorylation activity (Swen et al., 2006).  Sensor histidine kinase PrrB of 
R. sphaeroides, which also responds to DTT (Potter et al., 2006) is known to be 
connected to electron flow through the terminal cbb3-type cytochrome c oxidiase of the 
electron transport chain (Oh & Kaplan et al., 2000).  Both these redox sensors appear to 
have connection with components of the respiratory systems.  Thus, it is possible that 
EF3197 also senses such signals, or alternatively the energy status of the cell, and its 
phosphorylation activity in turn regulates of the lrg genes thereby contributing to a role 
in cell lysis or survival. 
GAF and PAS domains are ubiquitous cytoplasmic signalling units in 
prokaryotic and eukaryotic organisms (Martinez et al., 2002; Galperin, 2004), and are 
capable of binding small molecules, such as flavin, adenine and guanine, and heme as 
well as detecting changes in redox and light (Zhulin et al., 1997; Sardiwal et al., 2005; 
Ioanoviciu et al., 2007; Sousa et al., 2007).  These domains are unrelated in amino acid 
sequence, but share similarities in their structural topologies (Ho et al., 2000).  The role 
of the conserved cysteine residues found in the putative GAF domain of EF3197 (Figure 
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5.8 and Appendix 9) needs to be investigated further.  Some sensory kinases, such as 
DosT and DevS of Mycobacterium tuberculosis, involved in direct and specific oxygen 
sensing, contain two GAF domains, one of which has a heme prosthetic group and 
binding of oxygen leads to inhibited kinases activity (Sousa et al., 2007; Podust et al., 
2008).  Therefore, it is possible that the highly conserved GAF domain in the LytS 
proteins could have an important role in signal sensing, especially the conserved 
cysteine residues that is positioned in the GAF domain. 
The exact molecular mechanism of the lrg  and cid-regulated pathways remains 
unclear, but it is presumed that when the cell is under stress, for example the presence 
of antibiotics, holin is postulated to oligomerise within the bacterial membrane, creating 
lesions that disrupt the proton motive force, which then cause loss in cell viability.  
These lesions create a path for the murein hydrolases to access cell wall substrates, or 
perhaps even cause the release of eDNA for biofilm formation.  In unstressed respiring 
cells, antiholin binds to holin and prevents break down of the cell wall, whilst 
constitutive activity of holin gives rise to cell wall metabolism necessary for cell growth 
and renewal. 
A model of lrg- and cid- regulated cell wall metabolism, which summarises 
material in the literature, is presented in Figure 5.18.  The cysteine residues are also 
shown.  A decrease in membrane potential, proton motive force or changes in redox 
potential (oxidising conditions) is sensed by histidine kinase LytS, which then 
undergoes a phosphorylation cascade leading to transcription of the lrg genes that 
encode anti-holin and murein hydrolase regulatory proteins, and resulting in prevention 
of cell lysis (Rice & Bayles, 2008).  Alternatively, glucose metabolism in the cell leads 
to accumulation of acetate, causing activation of CidR (Patton et al., 2006).  Activated 
CidR binds to the cidABC and lrgAB promoters and increases the transcription of these 
operons.  The cid operon encodes for holin and a murein hydrolase regulatory protein 
that induce cell wall metabolism. 
Overall, the results of this work provide an insight into signals that affect 
autophosphorylation of EF3197 in vitro, and highlights the potential roles of the 
conserved cysteine residues amongst LytS homologues.  Continued studies of the 
histidine kinase EF3197, together with LytS of other bacteria, including signal testing 
could provide further details on the nature of signals sensed by these proteins.  
Alongside this, crystallisation studies could be performed to elucidate the structure, to 
provide additional information relating to structure and function. 
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Figure 5.18 A model of the lrg- and cid- regulated cell wall metabolism.  The cid 
genes encode for effectors of murein hydrolase activity and cell lysis, and the lrg genes 
encode for proteins that inhibit the process. 
 
 
5.3. Structural studies: crystallisation trials of histidine kinase EF1051 
 
5.3.1. Introduction 
 
5.3.1.1. A similarity search of histidine kinase EF1051 (EtaS).  A similarity search of 
histidine kinase EF1051 using FASTA3 (Pearson, 2000) indicates this protein is most 
similar to putative sensory proteins of the enterococcal species, sharing 69.7 – 100% 
identity and 90.4 – 100% similarity, suggesting that this protein is highly conserved 
within the enterococcal species.  Next, EF1051 is most similar to proteins of the 
Lactobacillus and Streptococcus species, having 35.8 – 46.6% identity and 71.7 –    
79.8% similarity.  The enterococcal EF1051 shows strong similarity to the LisK of 
Listeria monocytogenes (41.4% identity and 72.2 % similarity) (Cotter et al., 1999), 
CsrS of S. agalactiae (35.8% identity and 71.7%) (Lamy et al., 2004), CsrS of S. 
pyrogenes (35.7% identity and 71.1% similarity) (Levin & Wessels, 1998; Federle et al., 
1999) and ArlS of S. aureus (32.1% identity and 70.7% similarity) and these proteins 
are involved in virulence (see below).   
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An alignment of these proteins with EF1051 (Appendix 10) showed highly 
conserved residues in the phosphorylatable histidine kinase region and in the most of 
the cytoplasmic domain, whereas the transmembrane and periplasmic region are more 
variable (Appendix 10).  Construction of a phylogenetic tree reveals that EF1051 
clusters most closely to the LisK of L. monocytogenes (Figure 5.19), and SMART 
analysis of these proteins suggests that the size and position of the domains are highly 
similar (Figure 5.20).  All proteins have two putative transmembrane regions, a HAMP 
(histidine kinases, adenylyl cyclises, methyl binding proteins, phosphatases) domain, a 
HisKA (phosphoacceptor) domain, and a histidine kinase-like ATPase domain (Figure 
5.20). 
The LisRK system of L. monocytogenes plays a significant role in the virulence 
potential of this food-borne pathogen.  In addition to the contribution of this system in 
the tolerance of ethanol, pH, hydrogen peroxide stresses and osmolarity (Cotter et al., 
1999; Kallipolitis et al., 2001; Sleator & Hill, 2005), LisRK was shown to be involved 
in the ability of the cell to tolerate antimicrobial agents used in food and in medicine, 
such as lantibiotic nisin and the cephalosporin family of antibiotics (Cotter et al., 2002).  
It was also demonstrated, using a mouse model, that a deletion in the LisK histidine 
kinase component resulted in a 10-fold reduction in virulence compared to the parent 
wild-type strain (Cotter et al., 1999), confirming the importance of the LisRK system in 
listerial virulence. 
 
 
 
Figure 5.19 Phylogentic tree of EF1051, LisK, CsrS and ArlS.  The phylogenetic tree 
was created by Geneious Pro 4.6.5 software using amino acid sequences of EF1051, 
LisK, CsrS and ArlS.  EF1051 (histidine kinase of E. faecalis); LisK (LisK of L. 
monocytogenes), SAG_CsrS (CsrS of Streptococcus agalactiae), SP_CsrC (CsrC of S. 
pyogenes), ArlS (ArlS of S. aureus). 
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Figure 5.20 Domain analysis of EF1051 and its homologues.  The figure is based on 
the graphical output of the SMART web-based tool (Schultz et al., 1998; Letunic et al., 
2008).  The scale bar is in amino acids.  Blue vertical bars represent putative 
transmembrane segments ( ).  Green horizontal bar represents coil regions ( ).  Sizes 
and positions of conserved domains are indicated by the labeled symbols.  LisK (LisK 
of L. monocytogenes), SAG_CsrS (CsrS of Streptococcus agalactiae), SP_CsrC (CsrC 
of S. pyogenes), ArlS (ArlS of S. aureus). 
 
The CsrRS system was found to regulate hyaluronic acid capsule synthesis in 
group A Streptococcus (Levin & Wessels, 1998), and is therefore also considered to be 
a virulence factor.  An in-frame deletion mutation within response regulator csrR, 
resulted in sixfold increase in capsule production, producing mucoid colonies, and a 
corresponding increase in transcription of the has operon, which contains the essential 
genes for hyaluronic acid synthesis, and indicated that CsrR as a negative regulator of 
hyaluronic acid capsule synthesis and virulence (Levin & Wessel, 1998). 
 
5.3.1.2. The EF1051-EF1050 system of E. faecalis.  Using both a mouse peritonitis 
model and peritoneal macrophages, the EF1051-EF1050 system (Figure 5.21) has been 
shown to be involved in the stress response and virulence of E. faecalis and was named 
EtaSR (Teng et al., 2002; Muller et al., 2008).  An etaR (EF1050) disruption mutant 
was shown to be more sensitive to low pH than the parent strain, OG1RF, during 
logarithmic growth, similar to the phenotype of the lisK deletion mutant (Cotter et al., 
1999), and it also exhibited altered tolerance to high temperature (Teng et al., 2002).  In 
1 100 200 
EF1051 HisKA HAMP HATPase_c 
LisK HisKA HAMP HATPase_c 
SAG_CsrS HisKA HAMP HATPase_c 
SP_CsrS HisKA HAMP HATPase_c 
HisKA  HAMP HATPase_c ArlS 
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common with the homologous CsrRS system, the EF1051-EF1050 system may also 
negatively regulate capsule synthesis, since an E. faecalis etaR mutant, when recovered 
from the mouse spleen, was mucoid on plates, while the wild-type OG1RF was 
nonmucoid (Levin & Wessels, 1998; Federle et al., 1999; Heath et al., 1999; Miller et 
al., 2001; Teng et al., 2002).  This phenotype was only observed once and disappeared 
quickly in vitro, suggesting that some specific conditions in vivo may trigger the 
phenotype.   
The histidine kinase EF1051 gene is located downstream of the gene encoding 
the putative response regulator EF1050.  Located upstream is an open reading frame 
encoding a possible 6-phosphogluconate dehydrogenase (EF1049) which is transcribed 
in the same orientation (Figure 5.21).  Interestingly, upstream of listerial lisR there is 
also an open reading frame encoding a 6-phosphogluconate homolog, suggesting that 
lisRK and EF1051-EF1050 have similar gene organisation at their loci and that the 
dehydrogenase is linked in some way to the role of the two-component system.  EF1051 
of E. faecalis is classified as a group IIIA kinase based on the conservation of amino 
acids surrounding the phosphorylatable histidine residue (Fabret et al., 1999), having 
two putative transmembrane helices and a long periplasmic loop (Figure 5.22).  Like 
most histidine kinases, there is a large cytoplasmic domain in the C-terminus consisting 
of the catalytic domain (Figure 5.22).  Surprisingly, there are no cysteine residues in 
EF1051 (Figure 5.22), suggesting that this protein is not capable of forming disulphide 
bridges.   
 
 
Figure 5.21 Map of the EF1051-EF1050 two-component regulatory system in E. 
faecalis.  The green arrow represents a gene ( ), and the number below corresponds 
to the genome position of the gene.  This diagram is drawn based on the genome map in 
KEGG database (Kanehisa, 2002). 
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Figure 5.22 Topology model of E. faecalis histidine kinase EF1051.  Topology 
prediction by TMHMM (Krogh et al., 2001).  The predicted helices are numbered from 
the N- to C-terminus and are shown in roman numerals.  The phosphorylatable histidine 
is highlighted in yellow.  Conserved residues are highlighted in grey and black 
according to the alignment in Appendix 10. 
 
Membrane proteins are generally difficult to crystallise due to their hydrophobic 
nature.  Detergents are needed for their extraction from the membrane, and once 
extracted, certain conditions are needed to keep the protein from forming aggregates.  
Increased contact points on proteins will enhance interaction and stacking of the protein 
in crystal formation.  EF1051, with only two transmembrane helices, and a large 
periplasmic and cytoplasmic domain therefore may be considered to constitute a 
promising protein for crystallisation success. 
This section describes the preparation of the EF1051 protein for crystallisation 
trials; including testing the activity, integrity, purity and monodispersity of the purified 
protein. 
 
5.3.2. Cloning, expression and purification of EF1051 
  
The EF1051 gene of E. faecalis V583 was successfully amplified and cloned 
into plasmid pTTQ18-His6, followed by expression trials (Section 5.1.2).  EF1051 was 
expressed to 16% of E. coli membrane proteins and migrates at 50 kDa in SDS-PAGE 
gels (Table 5.1 and Figure 5.1).  To increase the expression of this protein, E. coli 
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BL21(DE3) cells transformed with pTTQ18(EF1051)-His6 were cultured and trials were 
performed to optimise expression conditions.  Expression in different growth media and 
using different the IPTG concentrations were trialled and the results are summarised in 
Table 5.1.  Growth of IPTG-induced cells transformed with pTTQ18(EF1051)-His6 was 
most rapid in 2TY medium, then in LB medium and finally in the minimal M9 medium, 
attaining absorbances (at 680 nm) of 2.464, 1.735 and 1.677 respectively at the time of 
harvesting.  Scanning densitometry of protein gels revealed that EF1051 constituted 13, 
18 and 12% respectively, of total E. coli membrane proteins (Figure 5.23 and 5.24), and 
therefore that some minor improvement over the 16% obtained initially were achieved.  
Although the overall cell density attained was highest when cells were grown in 2TY 
medium, expression of EF1051 was shown to be highest in LB medium, and taking into 
account the cost effectiveness of the medium, LB was therefore used for subsequent 
optimisation tests.  
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Figure 5.23 Growth of E. coli BL21(DE3) cells transformed with 
pTTQ18(EF1051)-His6 in LB, 2TY and minimal media.  E. coli BL21(DE3) cells 
transformed with pTTQ18(EF1051)-His6 were grown at 37
o
C in LB, 2TY or minimal 
media supplemented with 20 mM glycerol.  When the absorbance (at 680 nm) of 
cultures reached 0.4-0.6, cells were induced with 0.5 mM IPTG and harvested 3 hours 
post-induction. 
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Figure 5.24 Expression of E. coli BL21(DE3) cells transformed with 
pTTQ18(EF1051)-His6.  BL21(DE3) cells transformed with pTTQ18(EF1051)-His6 
were grown in LB, 2TY or minimal media supplemented with 20 mM glycerol. Cells 
were induced with 0.5 mM IPTG when A680nm reached 0.4 – 0.6 and harvested 3 hours 
post-induction.  Total E. coli membranes were prepared and proteins analysed by SDS-
PAGE. M (marker), U (uninduced) and I (induced). Arrow indicates position of EF1051. 
 
 Addition of 0.10 – 1.00 mM IPTG to the cultures attenuated cell growth of 
BL21(DE3) transformed with pTTQ18(EF1051)-His6 (Figure 5.25). Scanning 
densitometry indicated that induction with 0.5 mM IPTG was optimal for expression of 
EF1051 under the test conditions (Figure 5.25).  The cells were still in the exponential 
phase of growth at time of harvesting, therefore longer induction times should be tested 
to obtain more cells expressing the EF1051 protein. 
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Figure 5.25 Growth and expression of E. faecalis EF1051 using a range of IPTG 
concentrations in LB medium. E. coli BL21(DE3) pTTQ18(EF1051)-His6 cells were 
cultured at 37
o
C in LB in the presence of 100 μg/ml carbenicillin and 20 mM glycerol, 
and samples were induced with a range of IPTG concentrations (0 – 1 mM) when A680nm 
reached 0.4 – 0.6, and harvested 3 hours post-induction. (A) Growth curves. Total 
membranes were prepared from the harvested cells and analysed by (B) SDS-PAGE. 
Arrow indicates position of EF1051. 
 
 A six litre culture of E. coli BL21(DE3) cells expressing His6-tagged EF1051 
was grown aerobically at 37
o
C (Section 2.4.1).  Harvested cells were lysed by explosive 
decompression and membranes separated on sucrose density gradients (Section 2.5.1).  
The proteins of the membrane fractions obtained were analysed by SDS-PAGE.  The 
results showed that the EF1051 protein was enriched in the inner membrane fraction 
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(Figure 5.26).  EF1051 is present at approximately 18, 10 and <3% in the prepared inner, 
mixed and outer membranes, respectively (Figure 5.26). 
The inner membranes expressing EF1051 were subjected to solubilisation trials 
(Section 2.5.2).  The percentage of solubilised EF1051 was determined by calculating 
the intensities of EF1051 on the SDS-PAGE, in the inner membrane and in the soluble 
fractions, and representing the value for solubilised protein as the percentage of the total 
membrane proteins.  All detergents tested were successful for solubilising 56 – 95% of 
EF1051, and n-octyl pentaoxy-ethylene, DDM and HECAMEG were the most effective 
(Figure 5.27). 
 
Figure 5.26 SDS-PAGE and Western blot of membrane fractions of E. coli 
BL21(DE3) cells expressing EF1051. Total E. coli membranes were prepared from E. 
coli BL21(DE3) pTTQ18(EF1051)-His6 grown on LB medium containing 20 mM 
glycerol and 100 μg/ml carbenicillin in the presence of 0.5 mM IPTG and harvested 3 
hours post-induction. The membranes were separated on 25-55% sucrose gradients 
(Section 2.5.1) and membrane fractions extracted from the gradients were analysed by 
SDS-PAGE and Western blotting. The arrow indicates position of EF1051. 
 
Inner membranes expressing EF1051 were therefore solubilised in 1% (w/v) 
DDM and purification of His6-tagged EF1051 was performed by Ni-NTA affinity 
chromatography (Section 2.5.3.2).  Fractions from the purification were analysed by 
SDS-PAGE, which revealed that the majority of the protein was successfully solubilised 
by DDM (solubilised fraction) and successfully bound to the Ni-NTA resin (Figure 
5.28).  EF1051 was purified to >90% purity, as determined by scanning densitometry, 
and was shown to migrate at a position corresponding to ~50 kDa on SDS-PAGE gels 
(Figure 5.28). 
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Figure 5.27 SDS-PAGE of total and solubilised inner membranes of E. coli 
BL21(DE3) cells expressing EF1051.  Total E. coli inner membranes transformed with 
pTTQ18(EF1051)-His6 were tested for solubilisation in nine detergents.  Membranes 
were solubilised in 1% detergent for 1 hour and subjected to centrifugation to remove 
the insoluble fraction (Section 2.5.2).  Total inner membranes (T) and soluble fractions 
(S) were then analysed by SDS-PAGE.  Protein molecular weight markers (M).  Arrow 
indicates position of EF1051. 
 
Figure 5.28 SDS-PAGE and Western blot of fractions from purification of E. 
faecalis EF1051. EF1051 was purified from inner membrane of E. coli BL21(DE3) 
cells transformed with pTTQ18(EF1051)-His6. The inner membranes were solubilised 
in 1% DDM. Fractions (15 μg), and eluted fraction (5 μg) were analysed by SDS-PAGE. 
The panel on the right is a Western blot of the purified protein. 
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5.3.3. Size exclusion chromatography of EF1051 
 
 To check the monodispersity of purified EF1051, the eluted protein was buffer-
exchanged into FPLC buffer, followed by size exclusion chromatography to separate 
the proteins on basis of size (Section 2.5.3.3).  The protein was shown to elute in two 
separate elution volumes, indicated by the two symmetrical peaks in the chromatogram 
(Figure 5.29).  The majority of proteins were eluted in the first volume of higher 
molecular weight (~617 kDa) material and this fraction could constitute aggregates of 
EF1051.  The second volume of lower molecular weight species (~123 kDa) may 
comprise dimers of EF1051 (Figure 5.29).   
 
Figure 5.29 Size exclusion chromatography of purified EF1051.  The His6-tagged 
EF1051 protein purified by Ni-NTA was buffered exchanged into FPLC buffer (25 mM 
Tris-HCl pH8.0, 100 mM NaCl, 5% glycerol and 0.05% DDM) prior to gel filtration by 
size exclusion chromatography (Section 2.5.3.3).   EF1051 (10 mg) was loaded onto the 
S-200 column equilibrated and eluted in FPLC buffer.  Chromatogram of separation of 
purified EF1051 (top).  Proteins and detected by UV absorbance (280 nm) were analysis 
by SDS-PAGE (bottom) – analysed fractions are indicated by the red line on 
chromatogram.  Protein molecular weight marker (M).  The arrow indicates position of 
EF1051 on the SDS-PAGE gel. 
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The molecular weights of the eluted volumes were determined by the calibration 
curve shown in Figure 5.30.  Analysis by SDS-PAGE revealed that the EF1051 protein 
(~50 kDa) in the first peak contained many contaminants, and that the second peak 
showed highly pure EF1051 proteins (Figure 5.29).  A very faint band (~32 kDa) on 
SDS-PAGE is also co-eluted with the pure protein and could indicate possible 
degradation of the protein (Figure 5.29).  The fractions containing the pure proteins was 
concentrated and subjected to crystallisation trials.  The results are shown in Section 
5.3.6. 
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Figure 5.30 Calibration of the S200 column.  The graph was constructed using protein 
standards (blue dectran, void volume; tryglobulin, 669 kDa; apofemitin, 443 kDa; β-
amilase, 200 kDa; alcohol dehydrogenase, 150 kDa ; albumin, 76.5 kDa).  Red crosses 
indicate the positions of the elution volumes of monodispersed EF1051 proteins. 
 
5.3.4. Autophosphorylation activities of EF1051 
 
 Different kinetics were observed for the autophosphorylation of EF1051 bound 
in inner membranes and its purified form (Section 5.1).  In the inner membrane, EF1051 
exhibited rapid autophosphorylation initially, followed by rapid desphosphorylation 
after 1 minute, and a steady level being reached after 15 minutes and to the end of the 
reaction (Figure 5.2).  In the purified form, EF1051 showed slower rates of 
phosphorylation and maximum phosphorylation was not reached within the sixty 
minute time-course (Figure 5.4).  The rapid dephosphorylation of EF1051 observed 
when the protein is membrane-bound may occur as a result of the activities of E. coli 
× 
× 
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phosphatases present, or it could arise as an intrinsic property of the protein in this 
environment. 
 Prior to obtaining active EF1051 as described in the previous section and as 
shown in Figure 5.2 and 5.4, initial attempts to produce active protein were 
unsuccessful.  However, when DDM was excluded from all post-solubilisation buffers 
during protein purification steps, then active protein resulted.  The exclusion of 
detergent at key stages in the protein purification process was routinely adopted for the 
histidine kinases following initial observations that this was a requirement for 
purification of active VicK (Phillips-Jones, personal communication).  Therefore, in the 
subsequent purifications of EF1051, DDM was not added to the protein post-
solubilisation, and two buffers were tested, including Tris and HEPES.  The result gave 
rise to active proteins, though the protein in Tris buffer appears to be less active and 
partially degraded (Figure 5.31). 
 
Figure 5.31 Effect of buffer composition and detergent on autophosphorylation 
activities of purified EF1051.  EF1051 purified with DDM (+DDM) or without DDM 
(-DDM) addition post-solubilisation was buffer-exchanged into storage buffer (Section 
2.5.5.2).  The protein (160 pmoles) was then added to reaction buffer containing 10 mM 
Tris-HCl or HEPES-Na pH7.6 in a final reaction volume of 30 µl and 
autophosphorylation initiated using radiolabelled ATP (Section 2.5.5.2).  Samples 
volumes (15µl) were removed at the time points indicated.  The autoradiographic film is 
shown.  The arrows indicate position of the phosphorylated EF1051 protein. 
 
5.3.5. Mass spectrometry and circular dichroism spectroscopy studies of purified 
EF1051 
 
 Mass spectrometry (Section 2.6.2) was performed to confirm that the purified 
EF1051 protein was intact.   The results are shown in Figure 5.32, and these indicate 
that the measured mass of the protein was 60189 Da.  This represents a mass difference 
of 32 Da compared to the calculated mass of 60157 Da (Figure 5.32).   
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Figure 5.32 Electrospray ionisation mass spectrometry of EF1051.  Purified protein 
(5 mg/ml) in 10 mM HEPES pH 7.9 and 5% glycerol was prepared as described in 
Section 2.6.2.  Mass spectrometry analysis was performed by Miss Lynsey Jones. 
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This indicates possible N-terminal formylation of the protein, since formic acid was 
added to dissolve the protein prior to size exclusion chromatography for mass 
spectrometry (Section 2.6.2).  Thus, it was concluded that the protein is intact.  The 
other three peaks in the maximum entropy mass profile, of sizes 30094.1, 20062.8 and 
15046.6, which are 1/2, 1/3 and 1/4 of the main peak are artefacts from the maximum 
entropy algorithm (Figure 5.32). 
The secondary structure integrity of purified EF1051 was examined by circular 
dichroism spectroscopy (Section 2.6.1).  The negative indentation at 208 and 222 nm, 
and the positive signal at ~190 nm obtained in this study are indicative of α-helical 
content (Figure 5.33), suggesting that the protein is correctly folded. 
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Figure 5.33 Circular dichroism spectrum of purified EF1051.  Purified EF1051 
(0.05mg/ml) was buffer-exchanged into 10 mM potassium phosphate buffer pH 7.6 and 
0.05% DDM.  CD spectral analysis of EF1051 was performed using a Jasco J-715 
spectropolarimeter at 18
o
C with constant nitrogen flushing.  The sample was analysed in 
a Hellma quartz-glass cell of 1 mm path length.  The spectrum was recorded with 1 nm 
step resolution at a scan rate of 10 nm/min.  Response time was set at 1 second with a 
sensitivity of 20 mdeg and bandwidth of 1.0 nm.  The spectrum represents an 
accumulation of ten scans, from which the buffer contribution was subtracted.  The blue 
line represents the voltage applied to the photomultiplier. 
 
5.3.6. Crystallisation trials of EF1051 
 
 The pure homogeneous EF1051 protein prepared as described above (Section 
5.3.3) was subjected to crystallisation trials by the vapour diffusion method (Section 
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2.6.2).  Microscopic images of crystals obtained from the crystallisation trials were 
taken and are shown in Figure 5.34.    
 
Figure 5.34 Microscopic images of crystals from the crystallisation trials of EF1051.  
Purified homogeneous EF1051 proteins (~15mg/ml) were subjected to crystallisation 
trials by vapour diffusion (Section 2.6.6).  Each droplet (1 µl) consists of 0.5 µl protein 
and 0.5 µl screen buffer in each well of the 96 wells plate was monitored and visible 
images of conditions containing crystals were photographed.  Screen buffer conditions 
are shown below the image.  Bar represents 150 µm. 
 
Crystals of different shape and size were formed in the crystallisation trials 
(Figure 5.34).  There were large crystals (Images A, B and C), micro-crystals (Image D), 
thin needle clusters or sea urchins (Image E), 2D crystals (Image F), rhombus-shaped 
crystals (Image G), irregular crystals, (Image H) and rod crystals (Image I) (Figure 
5.34).  One of these conditions also gave rise to heavily precipitated proteins which is 
likely to be denatured proteins (Image B), and in some cases there was evidence of 
phase separation (Image E and H) (Figure 5.34).  Precipitation occurs in a state of 
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supersaturation and crystals can only grow from supersaturated states.  Phase separation 
(the tendency for detergent to separate from the aqueous solution) can inhibit crystal 
formation, due to high detergent concentrations (Newby et al., 2009). 
To determine whether the crystals grown obtained in these trials were composed 
of protein or salt, the larger sized crystals (Images A, B and C of Figure 5.34) were 
removed for further analysis.  They were firstly placed in the mother liquor (the buffer 
that the crystal was grown in) containing 10% glycerol, and flash frozen in liquid 
nitrogen.  The crystals were then subjected to x-rays at the Radiation Synchrotron (with 
the assistance from Dr Gerda Szakonyi).  The diffraction patterns obtained revealed that 
these crystals were composed of salts (Figure 5.34).  The remaining crystals (Images D 
– I of Figure 5.34) are yet to be tested. 
 
5.3.7. Discussion: structural studies of EF1051 
 
The EF1051 protein of E. faecalis is highly similar to the LisK, CsrS and ArlS 
of other bacteria (Section 5.3.1), and is involved in stress response and virulence of E. 
faecalis (Teng et al., 2002; Muller et al., 2008).  This work optimised the expression 
conditions for EF1051 in E. coli membranes and describes a successful purification 
method for the intact protein, and prepared the protein for subsequent crystallisation 
trials.  Purity, homogeneity and stability of membrane proteins, as well as individual 
properties, such as surface charge and isoelectric point of the protein, are the most 
important parameters for crystallisation.  It is therefore important to optimise the quality 
of the purified protein prior to crystallisation studies, and this often includes testing the 
purity of the protein, checking the CD spectrum of the protein to confirm that it has 
secondary structure, ensuring the mixture exists in solution as a single oligomeric 
species (monodispersity), e.g. monomer or dimer, and therefore ensuring that the 
protein is not degrading with time into a heterogeneous mixture. 
The EF1051 protein was firstly subjected to an in silico analysis to identify its 
putative function by a similarity search using FASTA3 (Pearson, 2000) for homologues 
with known functions (Section 5.3.1).  In agreement with previous reports, analysis here 
reveals the high similarity of the EF1051 protein with LisK of Listeria monocytogenes 
and with CsrS of Streptococcus agalactiae (Cotter et al., 1999; Lamy et al., 2004).   
Primary sequence analysis of EF1051 revealed an absence of cysteine residues, 
and prediction by TMHMM showed that it possess two predicted transmembrane 
segments and a large soluble periplasmic and cytoplasmic domain (Figure 5.20 and 
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5.22).   In this work, the EF1051 protein was overexpressed successfully in E. coli 
membranes and it was shown to retain activity in both inner membrane preparations as 
well as in its purified form (Section 5.1).  The expression of EF1051 was optimised 
using different media and a range of IPTG concentrations (Figure 5.23 to 5.25), and 
these optimised conditions were subsequently used for routine production of purified 
EF1051. 
In this study, choice of detergents for solubilisation of EF1051 from E. coli 
membranes was also examined.  All detergents screened showed successful 
solubilisation of EF1051 from inner membranes, suggesting that this protein is easily 
solubilised under these conditions.  Subsequent purification steps yielded protein 
purities of >90% (Figure 5.28).  Mass spectrometry and CD spectral data confirmed that 
purified EF1051 was intact and that its secondary structure was correctly folded (Figure 
5.32 and 5.33). 
The size exclusion chromatography of EF1051 produced two groups of 
monodispersed proteins, one of higher molecular weight which could be composed of 
aggregated proteins and the other of lower molecular weight that could be dimers of 
EF1051 (Figure 5.29).  Results indicated that most of the EF1051 protein was forming 
higher molecular weight complexes and that a small volume of pure homogeneous 
proteins was achieved.  The impure fraction could also be subjected to crystallisation 
trials, and some buffer optimisation might prove benefial for increased yields of pure 
homogenous protein.  The pure EF1051 homogeneous fractions were concentrated, and 
subjected to crystallisation trials (Section 5.3.6), which produced crystals of different 
shapes and sizes (Figure 5.34).  Three of the nine conditions tested produced crystals 
that were later confirmed as salt crystals, and the remaining are yet to be tested.  
Unfortunately, at the time these trials were set up (Feb 2007) there was no UV-
fluorescence microscope in the lab to test whether these crystals were protein or salt, 
and therefore the trial needs to be repeated in future crystallisation studies of this 
protein.  The UV-fluorescence microscopic technique is based on the UV-fluorescence 
of the amino acid tryptophan, which fluoresces at 360 nm when excited with UV-light 
at 280 nm, therefore easily distinguishing the protein crystal from salt (Judge et al., 
2005). 
  It was previously shown in an analysis of 9596 unique protein crystals, that 
there is a relationship between calculated pI and reported pH at which proteins were 
crystallised.  The analysis showed that proteins with calculated pIs of between 5 and 7 
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turn out to be the group exhibiting the highest frequency of crystallisation successes, 
and that most of the proteins crystallised at pHs between pH 7 and 8 (Kantardjieff & 
Rupp, 2004).  EF1051 has a calculated pI of 5.22 that lies in the range indicated, and 
could possibly indicate that this membrane protein stands a good chance of 
crystallisation.  However, it needs to be further tested. 
Monodispersed protein particles are the building blocks of stable crystal lattices.  
Membrane proteins that are hydrophobic in their nature tend to be subjected to non-
specific aggregation over time.  The irregular association of the protein particles in 
solution reduces the possibility of the regular association essential for crystal lattice 
formation.  In this case, the choice of detergent is one of the key factors to reduce 
formation of non-specific aggregates.  Large micelle-forming detergents such as DDM 
and C12E9 are more likely to stabilise membrane proteins in solution, but often prevent 
the protein-protein interactions necessary for crystal lattice formation due to the large 
size of the micelle (Keyes et al., 2003).  Smaller micelle-forming detergents, such as n-
octyl-β-D-glucoside and n-octyl-β-D-maltoside, allow more protein-protein interactions 
but could lead to undesirable aggregation of proteins (Keyes et al., 2003).  The DDM 
which was shown to be successful for solubilisation of most of the histidine kinases 
forms a large detergent micelle around the protein; but since it has a low critical micelle 
concentration (CMC), it enables buffer exchange of the protein into other detergents 
with smaller micelle-size that are more suitable for subsequent crystallisation trials. 
Not all types of detergents are suitable for solubilising membrane proteins, as 
they can inactivate the protein (Le Maire et al., 2000).  This study revealed that the 
presence of detergents in the post-solubilisation stages of protein purification did appear 
to be inhibitory to the activities of both EF1051 and EF2912, both of which possess just 
two transmembrane helices.  Other histidine kinases appear to be more resistant to the 
effects of detergent, including those with more transmembrane segments such as 
EF3197.  Transphosphorylation between monomers is required for activity of histidine 
kinases and therefore active kinases must occur as dimers both in vivo and in vitro.  
Thus it is possible that the inhibitory effects seen here and with other histidine kinases 
are attributable to an inhibition of the essential dimerisation events. 
Solving the structure of membrane proteins has always been hampered by their 
low expression level and therefore producing sufficient pure proteins for structural 
study is one of the main barriers.  This work has overcome one of the bottlenecks in 
structural study of membrane protein; highly pure milligrams quantity of 
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monodispersed EF1051 protein were obtained (Figure 5.28 and 5.29), which is 
sufficient for protein crystallisation studies.  The next barrier for determining the 
structure of EF1051 is crystallisation.  However, there are many more tests that could be 
perform to further test the stability of this protein, such as described in Postis et al. 
(2008).  After all, this study opened up more paths for further investigations, and there 
are more components, such as buffer, detergents and temperature, that could be tested to 
further improve the stability and homogeneity of this protein. 
 
5.4. Characterisation of signal interactions by the quorum sensor 
EF1820 (FsrC) 
 
5.4.1. Introduction  
 
5.4.1.1. Quorum sensing in bacteria.  Quorum sensing was discovered and described 
over thirty years ago in two bioluminescent marine bacterial species, Vibrio fischeri and 
Vibrio harveyi, one of which colonises the light organ of the Hawaiian Bobtail Squid 
Euprymna scolopes and the other is a free-living marine bacterium (Nealson & Hastings, 
1979).  Loss of luminescence was observed in these bacteria growing at low cell 
densities, and the enzymes responsible for light production; in both species, were found 
to be encoded by the luciferase structural operon luxCDABE (Engebrecht & Silverman, 
1984; Miyamoto et al., 1988).  The exchange of chemical signals between biological 
cells is a fundamental requirement for synchronisation of the activities of large groups 
of cells and was previously assumed to be a trait characteristic of eukaryotes.  It was 
only in the past two decades that cell-to-cell communication has been identified as of 
importance to bacterial cells and has become known as ‗quorum sensing‘.  Quorum 
sensing involves the production, release and detection of, and response to small 
hormone-like molecules termed autoinducers.  It is a process that allows the bacteria to 
monitor their environment for cell density and to alter gene expression within 
populations in response to changes in the number and/or species present in a community 
(Waters & Bassler, 2005).  Bacterial quorum sensing controls a wide variety of 
physiological activities such as symbiosis, virulence, competence, conjugation, 
antibiotic production, motility, sporulation, and biofilm formation (Magnuson et al., 
1994; Ji et al., 1995; Pestova et al., 1996; Swift et al., 1996; Gray, 1997; Hardman et al., 
1998; Hellingwerf et al., 1998; Miller & Bassler, 2001; Nakayama et al., 2001; Waters 
& Bassler, 2005). 
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5.4.1.2. Comparison of quorum sensing in Gram-negative and Gram-positive 
bacteria.  There are several notable similarities and differences in the quorum sensing 
systems of Gram-negative and Gram-positive bacteria.  The main similarity of course is 
the overall function of these systems amongst Gram-positive and Gram-negative 
bacteria regarding cell-cell communication, which is presumably a fundamental 
requirement of both bacterial groups.  The main difference is the nature of the signalling 
molecule.  Generally, Gram-negative bacteria use fatty acids derivatives, ‗acylated 
homoserine lactones‘ as autoinducers and many possess LuxIR-type proteins (Fuqua & 
Greenberg, 1998; Eberl, 1999; Parsek et al., 1999; Fuqua et al., 2001; Whitehead et al., 
2001; Manefield & Turner, 2002), whereas Gram-positive bacteria use oligopeptides 
termed ‗peptide pheromones‘ together with a two-component system to mediate quorum 
sensing (Nes et al., 1996; Dunny & Leonard, 1997; Kleerebezem et al., 1997; 
Podbiellski & Kreikemeyer, 2004; Shapakov, 2009). 
One of the first and best-studied quorum sensing systems in a Gram-negative 
bacterium includes the LuxIR circuit of V. fischeri (Figure 5.35).  There are five 
luciferase structural genes (luxCDABE) and two regulatory genes (luxR and luxI) 
involved in the control of light emission, and these genes are arranged in two adjacent 
but divergently transcribed units.  The LuxI protein synthesises the autoinducer, N-(3-
oxohexanoyl)-homoserine lactone, which increases in concentration both intracellularly 
and extracelluarly when the cell-population density increases.  This autoinducer is able 
to diffuse freely in and out of the cell, and when a critical concentration is reached, it 
binds to the LuxR protein forming the LuxR-autoinducer complex.  This complex acts 
on two promoter sites.  Binding to the luxICDABE promoter results in an exponential 
increase in autoinducer synthesis and light production, while binding to the luxR 
promoter represses the transcription of luxR which compensates for, and is in balance 
with the positive regulation of the luxICDABE promoter. 
In contrast to the widespread use of LuxR-type proteins as autoinducers in 
Gram-negative bacteria, Gram-positive bacteria employ peptide signals together with 
two-component signal transduction systems for detection of the peptide autoinducer 
(Hoch & Silhavy, 1995; Kleerebezem et al., 1997; Lazazzera & Grossman, 1998; 
Bassler, 1999; Podbielski & Kreikemeyer, 2004; Ng & Bassler, 2009).  For example, 
one of the best studied examples of a quorum sensing system in Gram-positive bacteria 
is the agr (accessory gene regulator) system in staphylococci (Dunman et al., 2001; 
Kornblum et al., 2003). 
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Figure 5.35 The LuxIR quorum sensing circuit in Gram-negative bacteria.  
Schematic diagram of a general model for ‗acylated homoserine lactone‘-mediated 
quorum sensing.  This LuxIR-type quorum sensing which is utilised by Gram-negative 
proteobacteria.  The regulon is not drawn to scale.  Diagram adapted from Miller & 
Bassler (2001). 
 
In pathogenic staphylococci, the agr system (Novick, 2003; Lyon & Novick, 
2004) is reported to have a critical role in biofilm formation (Vuong et al., 2000; 
Shompole, et al., 2003; Vuong et al., 2003).  The agr gene clusters are conserved 
throughout the genus Staphylococcus and they are divided into more than four types or 
specificity groups according to the mutual inhibition by the peptides of the agr response 
in heterologous pairs (Ji et al., 1997; Jarraud et al., 2000; Geisinger et al., 2008).  
Interestingly, the staphylococcal species have hypervariable regions in the agr locus and 
this probably gives rise to the different peptides sensed by these species (Dufour et al., 
2002).  The advance in genome sequencing projects led to the identification of agr-like 
systems in other pathogenic bacteria (Wuster & Babu, 2008), including the agr system 
of Listeria monocytogenes (Autret et al., 2003) and the fsr system in Enterococcus 
faecalis (Hancock & Perego, 2004a; Nakayama et al., 2001a; Nakayama et al., 2006), in 
which it was shown that these systems are important for virulence in these species.  In 
addition, agr-like systems are also present in non-pathogenic commensal organisms, 
such as the com system in Bacillus subtilis (Comella & Grossman, 2005), and the lam 
system in Lactobacillus plantarum (Kleerebezem et al., 2003; Sturme et al., 2005; Fujii 
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inner and outer 
membrane 
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- 
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+ 
LuxI 
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et al., 2008).  Recently, the lam system of L. plantarum, which naturally inhabits the 
human gastrointestinal tract (Ahrne et al., 1998), was shown to be involved in the 
regulation of adherence, cell morphology, cell viability, and biofilm formation (Storme 
et al., 2005; Fujii et al., 2008).  It appears that agr systems in bacteria are important for 
cell survival, biofilm formation and hence in virulence for many adherent pathogenic 
species. 
 
5.4.1.3. The Fsr quorum sensing pathway of E. faecalis.  The agr-like operon in E. 
faecalis is named fsr and comprises four genes (fsrA, fsrB, fsrD, and fsrC) together with 
the two virulence genes (gelE and sprE) (Figure 5.36) that are involved in biofilm 
formation (Hancock & Perego, 2004a; Pillai et al., 2004).  Mutants in fsr were shown to 
be less virulent in Caenorhabditis elegans killing, mouse peritonitis and rabbit 
endophthalmitis models (Qin et al., 2000; Mylonakis et al., 2002; Sifri et al., 2002), 
indicating the importance of the fsr system in enterococcal virulence. 
In common with the agr system of staphylococci, the fsr two-component system 
is involved in quorum sensing.  With increasing cell population density in E. faecalis, a 
peptide pheromone named ‗gelatinase biosynthesis-activating pheromone‘ (GBAP) 
consisting of eleven amino acids (Figure 5.43), is secreted from the cell by a putative 
dedicated GBAP transporter (FsrB).  The initially synthesised GBAP propeptide 
encoded by fsrD is inactive and presumably modifications such as processing and 
cyclisation are associated with secretion by FsrB that was found to function as a 
cysteine protease-like processing enzyme, to produce the active cyclic-GBAP peptide 
(Nakayama et al., 2001a; Nakayama et al., 2006).  A model depicting the mechanism of 
quorum sensing in enterococci is shown in Figure 5.36.  The histidine kinase FsrC 
detects the secreted GBAP peptide and undergoes autophosphorylation of a conserved 
histidine, followed by phosphotransfer to a conserved aspartate on its cognate response 
regulator FsrA.  Phosphorylated FsrA binds to the gelE-sprE and fsrBCD promoters and 
activates transcription of these genes (Su et al., 1991; Qin et al., 2000; Qin et al., 2001; 
Nakayama et al., 2001a; Nakayama et al., 2001b; Bourgogne et al., 2006).  The 
histidine kinase FsrC (previously referred to as EF1820 in Section 5.1) was therefore 
further studied in this project to initiate studies of the molecular details of FsrC-GBAP 
binding and to determine whether the in vitro approach developed by Potter et al. (2002) 
and Ma et al. (2008) is suitable for identifying signals of intact histidine kinases. 
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Figure 5.36 Quorum sensing regulation in enterococci.  Schematic diagram of a 
general model for peptide-mediated quorum sensing in enterococci is shown.  The 
regulon is not drawn to scale.  Diagram adapted from Podbielski & Kreikemeyer (2004), 
and Nakayama et al. (2006). 
 
5.4.2. The EF1820 protein (FsrC) of E. faecalis 
 
The FsrCA (EF1820-EF1822) proteins of E. faecalis belong to the Agr family of 
two-component regulatory systems according to the KEGG database (Kanehisa et al., 
2010).  The Agr family are characterised by possession of five to eight transmembrane 
segments in their N-terminal domain, connected to a C-terminal domain containing 
catalytic features of histidine kinases.  FsrC is grouped with the Agr kinases, and is 
predicted to possess seven putative transmembrane segments and a large soluble 
cytoplasmic catalytic domain (Figure 5.37).  The amino acid sequences of FsrC proteins 
are highly conserved amongst enterococcal species (25.6 – 100% identity).  Bacillus 
species exhibit less similarity with FsrC, for example Agr-like kinase BCE3043 
exhibited 25.8% identity and 68.2% similarity to FsrC, whilst AgrC of S. aureus 
exhibited 24.5% identity and 61.8% similarity.  An alignment of FsrC with some other 
Agr kinases (Appendix 11) reveal conserved leucine, isoleucine and valine residues in 
the N-terminal transmembrane domains, which could be involved in autoinducer 
binding, but otherwise the N-terminal/transmembrane regions are variable and this is 
perhaps consistent with the different autoinducers bound by these bacterial sensory 
proteins.  The cytoplasmic domain was also shown to be highly conserved around the 
phosphorylatable histidine region (Appendix 11). 
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Figure 5.37 Topology model of E. faecalis histidine kinase FsrC.  Topology 
prediction by TMHMM (Krogh et al., 2001).  The predicted transmembrane segments 
are numbered from the N- to C-terminus and are shown in roman numerals.  The 
phosphorylatable histidine is highlighted in yellow, and tryptophan in red.  Conserved 
residues are highlighted in grey and black according to the alignment in Appendix 11. 
 
 
 
 
Figure 5.38 Phylogenetic tree of FsrC and Agr family kinases.  The tree was created 
by Geneious Pro 4.6.5 software using amino acid sequences of FsrC (EF1820 of E. 
faecalis), BCE3043 (putative AgrC of B. cereus), BS_ComP (ComP of B. subtilis), 
LP_LamC (LamC of L. plantarum), LA_AgrC (AgrC of L. acidophilus), LM_AgrC 
(AgrC of L. monocytogenes), SA_AgrC (AgrC of S. aureus), SH_AgrC (AgrC of S. 
haemolyticus). 
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Construction of a phylogenetic tree reveals that the Agr kinase proteins of 
various bacteria do not cluster closely together, except for kinases derived from the 
same genus, e.g. S. aureus and S. haemolyticus, suggesting all Agr kinases are at least 
genus-specific, which is consistent with the different autoinducing peptides that they 
sense (Figure 5.38).  Analysis by SMART web-based tool showed that organisation of 
the predicted domains, including the transmembrane domains, amongst these Agr 
kinases is similar (Figure 5.39), though the number of transmembrane regions varies – 
FsrC has seven putative transmembrane segments compared to other Agr kinases which 
have six (Figure 5.39). 
 
 
 
Figure 5.39 Domain analysis of FsrC and its homologues.  The figure is based on the 
graphical output of the SMART web-based tool (Schultz et al., 1998; Letunic et al., 
2008).  The scale bar is in amino acids.  Blue vertical bars represent putative 
transmembrane segments ( ).  Green horizontal bar represents coil regions ( ).  Sizes 
and positions of conserved domains are indicated by the labelled symbols.  FsrC 
(EF1820 of E. faecalis); BCE3043 (putative AgrC of Bacillus cereus), SA_AgrC (AgrC 
of S. aureus), SH_AgrC (AgrC of S. haemolyticus), LM_AgrC (AgrC of L. 
monocytogenes), LP_LamC (LamC of L. plantarum). 
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5.4.3. Cloning, expression and purification of FsrC 
 
 The fsrC gene of E. faecalis V583 was amplified by PCR and cloned into 
plasmid pTTQ18-His6, followed by expression trials which revealed that the intact 
protein was successfully expressed to 3.5% of E. coli total membrane proteins (Table 
5.1 and Figure 5.1).  Six litre cultures of E. coli BL21(DE3) cells transformed with 
pTTQ18(FsrC)-His6 were prepared as described in Methods, the cells were harvested by 
centrifugation and lysed by explosive decompression.  The total membrane fraction was 
isolated by sucrose density gradients (Section 2.4.1 and 2.5.1) and analysed by SDS-
PAGE and Western blotting to reveal the presence of intact FsrC in the both inner and 
outer membrane fractions (Figure 5.40) (constituting approximately 4, 3 and 3% of 
inner, mixed and outer membrane protein fractions, respectively), indicating poor 
separation by the sucrose gradients for this protein and therefore perhaps an unessential 
step in the purification protocol.  The inner membranes were subjected to solubilisation 
trials (Section 2.5.2) which revealed that NN-dimethyloctylamine N-oxide was a poor 
detergent for solubilisation of FsrC (Figure 5.40).  Thus, it is possible that most of the 
protein was not successfully solubilised and therefore lost in the pellet during the 
centrifugation step.  DDM and LDAO were optimal for solubilising FsrC (Figure 5.41) 
and consequently DDM was used for subsequent purifications.   
 
Figure 5.40 SDS-PAGE and Western blot of membrane fractions of E. coli 
BL21(DE3) cells expressing FsrC.  Total E. coli membranes were prepared from E. 
coli BL21(DE3) pTTQ18(fsrC)-His6 grown on LB medium containing 20 mM glycerol 
and 100 µg/ml carbenicillin in the presence of 0.5 mM IPTG and harvested 3 hours 
post-induction.  Total membranes were separated on 25-55% sucrose gradients and 
membrane fractions were extracted from the gradients and analysed by SDS-PAGE and 
Western blotting.  The arrow indicates the position of FsrC (EF1820). 
Size 
(kDa) 
97 
66 
 
45 
 
 
 
30 
 
 
20 
 
14 
 
Marker   Inner   Mixed    Outer Marker   Inner    Mixed     Outer 
Size 
(kDa) 
 
66 
 
 
45 
 
36 
 
29 
24 
 
20 
 
14 
 
 209 
 
Figure 5.41 SDS-PAGE of total and solubilised inner membranes of E. coli 
BL21(DE3) cells expressing FsrC.  Total E. coli inner membranes transformed with 
pTTQ18(fsrC)-His6 were tested for solubilisation in ten detergents.  Membranes were 
solubilised in 1% (w/v) detergent for 1 hour and subjected to centrifugation to remove 
the insoluble fractions (Section 2.5.2).  Total inner membranes (T) and soluble fractions 
(S) were then analysed by SDS-PAGE.  Protein molecular weight markers (M).  Arrow 
indicates position of FsrC. 
 
Figure 5.42 SDS-PAGE of fractions isolated during the purification of E. faecalis 
FsrC.  FsrC (EF1820) was purified from the inner membranes of E. coli BL21(DE3) 
cells transformed with pTTQ18(fsrC)-His6.  The inner membrane proteins were 
solubilised in 1% (w/v) DDM.  Fractions (15 µg), and eluted fraction (5 µg) from the 
purification are shown.  Arrow indicates the position of FsrC. 
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Fractions resulting from the subsequent purification protocols (Section 2.5.3.2) for FsrC 
were analysed by SDS-PAGE and confirmed that FsrC was successfully extracted from 
inner membranes (Figure 5.42).  The purified FsrC was confirmed intact by N-terminal 
sequencing together with the Western blotting shown in Table 5.2 and Figure 5.3. 
 
5.4.4. Autophosphorylation activities of FsrC 
 
 The phosphorylation kinetics of FsrC bound within inner membranes are 
different when compared with those obtained using the purified protein (Figures 5.2 and 
5.4).  In inner membranes, FsrC exhibited a rapid initial autophosphorylation rate, 
followed by a gradual dephosphorylation after 20 minutes (Figure 5.2).  In the purified 
form, FsrC showed a steady and slower rate of increase in phosphorylation and 
maximum phosphorylation was not reached until sixty (Figure 5.4).  However, this 
difference was observed for several of the intact hisitidine kinases, suggesting that this 
may be a general feature (Section 5.2 and 5.4). 
 
5.4.5. GBAP specifically increases autophosphorylation of FsrC in in vitro 
autophosphorylation assays 
 
 In previous studies, the FsrCA two-component system was shown to regulate 
virulence genes such as gelE and sprE (Qin et al., 2000; Qin et al., 2001; Hancock & 
Perego, 2004; Pillai et al., 2004; Bourgogne et al., 2006), and also that GBAP (Figure 
5.43) was the activating signal of the Fsr system (Nakayama et al., 2001; Nakayama et 
al., 2006). 
 
Figure 5.43 Structures of GBAP and siamycin I.  GBAP is an eleven residue cyclic 
peptide containing a lactone structure (Nakayama et al., 2001).  Siamycin I is a twenty 
one residue peptide (Detlefsen et al., 1995; Tsunakawa et al., 1995). 
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Figure 5.44 Effect of the GBAP peptide pheromone on autophosphorylation 
activity of FsrC and other purified histidine kinases of E. faecalis.  Reactions (15 µl) 
containing 80 pmoles purified proteins were preincubated in reaction buffer for 20 
minutes in the presence or absence of synthetic GBAP, followed by initiation of 
reactions (Section 2.5.5.3).  After 60 minutes, 5 µl 4x SDS-PAGE loading buffer was 
added to terminate the reactions.  Phosphorylated protein was determined by SDS-
PAGE followed by autoradiography and phosphoimager analysis.  All reactions, 
including controls, contained a final reaction concentration of 3.4% acetonitrile required 
for dissolving GBAP.  (A) FsrC-P levels in response to increasing GBAP.  Means of 
duplicate data are shown (except for 0.7, 21.3 and 170.7 µM GBAP datapoints, for 
which single measurements were made), and averaged data points varied by ±0.07-
5.43%.  (B) Comparison of responses to 10.7 µM GBAP by six purified histidine 
kinases.  Single data measurements are shown for all proteins except FsrC (EF1820) 
which shows the mean and standard deviation derived from triplicate data.  
Autoradiographs of individual data are shown underneath the graph.  These results have 
been published in Ma et al. (2008) and are solely my own work. 
(B) 
(A) 
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GBAP was previously chemically synthesised in an active form (Nakayma et al., 
2001b) and demonstrated to successfully induce transcription of fsrB and fsrC, as well 
as gelE and sprE, at 1 to 30 nM concentrations (Nakayama et al., 2001; Nakayama et al., 
2007), though the exact mechanism is not yet known.  To test whether the in vitro 
approach adopted throughout the study of histidine kinases is successful for identifying 
cognate signals amongst purified intact histidine kinases in autophosphorylation assays, 
and to determine whether synthetic GBAP induces activation through direct interactions 
with FsrC, and that FsrC is able to respond to its expected GBAP signal in vitro, 
purified FsrC was pre-incubated with a range of synthetic GBAP concentrations for 
twenty minutes, followed by autophosphorylation assays (Section 2.5.5.3).  Mass 
spectrometry confirmed GBAP is in the active cyclic form, described in Section 5.4.8.  
Upon addition of increasing concentrations of GBAP, an increased level of 
phosphorylated FsrC was observed (Figure 5.44).  A maximum level of 
autophosphorylation was reached using ~10 µM GBAP, that is a two-fold molar excess 
of GBAP over FsrC (Figure 5.44A).  Further increase in GBAP concentrations up to 
170.7 µM elicited only small further changes in the levels of phosphorylated FsrC 
(Figure 5.44A).  To test if the action of GBAP is specific for the FsrC histidine kinase, 
other purified E. faecalis histidine kinases with no known or predicted roles in quorum 
sensing were tested as described above using 10.7 µM GBAP.  Little change in the 
activities of the other histidine kinases of E. faecalis was observed in presence of GBAP 
(Figure 5.44B), confirming that GBAP specifically exerts a strong effect on FsrC. 
 
5.4.6. Siamycin I inhibits GBAP-induced autophosphorylation of FsrC 
 
 Quorum sensing, which has been shown to be involved in virulence regulation 
of many Gram-positive bacteria, has been proposed as a new target for antimicrobial 
drug therapy (Smith & Iglewski, 2003; Otto, 2004; Raffa et al., 2005; Martin et al., 
2008; Kociolek, 2009).  Drugs that were effective in inhibiting quorum sensing were 
also shown to be effective for attenuating virulence without bactericidal or bacteriostatic 
activites, implying that the generation of drug resistance might be minimal.  In a screen 
for inhibitors of fsr quorum sensing, Nakayama et al., (2007) showed that siamycin I 
(Figure 5.43) inhibited both gelatinase and GBAP production at submicromolar 
concentrations without inhibiting E. faecalis cell growth, and that cell growth was 
inhibited above micromolar concentrations.  At sublethal concentrations of siamycin I, 
both fsrBDC and gelE-sprE transcripts were suppressed, and an overdose of GBAP 
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added to the culture did not cause any effect, suggesting siamycin inhibited GBAP 
signalling via the FsrCA two-component system (Nakayama et al., 2007). 
 To test if siamycin I exerts a direct effect on the FsrC protein, assays (15 µl) 
employing purified FsrC (80 pmole) and GBAP (160 pmole) were preincubated for 
twenty minutes in the presence or absence of up to a ten-fold molar excess of siamycin I 
(0 – 100 µM), and reactions were allowed to proceed for 30 minutes (Section 2.5.5.3).  
The results are shown in Figure 5.45 and reveal that whilst no inhibitory effect of 
siamycin I on GBAP-induced autophosphorylation at 0 – 12.5 µM (0 – 1.3 fold excess) 
siamycin I was detectable, at higher concentrations of inhibitors (25 – 100 µM), an 
inhibitory effect was observed (Figure 5.45).  The proportion of phosphorylated FsrC 
was reduced by 29, 76 and 91% respectively, indicating that siamycin I does exert a 
direct inhibitory effect on FsrC autophosphorylation activity. 
 
Figure 5.45 Inhibition of GBAP-induced autophosphorylation of FsrC by siamycin 
I.  Purified FsrC (80 pmoles) and a 2-fold molar excess of GBAP (10.7 µM) were 
preincubated for 20 minutes in a final reaction volume of 15 µl in the presence or 
absence of siamycin I (0 – 100 µM), followed by initiation of activity reactions (Section 
2.5.5.3).  Reactions proceeded for 30 minutes.  Autoradiographic film (top) and 
graphical representations (bottom) of phosphorylated FsrC are shown.  Control (C), 
which contains no GBAP and no siamycin I.  Arrow indicates the position of FsrC. 
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5.4.7. Time course of FsrC autophosphorylation in the presence and absence of 
GBAP and/or siamycin I 
 
 Time course experiments were then performed to further characterise the effects 
of GBAP and siamycin I on autophosphorylation rates of FsrC (Figure 5.46).  Assays 
were performed (Section 2.5.5.2) using purified FsrC in the presence and absence of 
GBAP (10.7 µM) and/or siamycin I (50 µM).  An approximate seven-fold increase in 
phosphorylated FsrC was obtained after 60 minutes when GBAP was present in the 
assays compared with when GBAP was absent (Figure 5.46).   
 
Figure 5.46 Time course of autophosphorylation of FsrC in the presence and 
absence of GBAP and/or siamycin I.  Reactions (150 µl) containing 800 pmoles 
purified proteins was preincubated in reaction buffer for 20 minutes in the presence and 
absence of two-fold molar excess of GBAP (10.7 µM) and/or a 5-fold molar excess of 
siamycin I (50 µM), followed by initiation of reactions (Section 2.5.5.2).  Samples (15 
µl) were removed at time intervals between 0 and 60 min.  All samples were analysed as 
described in Section 2.5.5.1.  Data represent the mean of triplicate experiments.  (A) 
Graphical representation of data.  (B) Autoradiographic film. 
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The presence of 50 µM siamycin I in the presence of GBAP resulted in reduced 
FsrC-P levels, which were 50% of the controls at the 60 minute time point (Figure 5.46).  
With siamycin I alone, the level of FsrC activity also appeared to be lower than the 
control, suggesting siamycin I could perhaps inhibit constitutive activity of FsrC as well 
as GBAP-stimulated activity, but since the error bars on the control data overlap with 
the siamycin I only data, this data is not statistically significant.  Further tests such as 
use of higher concentration of siamycin I (≥100 µM) could perhaps be useful to 
determine whether any statistical significance occurs in the absence of GBAP.  
Nevertheless, the assays here further confirm that siamycin I has a significant inhibitory 
effect on GBAP-induced activity of FsrC.   
 
5.4.8. Mass spectrometry of synthetic GBAP 
 
 The synthetic GBAP used in this project was prepared by Kenzo Nishiguchi 
(Kyushu University, Japan).  Active GBAP contains a cyclic lactone ring (Figure 5.43) 
and has a molecular weight of 1302.6 (Nakayma et al., 2001).  The GBAP used for the 
autophosphorylation assays in the present study were confirmed as cyclic and intact by 
ESI-mass spectrometry (Figure 5.47).  Figure 5.47A shows GBAP in the 1+ and 2+ 
charge states.  A peak which is present next to the 1303.58 peak was analysed and 
confirmed to be a sodium atom attached to GBAP (Figure 5.47B). 
 
5.4.9. Circular dichroism spectroscopy of FsrC 
 
 The secondary structure integrity of purified FsrC was examined by circular 
dichroism (Section 2.6.1).  The resultant spectrum is shown in Figure 5.48 and reveals 
the presence of alpha helices and therefore of intact secondary structure in the purified 
protein.  Any observable changes in the secondary structure of FsrC upon ATP and 
GBAP binding was then investigated by further CD experiments.  Firstly, a spectrum of 
FsrC alone was measured (dark blue line), followed by addition of 50 µM ATP (orange 
line) and 10.7 µM GBAP (grey line), accumulatively.  Figure 5.49 shows that a change 
in the secondary structure of FsrC was detectable upon addition of ATP (Figure 5.49) 
and that this could be a slight relaxation of the protein.  Addition of GBAP to the 
protein caused a negative shift in the curve (Figure 5.49).  To determine if the shift is 
caused by changes in the structure of FsrC or by absorbance of GBAP, a spectrum of 
GBAP alone was made (light blue line) (Figure 5.50).  GBAP absorbed at 190 – 240 nm, 
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shown by the negative indentations, which matches with a recent published CD 
spectrum of GBAP (Nishiguchi et al. 2009).   
 
 
 
 
 
Figure 5.47 Electrospray ionisation mass spectrometry of GBAP.  Samples were 
prepared in 3.4% acetonitrile and submitted for mass spectrometry analysis by School 
of Chemistry mass spectrometry service, University of Leeds.  (A) positive ESI-mass 
spectrum; (B) close up view of (A). 
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Figure 5.48 Circular dichroism spectrum of purified FsrC.  Purified FsrC 
(0.05mg/ml) was buffer-exchanged into 10 mM potassium phosphate buffer pH 7.6 and 
0.05% DDM.  CD spectral analysis of FsrC was performed using a Jasco J-715 
spectropolarimeter at 18
o
C with constant nitrogen flushing.  The sample were analysed 
in Hellma quartz-glass cell of 1 mm path length.  Spectrum was recorded with 1 nm step 
resolution at a scan rate of 10 nm/min.  The response time was set at 1 second with a 
sensitivity of 20 mdeg and bandwidth of 1.0 nm.  The spectrum represents an 
accumulation of ten scans, from which the buffer contribution was subtracted.  The blue 
line represents the voltage applied to the photomultiplier. 
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Figure 5.49 Circular dichroism spectrum of purified FsrC with ATP and GBAP.  
Purified FsrC (0.05mg/ml) was buffer-exchanged into 10 mM potassium phosphate 
buffer pH 7.6 and 0.05% DDM.  CD spectral analysis of FsrC was performed as 
described in legend of Figure 5.48. 
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Figure 5.50 Circular dichroism spectrum of purified FsrC with GBAP.  Purified 
FsrC (0.05mg/ml) was buffer-exchanged into 10 mM potassium phosphate buffer pH 
7.6 and 0.05% DDM.  CD spectral analysis of FsrC was performed as described in 
legend of Figure 5.48. 
 
The effect of GBAP on the secondary structure of FsrC was further investigated.  
A spectrum of buffer alone was measured, and as expected it showed low level of 
absorbance (Figure 5.50).  Next, FsrC was added, the spectrum measured (dark blue line) 
and this was followed by accumulative addition of 10.7 µM GBAP and a measurement 
made (red line).  The spectrum of ‗GBAP alone‘ was subtracted from ‗FsrC plus 
GBAP‘, giving rise to the change in secondary structure of FsrC upon GBAP binding 
(green line) (Figure 5.50).  Comparing this to ‗FsrC alone‘ (dark blue line), a reduction 
of the α-helical content of FsrC was observed in presence of GBAP (green line) (Figure 
5.50). 
 
5.4.10. Fluorimetry study of FsrC 
 
 There are four predicted tryptophan residues in the FsrC protein.  Three are 
predicted to be located in the putative transmembrane segments and one in the 
cytoplasmic domain (Figure 5.37).  Fluorimetry measurements of intrinsic tryptophan 
residues of FsrC were made upon titration by ATP and GBAP (Figure 5.51 and 5.52).  
Titration by ATP alone was made, and changes in fluorescence reaching a maximum 
intensity of ~3800 were observed (Figure 5.51).  A second titration was made with the 
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FsrC protein, for which the ATP fluorescence is subtracted to give FsrC fluorescence 
alone (Figure 5.51).  Firstly, concentrations of up to 5 µM ATP caused a rapid decline 
in FsrC fluorescence level, suggesting ATP binding could caused tighter packing of the 
FsrC structure leading to less tryptophan residues being exposed.  Further addition of 
ATP then led to a slow increase; this could be caused by hydrolysis of ATP to ADP 
leading to a reverse effect. 
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Figure 5.51 Typtophan fluoresecence measurements of FsrC titrated by ATP.  FsrC 
was titrated with ATP and the changes in the tryptophan fluorescence at 348 nm 
monitored (Section 2.6.3.4).  The measurements were performed with titration by ATP 
alone ( ), followed by titration by ATP in the presence of FsrC ( ).  The 
fluorescence of ATP alone was then subtracted from this to produce fluorescence of 
FsrC alone ( ). 
 
 In the titration experiments using GBAP alone, GBAP produced a rapid increase 
in fluorescence (Figure 5.52); this is caused by the presence of a tryptophan residue in 
the GBAP peptide (Figure 5.43).  Another titration by GBAP in the presence of FsrC 
was made, and the GBAP fluorescence was subtracted from this to produce values for 
FsrC fluorescence alone (Figure 5.52).  A gradual decrease in FsrC fluorescence was 
observed with increasing GBAP concentrations, suggesting that GBAP could be less 
exposed and more buried in the FsrC protein, thereby resulting in exposure of fewer 
tryptophan residues.  A tryptophan-free FsrC, in which the activity is not affected, could 
be used to investigate further the binding site of GBAP, and whether it binds between 
the helical bundles and/or periplasmic loops. 
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Figure 5.52 Typtophan fluorescence measurements of FsrC titrated with GBAP.  
The FsrC solution was titrated with GBAP and the changes in the tryptophan 
fluorescence at 348 nm monitored (Section 2.6.3.5).  The measurements were 
performed with titration by GBAP alone ( ), followed by titration by GBAP in the 
presence of FsrC ( ).  The fluorescence of GBAP alone was then subtracted from this 
to produce FsrC fluorescence alone ( ). 
 
5.4.11. Cloning of the putative GBAP transporter: EF1821 (FsrB) 
 
 In a rabbit endophthalmitis model, it was shown that fsrB was required for 
function of the Fsr quorum sensing system of E. faecalis (Mylonakis et al., 2002).  A 
nonpolar deletion mutation in fsrB was shown to significantly reduce virulence 
compared to wild type, and complementation restored the virulence (Mylonakis et al., 
2002).  It appears that FsrB is involved in the catalysing and release of GBAP 
(Nakayama et al., 2006), and therefore this study included the cloning of this membrane 
protein for further characterisation. 
 The fsrB (EF1820) gene was therefore amplified by PCR from the chromosomal 
DNA of E. faecalis V583 and cloned into plasmid pTTQ18-His6 to generate 
pTTQ18(fsrB)-His6.  DNA sequencing of the resultant clone confirmed that the gene 
had been successfully cloned (Appendix 12). 
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5.4.12. Discussion: study of the Fsr quorum sensing pathway of E. faecalis 
 
 Enterococci have become recognised as important global causes of nosocomial 
infections, being major contributors to hospital-acquired infections, associated with 
urinary tract infections, endocarditis, pelvic infections and surgical wound infections.  
Their ability to form biofilms on medical devices is an important aspect of pathogenesis 
in the hospital environment.  Over 60% of microbial infections in the body are 
associated with biofilms, and since bacteria in biofilms are resistant to phagocytosis, 
this makes it difficult to eradicate them from the living host (Lewis, 2001).  Clinical 
isolates growing as biofilms are more resistant than in their planktonic state to 
antibiotics such as ampicillin, linezolid and the last line glycopeptide vancomycin 
(Hancock & Perego, 2004a; Sandoe et al., 2006).  A mature biofilm is able to tolerate 
antibiotics at concentrations of 10 – 1000 times greater than those required to kill 
planktonic bacteria. 
 The importance of fsr of E. faecalis in virulence regulation and biofilm 
development have been documented in a few studies (Qin et al., 2000 Nakayama et al., 
2001; Mylonakis et al., 2002; Hancock & Perego, 2004; Nakayama et al., 2006; 
Thomas et al., 2008).  The FsrC histidine kinase regulates production of extracellular 
proteases GelE and SprE, involved in regulating proteolysis and release of eDNA, a 
critical component for E. faecalis biofilm formation (Thomas et al., 2008).  GelE was 
shown to activate lysis of a subpopulation of bacteria and consequently catalyse the 
release of eDNA; and SprE opposed the phenotype of GelE showing higher rates of 
lysis (Thomas et al., 2008).  Three autolysins (AtlA, AtlB and AtlC) were identified to 
be secreted by E. faecalis and one of these, AtlA, is thought to be important for biofilms 
(Kristich et al., 2008; Mesnage et al., 2008).  A recent study showed GelE together with 
SprE regulated enterococcal fratricide leading to eDNA release and biofilm 
development and AltA was demonstrated to be the target of these proteases (Thomas et 
al., 2009).  A model was suggested by Thomas et al. (2009), in which GelE mediates 
fratricide in E. faecalis in response to GBAP; the release of GelE extracelluarly binds to 
cells surface mediating fratricide, and SprE that is co-secreted was suggested to act as 
an immunity protein where binding to cell surface prevented autolysis and fratricide 
(Thomas et al., 2009). 
In this work it was demonstrated that purified full-length FsrC exhibited an 
approximately ten-fold increase in its autophosphorylation activity in response to a two-
fold molar excess of synthetic GBAP.  This provides the first evidence for direct and 
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specific interactions between GBAP and FsrC and in fact for any peptide pheromone 
with its quorum sensing kinase.  It is therefore possible that future work will be 
expected to be successful for identifying signals for other intact histidine kinases 
expressed and purified in this study (Ma et al., 2008), though there are some factors to 
be borne in mind.  For example, as mentioned earlier (Section 5.3.4), some detergents 
were found to be inhibitory towards the activities of some kinases which was first 
identified by Dr Phillips-Jones for VicK and later shown to be the case also for EF1051 
in the present study (Figure 5.31).  Also high concentrations of some ligands are needed 
to test direct interactions with histidine kinases; for example, relatively high 
concentrations of reducing agents (20 – 100 mM DTT or dithionite) were required to 
elicit a visible effect on the autophosphorylation of histidine kinase EF3197 (Figure 
5.17), and this was the same for redox sensors RegB (Potter et al., 2006). 
The study described will not only allow for identification of signals, but also for 
identification of inhibitors.  This study highlights the potential of one candidate 
inhibitor, siamycin I which is also identified for its anti-HIV activities (Lin et al, 1996).  
Concentrations of 25 – 100 µM (2.5 – 10 fold excess) siamycin I inhibited GBAP-
induced autophosphorylation of FsrC (Figure 5.45 and 5.46). 
Future work on FsrC might include further tests, such as phosphotransfer in 
response to its cognate response regulator FsrA, and DNA-binding assay for 
phosphorylated FsrA could be done in the future work.  Also, the threshold for GBAP-
induced autophosphorylation of purified FsrC could be determined by testing lower 
concentrations of GBAP – following the experiment described in Figure 5.44A.  The 
assay using purified kinase could be disadvantageous for screening expensive ligands, 
but nevertheless, it provides direct interaction of protein and its ligand and thus for 
signal/ligand screening. 
The frsB (truncated EF1821) gene with no fsrD portion was cloned in this study 
(Appendix 12).  A previous study by Nakayama et al. (2009) showed that ambuic acid, 
a fungal metabolite, targeted FsrB and that it inhibited the quorum sensing-mediated 
gelatinase production of E. faecalis without influence on cell growth.  It was also 
demonstrated using His6-tagged FsrD (GBAP propeptide) that ambuic acid prevented 
the release of GBAP (Nakayama et al., 2009).  Further study of this clone, together with 
FsrC, will enable deeper understanding of the fsr quorum sensing system of E. faecalis. 
Bacteria are able to live in a planktonic form, but they are advantageous to live 
within a biofilm.  Biofilms provide protection for the bacteria in a hostile environment 
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while maintaining nutrients for for inhabitants, protecting them from immune response, 
as well as an inherent antibiotic resistance that would not be present in their planktonic 
form (Sandoe et al., 2006).  This resistance is a major problem in persistent and chronic 
bacterial infections, and underscores the urgent need for innovative therapeutics.  To 
date, many medically relevant pathogens have been identified to have quorum sensing 
systems related to biofilm formation, and therefore inhibiting biofilm formation has 
become medically important. 
Traditional treatment of infectious diseases often involved compounds that kill 
or inhibit bacterial growth, and the major concern with these approaches are that 
bacteria are becoming resistance to antimicrobial compounds.  The discovery of quorum 
sensing in bacteria, which coordinate important chronological events during the 
infection process, have presented an important novel means to alleviate bacterial 
infections, and is now a target for novel therapeutics (Hentzer & Givskov, 2003; Raffa 
et al., 2005; Khmel & Metlitskaya, 2006; Martin et al., 2008; Njoroge & Sperandio, 
2009; Raina et al., 2009).  Quorum sensing regulation is species-specific and therefore 
drugs that selectively inhibit the pathogen would not have any interference effect on 
other naturally habiting microflora.  There are a few ways to inhibit quorum sensing: 
inhibition of autoinducer production, inhibition of autoinducer binding with the receptor 
protein, and acylated homoserine lactone degradation in Gram-negative bacteria (Khmel 
& Metlitskava, 2006).  Continued investigation of the Fsr quorum sensing system of E. 
faecalis will increase our understanding of enterococcal pathogenesis, and will aid the 
development of novel drugs that may overcome the problem of antibiotic resistance and 
for the treatment of hospital-acquired infections.  In particular, FsrC that senses, and 
FsrB that is required for the processing and transport of, the autoinducing peptide, may 
be potential therapeutic targets, and possible elucidation of their structure to promote 
drug development against enterococcal infections. 
In the case of FsrC, not only is there a potential for designing inhibitors of FsrC 
activity to prevent expression of gelatinase (GelE) and serine protease (SprE) involved 
in adherence in hospital strains, but there is also a potential to design cyclic pheromones 
or other peptides that increase FsrC activity, rather than inhibit it, in probiotic strains. 
Enterococci (in which FsrC is found) form part of the lactic acid bacteria and are natural 
members of the microbiota of human and animal intestinal tracts, and are used in health 
supplements and human probiotics by the food industries (e.g. E. faecalis Symbioflor I). 
They are also used as starter cultures in the food industry, where they play a beneficial 
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role in the production of various fermented foods such as traditional cheeses and 
sausages, playing important roles in ripening and aroma development. Modulation 
(particularly increases) of adherence characteristics through modulation of FsrC 
activities will be of potential benefit for increasing the survival and longevity of 
probiotic strains in the intestine and of food strains during food processing. A 
knowledge of GBAP interactions with the molecular structure of FsrC will play an 
important role in the design of new peptides and/or engineered FsrC proteins that can be 
used by the food industry to activate or increase adherence characteristics. 
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6.1. Summary of results – towards structural and functional 
determination of bacterial transport and sensory membrane proteins 
 
In both prokaryotes and eukaryotes, approximately 25 – 35% of the open 
reading frames in sequenced genomes encode for membrane proteins, which perform 
many important biological functions, from transport of solutes to signal transduction.  
Many successes in functional determination of these proteins have been established.  
However, there is a lack of detailed understanding of their structure-activity 
relationships, which is of paramount importance to facilitate drug design and 
development. 
In this thesis, the importance of the NCS1 family of transporters and the 
histidine kinases of the two-component system are described (Chapter 1).  The ultimate 
aim of this research is to facilitate elucidation of their structure-activity relationships.  
The results presented in this research describe a genomic approach for the study of these 
membrane proteins, and the methods used to accomplish this research are described in 
Chapter 2. 
In Chapter 3, experiments are described to investigate the NCS1 transporters.  A 
genomic approach was utilised to produce full-length His6-tagged protein for structural 
and functional study (Section 3.1).  Thirteen of the selected targets were cloned, and 
another seven are undergoing the cloning stages.  Twelve of the thirteen cloned proteins 
were successfully expressed in E. coli membranes, and substrates transported by five of 
them were confirmed or identified.  Three of these transporters: CodB – a cytosine 
transporter (Section 3.2); PucI – an allantoin transporter (Section 3.3); and PA0443 – a 
uracil transporter (Section 3.4) were characterised, and their substrate specificity and 
kinetics were also determined.  Bacteria are known to have many transport proteins with 
different kinetics, and transport of a particular substrate may occur through possession 
of multiple distinct transport systems.  This presumably permits bacteria to switch to 
transport systems that work better at a particular substrate concentration.  For example, 
if low concentrations of substrate prevail then bacteria are predicted to utilise transport 
system of lower Km. 
The molecular mechanisms for substrate transport by the NCS1 family of 
proteins are not completely understood, but three structures of Mhp1 (Weyand et al., 
2008; Shimamura et al., 2010), each in a different state, provides fundamental 
information regarding their transport mechanism.  The finding that transporters of the 
NSS, SSS, APC and BCCT families are structurally similar to those in the NCS1 family, 
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imply that these sodium-coupled symporters function by the same molecular 
mechanism. 
The study described in Chapter 4 was aimed at determining the identity of the 
cation coupled to benzylhydantoin uptake by Mhp1.  Radiolabelled transport assay and 
fluorimetry experiments were performed in this study to elucidate this identity, and 
these revealed that binding of benzylhydantoin to Mhp1 is sodium-dependent, with an 
increased affinity for benzylhydantoin when 15 mM NaCl was present. 
Chapter 5 reports an investigation of the genome complement of predicted 
histidine kinases of E. faecalis.  Using the same genomic approach for studying NCS1 
transporters, each of the sixteen genes encoding the full-length membrane histidine 
kinase of E. faecalis were successfully cloned and subjected to expression trial (Section 
5.1).  Fifteen of the sixteen histidine kinases were expressed successfully in E. coli, 
fourteen were solubilised from the inner membrane fractions, and thirteen successfully 
purified (Section 5.1).  Eleven of the fifteen membrane-bound proteins and twelve of 
the thirteen purified proteins were active in autophosphorylation assays, a striking 
success for production of active membrane histidine kinases, and in fact this is the first 
reported study of all intact membrane histidine kinases from a complete bacterial 
genome.  Additional understanding for three histidine kinases EF3197, EF1051 and 
EF1820 (FsrC) was achieved through further studies, including the following progress 
and findings: (1) EF3197 responds to increasing concentrations of reducing agents, 
suggesting a possible role in redox-sensing (Section 5.2); (2) EF1051 was purified to 90 
% purity and subjected to gel filtration, followed by promising crystallisation trials for 
future structural determination (Section 5.3); and (3) FsrC, the quorum sensing kinase 
of E. faecalis responded to increasing concentrations of its pheromone signal, GBAP, 
and GBAP-induced activity was inhibited by siamycin I (Section 5.4).  The work with 
FsrC and its known GBAP signal established unequivocally that use of intact sensor 
kinases in in vitro activity assays was sufficiently sensitive and specific to identify 
cognate environmental signals, paving the way for screening of purified and membrane-
bound proteins for systematic signal identification. 
 
6.2. Impact of this research and potential applications 
 
Drug discovery is an extensive and risky process with many pitfalls.  Classic 
drug discovery has involved selection of appropriate compounds, followed by biological 
evaluation in lead discovery, which is a time-consuming process (Lombardino & Lowe, 
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2004).  More recently, a number of high-throughput in vitro screening methods and the 
synthesis of combinatorial compound libraries have further advanced the field.  
Structure-based drug discovery is shown to improve and shorten the drug development 
process (Blundell, 1996; Nicola & Abagyan, 2009; Paul et al., 2010), accelerating lead 
optimisation, and therefore creating a therapeutic demand for protein structures. 
As up to 70% of currently successful drug targets are membrane proteins, many 
structural genomics networks (Lundstrom, 2006) were established to exploit membrane 
protein targets further, by improving the technologies for solving the bottlenecks in 
membrane protein structural determination.  However, to date there are only 641 (245 
unique) structures of membrane proteins in comparison to >60,000 structures of water-
soluble proteins in the Protein Data Bank (www.pdb.org; Berman et al, 2000).  The 
majority of these high resolution structures are bacterial proteins, with very few 
structures of eukaryotic proteins.  The number of membrane protein structures has been 
modest in comparison to soluble proteins, owing to the three major bottlenecks, which 
are expression, purification and structure determination (Figure 6.1).  However, the 
results presented in this thesis demonstrated that many of these bottlenecks have been 
overcome successfully, at least for the proteins included in this study, resulting in the 
successful production of milligrams quantities of many of these membrane proteins, 
which lead to characterisation and crystallisation studies.  These methods could now be 
applied to further membrane proteins.   
 
Figure 6.1 Structure determination pathway.  Each box represents a stage in the 
structure determination pathway of membrane protein.  The pink boxes are the rate-
limiting steps. 
 
Target selection Cloning Expression 
Purification Crystallisation Data Collection 
Structure 
determination 
Final Model Analysis 
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This study has also increased our understanding of the behaviour and properties 
of the membrane proteins that were investigated, and these will be vital for future 
studies.  Elucidation of their structures will contribute important information on their 
molecular mechanisms and thus will aid the development of inhibitors for diseases or 
bacterial infections related to these proteins.  The NCS1 family of transporters forms 
part of the essential salvage pathway of microorganisms.  They are also commercially 
important and structurally similar to bacterial homologues of neurotransmitter 
transporters.  With the recent structures of three states of the transport mechanism of a 
NCS1 protein (Mhp1) being elucidated (Weyand et al., 2008; Shimamura et al., 2010), 
further understanding to complete the transport cycle would be of great importance for 
the design of antidepressants.  In the case of histidine kinases of E. faecalis, 
understanding of their mechanisms are of medical importance because of their 
involvement in multiple aspects of bacterial regulation and their absence in animals 
make them ideal target for development of new classes of antimicrobial drug, and of 
course for treatment of enterococcal infections, the major cause of hospital acquired 
infection. 
 
6.3. Limitations and future perspectives 
  
Based on the work described in this thesis, a number of future studies can be 
proposed.  These studies would endeavour to overcome some of the limitations 
described herein to improve the success rate of the genomic approach, as well as to 
improve our understanding of membrane proteins further. 
 
6.3.1. Future studies related to expression and purification 
 
 Isolation of genes encoding the membrane proteins of interest was successful for 
the majority of the chosen targets.  All histidine kinases genes were successfully 
isolated from E. faecalis, and most NCS1 targets were cloned.  For NCS1 genes from 
high %GC organisms, such as Streptomyces and Pseudomonas, addition of DMSO and 
lowering of annealing temperature were required to improve the yields of PCR-
amplified gene productst.  Amplification of Streptomyces genes, for example SCO0572 
and SCO7500, produced smeared bands on the agarose gel (Figure 3.3), possibly 
resulting from low specific binding of the primers which is affected by the high %GC 
content of the genes.  
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High-level production of some of the His6-tagged membrane proteins in E. coli 
was unsuccessful, including the NCS1 transporters PA0438 and PPA0619, and histidine 
kinases EF2219 and EF1335.  Factors such as growth media, pH, temperature, induction 
time, expression host strains, induction systems (such as autoinduction; Grabski et al., 
2005), expression vector, could therefore be tested to attempt optimising protein 
expression levels.  To assess the quality of expressed membrane proteins, the method 
described by Geertsma et al. (2008) could be applied; this study used a fused green 
fluorescent protein as indication of successful protein folding.  Since GFP only 
fluoresces when it is correctly folded and active (in which case the fused recombinant 
protein is also assumed to be likewise correctly folded), this system could be used to 
distinguish well folded (and potentially active) proteins from aggregated proteins. 
All but one (Pden0678) of the NCS1 targets of this study possessed C-termini 
that were predicted to be located in the cytoplasm.  However, any protein (including 
Pden0678), possessing a His6-tag attached to a C-terminus that is located to the 
periplasm of E. coli will be expected to fail expression trials (Rahman et al., 2007).  It is 
unlikely that the His6-tag would be able to cross the membrane to take up its topological 
position and therefore presumably the protein would fail to integrate correctly into the 
membrane.  Therefore, to study Pden0678, the gene encoding this transporter should be 
incorporated into a vector that permits production of a Strep-tag instead of His6-tag. 
 
6.3.2. Future studies related to determination of function 
 
Further screening is required in order to identify substrates for some of the 
NCS1 proteins studied here.  This will require a wider selection of substrates to be 
screened and completing the gaps in Table 3.4.  For the histidine kinases used in this 
study, signal screening by in vitro assays has now been shown to be sufficiently 
sensitive and specific and therefore this approach can now be used with a wide range of 
candidate signals, including those signal(s) known to be perceived by homologues of 
these kinases in other bacterial species (Hancock & Perego, 2002).  Also, a reduced 
concentration of candidate signal in the assays should be used in the initial screenings.  
Although use of a 2-fold molar excess of candidate signals were used in the more 
detailed experiments included in this study, the initial screenings using 10 mM signal in 
the presence of 60 pmoles of sensor protein in 10 ul assays represents a ratio of 
signal:protein of approx 1800:1. Screening for the signals perceived by the histidine 
kinases should therefore involve use of lower concentraions of candidate signals. In any 
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cases where a range of different concentrations is to be trialled in addition to a wide 
range of different compounds, then use of 33P-ATP in these assays could be expensive.  
Methods for detection of phosphorylated proteins by other means could be used, which 
were developed and described by Kinoshita et al. (2006).  The methods involve 
visualisation of phosphorylated protein using alkoxide-bridged dinuclear metal (Zn
2+
 or 
Mn
2+
) complexes as novel phosphate-binding tag (Phos-tag) molecules (Kinoshita et al., 
2006; Kinoshita et al., 2009). 
Substrates for five of the NCS1 transporters were identified in this research 
(Table 3.5).  Mutagenesis experiments could now be performed to identify residues 
important for their substrate or cation transport.  This could also give us clues to which 
amino acid could lock the transporter in a particular form for crystallisation studies.  For 
histidine kinases, the same could be performed. 
 
6.3.3. Future studies related to structural determination 
 
Mutagenesis studies may turn out to be important, as mentioned above, for 
stabilising some of the proteins sufficiently for successful future crystallisation, as it 
could overcome the dynamic problems which many transporters face for crystallisation.  
This is probably the same for the histidine kinases, as mutants may reduce or 
completely abolish the flexibility of the kinase for crystallisation. 
A major factor in facilitating crystallisation is improvement of the thermal 
stability of the membrane protein.  Warne et al. (2008) were able to construct mutants 
that gave rise to more stable β1-adrenergic G-protein coupled receptors suitable for 
crystallisation, and these mutant proteins were successfully used to obtain crystals and a 
crystal structure.  Therefore, it is important to test the thermostability of the purified 
proteins prior to crystallisation.  This could be done by recording the thermal melt of the 
protein by circular dichroism as well as the method described in Postis et al. (2008). 
All proteins purified in this research could now proceed to size exclusion 
chromatography to obtain monodispersed proteins for crystallisation trials.  The buffer 
components including pH, salts and detergent could be optimised to stabilise the protein.  
Screens such as MemGold
TM
 could also be tested as well as the ones mentioned in the 
research. 
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6.4 Concluding remarks 
 
 It costs pharmaceutical industries US $ 1.3 – 1.8 billion for development of a 
new drug (Collier, 2009; Paul et al., 2010), and methods are being developed to shorten 
and reduce the cost of the drug developmental process.  Many high-throughput in vitro 
screening methods and structure-based drug design protocols have played important 
roles in optimising these processes.  Given the high percentage of drug targets being 
membrane proteins, development of structural genomic approaches to tackle issues 
relating to structural determination of membrane proteins (expression, purification and 
crystallisation) are important.  This study represents one of the successful ones.  
Successful approaches for the study of two different families of membrane proteins are 
shown, including descriptions for the production of milligrams quantities (~10 mg 
batches) of some of these important membrane proteins for their future structure 
determinations. 
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Appendices 
 
 
Appendix 1 Topology prediction by TMHMM of the selected NCS1 proteins. 
 
b0336      b0511 
  
 
Bsu36470     Bsu3867  
  
 
EF3000     lp3374    
  
 
PA0438     PA0443 
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 PA0476     PA2073 
  
PA5099      Pden0678 
  
 
Pden1111     Pden4351 
  
 
PPA0619     PPA2211 
  
 
SCO0572     SCO5579 
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SCO6417     SCO7500 
  
 
 
 
Appendix 2 Sequence alignment of Mhp1 and its homologues.  Amino acid sequence 
of Mhp1 and its homologues were aligned using ClustalW (Thompson et al., 2002; 
Larkin et al., 2007) and similarity between the sequences were analysed using Geneious 
Pro 4.6.5 software.   100% similar;  80-100% similar;  60-80% similar;   <60% 
similar.  The residues that are involved in substrate recognition and cation coupling in 
Mhp1 are boxed in red.    Note: Bsu3645 = Bsu36470 (PucI). 
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Appendix 3 DNA sequences of the recombinant NCS1 clones.  The N-terminal 
MNSH (blue) and C-terminal His6-tag (red).  Data for EF3000, Pden1111 and 
Pden4351 are not shown. 
 
b0336 (Note: silent mutation in b0336 which did not affect encoded amino acid 
sequence, highlighted in yellow) 
ATGAATTCGCATATGTCGCAAGATAACAACTTTAGCCAGGGGCCAGTCCCGCAGTCGGCGCGGAAAGGGGTATTGGCA
TTGACGTTCGTCATGCTGGGATTAACCTTCTTTTCCGCCAGTATGTGGACCGGCGGCACTCTCGGAACCGGTCTTAGC
TATCATGATTTCTTCCTCGCAGTTCTCATCGGTAATCTTCTCCTCGGTATTTACACTTCATTTCTCGGTTACATTGGC
GCAAAAACCGGCCTGACCACTCATCTTCTTGCTCGCTTCTCGTTTGGTGTTAAAGGCTCATGGCTGCCTTCACTGCTA
CTGGGCGGAACTCAGGTTGGCTGGTTTGGCGTCGGTGTGGCGATGTTTGCCATTCCGGTGGGTAAGGCAACCGGGCTG
GATATTAATTTGCTGATTGCCGTTTCCGGTTTACTGATGACCGTCACCGTCTTTTTTGGCATTTCGGCGCTGACGGTT
CTTTCGGTGATTGCGGTTCCGGCTATCGCCTGCCTGGGCGGTTATTCCGTGTGGCTGGCTGTTAACGGCATGGGCGGC
CTGGACGCATTAAAAGCGGTCGTTCCCGCACAACCGTTAGATTTCAATGTCGCGCTGGCGCTGGTTGTGGGGTCATTT
ATCAGTGCGGGTACGCTCACCGCTGACTTTGTCCGGTTTGGTCGCAATGCCAAACTGGCGGTGCTGGTGGCGATGGTG
GCCTTTTTCCTCGGCAACTCGTTGATGTTTATTTTCGGTGCAGCGGGCGCTGCGGCACTGGGCATGGCGGATATCTCT
GATGTGATGATTGCTCAGGGCCTGCTGCTGCCTGCGATTGTGGTGCTGGGGCTGAATATCTGGACCACCAACGATAAC
GCACTCTATGCGTCGGGTTTAGGTTTCGCCAACATTACCGGGATGTCGAGCAAAACCCTTTCGGTAATCAACGGTATT
ATCGGTACGGTCTGCGCATTATGGCTGTATAACAATTTTGTCGGCTGGTTAACCTTCCTTTCGGCAGCTATTCCTCCA
GTGGGTGGCGTGATCATCGCCGACTATCTGATGAACCGTCGCCGCTATGAGCACTTTGCGACCACGCGTATGATGAGT
GTCAATTGGGTGGCGATTCTGGCGGTCGCCTTGGGGATTGCTGCAGGCCACTGGTTACCGGGAATTGTTCCGGTCAAC
GCGGTATTAGGTGGCGCGCTGAGCTATCTGATCCTTAACCCGATTTTGAATCGTAAAACGACAGCAGCAATGACGCAT
GTGGAGGCTAACAGTGTCGAACATCATCATCATCATCAT 
 
b0511 
ATGAATTCGCATATGGAACATCAGAGAAAACTATTCCAGCAACGCGGCTATAGCGAAGATCTATTGCCGAAAACGCAA
AGCCAGCGGACCTGGAAAACATTTAACTATTTTACCTTATGGATGGGTTCGGTTCATAACGTTCCCAATTATGTGATG
GTCGGCGGCTTTTTTATTCTCGGCTTGTCTACCTTTAGTATTATGCTGGCAATTATCCTCAGCGCCTTTTTCATTGCC
GCGGTAATGGTATTAAACGGTGCTGCGGGCAGTAAATACGGTGTGCCTTTTGCCATGATCCTGCGTGCTTCTTACGGT
GTACGTGGTGCACTGTTTCCCGGATTATTAAGGGGCGGAATTGCCGCCATCATGTGGTTTGGTTTGCAATGTTACGCG
GGGTCACTGGCCTGCTTGATTCTGATTGGCAAAATCTGGCCGGGATTTTTAACTCTCGGTGGTGATTTCACTCTGTTA
GGCCTTTCTCTACCGGGCTTAATTACTTTCTTAATCTTCTGGCTGGTCAACGTTGGTATAGGTTTTGGCGGTGGCAAA
GTTTTAAATAAATTCACTGCCATTCTTAACCCGTGCATCTATATCGTTTTCGGCGGTATGGCGATTTGGGCGATTTCA
CTGGTCGGGATCGGTCCAATCTTTGACTACATTCCGAGCGGTATTCAGAAAGCAGAAAACGGTGGCTTCCTGTTCCTG
GTGGTGATTAACGCGGTAGTTGCGGTCTGGGCGGCACCGGCGGTGAGCGCATCCGACTTTACGCAAAACGCCCACTCG
TTTCGTGAGCAGGCGCTGGGGCAAACGCTGGGTTTAGTTGTGGCCTATATTCTGTTTGCGGTCGCCGGGGTATGTATT
ATTGCCGGAGCCAGTATTCACTACGGCGCTGATACCTGGAACGTGCTGGATATTGTTCAGCGTTGGGACAGCCTGTTC
GCCTCGTTCTTTGCGGTACTGGTTATTCTGATGACAACTATCTCCACTAACGCGACCGGTAATATTATTCCAGCCGGT
TATCAGATTGCCGCCATTGCACCGACAAAACTGACCTATAAAAACGGCGTACTGATTGCCAGTATTATCAGCTTGCTG
ATCTGCCCGTGGAAATTAATGGAAAATCAGGACAGCATTTATCTTTTCCTCGATATTATCGGCGGAATGCTTGGTCCG
GTAATTGGTGTCATGATGGCGCATTATTTTGTGGTGATGCGCGGACAAATTAATCTTGATGAACTGTATACCGCACCT
GGCGATTATAAATATTACGATAACGGTTTTAACCTCACTGCGTTTTCAGTAACTCTGGTGGCGGTTATTTTATCTCTT
GGCGGTAAGTTTATTCACTTTATGGAACCGTTATCGCGTGTTTCATGGTTTGTCGGCGTCATCGTCGCCTTTGCGGCC
TACGCCTTATTAAAGAAACGTACAACAGCAGAAAAAACAGGAGAGCAAAAAACCATAGGTGCTGCAGGCGGTCGTGGC
AGCCACCATCACCATCACCAT 
 
 279 
Bsu36470 
ATGAATTCGCATATGAAATTAAAAGAGAGTCAGCAGCAATCCAACAGGCTGAGCAATGAAGATCTGGTGCCTTTGGGA
CAGGAAAAACGGACGTGGAAAGCAATGAACTTTGCCTCCATTTGGATGGGATGTATACATAACATACCGACCTACGCG
ACCGTGGGAGGATTAATTGCGATCGGCCTTTCGCCTTGGCAGGTGCTGGCGATCATTATTACGGCATCACTTATCCTA
TTTGGCGCTCTTGCCTTAAACGGCCATGCGGGGACAAAATACGGGCTGCCGTTTCCAGTGATCATTCGGGCTTCTTAC
GGGATATACGGCGCGAATATCCCCGCGCTTCTAAGGGCGTTTACAGCTATCATGTGGCTTGGCATCCAGACCTTTGCG
GGTAGCACGGCACTGAACATTTTGCTTTTGAATATGTGGCCAGGTTGGGGAGAAATTGGCGGCGAGTGGAACATTCTC
GGCATTCACTTGTCCGGTTTGCTTTCCTTTGTATTCTTTTGGGCCATTCATTTACTCGTATTGCATCACGGCATGGAG
TCGATTAAACGTTTTGAGGTGTGGGCAGGGCCTTTAGTGTATCTGGTATTTGGCGGCATGGTATGGTGGGCCGTTGAT
ATTGCTGGAGGATTGGGCCCGATATACTCTCAACCAGGAAAGTTTCATACGTTTTCAGAAACATTCTGGCCGTTTGCT
GCCGGAGTTACTGGCATCATCGGCATCTGGGCGACATTGATCTTAAATATACCTGATTTTACACGGTTTGCTGAAACA
CAAAAAGAGCAAATCAAAGGACAATTTTACGGTTTGCCGGGAACGTTTGCGCTGTTCGCATTCGCAAGTATTACGGTG
ACCTCCGGCTCGCAGGTCGCGTTCGGAGAGCCGATTTGGGATGTTGTCGATATTTTGGCGCGGTTTGATAACCCTTAT
GTCATCGTCTTGTCCGTGATCACACTCTGCATCGCCACGATCTCTGTAAATGTCGCGGCGAATATCGTATCACCCGCT
TATGATATAGCGAATGCCCTGCCGAAATATATCAATTTCAAACGTGGCAGCTTTATCACAGCGTTGCTCGCTTTATTT
ACGGTTCCGTGGAAGCTGATGGAGAGCGCGACAAGCGTGTATGCGTTTCTTGGCTTAATAGGCGGCATGCTTGGACCG
GTGGCAGGCGTGATGATGGCCGACTATTTTATCATTCGCAAACGTGAGCTCTCGGTAGATGACCTGTATTCCGAAACA
GGACGGTATGTGTATTGGAAGGGCTACAATTACCGTGCGTTTGCAGCCACAATGTTAGGAGCGCTGATTTCGCTGATT
GGCATGTATGTTCCTGTATTGAAGAGCTTATACGATATTTCTTGGTTTGTAGGTGTGCTGATTTCCTTTCTTTTCTAC
ATTGTTCTGATGCGTGTTCACCCGCCTGCATCATTGGCAATTGAAACAGTTGAACATGCGCAGGTCCGCCAGGCTGAA
GCTGCAGGCGGTCGTGGCAGCCACCATCACCATCACCAT 
 
lp3374 (Note: silent mutation in lp3374 which did not affect encoded amino 
acid sequence, highlighted in yellow) 
ATGAATTCGCATGTGCAGCAAGAGTCAAAGTATCAAATAGAAGTGGTGGCGCCTAAGCACCGACACATGTCTAATTGG
GACATGTTTGCAACTTGGATTGGCGCCAATGCCAATAATGGCACGTGGTACGTTGGTGGTGTATTGGCTGCGTGTGGT
TTATTGACGGCGCTTAAAGTGATTGTAGCATCGTCCACGCTATCGTATTTATGTTTATCGTTAGTCGGCTTCATGGGG
TATAAGACCGGGGCGGCGACGATGAGCTTGATTCGTGGTTCCTTTGGTGTGCGGGGCAGTTACGTTCCGTCCTTTGTG
AACTTGACCCAGTATATTGGCTGGACAGCGGTAAACACGTTCATTGCAGCAACTTCTGTCAGCTATTTATTACACGAT
CTAGTTGGCTGGCCAGTCTATGGTAAACCCGGTGGGGCTAAAGGACTGATCCTCGGAATTATTGTCATGAGTGTGTTG
CATTTATTAAGTGTTTCGGTCGGTCAACGGTCGGTTCAGATGATTGAGCGTTTAGGTATTATTCTTGTCATCTTATTT
GTTTTATGGGAGACGGTCGTCGTGTTCCAGACGGTCTCAGTGCATGATTTGTTAACGTGGCAGGCGCCGACACATTTA
CATATGACGGCGGGTGCTGGGATGGATACGCTAGCGGCGTTCAATTTGTCTTGGGTGACAGCGGGTGCTGATTTTACG
CGGTTTACGCGCAAAAAGAGTGGCGCGACTGGCATGCCATTTTTAGGGGCCTTTACCGGCTTGTTCTGGTTCGCCTTT
ATCGGGCTTGCCGCGACGATCAGTATCGCGATTACTTCTGGAACTTATGATCCTAATAACTCTGACCCGAGTACCATT
GCGAGTCGACTAGGCTTGGGGGTATTAGCACTACTGGTGATTGTCTTAACGAGTATGACGGCGAACGCGGTAAACTTA
TTGGCGGCTGGTTCGGCGCTGTCGAATATCTTCCCACGGATTCGGTTACGACCAGCACTGTGGGCCGTGACAATCATT
GCCACGTTAGTCACACTGATTCCATTAATCATGGGGAGTTTTTTAGCTGCATTCACGGCGTTCCTAGATTATATTGGG
ATGGTGCTTGGACCGATGATCAGCGTGATGTTAGTCGATTACTATTGGCGGCATCGTCAGCACTATGATATCAACGAA
CTGGCGAGCTCTAAGGGGCAGTATTGGTATCATCATGGGGTGAACTGGATTGCGCTATTATGTTGGGTACTAGGTGTG
GCCATCTTCTTGTTATTGAAGCACGTTGTTTGGATTGCGACGGTGACTGGTGCAACTTTCATTGACATGGCGCTTATC
GGGGTCATTTACGTGGCTTTAATGCGAATTTTCTACCCGTTACCTGCCAAACGTGTCGCTGCAGGCGGTCGTGGCAGC
CACCATCACCATCACCAT 
 
PA0438 
ATGAATTCGCATATGTCCGCAGACAGCAACTACAGCCAGCAACCGGTCCCGCTGGCGGCGCGCAAGAGCGCGCTGGCC
CTGAGCGTGGTGATGCTCGGCCTGACCTTCTTTTCCGCCAGCATGTGGACCGGCGGCACCCTCGGCACCGGCCTGAGC
TACGACGACTTCTTCCTCGCCGTGCTGCTGGGCAACCTGATGCTCGGCCTGTACACCGCGATCCTCGGCTTCATCGGC
GCGCGCACCGGCCTTTCCACCCACCTGCTGGCGCATTACTCGTTCGGCAGCAAGGGCTCCTGGCTGCCCTCGGCGTTG
CTCGGCGGCACCCAGGTCGGCTGGTTCGGCGTCGGCGTAGCGATGTTCGCCATCCCGGTGGCCAAGGCCACCGGCCTC
GACGTCAACCTGCTGATCCTGGTTTCCGGAGCGCTTATGACCCTCACGGTGTTCTTCGGCATCGCCGGTCTGACCCTG
CTGTCGGCCATCGCGGTCCCGGCGATCGTCGTTCTCGGCAGCTACTCGGTATGGCTCGCGGTGCGCGACGCCGGCGGC
CTGGCGGCGCTGCAGCAGGTGACGCCGAGCGCGCCGCTGAGCCTCTCGACCGCGATCGCCCTGGTGGTCGGCTCGTTC
GTCAGCGCCGGCACCCTCACCGCCGACTTCGTCCGCTTCGGCCGCAGCGCGCGTACCGCCGTGGTGGTGTGCCTGGTG
GCGTTCTTCCTCGGCAACTCGCTGATGTTCATCTTCGGCGCGGCCGGCGCGGCGGCGGTGGGCAAGTCGGACATCTCC
GACGTGATGATCGCCCAGGGCCTGCTGATCCCGGCGATCCTGGTCCTCGGCCTGAACATCTGGACCACCAACGACAAC
GCGCTGTATGCCTCCGGCCTCGGCTTCGCCAACATCACCGGCCTCTCCAGCCGCTTCCTGGCGATGCTCAACGGCGCC
CTCGGCACCCTCGCCGCGCTCTGGCTGTACAACCACTTCGTCGGCTGGCTGACCTTCCTCTCCGCCGCCATCCCGCCC
ATCGGCGGGGTGATCATCGCCGACTACCTGAGTCGCCGCCGGCGCTACCGCCAGCACCCCTGCGCGGACATCCAGGCG
ATCAACTGGGCGGCGATCCTCGCCGTCGCTTGCGGCACCGCCGCCGGCCACTGGCTGCCGGGGATAGTGCCGGTCAAC
GCGGTGCTCGGCGCCGCCATCGCCTACCTGTTGCTCAATCCCCTGCTGAGCCGCAGCCCGAACAAACCAGAAGAGGTC
CTCCATGCTGATCATCATCATCATCATCAT 
 
 
 
 
 
 
 
 
 280 
PA0443 
ATGAATTCGCATATGCAACAGAGCAGATCGGAAGTGACCGAGCGCGACGGCTTGGTCGAGCTGTCCGCCGGCAGCGAC
GTACTCGACAGCCCCCGCTACAACCACGACATCGCCCCGACCCGGGTGGAACAGCGTACCTGGAACAGGTGGCACATC
ACCGCGCTGTGGATCGGCATGTCCATCTGCGTGCCCACCTACACCCTCGGCGGCGTCCTCACCGCCTACTTCGGCCTC
AGCGTCGGCGAAGCGCTGCTGGCGATCCTGCTGGCCAACCTGGTGGTGCTGATCCCGCTGACCCTCAATGCCTTCGCC
GGCACCCGCTACGGCATTCCCTTCCCGGTGCTGCTGCGCGCTTCGTTCGGCATCATCGGCTCCAACGTGCCATGCCTG
ATCCGCGCCGTGGTCGCGTGCGGCTGGTTCGGCATCCAGACGCTGTTCGGCGGGCTGGCGATCCATCTCTTCCTCGGT
TCGATCTTTCCCGCCTGGAAAGCCCTCGGCGGCACCGGCGAGGTGATCGGTTTCCTCCTGTTCTGGGGGCTGAACCTG
TGGGTGGTGCTGCGCGGCGCGGAGTCGATCAAATGGCTGGAGACACTCTCGGCACCGCTGCTGGTGCTGGTCGGCCTC
GGCCTGCTGGTGTGGGCGCTGCCGCACATATCGGTCAGCGAACTGCTGGCGCAGCCGCCGAAGCGCCCGGAAGGCGCC
AGCGTCACCGGCTACTTCATGGCCGGGCTGACGGCGATGGTCGGCTTCTGGGCCACGCTGTCGCTGAACATCCCCGAC
TTCAGCCGCTATGCGCGTAGCCAGAAGGACCAGATACTCGGGCAGATCTTCGGCCTGCCGCTGACCATGTTCCTGTTC
GCCGCCCTCGGCGTGGTGATGACCGCCGCCTCGGCTTCGCTGGTGGGCGAGACGGTTTCCGACCCGGTCAGCCTGATC
GGGCACATCCCCAGCCCCGGCTGGGTGGCGGTGGCGATGGCGTTGATCATCGTCGCCACCCTCTCGACCAACACCGCG
GCGAACATCGTCTCGCCGACCAACGACTTCCAGAACATCGCACCGAAACTCATCGGCCGCACCCGCGCCGTCTGGCTC
ACCGGTTTCATCGGCCTGGCGCTGATGGCCCACGAGTTGCTGAAGAAGCTCGGCTGGATCGTTTCCGACCTCAGCCTG
GAAAGCGTCTACTCCAACTGGCTGCTCGGCTACTCCAGCCTGCTCGGGCCGATCGCGGGGATCATGGTGGTGGACTAC
TTCCTGGTGCGCAGGCAACGCCTCGATCTCGCCGGACTCTACCGCGACGACGTCTACCCGGCCTGGAACTGGCCCGGC
TTCGCCGCCTTCGCGGTGCCGGTGGCGCTGACCGTCATGGCCCTCGGCAACCGCCAGTTCCACTGGTTCTACGACTAC
GGCTGGTTCACCGGCTCGCTGCTCGGCGGCGCGCTCTACTACGGCCTCTGCGGCCGCCGTGCGCGGAGCCCGGCGGCA
TTGGCCAAACCGCTGCCCGCTGCAGGCGGTCGTGGCAGCCACCATCACCATCACCAT 
 
PA2073 
ATGAATTCGCAGATGAGCAATAACAACGAGGCGTCACGCCCGAAGATCGAAGTGCGTTCGATCGATTACGTTCCCCGC
CACGAGCGTCACGGCAAGGTCTGGCACCAGGCGCCGTTCTGGTTCACCGGCAATTTCGTACTCACCACCATGGTCACC
GGCTTCACCGGGCCGGCCCTCGGCCTGGGGGCGCTGTACTCGATCCTGGCGATCGTCCTCGGCGTCTGCTTCGGCACC
TTCTTCATGGCCTTCCATGCCAACCAGGGTCCGCGCATGGGCTTGCCGCAGATGATCCAGTCGCGTGCCCAGTTCGGC
CTGCGCGGGGCCATCGTGCCGTTCGCCGCGGTGGTCTTCGTCTATATCGGCTTCAACGTGTTCAACGTGATCCTCGCC
ACCGACGCGATCAACACCGTGCTGCCGGGACACCGCGCGCCCTGGTACGTCCTGCTGATCGGCGTGGCGGTGTTGCTC
GCCATCGTCGGCCACGACCTGCTGCATACCGTGCAGCGCTGGCTGACCTACGTGATGATCGCGGTGTTCGGAGTCCTC
ACCGTCAGCGCGCTGCGCAGCCTCGAAGCGGACGCGGCGCTGGGCGGTACGCCGGCGTTCTCCTGGAGCGCGTTCCTG
GTCCAACTGTCGGCCGCCGCCGGCTACCAGATCAGCTATGCGGTCTACGTCTCCGACTACTCCCGCTACCTGCCGCAC
GAAACGCCGACCCGCAAGGTGATCTTCTGGACCTACCTGGGCGCCGCCGGTTCGGCGCTCTGGCTGATGTCGCTGGGC
GCATTCCTGGCCTCGGCATTGCCGGCGCCGGACGCCATCGGCAGCGTGCGCGAGGTGGGCAACCGGCTGTATCCCGGC
TTCGGCACCTTCACCGTGCTGATCGCCGTCCCGGCCCTGGTGGGGATCATGGCGGTCAACTGCTATGGCGCCATGCTC
ACCAGCCTCAGCGCCATCGATGCCTTCCGCAAGGTCACTCCGACCCTCAACCTGCGCGTCACCGGGATCGGCGTGATC
GCCCTGGTGGTATTCGGCGTGGCCCTGTCAATCCCGGAAAGCTACCTGGGCAGCTTCAACACCTTCGTCCTGCTGATG
CTGTACTTCCTGGTGCCCTGGACCGCGGTCAACCTGGTGGACTTCTACTTCGTGCGCAACGGTCACTACGCGATCAGC
GAAATCTTCAATCCCGAAGGCATCTACGGTCACTGGGGCCGACCGGGGTTGAGCGCCTACCTGGCCGGGTTGCTGGCG
ATGGTCCCGTTCATGTCCCTGAGCTTCTACAGCGGTCCCTTCGCCGTGGCGCTGGGCGGCGCCGACGTCGCCTTCGTG
GTCGGCCTGCTGGTGGCCGGCGCGGTCTATGCCTTCATGTGCCGGGCCCTGGACCTGGAGGCGGAACGACGGCTCGCC
ACCCTCGGCGAGCGCCTGCTGGAAGAGGGGGGCGCCGCTGCAGGCGGTCGTGGCAGCCACCATCACCATCACCAT 
 
PPA0619 
ATGAATTCGCATATGACGCAGACCGCCACCAAAACGAATGCGACGACGCACAAGGGCATCGAGACAACCGGAATCGAG
ATCGTCAAAGAATCACAGCGCACCGCACAGCCCCAGGACCTTTTCCTTCCCTGGTTCGCCTCAAATGTCTCGGTCTTT
GGCATGAGCTATGGAGCCTTCATGTTGGGATTCGGGGTGTCCTTCTGGCAGGCGATAGCCGCCACCCTCGTCGGCGTC
ATCGTCTCTTTCGGGTTCTGCGGCATTATCGCGATCGCCGGTAAACGCGGCTCCGCACCAACGATGGTGCTGTCTCGG
GCAGCCTTTGGTACCCAGGGCAACAAGATCCCCGGGGTCATCTCCTGGATGACCTCGATTGGTTGGGAAACATCTCTC
GCTATTACAGCCGTCTTAGCGACGACGACGATCTTCCGCCGACTGGGCTGGAGCTCCGGGAACTCGGTCAAGATCTGC
GCCACTATCATCGTGGCCTTTCTCATTGTCGGCGGTGCTGTGGCTGGTTATCACATCATCATGAAGTTGCAGGCCGTT
TTGACCTGGATTACCGGTATCCTTACCGTGATTTATCTAGTGATGGCGGTCAGCCATATCGACTGGCACGCCGCAACA
TCTTTGCCTGCGGCATCCTTCCCAGCCTTCGTCGGCACGCTCACCCTCATCATGACTGGCACCGGGCTGGGCTGGACG
AATATCGCTGCCGACTGGTCACGTTACCAGTCGCGCACATCTCCCGGGTTCGCCATCGCCTTCTGGAATGTCTTTGGG
GCCTCTTTGCCGCTCGTCATCCTCATTACCGGTGGATTGCTCTTAGCTGCATCCTCAAAAAATCTATCCGACGCCATT
GGGGCCGATCCCATTGGCGCGCTAGCAACCATCCTGCCGACGTGGTTCCTCATCCCGTTCTTGTTGGCTGCGATCCTC
TCCCTGTTGGCCGGTGCCATCAACGGCATCTATTCGTCTGGACTCACCTTGCTCACCCTGGGAATCCGAGTCCCACGC
CCAGCAGCTTCTCTCATTGACGAGACGATTCTCACCATCGGGACCCTGTACGTCGTCTTCGTGGCTCCGAACTTTATC
TCCCCCTTCCAGTCCTTCTTGGTGACGCTGGGTGTGCCGCTCTCAGGATGGACCGGCATCATGATGGCCGATATCACC
CTGCGCCGCCGTCCCTACGACGAGGCCGATCTCTTCAATGGCTCTGGGCGCTACGGTCATTTCGACCCCATCTCAATC
ATCACCTTCGTCATCGTGACCGTCATCGGGTGGGGATTGGTCGTCAACACCTACGAGGGCGTCAATTGGAACGACTGG
CAGGGATTTCTGCTTGGGCCCATTGGATTGGGTGGGCGTGAAGGTGATTGGGCCCACGCCAACCTTGGAGTATTCGGG
GCCCTCGTCCTCGGCTATGTTGTTACCCTCATCGCTCGGCGCGGCACCGTGCGTCGTCAGGAGTCACGAGCTGCAGGC
GGTCGTGGCAGCCACCATCACCATCACCAT 
 
 
 
 
 
 
 281 
PPA2211 
ATGAATTCGCATATGGTGTCCGCGCCAAATAGTGCTCAGGATGAAGTTCGTCATGGAAATACGGCTCCAACCGCTTCT
GGGGCTGGTCGCGGTGTTGAGAAGCGAACGATTGATATGGTTCCTGACGGCGAAAGGCACGGCACTCCGAAGAGTCAG
TTCACACTGTGGTTCGGAGTGAATATGCAGATTACGGCTGTCGTGAATGGTGCTTTGGCGATTGTTTTCGGGGCCGAT
GTTGTATGGGCGATAATTGGCCTTTTTATTGGGCAAGTCATCGGCGGCGCTGTTATGGCGCTCCATTCCGCTCAGGGG
CCCGCGCTGGGGCTCCCACAAATGATCAGTTCGCGGGCACAGTTTGGCGTTTATGGTGCTGCGCTTCCGCTGTTTCTC
GTACTGCTTCTCTACTTTGGCTTCGCTGCTACTGGAACTGTCTTGGCTGGACAAGCTATCAACAATGCATTTGGTGTC
CAGTCCAGGTGGATCGGAATACTGGTTTTTGCAGCTCTGACGGCAATTATTGCCATGTTTGGGTATGACCTAATCCAC
AAGCTGGTGAAGGTGTCATCGACAATTGGCCTCCTGGGGCTGCTTTATGTCGCGGTTCGTCTGTTCCAAGTGAGTTCC
TTTGGGCCGCAGCTGACCGATGTGCACTTCTCGGTGGTGCCTTTCCTCCTGTCGATTGCTTTAGCGGCAGGATGGCAG
TTGACTTACGCACCGTATGCCAGTGATTACTCACGCTATCTTCCCCGTGACACGAAGTTTGGGAGTGCGTGGTTCGGT
CCCTTCGCGGGATCAGTACTTGGAGCTACGATTTCGATGACGCTGGGTGTGTTCATTGCTGCTGCTGGTGGTCAAGCT
TTCATTGGCGATCAGGTTGGGTTTATGGGGAACCTTGCCCAGAATCGTGTTTTGGCGATCTTGGTTTTCATCTCCATT
GTGATTGGCAAGCTGACCATCAACACCTTGAATGCGTATGGCGGAGTCATGGCGTTGTCGACAGCTCTTTCGGGTTTC
ACCGGTAAGAGTAGTGTCTCTCCGAAGACTCGTTTCGGTTTCGTGATTGGTTTCAATGTTGTGGTTGTCCTGACGGCG
CTCGCGGCGTCGTCGGATTTTCTGCAAGTTTTCAAGTCTTTCATCTTGACTCTGCTGATGTTTTTCCTGCCATGGTCG
GCGATCAACTTGCTGAACTATTACCTTATATGTCGTCGCTGTATTGACATTCCTGCGCTGTACACTCCGAGGGGCCGT
TATGGCAAGCTCCACTGGCCGACCATTGTTGTTTATTTGCTAGGCGTGGTTGTGCAGATTCCGTTCATCTCTCAGGCC
TTTTATGTGGGGCCGGTCGCCGCAGCGATGGGTGGAGCGGACATCTCGTGGCTCGTGGGCCTTGTTGTTACAGCGTTG
GTATATTTTCCGCTTGGCAGACGAGCGTTTGATTACCCCTTGGAGATAGTCTATCCGAAGGATGTGGAGCTGGATCCA
AGCATTGTTTCTCGGGCTGCAGGCGGTCGTGGCAGCCACCATCACCATCACCAT 
 
SCO5579 
ATGAATTCGCATATGAGCAAGACCGCCGAGAACGAAGGCGCCCTGGAAACCCGCGGCATCGAGCAGGTGCCCGACCAC
GAGCGCACCGCCCGGACCCGCGAGCTGTTCCCGACCTGGGTCGGCGCCAACATCAGCGTGCTGTTGCTCACGATGGGC
GCGAGCCTCGTCGTGGCGTACCGGCTCAACTTCTGGCAGGCCCTGGTCGTCGCGGGGGCCGCGCCGGTCGTGTCGTAC
GGCCTGGTCGGGCTGATCGGCATCGCCGGCAAGCGGGGCGGGGCTCCCGGGATGGCGCTGTCCCGTGCCGTGTTCGGG
CAGCGGGGCAATCTGCTGCCCGGCTCGCTGATCTGGGTCGCCCGCTGGGGCTGGGAGACGATCAACGCGGTGACCGGT
GCCTATGCGCTGCTCACCGTGCTGGACATCGTCTTCGGCATACGCGCCAACAGCGTGCTGGACATGGTGACGCTGCTC
GCCTTCGTGGTGGCGACGTTCGCGATCTCGGGGCTGGGCATCAACGCCGTGCAGAAGTGCAACAAGTACGCGGCGTAC
CTCTTCGGTGCCTTCTCGGTGCTGGTGCTCGGCTATCTGGTCGTCGACACCGACTGGTCCGCCGTGTTCGACCGGTCC
GCCGGTTCGGTGGCCGCGATGATCACGGGTGTGGGTCTGATCGCGGCGGGCGGCGTCAGCTGGATCCCGTCCGCGCCC
GACTTCACCCGGTACCTGCCGCGCACGGCGTCCTCGAAGGGGATCGTCGGGGTCACGGTCGGCGGTGCGGGCATCGTC
GTACTGCCGATGGTGCTGATGGGCGCGGTCATGGCGGTCTCCACGCCGGATCTGGCCTCGGCCGCCGACCCGGTCTCC
TTCCTGGGCGAGATCCTGCCGACCTGGATCGCGGTGCCGTACCTGCTGATCGCGCTGATCGGCATGCTGCTGATCAAC
TCGATGTCGATGTACTCGGCCGGGTTCACCGCGCAGACCCTGGGCTTCAAGGTCCCGCGGCACTGGGCGGTCTCGGTC
AACGCCGTGATCTCGCTGGTCTTCGGCGGCGTGCTGATGCTGGTGGCGACCAGCTTCATGGGGTCCTTCATCGCGTTC
CTGTCGCTGCTCGCGGTCGCCTTCTCCGCCTGGGTCGGCGTCTTCGGCGCGGACATGCTGCGCGGCCGGGAGTACGAC
GGCGAGGCCCTGGCCGACACCGGCCGCACCAGCGCCTACTGGTACCGCGGCGGCTTCTCCCCCGCGGCGGTCGTCGCC
TGGGCGGTGGGCCTGGCCGCCGGTCTGATGTTCACCACGTCCGACTGGTTCACCGGTCCGCTCGCCACGGACAACTTC
GTCGGCGAGTACGGACTGGGCTGGGTGGCCACGGTCGTGATCTCCGCCCTGCTGTACGCGGTGCTGCCGAAGCCGGCG
CTGATCGTCCCGGATGCGCGCGCGGAGCGGGCCGAGCAGCCCGAGGCCGAGACCGTGACCGTCGCTGCAGGCGGTCGT
GGCAGCCACCATCACCATCACCAT 
 
 
 
 
Appendix 4 Amino acid sequences of the recombinant NCS1 clones.  The N-
terminal MNSH (blue) and C-terminal His6-tag (red).  Data for EF3000, Pden1111 and 
Pden4351 are not shown.   
 
b0336 (Note: silent mutation in protein, see DNA sequence) 
MNSHMSQDNNFSQGPVPQSARKGVLALTFVMLGLTFFSASMWTGGTLGTGLSYHDFFLAVLIGNLLLGIYTSFLGYIG
AKTGLTTHLLARFSFGVKGSWLPSLLLGGTQVGWFGVGVAMFAIPVGKATGLDINLLIAVSGLLMTVTVFFGISALTV
LSVIAVPAIACLGGYSVWLAVNGMGGLDALKAVVPAQPLDFNVALALVVGSFISAGTLTADFVRFGRNAKLAVLVAMV
AFFLGNSLMFIFGAAGAAALGMADISDVMIAQGLLLPAIVVLGLNIWTTNDNALYASGLGFANITGMSSKTLSVINGI
IGTVCALWLYNNFVGWLTFLSAAIPPVGGVIIADYLMNRRRYEHFATTRMMSVNWVAILAVALGIAAGHWLPGIVPVN
AVLGGALSYLILNPILNRKTTAAMTHVEANSVEHHHHHH 
 
b0511 
MNSHMEHQRKLFQQRGYSEDLLPKTQSQRTWKTFNYFTLWMGSVHNVPNYVMVGGFFILGLSTFSIMLAIILS
AFFIAAVMVLNGAAGSKYGVPFAMILRASYGVRGALFPGLLRGGIAAIMWFGLQCYAGSLACLILIGKIWPGFLTLGG
DFTLLGLSLPGLITFLIFWLVNVGIGFGGGKVLNKFTAILNPCIYIVFGGMAIWAISLVGIGPIFDYIPSGIQKAENG
GFLFLVVINAVVAVWAAPAVSASDFTQNAHSFREQALGQTLGLVVAYILFAVAGVCIIAGASIHYGADTWNVLDIVQR
WDSLFASFFAVLVILMTTISTNATGNIIPAGYQIAAIAPTKLTYKNGVLIASIISLLICPWKLMENQDSIYLFLDIIG
GMLGPVIGVMMAHYFVVMRGQINLDELYTAPGDYKYYDNGFNLTAFSVTLVAVILSLGGKFIHFMEPLSRVSWFVGVI
VAFAAYALLKKRTTAEKTGEQKTIGAAGGRGSHHHHHH 
 
 282 
Bsu36470 
MNSHMKLKESQQQSNRLSNEDLVPLGQEKRTWKAMNFASIWMGCIHNIPTYATVGGLIAIGLSPWQVLAIIITASLIL
FGALALNGHAGTKYGLPFPVIIRASYGIYGANIPALLRAFTAIMWLGIQTFAGSTALNILLLNMWPGWGEIGGEWNIL
GIHLSGLLSFVFFWAIHLLVLHHGMESIKRFEVWAGPLVYLVFGGMVWWAVDIAGGLGPIYSQPGKFHTFSETFWPFA
AGVTGIIGIWATLILNIPDFTRFAETQKEQIKGQFYGLPGTFALFAFASITVTSGSQVAFGEPIWDVVDILARFDNPY
VIVLSVITLCIATISVNVAANIVSPAYDIANALPKYINFKRGSFITALLALFTVPWKLMESATSVYAFLGLIGGMLGP
VAGVMMADYFIIRKRELSVDDLYSETGRYVYWKGYNYRAFAATMLGALISLIGMYVPVLKSLYDISWFVGVLISFLFY
IVLMRVHPPASLAIETVEHAQVRQAEAAGGRGSHHHHHH 
 
lp3374 (Note: silent mutation in protein, see DNA sequence) 
MNSHMQQESKYQIEVVAPKHRHMSNWDMFATWIGANANNGTWYVGGVLAACGLLTALKVIVASSTLSYLCLSLVGFMG
YKTGAATMSLIRGSFGVRGSYVPSFVNLTQYIGWTAVNTFIAATSVSYLLHDLVGWPVYGKPGGAKGLILGIIVMSVL
HLLSVSVGQRSVQMIERLGIILVILFVLWETVVVFQTVSVHDLLTWQAPTHLHMTAGAGMDTLAAFNLSWVTAGADFT
RFTRKKSGATGMPFLGAFTGLFWFAFIGLAATISIAITSGTYDPNNSDPSTIASRLGLGVLALLVIVLTSMTANAVNL
LAAGSALSNIFPRIRLRPALWAVTIIATLVTLIPLIMGSFLAAFTAFLDYIGMVLGPMISVMLVDYYWRHRQHYDINE
LASSKGQYWYHHGVNWIALLCWVLGVAIFLLLKHVVWIATVTGATFIDMALIGVIYVALMRIFYPLPAKRVAAGGRGS
HHHHHH 
 
PA0438 
MNSHMSADSNYSQQPVPLAARKSALALSVVMLGLTFFSASMWTGGTLGTGLSYDDFFLAVLLGNLMLGLYTAILGFIG
ARTGLSTHLLAHYSFGSKGSWLPSALLGGTQVGWFGVGVAMFAIPVAKATGLDVNLLILVSGALMTLTVFFGIAGLTL
LSAIAVPAIVVLGSYSVWLAVRDAGGLAALQQVTPSAPLSLSTAIALVVGSFVSAGTLTADFVRFGRSARTAVVVCLV
AFFLGNSLMFIFGAAGAAAVGKSDISDVMIAQGLLIPAILVLGLNIWTTNDNALYASGLGFANITGLSSRFLAMLNGA
LGTLAALWLYNHFVGWLTFLSAAIPPIGGVIIADYLSRRRRYRQHPCADIQAINWAAILAVACGTAAGHWLPGIVPVN
AVLGAAIAYLLLNPLLSRSPNKPEEVLHADHHHHHH 
 
PA0443 
MNSHMQQSRSEVTERDGLVELSAGSDVLDSPRYNHDIAPTRVEQRTWNRWHITALWIGMSICVPTYTLGGVLTAYFGL
SVGEALLAILLANLVVLIPLTLNAFAGTRYGIPFPVLLRASFGIIGSNVPCLIRAVVACGWFGIQTLFGGLAIHLFLG
SIFPAWKALGGTGEVIGFLLFWGLNLWVVLRGAESIKWLETLSAPLLVLVGLGLLVWALPHISVSELLAQPPKRPEGA
SVTGYFMAGLTAMVGFWATLSLNIPDFSRYARSQKDQILGQIFGLPLTMFLFAALGVVMTAASASLVGETVSDPVSLI
GHIPSPGWVAVAMALIIVATLSTNTAANIVSPTNDFQNIAPKLIGRTRAVWLTGFIGLALMAHELLKKLGWIVSDLSL
ESVYSNWLLGYSSLLGPIAGIMVVDYFLVRRQRLDLAGLYRDDVYPAWNWPGFAAFAVPVALTVMALGNRQFHWFYDY
GWFTGSLLGGALYYGLCGRRARSPAALAKPLPAAGGRGSHHHHHH 
 
PA2073 (Note: Cloned protein have a N-terminal MNSQ not MNSH) 
MNSQMSNNNEASRPKIEVRSIDYVPRHERHGKVWHQAPFWFTGNFVLTTMVTGFTGPALGLGALYSILAIVLGVCFGT
FFMAFHANQGPRMGLPQMIQSRAQFGLRGAIVPFAAVVFVYIGFNVFNVILATDAINTVLPGHRAPWYVLLIGVAVLL
AIVGHDLLHTVQRWLTYVMIAVFGVLTVSALRSLEADAALGGTPAFSWSAFLVQLSAAAGYQISYAVYVSDYSRYLPH
ETPTRKVIFWTYLGAAGSALWLMSLGAFLASALPAPDAIGSVREVGNRLYPGFGTFTVLIAVPALVGIMAVNCYGAML
TSLSAIDAFRKVTPTLNLRVTGIGVIALVVFGVALSIPESYLGSFNTFVLLMLYFLVPWTAVNLVDFYFVRNGHYAIS
EIFNPEGIYGHWGRPGLSAYLAGLLAMVPFMSLSFYSGPFAVALGGADVAFVVGLLVAGAVYAFMCRALDLEAERRLA
TLGERLLEEGGAAAGGRGSHHHHHH 
 
PPA0619 
MNSHMTQTATKTNATTHKGIETTGIEIVKESQRTAQPQDLFLPWFASNVSVFGMSYGAFMLGFGVSFWQAIAATLVGV
IVSFGFCGIIAIAGKRGSAPTMVLSRAAFGTQGNKIPGVISWMTSIGWETSLAITAVLATTTIFRRLGWSSGNSVKIC
ATIIVAFLIVGGAVAGYHIIMKLQAVLTWITGILTVIYLVMAVSHIDWHAATSLPAASFPAFVGTLTLIMTGTGLGWT
NIAADWSRYQSRTSPGFAIAFWNVFGASLPLVILITGGLLLAASSKNLSDAIGADPIGALATILPTWFLIPFLLAAIL
SLLAGAINGIYSSGLTLLTLGIRVPRPAASLIDETILTIGTLYVVFVAPNFISPFQSFLVTLGVPLSGWTGIMMADIT
LRRRPYDEADLFNGSGRYGHFDPISIITFVIVTVIGWGLVVNTYEGVNWNDWQGFLLGPIGLGGREGDWAHANLGVFG
ALVLGYVVTLIARRGTVRRQESRAAGGRGSHHHHHH 
 
PPA2211 
MNSHMVSAPNSAQDEVRHGNTAPTASGAGRGVEKRTIDMVPDGERHGTPKSQFTLWFGVNMQITAVVNGALAIVFGAD
VVWAIIGLFIGQVIGGAVMALHSAQGPALGLPQMISSRAQFGVYGAALPLFLVLLLYFGFAATGTVLAGQAINNAFGV
QSRWIGILVFAALTAIIAMFGYDLIHKLVKVSSTIGLLGLLYVAVRLFQVSSFGPQLTDVHFSVVPFLLSIALAAGWQ
LTYAPYASDYSRYLPRDTKFGSAWFGPFAGSVLGATISMTLGVFIAAAGGQAFIGDQVGFMGNLAQNRVLAILVFISI
VIGKLTINTLNAYGGVMALSTALSGFTGKSSVSPKTRFGFVIGFNVVVVLTALAASSDFLQVFKSFILTLLMFFLPWS
AINLLNYYLICRRCIDIPALYTPRGRYGKLHWPTIVVYLLGVVVQIPFISQAFYVGPVAAAMGGADISWLVGLVVTAL
VYFPLGRRAFDYPLEIVYPKDVELDPSIVSRAAGGRGSHHHHHH 
 
SCO5579 
MNSHMSKTAENEGALETRGIEQVPDHERTARTRELFPTWVGANISVLLLTMGASLVVAYRLNFWQALVVAGAAPVVSY
GLVGLIGIAGKRGGAPGMALSRAVFGQRGNLLPGSLIWVARWGWETINAVTGAYALLTVLDIVFGIRANSVLDMVTLL
AFVVATFAISGLGINAVQKCNKYAAYLFGAFSVLVLGYLVVDTDWSAVFDRSAGSVAAMITGVGLIAAGGVSWIPSAP
DFTRYLPRTASSKGIVGVTVGGAGIVVLPMVLMGAVMAVSTPDLASAADPVSFLGEILPTWIAVPYLLIALIGMLLIN
SMSMYSAGFTAQTLGFKVPRHWAVSVNAVISLVFGGVLMLVATSFMGSFIAFLSLLAVAFSAWVGVFGADMLRGREYD
GEALADTGRTSAYWYRGGFSPAAVVAWAVGLAAGLMFTTSDWFTGPLATDNFVGEYGLGWVATVVISALLYAVLPKPA
LIVPDARAERAEQPEAETVTVAAGGRGSHHHHHH 
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Appendix 5 Comparison of the codon usage of the NCS1 family of transporters 
and the E. coli expression host.  The fraction of usage of each codon in the protein was 
computed and plotted against the fraction of usage of the codon in the E. coli expression 
host (relative adaptiveness), and a mean difference value (mean relative adaptiveness) 
of codon usage calculated.  The analysis were computed and plotted by ‗Graphical 
codon usage analyser‘ (Fuhrmann et al., 2004).  Black bars represent the E. coli codon 
usage, and red bars represent the codon usage of the selected NCS1 protein. 
 
 
b0336  mean difference: 26.34%      
 
 
b0511  mean difference: 20.38% 
 
 
Bsu36470 mean difference: 22.52%     
  
EF3000 mean difference: 30.16% 
 
 
lp3374  mean difference: 29.08% 
 
 
PA0438 mean difference: 43.88% 
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PA0443 mean difference: 42.95% 
 
 
PA2073 mean difference: 43.33% 
 
 
Pden4351 mean difference: 31.83% 
 
 
Pden1111 mean difference: 28.94% 
 
 
PPA0619 mean difference: 29.70% 
 
 
PPA2211 mean difference: 26.05% 
 
 
 
SCO5579 mean difference: 34.14% 
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Appendix 6 GC contents and rare codons in the NCS1 family of transporters.  The 
number of rare codons in each NCS1 protein was calculated using ‗Rare codon caltor‘ 
(Ng, E., 2001). 
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b0336 0 2 0 0 4 7 0 1 1 7 22 (0) None 53 
b0511 0 1 1 1 7 4 2 3 2 3 24 (1) CCC,GGA (x1) 47 
 
 
Bsu36470 
 
 
0 
 
 
5 
 
 
2 
 
 
0 
 
 
15 
 
 
 
4 
 
 
7 
 
 
2 
 
 
2 
 
 
8 
 
 
45 (7) 
CGG,AGG (x1) 
GGA,GGA (x2) 
GGG,AUA (x1) 
CUA,AGG (x1) 
GGA,AGG (x1) 
GGA,CGG (x1) 
 
 
49 
 
EF3000 
 
8 
 
7 
 
6 
 
4 
 
3 
 
0 
 
13 
 
 
0 
 
9 
 
4 
 
54 (4) 
AUA,AUA (x1) 
CCC,AUA (x1) 
AUA,GGA (x1) 
CGG,CGA(x1) 
 
42 
 
lp3374 
 
4 
 
6 
 
0 
 
0 
 
4 
 
12 
 
 
1 
 
8 
 
1 
 
18 
 
54 (4) 
ACG,CUA (x2) 
ACG,CGG (x1) 
CGA,CUA (x1) 
 
49 
PA0438 0 1 0 0 1 2 1 0 4 2 11 (1) GGG,AUA (x1) 68 
PA0443 0 2 2 1 1 7 2 0 9 4 28 (0) None 67 
PA2073 2 3 0 0 2 8 0 0 6 2 22 (1) CGA,CGG (x1) 66 
Pden4351 0 6 2 0 1 12 1 0 7 6 35 (3) GGG,ACG (x2) 
GGA,CGG (x1) 
65 
Pden1111 0 4 1 0 3 13 1 1 11 4 38 (1) GGA,ACG (x1) 65 
 
PPA0619 
 
3 
 
2 
 
0 
 
0 
 
11 
 
14 
 
1 
 
3 
 
9 
 
13 
 
56 (5) 
ACG,ACG (x1) 
CCC,GGG (x2) 
ACG,ACG,ACG (x1) 
GGG,CCC (x1) 
 
58 
 
PPA2211 
 
2 
 
2 
 
3 
 
1 
 
10 
 
12 
 
4 
 
2 
 
4 
 
8 
 
48 (4) 
CGA,ACG (x1) 
GGG,CCC (x1) 
GGA,AUA (x1) 
AGA,CGA (x1) 
53 
SCO5579 0 9 0 0 1 10 1 0 6 11 38 (1) CCC,GGG (x1) 70 
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Appendix 7 DNA sequences of the recombinant histidine kinases clones.  The N-
terminal MNSH (blue) and C-terminal His6-tag (red).  Only the clones that are made by 
myself are shown. 
 
EF1051  
ATGAATTCGCATATGAAAAGAACGATTAAAAAAGAACTGGAAGGCCCATCTTTAACTATAAAGTGGGCTTTCGCAAGT
TCTTTCTTTATATTTGTAGTTTTTACCATTTTTGCGGTGATTACCTATAAGTCTTCTGTCAGTCTTATTGTTGCCAAA
GAAAAGGAAAATGTCGAAGCAACGATTGCAGAAGTAACAAATCGATTAGCTAATGCCAATGAAAATTTAACGGTAACA
GACGTTTTTGACTATTTAAAAACGCCGAGTGAAAGAGATGAAAACTACTATAATAAGCATACAGCAGTAGAAGGTTCG
TTTATGGAAATGGACAGTTTCATATCTGAACTAGGACAACCAGAACTTTATTTATCTGTGTATGACACAAACCAAAAG
CTAGTTTTTAAAACACAAAATGAATATGATAAGTTATTACAATTGGATCGACAATTACCTGTTGTTCGAACCGTTTTT
GATAAAACCGGTTTTTATTCCGTGGAACCTATTTTTTCAAAAGAAACACGAGAAAAGATTGGCTATATTCAAGCGTTT
TATGAACTTTCTTCTTTTTATGAAATTCGTAATCATTTATTATTAACACTTGTAGTTTTAGAAGTGATTTCTCTGATT
GTAAGTAGTGTCTTAGGCTTTATCCTCTCTTCTTATTTCTTAAAACCATTAAAAGTATTGAGAGACACGATGGATACA
ATCCGCAAAGACCCGCAATCAGATGTCCACATGCCGGAGATTAATACGAGAGATGAGTTAGCAGATATCTCGGAAATC
TTTAATGAAATGTTAGATCGTATGAGACGCTATATCGAACAACAAGAGCAGTTTGTTGAAGATGTTTCCCATGAATTA
AGAACGCCCGTTGCGATTATGGAAGGCCATTTAAACCTTTTAAATCGTTGGGGGAAAGACGATCCTGAAATTTTAGAT
GAATCATTAAAGGCCAGTTTACAAGAAATTAGTCGTATGAAGAGTTTGGTCCAAGAAATGCTTGACCTTTCACGCGCT
GAACAAGTGGACACCCAATATGCAAATGAACGAACAGATGCTAAACAAGTAGTCTACCAAGTATTTAATAACTTCCAA
TTGGTTTATCCTGAGTTTCATATCACATTAGATGACGATTTACCAACCGAAGTTGAGCTGAAAATCTATCGTAATCAC
TTTGAACAATTGCTAATTATTCTATTAGATAATGCGATTAAATATTCAACCGATCGAAAAGAAGTGCATATTTCCATT
TCTCGAACGATGAATGAATTTGAAATAGCTGTGCAAGATTTTGGTGAAGGAATCACTGAAGAAGACTTGGAGAAAATA
TTTGATCGATTCTATCGAGTAGATAAAGCCCGTGCAAGAAATAAAGGTGGTAATGGCTTAGGTCTATCGATTGCAAAA
CAATTAGTCGAAAACTATAAAGGACGTATTGATGCAGAAAGCGTATTGCATCAAGGAACGATCTTTAGAATTTTTATT
CCAATCGCTGGAATAAAAGAAGAGAGCAACGTACAAGCTGCAGGCGGTCGTGGCAGCCACCATCACCATCACCAT 
 
EF1820 
ATGAATTCGCATATGATTTTGTCGTTATTAGCTACTAACGTTTTGCTTGTATCTAGCTTTATCGTTTTTGTCTTTTTA
CGAGTAACATTGATCAAGATTGAATGTAAAATACCGTTACTTTCATTGCTTATTGTCATTAATCTTTGTTCGTTTGCG
GCATTAATGTTGGGCTACTCTTGGTTGATTTATGCGCTGACAGTCGTTATTTTTACAGGATTTTTACTCATTCACAAA
AAGAGGTTCTCAATTTTTAAAGCGATATTTTTGTCTGTTTTTACATTGCTTATGGTTTCGTTTATCAATTACACGGAG
CAAACGATTTTAAGTGTTTTTTTTCAACAGATTTATCAAAATAAATTATTATGGATTGCCTCAAATGTTCTTCTGTTG
CTTATAAATATCTGGATTGCTTTAAAAATTCCCAATAGTGTTTTTTTAAGATTAAATCGTGTGTTAGAAAATAGCCGA
ATTTTTTTTGGTTGTTTACTTTTATTGTTGATTCTGTTGTTACTTTTTGTGTTTTTGATTTCGCCAGAGATTTCACCT
GACTTTATGCGAGGATTTGTCACGGTAAATAGTTCTAAATTGGAGTTATTAATAAGTGTAGGTTTATTTTTAATTCTG
ATTGGCTTAGTCATTGAAGCTTATTTGGAAGAACAACGTATCAACACTCAATTATTGAATAATTTAACGATTTATACT
GAAAAAATAGAATCCATTAACGAAGAGCTAGCGATGTTTCGTCATGATTATAAAAATTTATTGTATAGTTTACAAATT
GCTATTTCATACGAAGATATTCTGGAAATCAAAAGAATTTATGAAGAAACGATTGCACCAACCAAAAAAATTATTGAT
AATGAAGAATTTGAACTTATGAAGTTAAATCGTTTGAAAAATATGGAACTTAAGGCACTCATAAGTATGAAAATTAAT
ACCGCAAAGCAAGCAAAACTAAAAGTGATTGTTGATGTGCCAGAAGTATTTATTCTTGATACATCAATCGACTTAGTG
GTTGTGATTCGTTTGTTGGCTATTCTATTAGATAACGCGATTGAAAACAGTGCAAAATCAGAATTGAAAATGTTCGCT
ATCTCAATTTTCAATAAAAATGAAACACAAGAGTTTGTGATAACAAATAGTGTCCAAGCCGAATTTGATTTTAAGGTT
ATGAAGAAAACCAAATTTAGTTCTAAAAGTAATCCAGAAGAGCACGGTTGGGGATTGTTATATGTAAAAGAAATTGTT
GATTTTTCAGATCAATTTGATTTGCAAACGTCCTTCAATGAAGGAGCGGTCACTCAACATTTAATTATTGAAAAAAAT
CATAACAGTAAAAAAGTTGTTAACGAAGCTGCAGGCGGTCGTGGCAGCCACCATCACCATCACCAT 
 
EF2912 
ATGAATTCGCATATGACCGATCGGATTTCAAGACGCATGATTTCATTATATGCGTCCCTTAGCACCTTTATTGTTATC
TTAATTACATTGTTTTCATATTTTCATTCGATTAAACAAAACCGGTGGTTATTAGAGCTTCTTCAGAGAAAAGTCTTT
TATTTACCACTAATTGTGCACATTGTTCTCATATCCTTACTAATAGGCTTATTGACCTTTTTACTGATTTCATTGGTT
CAAAAAGGGCAATATGGACGGATTGAAGAAAAACTTCGGTTATTGGCCAACGGTAATTATGAAAGTCCAGTCTTAAAC
AAACCAACGACCAGTGAAAATCAAGACCATTATCTAACCGAAGTCGAACAAGATATTTGGTCGATTAAAAATAAATTA
TTAGAGATGTCTAAAGAATTGCAATTATTAAACAGTCGACCGCAATTAATGGATGGGCAAACAAAAGAAGAAATTTTA
GAGAACGAGCGGCATCGTTTGGCGCGGGAGTTGCATGATTCAGTCAGTCAACAACTTTTTGCAGCCATGATGATGTTG
TCTGCATTAAATGAACAAGCACAACGAACAGAAACCCCGGAACCATATCGTAAACAACTAGCCATGGTGGCAGAAATC
ATTAATGCCTCCCAATCGGAAATGCGCGCGCTACTATTGCACTTGCGTCCTATCAGTCTAGAAGGAAAAAGTTTGCGT
AAAGGTATTGAACAATTACTGAAAGAACTACAAACAAAAATTAAAATTGAATTGATTTGGGATGTTGAAGATGTTCAT
TTAAATAGCAGCATTGAGGATCATCTTTTCCGAATTGTGCAGGAGTTACTTTCAAATACCTTAAGACATGCCAAAGCA
AAGGAATTAGAGGTATACTTACACCAAGTCGATAAAAACGTGTTATTGCGTATTGTTGATGATGGTGTCGGCTTTGAT
ATGAAGGAACAAAGTAATAAAGCCGGTAGTTATGGCTTAAATAATATTCGAGAACGTGTTGTCGGCATGGGCGGTACA
GTTAAAATTATTAGTTTTAAAGGGCAGGGAACCAGCGTTGAAATTAAAGTTCCTGTCATAAAGGAGGAAACTGCAAGT
GATCAAAGTAATGTTAGTGGAGCTGCAGGCGGTCGTGGCAGCCACCATCACCATCACCAT 
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EF3197 
ATGAATTCGCATATGGTCGAATTATTTATTTTAATGATGGAACGGGTGGGCTTAATTATTTTACTGGCCTTTCTTTTA
GTGAATGTGCCTTATTTTAAGCGTGTTTTATTAAGTCGTGAAAAAATGTCTTCAAAAGTTCAGTTGATTTTGATTTTT
GGTTTATTTGCTATTATTTCTAATTTTACAGGTATCGAAATCGCTAAGAATCAGATTGTTCCCAATAATTTACTAACC
TATTTAAGCAGCAATGCTTCCATTGCGAATACGCGTACGTTAGTAATTGGCGTTTCTGGATTAGTGGGTGGTCCGATT
GTCGGCAGTGCGGTTGGTTTAATTGCTGGCTTTCATCGGGTTATTCAAGGCGGGGGGCATAGTTTCTTTTATGTGCCT
GCTTCTTTAATTGTTGGCTTAATTGCCGGTTTTTTAGGGAGCCGCATGGCAAAGCAAACTGTTTTTCCGTCTGCCGGC
TTTTCTGCCATTGTCGGAGCGTGCATGGAAATGATTCAGATGATTTTTATTTTCTTTTTCAGCGGTGATCTATCGGAT
GGGGCCACGTTGGTTCGTTTTATTGCGCTGCCGATGATTTTGTTAAATAGCGTAGGAACGTTCATTTTTATGTCGATT
CTAACGACGACATTGAAACAAGAAGAGCAGGCCAAAGCGGTTCAGACGCACGATGTTTTGGAATTAGCAGCGGAAACA
CTGCCATATTTTCGAGAAGGCCTCAATAAAAATTCCAGCAAAAAAGTTGCGGAGATTATTAAGCATTATACAAAAGTC
AGTGCGATTAGCATGACAAACAGTCATCAAATTTTAGCTCATGTTGGCGCAGGAAGCGATCATCATATTCCAGAGCTA
GAAGTCATTACGGAGCTTTCTCGGGAAGTGTTACGGACGGGCCGAATGACCATCGCGCATGCCAAAGAAGAAGTTGGT
TGTTCGGACCCTAATTGTCCGTTGCAAGCGGCGATTGTGATTCCATTATTTTCCCATCAGCAAATTGTTGGCACCTTA
AAAATGTACTTTACAGATCCAGCGCAGTTAACGCATGTCGAGGAGCAGTTAGCAGAAGGTCTTGGGACAATCTTTTCT
TCACAAATTGAATTAGGTGAAGCGGAAGTACAATCAAAATTACTTAAAGAAGCTGAAATTAAATCCTTGCAAGCGCAA
GTGAACCCGCATTTCTTCTTTAATGCCATCAATACTATTTCCGCATTAATGCGGAAAGACAGTGAAAAAGCGCGGAAA
CTATTGCTCCAATTAAGCAAATACTTTCGAGGCAACTTGCAGGGAGCCGTGCAAACTACGATCCCAGTTTCACAAGAA
CTAGAACAAGTAAAAGCCTATTTGTCATTAGAACAAGCACGGTTTCCGAATCGTTATCAAGTAACATTTGACGTGGAA
GAAGCGGTTGCTTCAGAAAAAGTACCGCCGTATGCGATTCAGGTGTTAGTGGAAAATACCATCAAGCATGCATTTGGC
AGCCGGAAGGAGAACAATCAAGTCCGGGTAGTGGTCAAAGCAAAACAACACAAATTACATGTGGATGTGTATGACAAT
GGGCAAGGGATTCCTGAAGAACGCCGCTTGCTATTAGGAAAGACGACAGTGACTTCGGAAAAAGGCACCGGCACGGCA
CTGGAAAACTTGTCCCGCAGAATGGCGAACCTTTATGGATCAGAAGGTTGTTTTTTAATTGAAAATTTAGAGACAGGC
GGGAGCCATGTTCATTTAGAAATCCCGATGGAACAGGAGGAATTAGATGCACGTATTAATCGTGCTGCAGGCGGTCGT
GGCAGCCACCATCACCATCACCAT 
 
EF1209 (mutation highlighted in yellow, from C to T, giving rise to amino acid 
change H to Y) 
ATGAATTCGCATATGAAGCGTGGCGGGAAATTATGGTGTTTCTTATCAGTGATTTTTATTGCAACATTAATTATTATG
ATTACTTTCTTTTACGGAGTAACGACGGTTCAAACAATTAAAGAAGTTCGTAAAAACCAAGAGCAAGCACTTTTAGCC
GTCGGGGAACAGTTGGCTATTGAACCGAATGTTATTGAAGCCTTAAAGAATGATCACTATTCAGATGAATTGGAAGCG
TATACGGTTCGTTTAGGTGAAATCCATCAGTTGGATTTTATCGTGATTATGAATATGCAGGGGATTCGTTTAACACAT
CCTGATCGCCAAAAAATAGGTAAGCATTTTGAAGGTGGCGATGAAGTGCGAGCATTAAAAGGGGAGGAACATTTGTCT
GTTAGTCAAGGGAGTTTAGGAGAATCATTACGAGGTTTTGTCCCAGTCTATGATCAAGGAAAACAAATTGGGGTTGTG
GCAATGGGCATTAAAATGACCTCGCTTTCACAATTGATTGAACGAACAAAAAATGATTACACAGTGAGTGTCCTTTTA
AGTGTTGGTTTTGGCTTTATATTAGCCATCGTGGTTTCTTATTATTTAAAAAAACAACTTCACGATTTAGAGCCAAGA
GAAATTGCTCGTCTATTAGAAGAGCGAAACGCCATGCTTGAGGAAACGAAAGACGCAATCCTTGTGATTGATACCGAT
CAAAATATTTTATTAGCAAATATTGAGGCGACTAAAATGTATCATAATATAACAAATAGTGAAGAAAATTTACTAGGA
AAGAAACTTTCAGCATTGGTTTTATCTCCTGAAAAATTAGTCGTACATTCAAAAACAGAGCAATTCTATCGTCAAAAT
GGCCAGGATTATTTCGTCTCAATCGCCCCGATTAATGTCCGTAAAAAAACAATTGGGCATGTTATCTTTCTGAAAAAT
GCGACAGAAACGTTTATTGTCGCAGAACAGCTTGTCAGCACAACAACATATGCTTCGGCATTACAAAGTCAATCACAC
GAATTTATGAATAAGATGCATGTCATTTATGGCTTAGTCGATTTAGAAGATTATGAGGCGCTAAAACATTATCTAGCC
GATTTATTGAAACCAGAAAAGGAATTTGCACAGCGCTTAGCTATTTTGGTCAGAAATCCTATTCTAGCAGGTTTTTTA
AGTGGGGAAAGAATCAAGTTTGCAGAAATTAAAACACAATTAGCTATTGAAATTTATCCAGAAATTCCACCAAATAAA
CGAGATGAAGATACGCAAAATTTGATTGCTATCTACCGTTATATTTATCGTTTCCTGATGGAGCAAACGTTGCCAGAA
GAGATCATTGAAACCATTGATTATCAGCCAGGAAGTTTGACGACGACTTATTCGTTTGCTTATCCAAAAGAACAACTG
GAACGCTTTGAGCAAGAGTTTTTCACTTCTTATTTGGCAAGATTATTAGAGAATGCGGAAGCGACATTGACTTGGGAA
AACCAACAAAACAATTGGCTTGTCCTTCGCATAAATGTTCATTACGAAGGAGCAGAGGAAAATGAACCTATTGATTAT
GCTGCAGGCGGTCGTGGCAGCCACCATCACCATCACCAT 
 
EF0373 
ATGAATTCGCATATGACCATTAAACGCCGCTTTTTTATTTCTTATATTAGTGCCATCATTATTACTTTAGCCTCTGTTTTAGCTGTTT
TATCCTTAGCTTCTTACATCACATTAGGAACTGTCCCCAGTTTGCCCCAAGCTTACCGAATGATGAATAAGCAACGACCATTGACCGC
TAACGAAGAAGAAAGTTATTTGGCCTTAGATCAACTGCTAAAAAAATCACCGAAATTACTAGATACACCTTTGAGTAAAGAATTAAAG
GAAACGATTCAAACAATTGAAGCAAAAGGATTAAGTGTGATTATTCGAAAGAATGCACGGTTTCCTTATTATTCGGATAATTTAGTAG
AAAAATCTTTGTCTGTACATATTCCAAACTACGAAATGAATAATATTATGCCAACTGGCACACTGGATAATGCAGGGCGTCTATATCA
TTATGTCAAATCCGATTTTCATTATTTAGATGGTTCTAACGGGAGCTTTATTGTCTTGAAACGCGAAAGCAGCCTTTTTGAATTCTTC
ACACGCTGGATTATCTGGATGATTTTGTTAATTATCCTTGTAGCAATTGCGGCAGCTTGGCTCATTAATAAGCGCTTAACCAAAACCA
CTATCGAGCCATTAGAAGCATTAGAAAAAGCGACTAAAACATTGGGTAAGGATGCCCAAAAAGAAAATCCATTTACGCCAACTAGCCA
CCAAACCGTCTCAACAGAAGTCAAACAGCTCCAACTTAGTTTTGAACAAATGTGGCAAGATTTAGAAGAAGCCAATGCGGAACGCGAA
AAATATGAAGCTAATCGGAAAGAATTAATTGCAAATATTTCTCATGACTTAAAAACACCAATTACTTCTATTATTGGTTATGTTGAAG
GTTTGATGGATGGCGTTGCCAATACTGAAGAAAAAAAACAGCGCTATTTAACGGTCATTCATGAAAAAAGTTTAGGCCTCAATGATTT
AATTGAAGAATTATTTTTGTATTCTAAATTAGACCTAGACCGTGCTGTCTTTACAATGGAAAAGACCAATTTCACTCGTTTTATTGCA
CATATTCTTGAAGAATACCGTTTGGAACAAGAACTCGTAATCACTTCTGTACTTCCCACCGAAGCTTTATACGTTCAAATGGATCCCA
CGCAGATGAATCGCGTGATTACCAATCTAATTCAAAATAGCATTAAATTTGCGGATCCCACTAAAGAACAACTAGCCTTTACGATTTC
TTTAACGCATAATCAAACAGACTTAGTTTTAACCATTACAGATAACGGCATTGGTATCGATAAAAAAGAATTACCTTATTTATTCGAA
CGCTTCTATCGTGTAGACAAATCTCGAACCCCAACAGTTAAAGGAAGCGGCTTGGGATTAAGTATTGTCAAACAAATTATTGACTATC
ATCAGGGAACAATCACTGTCACAAGTAAAAAAGGAGACGGCACCAACGTGATAATTACGCTGCCGTTGTTGGAGGATGAAAAAGCTGC
AGGCGGTCGTGGCAGCCACCATCACCATCACCAT 
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Appendix 8 Amino acid sequences of the recombinant histidine kinase clones.  The 
N-terminal MNSH (blue) and C-terminal His6-tag (red).  Only the clones that are made 
by myself are shown. 
 
EF1051  
MNSHMKRTIKKELEGPSLTIKWAFASSFFIFVVFTIFAVITYKSSVSLIVAKEKENVEATIAEVTNRLAN 
ANENLTVTDVFDYLKTPSERDENYYNKHTAVEGSFMEMDSFISELGQPELYLSVYDTNQKLVFKTQNEYD 
KLLQLDRQLPVVRTVFDKTGFYSVEPIFSKETREKIGYIQAFYELSSFYEIRNHLLLTLVVLEVISLIVS 
SVLGFILSSYFLKPLKVLRDTMDTIRKDPQSDVHMPEINTRDELADISEIFNEMLDRMRRYIEQQEQFVE 
DVSHELRTPVAIMEGHLNLLNRWGKDDPEILDESLKASLQEISRMKSLVQEMLDLSRAEQVDTQYANERT 
DAKQVVYQVFNNFQLVYPEFHITLDDDLPTEVELKIYRNHFEQLLIILLDNAIKYSTDRKEVHISISRTM 
NEFEIAVQDFGEGITEEDLEKIFDRFYRVDKARARNKGGNGLGLSIAKQLVENYKGRIDAESVLHQGTIF 
RIFIPIAGIKEESNVQAAGGRGSHHHHHH 
 
EF1820  
MNSHMILSLLATNVLLVSSFIVFVFLRVTLIKIECKIPLLSLLIVINLCSFAALMLGYSWLIYALTVVIF 
TGFLLIHKKRFSIFKAIFLSVFTLLMVSFINYTEQTILSVFFQQIYQNKLLWIASNVLLLLINIWIALKI 
PNSVFLRLNRVLENSRIFFGCLLLLLILLLLFVFLISPEISPDFMRGFVTVNSSKLELLISVGLFLILIG 
LVIEAYLEEQRINTQLLNNLTIYTEKIESINEELAMFRHDYKNLLYSLQIAISYEDILEIKRIYEETIAP 
TKKIIDNEEFELMKLNRLKNMELKALISMKINTAKQAKLKVIVDVPEVFILDTSIDLVVVIRLLAILLDN 
AIENSAKSELKMFAISIFNKNETQEFVITNSVQAEFDFKVMKKTKFSSKSNPEEHGWGLLYVKEIVDFSD 
QFDLQTSFNEGAVTQHLIIEKNHNSKKVVNEAAGGRGSHHHHHH 
 
EF2192  
MNSHMTDRISRRMISLYASLSTFIVILITLFSYFHSIKQNRWLLELLQRKVFYLPLIVHIVLISLLIGLL 
TFLLISLVQKGQYGRIEEKLRLLANGNYESPVLNKPTTSENQDHYLTEVEQDIWSIKNKLLEMSKELQLL 
NSRPQLMDGQTKEEILENERHRLARELHDSVSQQLFAAMMMLSALNEQAQRTETPEPYRKQLAMVAEIIN 
ASQSEMRALLLHLRPISLEGKSLRKGIEQLLKELQTKIKIELIWDVEDVHLNSSIEDHLFRIVQELLSNT 
LRHAKAKELEVYLHQVDKNVLLRIVDDGVGFDMKEQSNKAGSYGLNNIRERVVGMGGTVKIISFKGQGTS 
VEIKVPVIKEETASDQSNVSGAAGGRGSHHHHHH 
 
EF3197 
MNSHMVELFILMMERVGLIILLAFLLVNVPYFKRVLLSREKMSSKVQLILIFGLFAIISNFTGIEIAKNQ 
IVPNNLLTYLSSNASIANTRTLVIGVSGLVGGPIVGSAVGLIAGFHRVIQGGGHSFFYVPASLIVGLIAG 
FLGSRMAKQTVFPSAGFSAIVGACMEMIQMIFIFFFSGDLSDGATLVRFIALPMILLNSVGTFIFMSILT 
TTLKQEEQAKAVQTHDVLELAAETLPYFREGLNKNSSKKVAEIIKHYTKVSAISMTNSHQILAHVGAGSD 
HHIPELEVITELSREVLRTGRMTIAHAKEEVGCSDPNCPLQAAIVIPLFSHQQIVGTLKMYFTDPAQLTH 
VEEQLAEGLGTIFSSQIELGEAEVQSKLLKEAEIKSLQAQVNPHFFFNAINTISALMRKDSEKARKLLLQ 
LSKYFRGNLQGAVQTTIPVSQELEQVKAYLSLEQARFPNRYQVTFDVEEAVASEKVPPYAIQVLVENTIK 
HAFGSRKENNQVRVVVKAKQHKLHVDVYDNGQGIPEERRLLLGKTTVTSEKGTGTALENLSRRMANLYGS 
EGCFLIENLETGGSHVHLEIPMEQEELDARINRAAGGRGSHHHHHH 
 
EF1209  
(NOTE: mutation hightlighted in yellow, H to Y) 
MNSHMKRGGKLWCFLSVIFIATLIIMITFFYGVTTVQTIKEVRKNQEQALLAVGEQLAIEPNVIEALKND 
HYSDELEAYTVRLGEIHQLDFIVIMNMQGIRLTHPDRQKIGKHFEGGDEVRALKGEEHLSVSQGSLGESL 
RGFVPVYDQGKQIGVVAMGIKMTSLSQLIERTKNDYTVSVLLSVGFGFILAIVVSYYLKKQLHDLEPREI 
ARLLEERNAMLEETKDAILVIDTDQNILLANIEATKMYHNITNSEENLLGKKLSALVLSPEKLVVHSKTE 
QFYRQNGQDYFVSIAPINVRKKTIGHVIFLKNATETFIVAEQLVSTTTYASALQSQSHEFMNKMHVIYGL 
VDLEDYEALKHYLADLLKPEKEFAQRLAILVRNPILAGFLSGERIKFAEIKTQLAIEIYPEIPPNKRDED 
TQNLIAIYRYIYRFLMEQTLPEEIIETIDYQPGSLTTTYSFAYPKEQLERFEQEFFTSYLARLLENAEAT 
LTWENQQNNWLVLRINVHYEGAEENEPIDYAAGGRGSHHHHHH 
 
EF0373  
MNSHMTIKRRFFISYISAIIITLASVLAVLSLASYITLGTVPSLPQAYRMMNKQRPLTANEEESYLALDQ 
LLKKSPKLLDTPLSKELKETIQTIEAKGLSVIIRKNARFPYYSDNLVEKSLSVHIPNYEMNNIMPTGTLD 
NAGRLYHYVKSDFHYLDGSNGSFIVLKRESSLFEFFTRWIIWMILLIILVAIAAAWLINKRLTKTTIEPL 
EALEKATKTLGKDAQKENPFTPTSHQTVSTEVKQLQLSFEQMWQDLEEANAEREKYEANRKELIANISHD 
LKTPITSIIGYVEGLMDGVANTEEKKQRYLTVIHEKSLGLNDLIEELFLYSKLDLDRAVFTMEKTNFTRF 
IAHILEEYRLEQELVITSVLPTEALYVQMDPTQMNRVITNLIQNSIKFADPTKEQLAFTISLTHNQTDLV 
LTITDNGIGIDKKELPYLFERFYRVDKSRTPTVKGSGLGLSIVKQIIDYHQGTITVTSKKGDGTNVIITL 
PLLEDEKAAGGRGSHHHHHH 
 
 
 
 289 
Appendix 9 Sequence alignment of EF3197 and LytS.  Amino acid sequence of the 
proteins were aligned using ClustalW (Thompson et al., 2002; Larkin et al., 2007) and 
similarity between the sequences were analysed using Geneious Pro 4.6.5 (Drummond 
et al., 2009).   100% similar;  80-100% similar;  60-80% similar;  <60% 
similar.  LytS of: Bacillus cereus (BC_LytS); Bacillus anthracis (BA_LytS); Bacillus 
subtilis (BS_LytS); Staphylococcus aureus (SA_LytS).  Conserved cysteine residues in 
red box ( ); conserved group of charged amino acids in blue box ( ); conserved 
histidine, putative in autophosphorylation in yellow box ( ). 
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Appendix 10 Sequence alignment of EF1051, LisK, CsrS and ArlS.  Amino acid 
sequence of the proteins were aligned using ClustalW (Thompson et al., 2002; Larkin et 
al., 2007) and similarity between the sequences were analysed using Geneious Pro 4.6.5 
(Drummond et al., 2009).   100% similar;  80-100% similar;  60-80% similar;  
<60% similar.  EF1051 (sensor kinase of E. faecalis); LisK (LisK of Listeria 
monocytogenes); SAG_CsrS (CsrS of Streptococcus agalactiae); SP_CsrS (CsrS of 
Streptococcus pyogenes); ArlS (ArlS of Staphylococcus aureus).  Phosphorylatable 
histidine in yellow box ( ). 
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Appendix 11 Sequence alignment of EF1820 (FsrC) and AgrCs.  Amino acid 
sequence of the proteins were aligned using ClustalW (Thompson et al., 2002; Larkin et 
al., 2007) and similarity between the sequences were analysed using Geneious Pro 4.6.5 
(Drummond et al., 2009).   100% similar;  80-100% similar;  60-80% similar;  
<60% similar.  FsrC (EF1820 of E. faecalis), BCE3043 (putative AgrC of B. cereus), 
LP_LamC (LamC of L. plantarum), LM_AgrC (AgrC of L. monocytogenes), SA_AgrC 
(AgrC of S. aureus), SH_AgrC (AgrC of S. haemolyticus). 
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Appendix 12 DNA and amino acid sequences of recombinant fsrB.  The N-terminal 
MNSH (blue) and C-terminal His-tag (red). 
 
EF1821 (FsrB) 
 
ATGAATTCCCTAATCGATTGGATTCTAAAAAATATTATGGATATGGATCAGGAAGATCAATCAGGAAAAACACAATGG
ACAAAGTATTATCTAACCGTTTATTTTTCTGGCTTATTTAATCTTCTGATGATTCTGATTTTATCAGTTTTATTTGGG
ACGTTAAGCGAAACCTTTATTGTATACGTCGTACTGATTTTTTTACGGCCTGTCGCAGGTGGCTGGCATGCAAAAACT
AAATGGCTCTGTCGTCTAGAAAGCATTGTTATCTATGTCGCCATACCATTTGTATTGAAAAATTCTTCTGTGAGCTTA
CCGTTTATTTATAAAATTCTATTGATGTGCCTCTTAGTCGTATTATTTTATTGGTATGCGCCACAAGGAACAGCGATT
GAACCTGTTCAGCCATCTGATTTAAACGTGCTCAAAAAGCAAAGCCTTATAAGGGTGTGTTTACTTATTTTATGTAGT
CTGTTTGTCAAAGAAAAGATTGCTTCAGTAATACTCTACGGTCTCGTCATCCAAGGTCTGATGATACTCCCTGTAACA
AAAAATTTAATTGAAGGAAGTGTTTTTGCA 
GCTGCAGGCGGTCGTGGCAGCCACCATCACCATCACCAT 
 
 
MNSLIDWILKNIMDMDQEDQSGKTQWTKYYLTVYFSGLFNLLMILILSVLFGTLSETFIV 
YVVLIFLRPVAGGWHAKTKWLCRLESIVIYVAIPFVLKNSSVSLPFIYKILLMCLLVVLF 
YWYAPQGTAIEPVQPSDLNVLKKQSLIRVCLLILCSLFVKEKIASVILYGLVIQGLMILP 
VTKNLIEGSVFAAGGRGSHHHHHH 
 
 
